Characterisation of Escherichia coli of the bovine intestinal tract by Clark, Ewan M.
 
 
 
 
 
Characterisation of Escherichia coli of the 
bovine intestinal tract 
 
 
 
 
 
 
Ewan McIntosh Clark 
BSc (Hons) 
 
 
 
 
 
 
 
 
Submitted in fulfilment of the requirements for the degree of Doctor of 
Philosophy  
 
Faculty of Veterinary Medicine, University of Glasgow 
 
April 2009 
 
 
 
 
© Ewan Clark 2008   2 
 
ABSTRACT 
Enterohaemorrhagic E. coli (EHEC) are important gastrointestinal pathogens of humans. E. 
coli serotype O157:H7 is the EHEC most commonly associated with human illness. E. coli 
O157:H7  is  carried  asymptomatically  by  cattle  which  form  an  important  reservoir  for  the 
bacterium. E. coli O157:H7 has been found to colonise at the terminal rectum of cattle in 
preference to other sites in the bovine gastrointestinal tract. The first objective of this work 
was to characterise the roles of bacterial secreted components responsible for key functions in 
the  modulation  of  host defences  against  EHEC.  Data  presented  here  reaffirms  the  role  of 
flagellin in the elicitation of a proinflammatory response in a cultured human epithelial cell 
line; however, the response of a bovine epithelial cell line to bacterial secreted products was 
not affected by the presence or absence of flagellin. A role in the modulation of the host 
response for the StcE protease was also investigated: although its role in interaction with the 
bovine host was not established, bovine secretory antibodies to StcE were detected in rectal 
mucosal scrapings from an E. coli O157:H7-challenged calf, suggesting that StcE is expressed 
and  recognised  in  vivo.  The  second  key  objective  was  to  isolate  E.  coli  from  the  bovine 
intestinal tract in order to define the colonisation patterns of E. coli within the bovine intestinal 
tract and relate this to bacterial genotype and to provide bovine E. coli isolates to test for 
inhibitory  activity  against  E.  coli  O157:H7  which  may  yield  bacteria  with  potential  as 
probiotic agents with a view to reducing the prevalence of EHEC in cattle. Genotypic analysis 
of bovine resident E. coli confirmed that these strains carry  a variety  of virulence  factor-
encoding  genes;  however,  certain  dominant  genotypes  were  identified  and  the  genomic 
structure  of  representative  isolates  was  predicted  by  genomic  microarray.  EHEC-related 
genotypes were found to be positively associated with colonisation at the rectum, whereas 
non-EHEC genotypes were found to colonise multiple intestinal sites without showing any 
apparent  site-specificity.  The  third  and  final  objective  of  this  analysis  was  to  carry  out 
genotypic analysis of Scottish EHEC strains in order to predict whether increased incidence of 
EHEC infection in Scotland may be related to the presence of EHEC strains carrying altered 
complement of virulence factor-encoding genes. The analysis of EHEC isolated in Scotland 
revealed that these strains exhibit a genomic profile which is largely typical of EHEC isolated 
elsewhere,  although  there  were  certain  differences  in  the  carriage  of  a  certain  genomic 
elements.  The  results  presented  here  support  the  proposal  that  bacteriophages  are  the  key 
mediators of genetic variability among E. coli isolates.   3 
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PI3K  Phosphoinositide-3-kinase 
pO157  large plasmid encoded by E. coli O157:H7 
PRR  Pattern recognition receptor 
PT  Phage type 
PTS  phosphoenolpyruvate:sugar phosphotransferase system 
Rac1  Ras-related C3 botulinum toxin substrate 1 
RAJ  Recto-anal junction 
RAPD  random amplification of polymorphic DNA 
RDNC  reacted but did not conform to any reference pattern 
REML  Restricted maximum likelihood 
RFLP  Restriction fragment length polymorphism 
RNA  ribonucleic acid 
rpm  revolutions per minute 
rRNA   ribosomal RNA 
RsaI  Restriction endonuclease I encoded by Rhodopseudomonas 
sphaeroides 
rStcE  Recombinant StcE 
RT  Rectal tropic 
RT-PCR  Reverse transcriptase PCR 
RTX  Repeats in toxin 
SAC  Scottish Agricultural College 
SDS-PAGE  Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEM  Standard error of mean 
SERL  Scottish E. coli Reference Laboratory 
SF/nSF  Sorbitol-fermenting/non-sorbitol-fermenting 
sfa (D/E)  S-fimbrial antigen genes D/E 
sfp  Sorbitol-fermenting O157 P-fimbriae 
SMAC (CT-SMAC)  Sorbitol MacConkey medium (cefixime/tellurite-SMAC) 
SN  Supernatant 
SSC  Saline sodium citrate 
SSH  Suppression subtractive hybridisation 
StcE  Secreted protease of C1-inhibitor of EHEC 
STEC  Shiga-like toxin-producing E. coli 
Stx  Shiga-like toxin 
T3SS  Type III secretion system 
TAK-1  TGF-activated kinase-1 
Taq polymerase  DNA polymerase from Thermus aquaticus 
TaqI  Restriction endonuclease I encoded by Thermus aquaticus 
TBS (TBS-T)  Tris-buffered saline (TBS plus Tween 20) 
TBX  Tyryptone/bile salts/X-glucuronide medium 
TccP  Tir-cytoskeleton coupling protein 
TEMED  N,N,N’,N’-tetramethylethyldiamine 
Tir  Translocated intimin receptor 
TIRAP  TIR domain-containing adaptor protein 
TLR  Toll-like receptor 
TNFα  Tumour necrosis factor-α   16 
TOLLIP  Toll-interacting protein 
TR  Terminal rectum 
TRAF-6  TNF receptor associated factor-6 
TRIF  TIR-domain-containing adapter-inducing interferon-β 
TSPE4.C2  Anonymous DNA fragment from subtractive library cleaved 
with the Tsp509I restriction endonuclease 
Tsp509I  Restriction endonuclease 509I encoded by Thermus sp. 
TTP  thrombotic thrombocytopaenic purpura 
UPEC  uropathogenic E. coli 
UV  Ultra violet 
V  Volts 
v/v  volume per volume 
VLA  Veterinary Laboratories Agency 
VTEC  vero-cytotoxigenic E. coli 
w/v  weight per volume 
wrbA  tryptophan (W) repressor-binding protein 
WSU  Washington State University 
X (10X, 5X, 2X et cetera)  Multiplication of concentrated solution (e.g. a 10X solution is 
diluted 1:9 to form a 1X working concentration) 
∆(delta)  Before a gene name to denote that gene is deleted (e.g. ∆stx) 
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Chapter 1: General Introduction   18 
1.1  Escherichia coli 
 
E. coli is a Gram-negative, facultative anaerobic bacterium of the genus Escherichia, type 
genus of the family Enterobacteriaceae within the class of Gamma Proteobacteria (Scheutz 
and  Strockbine,  2001).  E.  coli  and  related  organisms,  including  species  of  the  genera 
Salmonella, Shigella, Yersinia, Citrobacter and Klebsiella spp. are able to cause an extensive 
range of diseases in humans and animals; however, E. coli form part of the gastrointestinal 
microflora  of  many  animals  where  they  normally  exist  without  causing  disease.  The  host 
gastrointestinal microflora is an important part of the healthy gut and so can be described as a 
component of host innate defences. E. coli provide vitamin K2, which is required for post-
translational modification of proteins involved in blood coagulation and bone metabolism and 
have been recognised as a protective agent against infection by pathogenic bacteria (Dam, 
1935;Bentley and Meganathan, 1983;Price, 1988;Mann, 1999;Hudault et al., 2001). However, 
members of the normal gut microbiota, including E. coli, may act as opportunistic pathogens, 
especially  in  the  immunocompromised  host.  Different  strains  of  E.  coli  present  different 
complements of molecules, termed virulence factors, which may determine the pathogenic 
functions of the bacterium, including the host molecules to which it may adhere and the host 
molecules which the bacterium may affect using toxins and enzymes. As different hosts and 
different tissues present an altered complement of molecules accessible to bacterial virulence 
factors, pathogenic E. coli often exhibit host and tissue specificity, in that a bacterium may 
exhibit differing levels of colonisation and pathogenicity in different hosts and at different 
locations  within  the  host.  Differential  behaviour  in  different  hosts  is  an  important 
characteristic of enterohaemorrhagic E. coli (EHEC) which is the organism that is the focus of 
this  research.  EHEC  serotype  O157:H7  is  the  most  common  EHEC  serotype  worldwide 
(Gyles, 2007) and has been found to be carried in the ruminant gastrointestinal tract (GIT) 
without  overt  signs  of  clinical  disease  (Borczyk  et  al.,  1987)  but  infection  of  humans, 
particularly colonisation of the human ileum (Phillips et al., 2000), may lead to severe disease 
(Karmali et al., 1983b), as discussed further in Section 1.3.1.   19 
1.2  Molecular classification of E. coli 
 
1.2.1  Phenotypic Classification of E. coli 
 
Initial classification of bacteria has traditionally relied upon the biochemical activities of the 
organism. Screening for the presence of a particular bacterium is regularly performed using 
selective media, often indicator media. Such methods rely on specific fermentative growth 
characteristics  and  resistance  to  antimicrobial  compounds.  Further  profiling  of  bacterial 
metabolism can be used to predict bacterial species or subspecies. E. coli can be identified on 
the basis that it produces acidic metabolites and gas on fermentation of D-glucose and that it 
can utilise acetate but not citrate, malonate or potassium cyanide as a sole carbon sources. The 
majority of E. coli strains produce lysine decarboxylase and indole but do not produce acetyl-
methy  carbinol  (Voges  Proskauer  negative).  E.  coli  strains  generally  ferment  lactose,  D-
mannitol,  melibiose,  mucate  and  D-sorbitol  but  not  D-adonitol,  D-arabitol  or  cellobiose 
(Scheutz and Strockbine, 2001). These biochemical properties have been exploited for the 
development of kits which may be used to predict bacterial species, such as the analytical 
profile index (API, Biomerieux) and the Biolog system (Biolog Inc.). Similarly to other Gram-
negative bacteria, E. coli exhibit decreased sensitivity to hydrophobic antibiotics compared 
with  Gram-positive  organisms.  This  is  due  to  the  decreased  permeability  of  the  double 
membrane and the presence of multidrug efflux pumps (Nikaido, 1996).  
 
E. coli O157:H7 can be distinguished from the majority of E. coli subtypes as it is generally 
non-sorbitol-fermenting  (nSF)  and  is  glucuronidase  negative  (gluc-)  (March  and  Ratnam, 
1986;Krishnan et al., 1987;Ratnam et al., 1988). Tryptone-bile salts-X-glucuronide (TBX) and 
4-methylumbelliferyl-D-glucuronide  (MUG)  agar  culture  media  have  been  used  to 
discriminate  E.  coli  O157:H7  from  other  E.  coli  on  the  basis  of  glucuronidase  activity 
(Thompson  et  al.,  1990).  Sorbitol  MacConkey  (SMAC)  agar  may  be  used  to  distinguish 
sorbitol-fermenting bacterial colonies from non sorbitol-fermenting colonies. On this growth 
medium sorbitol-fermenting colonies are stained pink, due to the effects of acids, such as 
lactate, produced on fermentation of sorbitol on phenol red: a pH indicator included in the 
medium (Rappaport and Henig, 1952). Non-sorbitol-fermenting colonies (such as the majority 
of E. coli O157:H7 strains) remain brown. SMAC contains inhibitory compounds such as bile   20 
salts, which inhibits most Gram-positive organisms. The selective power of this medium for E. 
coli O157:H7 is enhanced by the addition of antimicrobial chemicals cefixime and potassium 
tellurite (CT-SMAC) which inhibit the majority  of organisms other than E. coli O157:H7 
(Chapman et al., 1991;Zadik et al., 1993). Hence, CT-SMAC has been widely adopted for the 
detection of E. coli O157:H7 in food and environmental samples (de Boer and Heuvelink, 
2000). However, not all EHEC strains are non-sorbitol fermenting or glucuronidase negative. 
The presence of gluc-/nSF/CT-resistant organisms in a patient or biological sample does not 
confirm that the organisms recovered are disease-causing EHEC. Nevertheless, the prevalence 
of gluc-/nSF/CT-resistant E. coli O157:H7 strains in human infection means that such media 
remain useful for the prediction of the presence of the most common EHEC subtype in a given 
biological sample.  
 
Differential immune recognition of bacterial subtypes has been exploited to identify serotypes 
of bacteria within the species. For E. coli, a serotyping scheme has been established, based on 
the  serologically  distinct  types  of  O,  H  and  K  antigens  presented  by  the  bacterium 
(Kauffmann, 1947). One hundred and eighty six types of somatic antigen, or O-antigen, have 
been described to date (Guo et al., 2008). O-antigen types are defined by the composition of 
the sugar residues in the repeating unit of outer membrane lipopolysaccharide (Reeves et al., 
1996). The genes underlying O-antigen biosynthesis have been identified as the rfb/gnd locus 
and polymorphisms in this region have been exploited for the development of DNA-based 
methods of O-antigen determination (Wang and Reeves, 1998;Coimbra et al., 2000). Acidic 
capsular polysaccharide forms the K-antigen, of which there are 80 types currently described 
(Whitfield and Roberts, 1999). 
 
Variation  in  the  immune  recognition  of  flagellar  (H)  antigen  is  based  on  changes  in  the 
primary  sequence  of  flagellin  (Kuwajima,  1988).  Flagellin  is  the  protein  which  forms  the 
repeating  unit  which  is  polymerised  to  form  the  major  subunit  of  the  bacterial  flagellar 
filament (Kuwajima et al., 1986;Iino et al., 1988;Fields et al., 1997) as described in more 
detail in Section 1.4.4. Fifty-six H-types have been described to date, although two have been 
removed  (H13  and  H22)  as  the  isolates  exhibiting  these  serotypes  were  reclassified  as 
Citrobacter  freundii  and  H50  has  been  withdrawn  as  it  is  identical  to  H10  (Scheutz  and 
Strockbine, 2001). 
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As  certain  serotypes  are  commonly  associated  with  particular  pathotypes,  serotyping  has 
provided  advances  in  the  diagnosis,  epidemiological  analysis,  detection  and  control  of 
bacterial disease. For example: the O157 antigen has provided a target for the isolation and 
detection of E. coli O157 using immunomagnetic separation and latex agglutination assays 
(Wright et al., 1994). Both the O157 LPS and H7 flagellin antigen have been evaluated as a 
target for vaccine development (Ahmed et al., 2006;McNeilly et al., 2008). These strategies 
are valid for the targeting of E. coli O157:H7; however, many serotypes of E. coli have now 
been  described  as  EHECs  and  targeting  this  serotype  alone  leaves  many  EHEC  subtypes 
unaccounted for. In total, 404 different (non-O157) O:H serotypes have been implicated in 
cases of EHEC infection (a complete list of those identified as of 05/08/2008 is available at: 
http://www.microbionet.com.au/frames/feature/vtec/brief02.html).  A  great  many  E.  coli 
isolates, including EHEC, are untypeable by serological methods, including those which do 
not possess one or more of the antigen types. The O-antigen may be lost under laboratory 
culture  conditions,  such  as  in  the  case  of  E.  coli  K12  where  a  mutation  in  the  rhamnose 
transferase gene of this bacterium prevents it from producing the O-polysaccharide (Liu and 
Reeves, 1994). Furthermore, serotyping is an expensive process to implement and is only 
performed in a few reference laboratories.   
 
The electrophoretic mobilities of bacterial metabolic enzymes have been used to develop a 
bacterial  typing  scheme  termed  multi-locus  enzyme  electrophoresis  (MLEE),  whereby 
bacterial proteins are separated by gel electrophoresis and enzyme activity is detected using 
indicator  compounds  (Selander  et  al.,  1986).  This  technique  has  been  used  to  infer 
phylogenetic  relationships  among  E.  coli  and  has  allowed  the  designation  of  several 
phylogenetic groups within the species (Whittam et al., 1983;Herzer et al., 1990). 
 
Patterns of susceptibility to particular bacteriophages have been exploited to discriminate E. 
coli O157:H7 subtypes (Ahmed et al., 1987;Khakhria et al., 1990). Phage-typing has been 
widely adopted for epidemiological analysis of E. coli O157:H7 (Milford et al., 1990;Izumiya 
et al., 1998;Lynn et al., 2005). Analysis of phage types of E. coli in the British Isles has 
revealed that by 1997 a recently emerging phage type (PT21/28) had replaced a phage type 
(PT2) prevalent in the late 1980s and that PT21/28 and PT2 were more frequently associated 
with HUS than other phage types (Milford et al., 1990;Lynn et al., 2005). This analysis also 
revealed that phage types differ in their geographical distribution, with phage type 21/28 being   22 
particularly prevalent in Scotland (Lynn et al., 2005). The prevalence of PT21/28 in human 
infection in Scotland is reflected by the prevalence of strains exhibiting this phage type among 
colonised cattle in Scotland (Halliday et al., 2006). 
 
Phenotypic  typing  schemes  are  a  useful  tool  in  the  identification  and  discrimination  of 
bacterial  subtypes  and  generally  correlate  well  with  underlying  genotypic  characteristics, 
exemplified by the correlation between multi-locus enzyme electrophoresis and phylogenetic 
group as determined by rRNA-typing (Whittam et al., 1983;Herzer et al., 1990). However, 
such techniques give only a general indication of the underlying genetic nature of a bacterial 
type. One consequence of widespread horizontal gene transfer among bacteria is that bacteria 
that  share  a  phenotypic  characteristic,  such  as  serotype,  may  exhibit  extensive  genomic 
variation. One example was this is illustrated in a study by Wu et al. (2008) in which E. coli 
isolates of serotype O157 were found to exhibit extensive genomic variation from the majority 
of E. coli O157:H7 isolates. Hence, determination of serotype does not directly predict the 
genotype of E. coli strains. 
 
The resolution of phenotypic typing schemes may be improved by the adoption of proteomic 
techniques (reviewed in Han and Lee, 2006). Molecular identification of proteins using mass 
spectrometry is a key technology in this area. MALDI-TOF has recently been applied for the 
rapid molecular typing of whole bacterial cells and may aid swift identification of bacterial 
isolates and discrimination between bacterial subtypes (Holland et al., 1996;Krishnamurthy 
and Ross, 1996;Fenselau and Demirev, 2001;Mellmann et al., 2008). 
 
1.2.2  Genotypic classification of E. coli 
 
Recent  advances  in  genomic  analysis  have  allowed  DNA-based  typing  procedures  to  be 
developed for the classification of bacterial isolates. The polymerase chain reaction (PCR) and 
sequencing  technology  has  allowed  simplification  of  the  genotyping  process  over  existing 
phenotypic methods. Bacterial taxonomy has been standardised by the use of 16S ribosomal 
RNA-encoding  gene sequences,  allowing species and subspecies  groupings to be assigned 
(reviewed in Staley, 2006). A protocol for multi-locus sequence typing (MLST) which groups 
organisms according to nucleotide polymorphisms in selected genes, has been developed for   23 
E.  coli,  based  on  the  sequence  types  of  7  housekeeping  genes  (Wirth  et  al.,  2006).  The 
resolution of the standard MLST method is comparable to that of MLEE (Section 1.2.1).  
 
PCR may also be used to screen the genomes of E. coli isolates for genes including those 
encoding virulence factors. This process aids the prediction of pathotype (Section 1.3). PCR 
has  also  been  utilised  for  random  amplification-based  procedures  such  as  “random 
amplification of polymorphic DNA” (RAPD) whereby arbitrary oligonucleotides are utilised 
to generate an amplification profile for each strain analysed, allowing comparison of related 
bacteria  (Welsh  and  McClelland,  1990).  Random  amplification  using  octamer 
oligunucleotides was utilised to identify two lineages of E. coli O157:H7, one of which is 
more prevalent in human infection and the other more prevalent in bovine colonisation (Kim 
et  al.,  1999).  Subsequently,  genomic  markers  for  these  lineages  were  determined  by 
comparative  genomic  hybridisation  (CGH)  using  microarray  (Zhang  et  al.,  2007).  The 
sensitivity of PCR means that it may be performed on extracts from biological samples to 
detect and identify organisms present without prior culture. Upgrades to PCR, such as the 
development of real-time PCR, allow the quantification of certain sequences in a biological 
sample. 
 
Restriction endonucleases, which cleave DNA at specific sequences, are useful tools in the 
molecular  profiling  and  identification  of  different  genotypes.  Sequence  polymorphisms  at 
restriction sites are detected by restriction fragment length polymorphism (RFLP). This may 
be coupled with PCR, to allow typing of individual genes or genomic regions (PCR-RFLP) or 
performed on a  genomic scale using pulsed-field gel electrophoresis (PFGE). RFLP-based 
methods have been developed for the typing of numerous virulence factors and to predict both 
O and H serotypes (Fields et al., 1997;Coimbra et al., 2000). PFGE has been widely adopted 
for the epidemiological tracking of E. coli O157:H7 subtypes (Gerner-Smidt et al., 2006). 
 
As many of the high resolution genotyping techniques are complex, difficult to interpret or 
expensive, there is often scope for simplification. This requires understanding of the basis of a 
polymorphism observed for the more complex techniques. For example, sequencing of 16S 
rRNA loci may be simplified using PCR-RFLP (ribotyping) (Desjardins et al., 1995). E. coli 
phylogenetic groupings established by MLEE, MLST and ribosomal RNA sequencing may be 
predicted rapidly and reproducibly using a simple triplex PCR (Clermont et al., 2000).   24 
 
Similarly to phenotypic classification schemes, genotyping technologies give an indirect view 
of the genome of an organism, as they rely on variation within a small subset of genomic loci. 
To  obtain  a  global  view  of  bacterial  genomes,  whole  genome  microarray  allows  the 
comparison  of  an  isolated  strain’s  genome  against  that  of  one  or  more  strains  for  which 
genome sequence has been resolved. This technique can be highly descriptive and gives a 
direct reflection of the genes encoded by the organism; however, it can only identify diversity 
by presence or absence of sequences printed onto the array chip and can not be easily used to 
identify acquisitions of sequences that have not yet been described. Whole genome sequencing 
is the highest resolution and most descriptive bacterial genotyping scheme available currently. 
The  cost  of  this  technology  has  decreased  recently  and  the  speed,  detail  and  accuracy  of 
computerised analysis have improved, making this technique more accessible. Nevertheless, 
higher-throughput  low-cost  techniques,  such  as  PCR-based  methodology,  are  still  heavily 
relied upon for preliminary characterisation of isolated bacteria, in that many isolates may be 
characterised  simultaneously.  A  limitation  of  genomic  and  genotypic  analysis  is  that  the 
expression, biological function and interaction of gene products with other molecules (the 
defining features of bacterial phenotype) are not yet simple to predict from the data generated. 
It is envisaged that improved bioinformatic analysis coupled with the accessibility of genome 
sequencing technology may yield improved predictions which may be testing by analysis of 
gene  expression  and  biological  function  of  the  organism  in  vitro  and  in  vivo.    To  date 
(01/08/2008) nineteen E. coli genome sequences are currently available, including 2 isolates of 
E.  coli  O157:H7  (Perna  et  al.,  2001;Hayashi  et  al.,  2001b).  Many  more  are  currently  in 
preparation and the results of a large scale sequencing project of E. coli O157:H7 genomes at 
the J. Craig Venter Institute (http://msc.jcvi.org/o157h7/index.shtml) are expected. These data, 
coupled  with  sequences  of  single  genes  submitted  to  the  NCBI  provide  an  extensive  and 
constantly improving reference database for comparative genomic analysis of E. coli isolates.   25 
1.3  Pathogenic E. coli of animals and man 
 
Pathogenic  E.  coli  include  certain  types  which  may  establish  enteric  infections  and  those 
which  may  establish  extraintestinal  infections.  E.  coli  may  be  grouped  according  to  their 
pathotype  referring  to  the  organism’s  virulence  mechanisms,  its  host  specificity  and  the 
resultant disease symptoms. Currently described pathotypes of E. coli known to affect humans 
are summarised in Table 1.1. 
 
The virulence mechanisms of each E. coli pathotype are determined by the carriage of key 
virulence  factors.  These  include  factors  promoting  colonisation  of  the  host,  cellular 
adherence/invasion, evasion of host defences and disruption of host cell signalling pathways. 
These include surface receptors, secreted enzymes and toxins. Several pathotypes of E. coli 
which  cause  enteric  disease  in  humans  have  been  described.  The  first  recognised  were 
enteropathogenic E. coli (EPEC) and enterotoxigenic E. coli (ETEC)  (Bray, 1945). ETEC 
encodes one or more enterotoxins which may include heat labile (LT) or heat stable (ST) 
which act to activate adenylate and guanylate cyclases respectively, triggering events which 
lead to fluid accumulation in the gut lumen (Gill and Richardson, 1980). Enteroinvasive E. 
coli (EIEC) shares virulence mechanisms with Shigella spp. in that it is able to invade and 
multiply within intestinal epithelial cells of the large intestine (Lan and Reeves, 2002). Other 
diarrhoeagenic E. coli pathotypes include enteroaggregative E. coli (EAggEC) and diffusely 
adherent E. coli (DAEC). These two pathotypes may be distinguished by their patterns of 
adherence  to  cultured  epithelial  cells  of  the  HEp-2  line  (Nataro  and  Kaper,  1998).  Their 
pathogenic mechanisms are poorly understood, although putative virulence factors have been 
related to these pathotypes (Table 1.1). 
 
EPEC and Enterohaemorrhagic E. coli (EHEC) belong to a related group of organisms which 
adhere to and efface the membrane of enterocytes. This activity depends upon the functions of 
a type III secretion system (T3SS) and an outer membrane protein termed intimin (discussed 
in detail in Sections 1.3.1 and 1.4.1). Attaching and effacing (A/E) bacteria include pathogens 
of many different host species, including Citrobacter rodentium, which has been employed as 
a mouse model for prediction of the mechanisms of A/E bacterium-host interactions (reviewed 
in Mundy, 2005). 
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Extraintestinal pathogenic E. coli (ExPEC) establish infections at a variety of locations. Most 
common among ExPEC infections are those affecting the urinary tract, although E. coli have 
been noted to cause neonatal meningitis and pneumonia (reviewed in Russo and Johnson, 
2000). Human ExPEC are phylogenetically distinct from non-pathogenic (“true commensal”) 
strains and those which cause enteric infections and are frequently found among the normal 
faecal  and  environmental  bacterial  flora.  ExPEC  often  express  adhesins  such  as  P  and  S 
fimbriae, iron acquisition systems (e.g. presentation of the aerobactin receptor) and toxins 
including cytolethal distending toxin (CDT), cell necrotising factor (CNF) and α-haemolysin 
(Johnson et al., 2002;Usein et al., 2003). 
 
E. coli infections in animals reflect the diversity of the human E. coli pathotypes. E. coli has 
been observed to have an aetiological role in various diarrhoeal and extraintestinal diseases of 
livestock. ETEC infections are particularly prevalent in neonatal calves, lambs and piglets 
(Wray et al., 1993). ExPEC is an important agent of mastitis in cows (reviewed in Hogan and 
Smith, 2003). ExPEC-like organisms (termed avian pathogenic E. coli; APEC) are commonly 
associated with avian colibacilliosis (Johnson et al., 2007). Host and tissue specificity may be 
related to the presentation of different fimbriae by the bacterium and differential presentation 
of molecules with affinity for those fimbriae by host cells. For example, E. coli isolated from 
diarrhoeic  calves  have  been  observed  to  express  K99  (F5)  and  F41  fimbriae  (ETEC-like 
strains)  or  F17  fimbriae  (ExPEC-like  strains)  (Discussed  further  in  Section  1.5.2)  (Acres, 
1985;Bertin et al., 1996a;Bertin et al., 1996b;Contrepois et al., 1998;Güler et al., 2008).   27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.1: Common pathotypes of disease-causing E. coli of humans: Compiled from Nataro & Kaper (1998) and Scheutz & Strockbine (2001). UPEC: uropathogenic E. 
coli. NMEC: neonatal meningitis E. coli. * The most common O-serotypes of EHEC associated with human disease are listed here although many more have been described as 
EHEC (Section 1.2.1). 
Pathotype  Common O-serotypes  Disease characteristics  Virulence factors and mechanisms 
Enteropathogenic  
E. coli (EPEC) 
O26, O55, O86, O88, O103, O111, O119, O125ac, O126, 
O127, O128ab, O142, O145, O157, O158. 
Watery diarrhoea  Initial localised adherence via bundle-forming pili (BFP) 
followed by intimate adherence  
Enterotoxigenic  
E. coli (ETEC) 
O6, O7, O8, O9, O11, O15, O17, O20, O21, O25, O27, O29, 
O48, O55, O56, O63, O64, O65, O71, O73, O77, O78, O85, 
O86, O88, O105, O114, O115, O119, O126, O128ac, O133, 
O138, O139, O141, O147, O148, O149, O153, O159, O166, 
O167. 
Watery diarrhoea.  Heat labile/Heat stable enterotoxin 
Enterohaemorrhagic E. 
coli (EHEC) 
O26, O103, O111, O121, O145, O157. * 
 
Watery or bloody diarrhoea, haemorrhagic 
colitis progression to systemic diseases. 
T3SS, Shiga-like toxins, enterohaemolysin, plasmid 
encoded protease (EspP) (See section 1.3) 
Enteroaggregative E. coli 
(EAggEC) 
O3, O15, O44, O86, O111, O125.  Persistent mucoid diarrhoea.  Aggregative adherence, dependent on plasmid-encoded 
genes such as AAF-fimbriae. Also heat stable enterotoxin 
(EASTI) and plasmid-encoded enterotoxin (PET) 
Enteroinvasive  
E. coli (EIEC) 
O28ac, O29, O112ac, O115, O121, O124, O135, O136, 
O143, O144, O152, O159, O164, O167, O173. 
Watery or bloody diarrhoea.  Cellular invasion similar to Shigella spp. dependent on 
proteins encoded on pInv plasmid, including a T3SS. 
Diffusely adherent E. coli 
(DAEC) 
O126:H27  Watery diarrhoea  Diffuse adherence F1845 fimbriae, AIDA-I adhesin 
Extraintestinal pathogenic 
E. coli (ExPEC) 
UPEC: O1, O2, O4, O6, O7, O18ac, O75, O16, O15 
NMEC: O7, O18ac, O1, O6, O83 
UTIs, pneumonia, wound infections, intra-
abdominal infections, osteomyelitis, 
meningitis. 
P-fimbriae, S-fimbriae, K1 capsule, α-haemolysin, CDT, 
CNF.   28 
1.3.1  Enterohaemorrhagic E. coli 
 
As mentioned in Section 1.3, EHEC is the pathotype which is central to this research. 
EHEC  shares  evolutionary  origins  with  EPEC  and  both  share  common  adherence 
mechanisms, which depend on the locus of enterocyte effacement (LEE; Section 1.4.1). 
Possibly the most important difference between EHEC and EPEC is the acquisition of 
genes encoding verotoxin (also referred to as verocytotoxin and shiga-like toxin; Stx) by 
EHEC  through  the  action  of  integrative  bacteriophages  which  aid  the  spread  of  these 
virulence  factor-encoding  genes  (Konowalchuk  et  al.,  1977;Scotland  et  al.,  1983). 
Symptoms of EHEC infection include abdominal pain accompanied by watery diarrhoea 
and  can  progress  to  haemorrhagic  colitis  (HC)  which  is  manifested  as  grossly  bloody 
diarrhoea  (BD)  (Riley  et  al.,  1983).  HC  sufferers  may  develop  more  severe  sequelae, 
including haemolytic uraemic syndrome (HUS) which is particularly prevalent in younger 
children (Griffin and Tauxe, 1991). HUS symptoms include microangiopathic haemolytic 
anaemia, thrombocytopaenia and acute renal dysfunction (often renal failure). Stx induces 
these symptoms which are the result of the action of the toxin on the endothelial cells of 
blood  vessels  especially  in  the  kidney  (Karmali  et  al.,  1983a).  Thrombotic 
thrombocytopaenic purpura (TTP) is another consequence of EHEC infection, generally 
occurring in adults. It can occur without an initial diarrhoeic phase of infection and can 
result in neurological disorders (Pickering et al., 1994). 
 
There is currently no effective targeted treatment in instances of human EHEC infection. 
Treatment is largely supportive including fluid management and dialysis when required. 
There have been reports of the efficacy of antibiotics in the prevention of EHEC disease 
progression  when  administered  early.  This  remains  controversial  since  adequate  case-
control  studies  have  not  been  carried  out  and  it  has  been  suggested  that  the  use  of 
antibiotics could exacerbate EHEC-induced disease (reviewed in Nataro & Kaper 1998). 
The  potential  severity  of  human  EHEC  infection  coupled  with  the  lack  of  adequate 
treatment  methods  means  that  effective  control  and  prevention  strategies  would  be  of 
significant benefit to human health.   29 
1.3.2  Epidemiology of EHEC infection 
 
Although O157:H7 remains the most commonly detected serotype among cases of human 
EHEC infection other EHEC serotypes are prevalent in certain geographical areas. E. coli 
O157:H- (sorbitol-fermenting) isolates were recently identified as a threat to human health 
(Karch et al., 1990). Outbreaks related to sorbitol-fermenting E. coli O157:H- strains were 
confined to continental Europe until outbreaks occurred recently in Scotland (Karch and 
Bielaszewska, 2001;Taylor et al., 2003). Non-O157 EHEC, particularly O26, O103, O111, 
O121, O145 and ONT (O-untypeable) are significant in human infection and are prevalent 
in  southern  Europe,  South  America  and  Australasia  (Lopez  et  al.,  1989;Ojeda  et  al., 
1995;Goldwater and Bettelheim, 2002;Tozzi et al., 2003;Gyles, 2007). 
 
The range of outcomes of human EHEC infection suggests that there is a significant host-
factor in the progression of EHEC-induced disease. The young and elderly are at particular 
risk  for  the  progression  of  the  disease  to  more  severe  sequelae  yet  in  healthy  adults 
infection may be restricted to watery diarrhoea or may even be sub-clinical (Wilson et al., 
1996;Wilson et al., 1998;Rios et al., 1999;Silvestro et al., 2004). Asymptomatic carriage 
of E. coli O157:H7 and other VTEC has been detected in numerous domestic animal hosts, 
most frequently in ruminants but also in pigs, cats, dogs and chickens (Doyle and Schoeni, 
1987;Griffin and Tauxe, 1991;Beutin et al., 1993;Nakazawa and Akiba, 1999). Since cattle 
are the principal hosts of E. coli O157:H7 many outbreaks and sporadic cases of EHEC 
infection  have  been  linked  with  bovine  faecal  contamination  of  items  consumed  by 
humans,  including  undercooked  beef,  unpasteurised  milk,  vegetables,  fruit  juices  or 
drinking water (Riley et al., 1983;Borczyk et al., 1987;Morgan et al., 1988;Besser et al., 
1993;Swinbanks, 1996;Yarze and Chase, 2000;Licence et al., 2001). Outbreaks have also 
been traced to caprine and ovine hosts (Bielaszewska et al., 1997;Ogden et al., 2002). 
Direct contact with cattle and the farming environment is a risk factor for EHEC infection, 
surpassing foodborne incidences of illness in the UK (Locking et al., 2001;O'Brien et al., 
2001). E. coli O157:H7 has been isolated from wild animals, including deer and rabbits, 
suggesting that interaction between farm animals and wild animals could be important in 
the spread of EHEC between farms (Renter et al., 2001;Pritchard et al., 2001). Despite the 
variety of hosts of E. coli O157:H7, the bovine host remains the most significant in terms 
of the threat to human health (Locking et al., 2001;O'Brien et al., 2001;Kassenborg et al.,   30 
2004). Epidemiological studies have estimated that prevalence of E. coli O157:H7 in cattle 
is  just  under  2%  in  Japan,  Australia  and  the  USA  (Faith  et  al.,  1996;Miyao  et  al., 
1998;Cobbold and Desmarchelier, 2000). Estimates of 4.7% in England and Wales and 
8.6% in Scotland have  been reported (Synge and Paiba, 2000;Paiba et al., 2002). The 
frequency of human E. coli O157:H7 infection reflects these data as incidence of disease in 
Scotland has been consistently above the UK average, as shown in Figure 1.1. 
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Figure 1.1: Prevalence of E. coli O157 in Scotland compared to the rest of the UK: Cases of EHEC 
infection in Scotland have been consistently higher than the UK average (redrawn from Lynn et al., 2005).   32 
1.3.3  Enterohaemorrhagic E. coli in cattle 
 
As highlighted in Section 1.3.2, cattle provide a reservoir for E. coli O157:H7, which is 
important  for  its  transmission  to  humans  (reviewed  in  Caprioli  et  al.,  2005).  E.  coli 
O157:H7  is  essentially  non-pathogenic  in  cattle  although  it  has  been  associated  with 
diarrhoea in very young calves (Kang et al., 2004). Non-O157 serotypes also identified as 
human  EHEC,  including  O5,  O26  and  O118,  have  been  noted  to  induce  diarrhoea  in 
weaned  cattle  exhibiting  extensive  A/E  lesion  formation  in  the  bovine  large  intestine 
although  progression  towards  haemorrhagic  symptoms,  as  observed  in  human  EHEC 
infection, has only been noted in very young calves (Wieler et al., 1996;Pearson et al., 
1999;Stevens  et  al.,  2002;Sandhu  and  Gyles,  2002).  The  lack  of  clinical  signs  and 
asymptomatic tolerance of E. coli O157:H7 in ruminants is likely to be an important factor 
in the prevalence of this serotype in human disease. Unlike the strains associated with 
diarrhoea in cattle (mentioned above) E. coli O157:H7 does not persist throughout the 
large intestine in weaned cattle and has been found to colonise in the largest numbers at the 
recto-anal junction (RAJ) (Naylor et al., 2003;Low et al., 2005;Lim et al., 2007). Several 
efforts have been made to define the gastrointestinal localisation of EHEC in the ruminant 
host. Early studies concluded that E. coli O157:H7 is able to colonise the bovine GIT at 
multiple sites with a general predominance at large intestinal sites (Cray, Jr. and Moon, 
1995;Brown  et  al.,  1997;Dean-Nystrom  et  al.,  1998a;Laven  et  al.,  2003).  However, 
Grauke et al. (2002) noted that colonisation of these intestinal sites was only observed up 
to 16 days post infection, although faecal shedding was observed up to 34 days later. 
Naylor  et  al.  (2003)  hypothesised  that  lengthened  shedding  may  be  due  to  rectal 
colonisation  and  were  able  to  show  that  E.  coli  O157:H7  shows  a  preference  for  the 
terminal 5cm of the rectum, proximal to the recto-anal junction (RAJ). Preference for this 
site has since been reported in naturally colonised cattle, confirming that this is not merely 
a feature of experimental challenge (Low et al., 2005;Lim et al., 2007). 
 
It  has  been  proposed  that  persistent  rectal  colonisation  is  the  major  feature  of  “super-
shedders” (Cobbold et al., 2007). These comprise a small proportion of cattle which are 
responsible for a large proportion of the transmission of E. coli O157:H7 among herds 
(Matthews et al., 2006a;Matthews et al., 2006b;Chase-Topping et al., 2007). Rectal E. coli 
O157:H7 is proposed to coat the faeces on egestion, allowing shedding and transmission of   33 
the organism to be maintained. The site of colonisation at the terminal rectum is an area 
densely  populated  by  lymphoid  follicles  (LFs).  Bacterial  interaction  with  LF-dense 
mucosal tissue is discussed in detail in Section 1.5.2. 
 
Due to the preference shown for the bovine terminal rectum by E. coli O157:H7 this region 
could represent a target for the development strategies for the control of EHEC in cattle. 
As the area is fairly accessible, topical applications of antimicrobial agents to the rectum 
have  been  investigated  as  a  method  of  control  (Naylor  et  al.,  2007)  although  the 
impracticality of such a strategy is likely to prohibit widespread adoption of such methods.  
 
As the bovine gastrointestinal tract provides a refuge for the propagation of EHEC, this 
poses a significant risk to human health due to the potential for human contact either via 
food  or  via  contact  with  cattle  or  environments  contaminated  with  cattle  faeces. 
Intervention at this point of contact would theoretically reduce the incidence of human 
EHEC infection. 
 
1.3.4  Options for control of EHEC infection 
 
As mentioned previously, there is no effective treatment for EHEC in humans once it has 
established infection. Therefore, prevention of infection by targeting environmental and 
animal sources of the organism is likely to have positive benefits in terms of reduction of 
the transmission of EHEC to humans. As the bovine host represents an important vector 
for  EHEC,  the  reduction  of  EHEC  prevalence  in  cattle  may  in  turn  help  to  reduce 
incidence of human infection. Simplistic interventions include improvements in drinking 
water,  feed  and  pen  hygiene  (Garber  et  al.,  1999;Lejeune  et  al.,  2001;Smith  et  al., 
2001;Dodd  et  al.,  2003).  Prevention  of  contact  between  wildlife  and  cattle  is  another 
possible  control  point,  as  many  animals  may  carry  EHEC,  facilitating  its  transmission 
(Daniels et al., 2003). Modulation of gastrointestinal acidity by switching feed from grain 
to hay prior to slaughter has been suggested as a means of reduction of the carriage of E. 
coli O157:H7 but this is a subject of contention and has not been reproduced on a larger 
scale (Diez-Gonzalez et al., 1998;Hovde et al., 1999). 
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Control methods employing antimicrobial substances has also been proposed (Elder et al., 
2008) although the use of antibiotics poses problems such as disruption of the normal 
gastrointestinal microbiota of the animal and promoting the proliferation of pathogenic 
antibiotic-resistant bacteria. Numerous vaccination strategies have been devised, although 
none  have  yet  led  to  an  effective  product  (Konadu  et  al.,  1999;Dean-Nystrom  et  al., 
2002;Potter et al., 2004;Ahmed et al., 2006;McNeilly et al., 2008). 
 
Biological control is another option for targeted control of EHEC in cattle. Exclusion of E. 
coli  O157:H7  using  bacteriophages  has  been  validated  in  murine  models  but  not  yet 
implemented in ruminants (Sheng et al., 2006a). Probiotic bacteria have been tested for 
this purpose, most significantly  Lactobacillus acidophilus which is widely  available in 
USA for addition to feed which is proposed to reduce the numbers of bacterial pathogens 
present in the ruminant gut (Elam et al., 2003). Probiotic E. coli strains have also been 
found to have efficacy in reduction of EHEC prevalence in farm animals (Zhao et al., 
1998;Tkalcic et al., 2003;Zhao et al., 2003;Schamberger et al., 2004;Schamberger  and 
Diez-Gonzalez, 2004). The most promising strains for this application are those able to 
elaborate bacteriocins, including colicins (large protein bacteriocins) and microcins (small 
peptide  bacteriocins)  (Sable  et  al.,  2000;Callaway  et  al.,  2003).  These  are  molecules 
produced by E. coli which have antibacterial activity, increasing the competitive fitness of 
the bacteriocin-producing strain. Direct application of bacteriocins to food products has 
also  been  considered  as  a  strategy  for  post-harvest  control  of  EHEC  in  foodstuffs 
(Nandiwada et al., 2004;Abercrombie et al., 2006). 
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1.4  Molecular basis of EHEC colonisation and pathogenesis 
 
EHEC-pathogenicity is complex and multifactorial. EHEC possess elaborate mechanisms 
which aid the subversion of host defences and the progression of EHEC pathogenesis.  
 
1.4.1  Type III Secretion System 
 
The genomes of EHEC and closely related EPEC carry a pathogenicity island known as 
the locus of enterocyte effacement (LEE) (McDaniel et al., 1995). This locus encodes the 
genes necessary for the bacterium to induce attaching/effacing (A/E) lesions associated 
with  EHEC  and  EPEC  colonisation,  including  a  functional  type  III  secretion  system 
(T3SS)  (Jerse  et  al.,  1990;Jarvis  et  al.,  1995).  The  LEE  of  EPEC  O127:H6  is  wholly 
sufficient for the induction of A/E lesions, whereas the LEE of EHEC O157:H7 requires 
additional factors encoded elsewhere on the genome (McDaniel and Kaper, 1997;Elliott et 
al., 1999). The LEE carried by EPEC and EHEC is approximately 35.5kbp and the genes 
encoded are organised into 5 operons: LEE1-LEE5 (Figure 1.2) (McDaniel et al., 1995). 
Operons  1-3  encode  the  proteins  required  to  form  the  secretion  apparatus,  the  E.  coli 
secretory complex or esc genes. The LEE4 operon encodes EspA (E. coli secreted protein 
A) which forms the needle structure of the T3SS, EspB and EspD which form a pore in the 
host  cell  membrane  (Sekiya  et  al.,  2001;Ogino  et  al.,  2006).  Through  this  complex  a 
number  of  proteins  are  injected  into  the  cell.  These  include  LEE5-encoded  Tir 
(translocated intimin receptor) which becomes embedded in the host cell membrane. Tir 
interacts with intimin (also LEE5-encoded) which is a bacterial outer membrane protein 
and this interaction facilitates intimate adherence between bacterium and host (Kenny et 
al., 1997;Deibel et al., 1998). Intimin is proposed to have a second, Tir-independent, role 
in adherence to host enterocytes in that initial bacterial adherence to host cells is proposed 
to be aided by interaction between intimin and host protein nucleolin (Sinclair and O'Brien, 
2002). 
 
Tir protein is central to the divergent mechanisms of EHEC- and EPEC-induced A/E lesion 
formation (Ismaili et al., 1995;DeVinney et al., 2001). Intimate adherence of EHEC or 
EPEC to the enterocyte, facilitated by Intimin-Tir binding, triggers the process of actin 
polymerisation  to  form  the  pedestal  structure  of  the  A/E  lesion  (Cantarelli  et  al.,   36 
2000;Goosney et al., 2001). EPEC-encoded Tir is phosphorylated on a tyrosine residue and 
recruits Nck adaptor protein leading to activation of neuronal Wiskott Aldrich syndrome 
protein (N-WASP). N-WASP then acts to activate the Arp2/3 complex leading to actin 
nucleation (Kalman et al., 1999;Higgs and Pollard, 2001;Rohatgi et al., 2001;Campellone 
et al., 2004a). EHEC-encoded Tir requires non-LEE encoded effector EspFU (or TccP) 
which is functionally similar to host adaptor protein Nck and mediates signalling between 
EHEC  and  N-WASP  (Garmendia  et  al.,  2004;Campellone  et  al.,  2004b).  Intimate 
adherence  between  bacterium  and  host  cell  leads  to  microcolony  formation.  The 
subsequent  condensation  of  filamentous  actin  leads  to  effacement  of  microvilli  and 
formation of the pedestal structure of the A/E lesion.  
 
In addition to the aforementioned effectors A/E lesion-inducing bacteria (EHEC, EPEC 
and Citrobacter rodentium) inject a number of effector proteins into the host cell, many of 
which interact in some way with the cell cytoskeleton. Mitochondria-associated protein 
(Map)  and  EspF  are  proposed  to  aid  disruption  of  transepithelial  resistance  and 
mitochondrial membrane potential (McNamara and Donnenberg, 1998;McNamara et al., 
2001a).  Map,  along  with  EspH  and  EspB,  also  have  roles  in  the  modulation  of  the 
cytoskeleton to induce elaboration of filopodia (Kenny et al., 2002;Tu et al., 2003). EspF 
has been observed to contribute significantly to the induction of cell death (Crane et al., 
2001; Viswanathan et al., 2004) and EspG induces destruction of microtubule network 
(Matsuzawa et al., 2004). Certain effector proteins are encoded outwith the LEE. Several 
T3SS effector proteins have not been assigned a function, including LEE-encoded EspZ 
and Non-LEE-encoded NleA(EspI), NleB, NleC, NleD, NleE, NleF and NleH (Deng et al., 
2004;Gruenheid  et  al.,  2004;Kanack  et  al.,  2005).  NleA  is  proposed  to  inhibit  protein 
export by the host cell (Kim et al., 2007). NleD has been proposed to aid colonisation of 
experimentally infected calves, although the mechanism by which it achieves this is as yet 
unknown (Dziva et al., 2004). Certain non-O157 strains of EHEC and EPEC have been 
observed to inject a cell cycle inhibitory protein (Cif) into the host cell (Marches et al., 
2003). Bioinformatic analysis suggests that the extent of the function of the T3SS is greater 
than previously imagined. Mining of the E. coli O157:H7 genome revealed a number of 
putative  T3SS  effectors  of  which  39  were  confirmed  as  injected  proteins  using 
translocation assays (Tobe et al., 2006); however, functions are not yet assigned to the 
majority of these injected proteins. Thus, type III secreted proteins perform a range of   37 
function, some of which remain to be elucidated, which may aid the hijacking of host cell 
function for the benefit of the bacterium. 
 
Complex regulatory control ensures the expression of the T3SS at the optimal stage in 
bacterium-host  interaction.  Regulation  of  the  expression  of  LEE-encoded  operons  is 
defined by the action of Ler which is encoded on the LEE1 operon. Ler acts to upregulate 
both LEE-encoded and non-LEE-encoded virulence factors (Mellies et al., 1999;Friedberg 
et al., 1999;Sperandio et al., 2000;Sanchez-SanMartin et al., 2001). Quorum sensing has 
been implicated as a key signal which triggers transcription of the LEE-encoded genes 
(Sperandio et al., 1999). 
 
As  mentioned  earlier,  LEE-encoded  intimin  protein  is  an  important  determinant  of 
adherence  to  human  enterocytes  both  in  combination  with  the  T3SS,  in  the  form  of 
intimin-Tir binding and independently of Tir. Intimin-Tir binding has also been shown to 
be important for the colonisation of ruminants and A/E lesions have been observed in 
EHEC-infected  bovine  and  ovine  intestinal  tissues,  even  though  the  ruminant  host 
generally  remains  healthy  throughout  EHEC  infection  (Dean-Nystrom  et  al., 
1998b;Cornick et al., 2002;Woodward et al., 2003;Naylor et al., 2005). 
 
The intimin gene exhibits significant diversity between A/E E. coli subtypes and currently 
14 serologically distinct intimin types have been described denoted by Greek letters α 
(alpha) to ξ (xi) (Agin and Wolf, 1997;Adu-Bobie et al., 1998;Oswald et al., 2000;Tarr and 
Whittam, 2002;Zhang et al., 2002;Jores et al., 2003). The substitution of intimin types has 
been noted to alter the tissue tropism of E. coli, as determined using in vitro organ culture 
(IVOC)  (Phillips  and  Frankel,  2000;Hartland  et  al.,  2000;Fitzhenry  et  al.,  2002).  This 
feature could relate to a Tir-independent receptor binding such as the affinity of intimin γ 
of E. coli O157:H7 for nucleolin (Sinclair and O'Brien, 2002). Thus, intimin subtypes may 
be related to tissue and host specificity.   38 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: The LEE and T3SS 
 
Figure 1.2: The LEE and T3SS: 
 
(A)  Organisation  of  the  genes  broadly  conserved 
between the LEE of EHEC and EPEC.  
(B)  Representation  of  the  proposed  structure  and 
role of the T3SS. The basal body is composed of 
inner  membrane  proteins  EscR,  S,  T,  U  and  V, 
connected  to  outer  membrane  ring  of  the  EscC-
secretin complex via the EscJ lipoprotein. On this 
basal  structure  lies  the  EscF  needle  complex, 
forming  a  base  for  the  EspA  filament  polymer, 
tipped  by  a  pore  comprising  EspB  and  EspD, 
anchored in the host cell membrane. T3SS effector-
proteins  (e.g.  Tir)  are  often  accompanied  by  a 
chaperone (e.g. dimeric CesT protein), to prevent 
improper folding. The effector-chaperone complex 
dissociates to allow effectors to pass through a pore 
which  runs  the  length  of  the  complex.  EscN 
provides energy for this process through hydrolysis 
of ATP (redrawn from Garmendia et al. 2005). 
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1.4.2  Shiga-like/Vero-toxins 
 
As denoted in Section 1.3, Shiga-like toxins have a major role in the severity of EHEC 
induced disease. Stx is responsible for the majority of the damage to the intestinal mucosal 
vasculature during haemorrhagic colitis and damage to the renal, circulatory and central 
nervous system in cases of HUS and TTP (O'Brien and Holmes, 1987). The importance of 
Stx in EHEC-infection has been highlighted by the discovery that the neutralisation of Stx 
activity reduced the effects of infection in animal models (Matise et al., 2001;Paton et al., 
2001a;Sheoran et al., 2003). Stx is an example of an AB5 toxin, comprising a catalytic A-
subunit (32kDa) and a pentameric B-subunit (five 7.7kDa monomers) (Donohue-Rolfe et 
al., 1984;Stein et al., 1992;Fraser et al., 2004). The pentameric B subunit binds to the 
globotriaosylceramide  (Gb3)  receptor  (also  known  as  CD77)  (Lindberg  et  al., 
1987;Lingwood, 1996). The toxin is then internalised by endocytosis, in clathrin coated 
pits. Depending on the cell type, internalised toxin may have two fates: (i) the toxin is 
transported to the cytoplasm via the endoplasmic reticulum and Golgi apparatus followed 
by the cleavage of the A1 peptide of the A-subunit by furin, releasing a 28kDa catalytically 
active protein which acts to cleave 28S rRNA (Endo et al., 1988;Lea et al., 1999); resultant 
inhibition of protein synthesis causes apoptosis (Sandvig et al., 2002) (ii) in cell types 
which present Gb3 receptors but resist the action of verotoxin internalised toxin vesicles 
are fused with lysosomes leading to degradation of the toxin (Falguieres et al., 2001;Hoey 
et al., 2003). 
 
The  host  inflammatory  response  to  EHEC  (examined  further  in  Section  1.5.3)  may 
enhance the effects of Stx as TNFα and IL-1β levels increase presentation of Gb3 receptors 
on human vascular endothelial cells (Louise and Obrig, 1991;van de Kar et al., 1992;Kaye 
et al., 1993;Louise et al., 1995). Polymorphonuclear leukocytes (PMLs) localised to the 
site of EHEC infection are proposed to facilitate the carriage of Stx to target organs as Stx 
has been observed to bind to the surface of these cells and this may allow the toxin to be 
transported  systemically.  Stx  is  proposed  to  have  greater  affinity  for  Gb3  receptors 
presented by epithelial cells; hence, the toxin may be delivered by PMLs to regions where 
the greatest Stx-mediated damage is observed (Hurley et al., 2001;te Loo et al., 2001a;te 
Loo et al., 2001b). 
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It  has  not  yet  been  determined  whether  Stx  is  toxic  to  the  bovine  host.  Cattle  remain 
largely unaffected by colonisation by Stx-producing E. coli strains, despite the detection of 
significant  levels  of  Stx  in  bovine  faecal  matter  (Ball  et  al.,  1994;Hyatt  et  al.,  2001). 
Immune recognition of Stx by the bovine host is likely to occur, as anti-Stx antibodies 
have  been  detected  in  bovine  serum,  colostrum  and  mucosal  material  (Pirro  et  al., 
1995;Johnson et al., 1996). The insensitivity of the bovine host to Stx may be due to the 
lack of Gb3 receptors on bovine vascular endothelial cells (Pruimboom-Brees et al., 2000). 
The differential consequences of EHEC infection of the bovine host could depend on the 
method of processing the toxin by Gb3-positive basal crypt cells, which have been shown 
to target the protein to lysosomes (Hoey et al., 2003). Stx may also modulate the immune 
response  of  cattle  and  there  is  evidence  that  the  toxin  reduces  the  proliferation  and 
activation of peripheral blood mononuclear cells (PBMCs) and inhibits proinflammatory 
cytokine  secretion  by  intraepithithelial  lymphocytes  (Menge  et  al.,  1999;Menge  et  al., 
2004). In this way, Stx could contribute to immune tolerance of EHEC in the bovine host, 
may be important in defining the different outcomes of EHEC colonisation of bovine and 
human hosts, especially as immune/inflammatory damage contributes to the severity of the 
disease in humans and the likelihood of progression to HUS (Westerholt et al., 2003). 
 
Two distinct subgroups of Stx are produced by EHEC (Scotland et al., 1983;Strockbine et 
al., 1986). Stx1 is indistinguishable from shiga toxin produced by Shigella dysenteriae, 
whereas Stx2 exhibits 56% amino acid identity to Stx1. Isolates expressing Stx2 have been 
linked  to  increased  likelihoods  of  causing  HUS  (Gewirtz  et  al.,  2001a;Zhou  et  al., 
2003;Khan et al., 2004). Up to 11 variants of Stx2 have been identified. These include 
“conventional” Stx2EDL933 (also termed Stx2vha) Stx2c (also termed Stx2vhb) Stx2d, Stx2e, 
Stx2f and Stx2g each are antigenically non-cross reactive (Perera et al., 1988;Schmitt et 
al., 1991;Schmidt et al., 2000;Brett et al., 2003). Stx2EDL933/Stx2vha will be termed simply 
“Stx2” or “conventional Stx2” in this study as it is the prototype Stx2 allele encoded by 
reference strains of E. coli O157:H7. Intestinal mucous has been observed to increase the 
activity of Stx2d, due to the action of elastase, cleaving Stx2d to form a toxic mature 
protein  (Melton-Celsa  et  al.,  1996).  Stx2e-producing  E.  coli  causes  oedema  disease  in 
swine and differs from other Stx subtypes in that it binds to globotetraosylceramide (Gb4) 
receptor (DeGrandis et al., 1989). Thus, verotoxin subtype may aid determination of host 
specific pathogenesis among shiga-toxin producing E. coli. Levels of toxicity of Stx vary 
between  Stx  subtypes.  For  example:  toxicity  of  activated  Stx2d  is  greater  than  that  of   41 
Stx2/Stx2c and the activity of Stx1 and Stx2e are the least verotoxic (O'Brien and LaVeck, 
1983;Samuel et al., 1990;Paros et al., 1993;Lindgren et al., 1994). Hence, the Stx subtype 
could be important in the levels of cellular damage caused by pathogenic STEC and the 
increased toxicity of Stx2 could explain the increased severity of infections caused by Stx2 
producing EHEC strains.  
 
The action of Stx has also been proposed to aid gastrointestinal colonisation, perhaps by 
increasing presentation  of nucleolin which is proposed to act as an initial receptor for 
intimin, enhancing bacterial adherence to the enterocyte (Robinson et al., 2006). This was 
determined using epithelial cell line and a mouse model of infection and verification of this 
function  in  relevant  host  species  has  not  been  performed.  Nevertheless,  this  discovery 
suggests a link between Stx and intimin which further highlights the complex interplay 
between EHEC virulence factors during intestinal colonisation. 
 
1.4.3  Plasmid-encoded factors 
 
The majority of human EHEC isolates generally carry a large (~90kbp) plasmid, which 
contributes to virulence (Levine et al., 1987;Beutin et al., 1994;Schmidt et al., 1994). In 
the majority of E. coli O157 isolates the plasmid carries genes encoding several putative 
virulence factors including ehxA, espP and toxB which are described below. It has been 
noted that the plasmid confers enhanced adherence to cultured cells when compared with 
plasmid-cured E. coli O157:H7 derivatives and increases adherence of transformed E. coli 
K12 to the rabbit intestinal epithelium (Toth et al., 1990;Dytoc et al., 1993) suggesting that 
the plasmid carries genes contributing to adherence mechanisms.   
 
EspP  is  a  member  of  the  SPATE  (serine  protease  autotransporters  of  the 
Enterobacteriaceae) family of proteases secreted by the type V secretion system (reviewed 
in Henderson et al., 2004). EspP is highly expressed under laboratory culture conditions 
and is also recognised during the course of human infection, as anti-EspP antibodies have 
been detected in the sera of EHEC-infected patients (Brunder et al., 1997). EspP cleaves 
pepsin  A  and  human  coagulation  factor  V  and  thus  could  act  to  exacerbate  the 
haemorrhagic effects of EHEC infection (Brunder et al., 1997). EspP has also been noted   42 
as an enhancer of bacterial adherence to bovine enterocytes (Dziva et al., 2007); hence, 
this protein could aid colonisation of the bovine host by E. coli O157:H7. 
 
Plasmid-encoded enterohaemolysin (EhxA) belongs to the RTX (repeats in the structural 
toxin) toxin family, which are expressed by several Gram-negative pathogens of humans 
and animals, including Mannheimia haemolytica, Bordetella pertussis and Actinobacillus 
spp. (Bauer and Welch, 1996;Frey and Kuhnert, 2002). EhxA is highly conserved among 
EHEC strains but its role in pathogenesis remains undefined (Schmidt et al., 1996;Boerlin 
et  al.,  1999).  EHEC  strains  which  express  EhxA  exhibit  weak  calcium  dependent 
haemolysis  of  sheep  erythrocytes,  which  is  dependent  on  Ca
2+  ions  (Beutin  et  al., 
1989;Bauer and Welch, 1996). Low levels of haemolysis have been attributed to the lack 
of  a  fully  functional  export  system  for  this  protein  and  complementation  of  E.  coli 
O157:H7 with the further components of this system vastly increases  EhxA-dependent 
haemolytic  activity  (Schmidt  et  al.,  1995a).  Expression  of  EhxA  is  increased  under 
anaerobic conditions and in vivo expression is also suggested, as antibodies to Ehx have 
been  detected  in  the  sera  of  HUS  patients  (Schmidt  et  al.,  1995a;Chart  et  al.,  1998); 
however,  whether  this  protein  influences  virulence  functions  of  the  bacterium  in  vivo 
remains unclear. 
 
StcE  (secreted  protease  of  C1  inhibitor  from  EHEC),  also  referred  to  as  TagA  for  its 
similarity to the ToxR-regulated lipoprotein of Vibrio spp., was identified as an antigen in 
the sera of HUS patients (Paton and Paton, 2002). Like EspP, it is a plasmid-encoded 
protease which cleaves a factor which is important to host immunity by catalysing the 
cleavage  of  C1-esterase  inhibitor  (C1-INH)  which  is  an  inhibitor  of  the  complement 
cascade (Lathem et al., 2002). The cleavage of C1-INH by StcE increases the inhibitory 
activity  of  C1-INH,  hence  decreasing  complement-mediated  cell  lysis  (Lathem  et  al., 
2004). Secretion of StcE depends upon the etp gene cluster which encodes a functional 
type II secretion system, also encoded on the plasmid (Schmidt et al., 1997;Lathem et al., 
2002). The precise role of this protein in EHEC infection is not yet confirmed, although 
prevention of the death of host cells could aid the survival of EHEC-infected cells and 
hence aid persistence of the bacterium as EHEC relies on adherence to enterocytes for 
survival and proliferation within the host. StcE is also proposed to have mucinase activity 
and may affect surface proteins of the enterocyte, which could increase bacterial adherence 
(Grys et al., 2005;Grys et al., 2006).   43 
 
Also encoded on the plasmid is ToxB, a homologue of the Tox proteins of C. difficile 
(Burland et al., 1998). Homologues of ToxB are also encoded by sorbitol-fermenting E. 
coli  O157:H-,  non-O157  EHEC  and  EPEC  termed  Efa-1  or  LifA  (Nicholls  et  al., 
2000;Klapproth et al., 2000;Janka et al., 2002). ToxB and Efa-1 have been suggested to 
increase adherence of EHEC to cultured cells and aid colonisation of cattle by mediating 
increased T3SS expression (Nicholls et al., 2000;Stevens et al., 2002). However, mutation 
of  the  toxB  gene  did  not  significantly  affect  the  length  of  faecal  shedding  of  E.  coli 
O157:H7 in cattle (Stevens et al., 2004).  
 
Although a similar large plasmid is carried by many EHEC subtypes, considerable strain-
dependent variation exists in its genetic composition. The plasmid encoded by sorbitol-
fermenting E. coli O157:H- (pSFO157) is roughly 30kbp larger than that carried by E. coli 
O157:H7. It lacks katP (catalase peroxidise), espP and toxB genes and carries a larger 
proportion of genes related to conjugal transfer, along with a novel fimbrial locus termed 
sfp,  which  has  homology  to  P-fimbriae  encoded  by  ExPEC  strains  (Burland  et  al., 
1998;Brunder et al., 2001;Brunder et al., 2006). Plasmid-encoded genes for a novel auto-
agglutinating adhesin have been identified in LEE-negative STEC strains including E. coli 
O113:H21 (Paton et al., 2001b). The virulence factor encoding genes espP and ehxA also 
exhibit strain-specific polymorphisms (Brunder et al., 1999;Cookson et al., 2007). Certain 
subtypes  of  EspP  are  inactive  against  pepsin  A  and  human  coagulation  factor  V 
(Brockmeyer et al., 2007), although the roles of the proteolytically inactive forms of EspP 
as adhesins have not been investigated. The significance of ehxA variants remain to be 
determined, although all subtypes identified by Cookson et al. (2007) were found to have 
comparable haemolytic activities. 
 
1.4.4  Flagella 
 
The  flagella  are  filamentous  appendages  which  the  bacterium  may  rotate  to  facilitate 
motility  (Berg  and  Anderson,  1973).  The  flagellar  filament  is  made  up  of  11 
protofilaments,  which  are  essentially  chains  of  polymerised  flagellin  (FliC  protein) 
monomers (Samatey et al., 2001). The FliC monomers are connected via the interactions 
of concave and convex domains (Samatey et al., 2001;Smith et al., 2003;Yonekura et al.,   44 
2003). The filament is attached to a hook complex, which is anchored to the basal body, 
forming  the  flagellar  motor  (reviewed  in  MacNab,  2003).  Flagella  and  T3SS  share 
structural and functional similarities and polymerisation of flagellin is proposed to occur 
by a similar mechanism to the translocation of T3SS effector proteins (Galan et al., 1992). 
 
Motility coupled with regulation of motility using two-component regulatory systems (e.g. 
Che proteins) allows chemotaxis of the organism, facilitating the acquisition of nutrients, 
evasion of toxic environments and translocation to preferred sites in the host (Adler and 
Tso,  1974).  However,  the  flagellum  provides  a  target  for  host  innate  immunity  and  is 
recognised by host pattern recognition receptors (PRRs) including Toll like receptor (TLR) 
5  (discussed  further  in  Section  1.5.1).  The  conserved  amino  and  carboxy  termini  of 
flagellin  are  recognised  by  TLR5  (Eaves-Pyles  et  al.,  2001;Donnelly  and  Steiner, 
2002;Smith et al., 2003;Murthy et al., 2004). Flagellin has also been found to activate 
alternative PRR-signalling pathways, including TLR2 and glycolipids such as gangliosides 
(McNamara  et  al.,  2001b;Adamo  et  al.,  2004;Ogushi  et  al.,  2004).  Adaptive  immune 
responses in the form of antibodies are  generally  observed against the variable central 
domain and his variability has given rise to the serological diversity exemplified by the H-
serotyping scheme, described in Section 1.2.1 (Kuwajima, 1988;Newton et al., 1991;He et 
al., 1994;Yoshioka et al., 1995).  
 
Although a role for the flagellum in adherence of EPEC to host cells has been suggested 
several lines of evidence suggest that H7-flagellin is unlikely to have a direct role as an 
EHEC adhesin, in that antibodies against H7-flagellin do not inhibit adherence and purified 
H7 flagellin does not adhere directly to cells (Giron et al., 2002). EHEC also shuts down 
flagellar expression in microcolonies and upregulates expression of the T3SS, at a time 
when adherent mechanisms are required to function at their maximal levels. This switching 
mechanism is mediated by integration host factor (IHF) which activates the expression of 
Ler and prevents expression of the flhDC regulon, shutting down expression of flagellar 
components  (Yona-Nadler  et  al.,  2003).  However,  recent  evidence  suggests  that  H7 
flagellin is important in binding to intestinal mucins (Erdem et al., 2007) and therefore 
may have an initial role in localising the bacterium to the mucosal surface. 
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1.4.5  Additional EHEC virulence and colonisation factors 
 
The resolution of the complete genome sequences of two E. coli O157:H7 isolates has 
allowed the prediction of further potential virulence factors (Perna et al., 2001;Hayashi et 
al., 2001b). These are encoded on genomic regions present in E. coli O157:H7 genome 
which are absent from the E. coli K12 MG1655 genome, termed “O-islands” (Perna et al., 
2001).  Candidate  factors  with  predicted  roles  in  the  infective  process  include  fimbrial 
adhesins such as two long polar fimbriae operons (LPF1 and LPF2) encoded on O-island 
154 (Torres et al., 2002;Torres et al., 2004). Long polar fimbriae have been suggested to 
aid  initial  adherence  of  the  bacterium  to  host  enterocytes  (Jordan  et  al.,  2004).  Curli 
fimbriae are also expressed by E. coli O157:H7 and may have a role in adherence (Torres 
and Kaper, 2003). Outer membrane proteins OmpA and Iha (IrgA homologue adhesin) 
have also been put forward as adhesins in EHEC and UPEC strains. Both of these adhesins 
are  also  believed  to  have  functions  in  bacterial  iron-uptake  mechanisms  (Tarr  et  al., 
2000;Torres and Kaper, 2003;Leveille et al., 2006). EHEC also produces a pilus which is 
also common among human commensal E. coli isolates, termed “E. coli common pilus” 
and has been suggested to aid adherence to epithelial cells (Rendon et al., 2007). A role in 
adherence was established using HEp-2 cells as an epithelial model (derived from a larynx 
carcinoma) and its role in adherence to the intestinal epithelium or in interactions with 
non-human hosts remains to be established. 
 
The level of horizontal gene transfer among E. coli especially facilitated by bacteriophages 
has  lead  to  the  differential  carriage  of  potential  virulence  factors  by  EHEC.  Sorbitol-
fermenting E. coli O157:H- and other non-O157 STEC serotypes have been observed to 
produce cytolethal distending toxin, generally associated with ExPEC strains, encoded by 
genes cdtB (encoding the catalytic subunit), cdtA and  cdtC (which facilitate the delivery 
of the catalytic subunit to the host cell) (Janka et al., 2003;Bielaszewska et al., 2005). The 
production  of  cytolethal  distending  toxin  by  EHEC  strains  could  contribute  to  the 
induction of endothelial cell death in cases of human EHEC infection although this is yet 
to be ascertained. Certain EHEC strains, including EHEC serotypes O113 and O157, have 
been  observed  to  produce  subtilase  toxin.  Subtilase  toxin  shares  similarity  with  toxins 
produced by Bacillus spp. and Yersina pestis. Similarly to Stx, subtilase is an AB5 toxin 
and has been proposed to be a major inducer of HUS in response to EHEC strains that lack 
conventional stx genes (Schmidt et al., 1999;Paton et al., 2004).    46 
 
In summary, EHEC interactions with the host are complex and mediated by many factors. 
The  multiple  adherence  mechanisms  proposed  show  that  there  may  be  functional 
redundancy,  possibly  providing  backup  adherence  mechanisms.  The  wide  range  of 
adhesive and pathogenic mechanisms could be important for the interaction of E. coli with 
different hosts or different tissue types. 
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1.5  Bacteria and the Gut  
 
1.5.1  E. coli and the gastrointestinal microflora 
 
Bacteria  populate  the  mammalian  gut  in  substantial  numbers.  In  the  human  GIT, 
colonisation ranges from 10
2-10
5 cfu/ml of gut contents in the upper regions of the GIT to 
10
11-10
12cfu/ml in the colon (Evaldson et al., 1982). The gut microbiota comprises a large 
variety of bacterial genera and there are estimated to be more than 500 different species of 
bacteria commonly found in the human gut. Obligate anaerobes predominate, especially 
species  of  the  genera  Clostridium  and  Bacteroides  (Eckburg  et  al.,  2005).  Facultative 
anaerobes  including  E.  coli  are  thought  to  comprise  only  a  small  proportion  of  the 
microbial  flora  (~0.1%)  but  are  consistently  present  (Suau  et  al.,  1999;Hayashi  et  al., 
2002;Wang et al., 2003). The presence of the gastrointestinal microflora has significant 
benefits for both bacterium and host and can be considered as an example of symbiosis. 
The host provides a supply of nutrients and maintains an optimal temperature for bacterial 
growth, while the microflora benefits the host by protection from cellular injury, regulation 
of lipid storage and stimulation of the development of intestinal tissues (Stappenbeck et al., 
2002;Rakoff-Nahoum  et  al.,  2004;Backhed  et  al.,  2004).  The  constant  basal  level  of 
pattern recognition receptor (PRR)-stimulation (discussed in more detail in Section 1.5.3) 
by the gastrointestinal microbiota is important in these functions (Rakoff-Nahoum et al., 
2004). The normal gut microflora is also important for the prevention of colonisation of 
pathogenic bacteria, evidenced by the fact that clearing of the gastrointestinal microflora 
using antibiotics can lead to the proliferation of pathogens such as Clostridium difficile 
(Zwiener  et  al.,  1989).  Thus,  the  gut  microflora  serves  as  a  source  of  opportunistic 
bacterial  pathogens  including  E.  coli  such  as  ExPEC  (described  in  Section  1.3).  In 
addition,  dysregulated  responses  of  the  human  host  to  the  intestinal  microflora  are 
proposed  to  be  central  to  the  progression  of  inflammatory  gut  diseases  (reviewed  in 
Tlaskova-Hogenova et al., 2004) . 
 
The benefits of non-pathogenic strains of E. coli in promotion of human health have been 
recognised. Certain strains of E. coli have proven probiotic effects, such as the Mutaflor 
isolate  of  E.  coli  (Nissle  1917)  which  has  been  shown  to  reduce  gastrointestinal 
colonisation by pathogenic bacteria and have efficacy for the treatment of inflammatory   48 
disorders, such as IBD and Crohn’s disease, by modulation of epithelial signal transduction 
pathways  (Lodinova-Zadnikova  and  Sonnenborn,  1997;Lodinova-Zadnikova  et  al., 
2003;Kamada et al., 2008). Probiotic E. coli strains have shown promise as agents which 
may  be  applied  to  reduce  the  carriage  of  E.  coli  O157:H7  in  cattle;  however,  further 
investigation  is  required  in  order  to  develop  an  applicable  probiotic  strategy  for 
commercial use in the cattle farming industry (examined in more detail in Chapter 5). 
 
1.5.2  Gastrointestinal physiology and Bacterial interactions with the host 
 
Bacteria are found in large numbers in the faeces but the most successful gastrointestinal 
colonists include those which are able to adhere to the gastrointestinal mucosal surface 
allowing persistence and propagation of the organism within the host. In order to adhere to 
host enterocytes, certain bacteria have evolved diverse adherence mechanisms which are 
often based on the binding bacterial surface molecules with receptor molecules presented 
by the host cell. E. coli strains elaborate a variety of fimbriae, which enhance adherence to 
particular  cellular  receptors.  Many  of  the  fimbrial  subtypes  have  affinity  for  particular 
sugar residues contained in host glycoproteins or glycolipids. Alteration of the presentation 
of host cell surface molecules differs both between host species and regionally within a 
host, often due to host or tissue specific regulation of glycosyltransferases (reviewed in 
Varki,  1996).  As  different  tissue  types  present  a  different  complement  of  receptor 
molecules, the expression of different adhesin molecules by a bacterium aids definition of 
its tissue and host specificity.  
 
The most commonly encoded E. coli adhesins are type I fimbriae, which have affinity for 
mannosides, laminin, fibronectin and plasminogen (Krogfelt et al., 1990;Sokurenko et al., 
1998;Pouttu  et  al.,  1999;Pouttu  et  al.,  2000).  The  affinity  of  type  I  fimbriae  for  such 
complexes is important in colonisation during E. coli-induced meningitis (Pouttu et al., 
1999), although the ubiquitous nature of these fimbriae are among E. coli suggests that 
they are a general adherence molecule of both pathogenic and commensal organisms. P-, 
Prs- and S- fimbriae are commonly expressed by ExPEC and also E. coli strains which 
persist in the human gastrointestinal tract (Nowrouzian et al., 2001). These fimbriae target 
galactose-based surface carbohydrates (Hull et al., 1981;Korhonen et al., 1984;Lund et al., 
1988). K88 (F4) and K99 (F5) fimbriae, which are prevalent among pathogenic ETEC   49 
strains of pigs and calves respectively, also recognise carbohydrate-based cellular receptors 
(Smit  et  al.,  1984;Erickson  et  al.,  1994).  The  ligand  recognised  by  K99  fimbriae:  N-
glycosylneuraminic  acid  (NeuGc)  is  not  presented  by  human  enterocytes;  hence,  K99 
presenting ETEC strains have not been identified in cases of human infection (Smit et al., 
1984;Mouricout et al., 1990). Production of F17 fimbriae has been observed among strains 
which cause diarrhoea and septicaemia in cattle (Bertin et al., 1996b) and also among 
bovine commensal E. coli (Güler et al., 2008). F17 fimbriae have affinity for receptors 
containing N-acetyl glucosamine residues (Saarela et al., 1996;Bertin et al., 1996a). In this 
way, pathogenic and commensal E. coli elaborate a variety of fimbrial adhesins many of 
which are dependent on polysaccharide components of the host cell membrane; hence, 
differential presentation of these polysaccharides may contribute to definition of E. coli 
host and tissue specificity.  
 
E. coli O157:H7 has been proposed to exhibit tissue specificity in colonisation of the GIT 
of the bovine and human hosts. The bacterium localises preferentially to areas of mucosal 
tissue which are densely populated by lymphoid follicles especially at the ileal Peyer’s 
patches  during  human  infection  and  at  the  recto-anal  junction  in  cattle  (Phillips  and 
Frankel, 2000;Phillips et al., 2000;Naylor et al., 2003). 
 
The  mammalian  GIT  is  sporadically  populated  with  gatherings  of  mucosa-associated 
lymphoid  tissue  (MALT,  also  referred  to  as  GALT:  Gut  associated  lymphoid  tissue). 
MALT is important for both innate and acquired immunity in that MALT is characterised 
by large populations of lymphocytes. They  consist of a central core of B-lymphocytes 
embedded in a network of dendritic cells. Dendritic cells and “membraneous” (M-) cells 
perform antigen sampling at these sites (Rescigno and Borrow, 2001). Smaller populations 
of T-lymphocytes are also integral to the immune function of this site. MALT may be 
present as individual lymphoid follicles (LFs) or aggregates of multiple lymphoid nodules. 
The epithelium which overlays the lymphoid follicle is thinner than non-lymphoid regions, 
lacks  prominent  villi  and  is  heavily  infiltrated  by  lymphocytes.  The  distribution  of 
lymphoid tissue differs between animal species, although certain features are ubiquitous 
among mammals, such as the ileal Peyer’s patch which is most LF-dense close to the 
terminal  ileum.  The  bovine,  ovine  and  caprine  gut  share  similar  GALT-distribution 
patterns.  In  addition  to  terminal-ileal  Peyer’s  patches  and  interspersed  jejunal  Peyer’s 
Patches, sites at the terminal rectum and proximal colon are particularly densely populated   50 
with lymphoid follicles (reviewed in Liebler-Tenorio and Pabst, 2006). Targeting of the 
ileal  Peyer’s  patches  has  been  noted  for  other  bacterial  enteric  pathogens  such  as 
Salmonella  typhimurium,  Listeria  monocytogenes,  Yersinia  enterocolitica  and  Shigella 
spp.  (Grutzkau  et  al.,  1990;Perdomo  et  al.,  1994;Jones  et  al.,  1994;Jensen  et  al., 
1998;Vazquez-Torres and Fang, 2000;Chong et al., 2007).  The prevalence of phagocytic 
cells  at  these  regions  means  that  bacteria  frequently  associate  with  such  regions.  This 
represents  a  feature  of  the  antagonism  between  host-mediated  destruction  of  invading 
pathogens by binding and phagocytosis and bacterial subversion of this process. 
 
The genome sequence of E. coli O157:H7 has revealed 14 putative fimbrial loci encoded 
by E. coli O157:H7 (Perna et al., 2001). Some of those with a proposed role in cellular 
adherence are summarised in Section 1.4.5.  Several adhesins have been implicated in the 
preference shown by the bacterium for the follicle associated epithelium (FAE). Intimin 
gamma was found to induce FAE-tropism in EPEC, when eae γ was cloned and expressed 
in EPEC (∆eae) (Fitzhenry et al., 2002). As mentioned earlier, intimin is proposed to bind 
to cellular receptors, such as nucleolin (Robinson et al., 2006), which enhances adherence 
of the bacterium to the mucosal surface. It is possible that host cells present at lymphoid 
follicle dense regions present receptors for intimin (or other bacterial molecules) at greater 
levels than enterocytes at regions outwith these sites. E. coli O157:H7 has been noted to 
elaborate long polar fimbriae (Torres et al., 2002;Torres et al., 2004). These may also aid 
colonisation of the FAE as has been noted for Salmonella enterica serovar Typhimurium 
(Baumler et al., 1996; Jordan et al., 2004;Fitzhenry et al., 2006).  
 
E. coli O157:H7 has been observed to form A/E lesions in the bovine GIT (Naylor et al 
2005) but has not been reported to persist in the bovine ileum or target bovine ileal Peyer’s 
patches. The lack of persistence in the ileum could be a key factor in the absence of further 
clinical manifestations of EHEC colonisation. The reasons why E. coli O157:H7 does not 
colonise at the ileal Peyer’s patches in the bovine ileum are unclear, but could potentially 
rely on differential receptor presentation at the sites. Alternatively, immune tolerance of E. 
coli  O157:H7  at  the  terminal  rectum  and  not  at  the  ileum  could  be  the  basis  for  the 
observed absence of the bacterium at the ileum. 
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1.5.3  Host responses to bacterial colonisation 
   
Host innate and adaptive immune systems are  vital in defining the  results of bacterial 
colonisation  of  the  mammalian  GIT.  Immune  recognition  of  colonising  bacteria  is 
delicately balanced in that non-recognition of a potentially pathogenic bacterium leads to a 
permissive host state, allowing pathogen-mediated damage to host tissues. Conversely, an 
excessive host immune response to an invading microorganism may succeed in elimination 
of the bacterial pathogen but may also exacerbate the damage caused to the host system by 
inflammatory-mediated tissue injury. Hence, for an organism to remain in the host GIT 
without  causing  damage  or  eliciting  a  response  which  leads  to  its  elimination,  an 
equilibrium is maintained between bacterium and host defences. 
 
Pattern recognition receptors (PRRs) are vital in pathogen  recognition  by the host and 
initiation  of  cellular  responses.  PRRs  include  the  Toll  like  receptors  (TLRs)  normally 
presented on the surface of mammalian cells and Nod proteins, which are intracellular 
PRRs.  PRRs  recognise  pathogen-associated  molecular  patterns  (PAMPs)  which  are 
molecular motifs that are broadly conserved among pathogens. To date, eleven distinct 
TLR types have been recognised in mammals (Roach et al., 2005). Certain TLRs have 
been related to recognition of molecules produced by bacteria. Of these, TLR2, 4 and 5 are 
perhaps  the  most  important.  TLR4  recognises  lipid  A  of  bacterial  lipopolysaccharides 
(LPS) via LPS binding protein, CD14 and MD-2 (Poltorak et al., 1998;Shimazu et al., 
1999;Bernheiden et al., 2001). TLR2 forms heterodimers with either TLR1 or TLR6 and 
these complexes recognise components of the bacterial membrane such as lipoproteins, 
diacyl  and  triacyl  lipopeptides  and  atypical  LPS  (Medzhitov  et  al.,  1997;Werts  et  al., 
2001;Takeuchi  et  al.,  2001;Takeuchi  et  al.,  2002;Alexopoulou  et  al.,  2002).  TLR5 
recognises flagellin proteins, which make up the major flagellar subunit. Recognition is 
through a conserved domain which interacts directly with TLR5 (Hayashi et al., 2001a). 
Thus,  multiple  sensing  systems  are  possessed  by  the  mammalian  host,  required  for 
recognition  and  responses  to  invading  microorganisms.  The  mechanism  by  which  the 
mammalian  cell  responds  to  activation  of  TLRs  is  a  highly  complex  network  joining 
together many facets of cellular signal-transduction centered around transcription factors 
NF-κB,  AP-1  and  the  mitogen-activated  protein  kinases  (MAPKs).  A  summary  of  the 
TLR-dependent response to bacterial products is provided in Figure 1.3.   52 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Bacterial interactions with Toll-like receptors: Direct effects are denoted by solid arrows 
while indirect transduction via intermediary factors is denoted by dashed arrows. Bacterial products such as 
LPS, flagellin and other ligands (set out in Section 1.5.2) interact with their respective TLR. The activation 
of each of the TLRs depicted causes the activation of MyD88 and subsequent signalling through IRAK, 
TRAF6 and TAK1. TAK1 forms a branch-point activating the IKK complex and MAPKs p38 and JNK. IKK 
activation leads to activation of ERK1/2 which (along with JNK and p38) activates AP-1. IKK also causes 
degradation of IκBα allowing NF-κB to enter the nucleus. NF-κB and  AP-1 act as transcription  factors 
facilitating  production  of  proinflammatory  cytokines.  Two  MyD88-bypass  mechanisms  are  depicted:  (i) 
TLR4-dependent signalling via TRIF which activates both TRAF-6 and a mechanism leading to production 
of  interferons  (IFN)  and  T-cell  interacting  molecules  (ii)  signalling  via  Rac1,  PI3K  and  AKT,  leading 
eventually to NFκB activation. Activation of TLR2 or TLR4 also leads MyD88-dependent caspase activation 
and caspase-dependent apoptosis. 
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Nucleotide  binding  and  oligomerisation  domain  (NOD)  -like  receptors  (NLRs)  are 
intracellular PRRs. NLRs include Nod1 which recognises a peptidoglycan fragment more 
common  in  Gram-negative  bacteria,  whereas  Nod2  recognises  bacterial  peptidoglycan 
from Gram-positive and Gram-negative bacteria (Girardin et al., 2003a;Girardin et al., 
2003b). NLRs including neuronal apoptosis inhibitory protein (NAIP)-5 and ICE protease 
activating factor (IPAF) are activated by bacterial flagellin (Molofsky et al., 2006;Franchi 
et al., 2006). NLRs activate both NFκB and proapoptotic pathways (reviewed in Delbridge 
and O’Riordan, 2007). 
 
The distribution and localised presentation of PRRs by the cell has implications for the 
recognition of pathogenic bacteria and the tolerance of non-pathogenic bacteria. IECs in 
vivo have been shown to present TLR5 at the basolateral surface and not the apical surface 
(Gewirtz  et  al.,  2001a).  This  ensures  that  a  proinflammatory  response  to  flagellin  is 
initiated  only  when  bacteria  have  penetrated  the  epithelium  or  flagellin  is  transported 
across the epithelium (Gewirtz et al., 2001b). Both TLR2 and TLR4 are underexpressed by 
IECs  and  therefore  the  responses  to  bacterial  LPS  lipoproteins  and  lipopeptides  are 
reduced (Abreu et al., 2001;Naik et al., 2001;Melmed et al., 2003). As Nod proteins are 
intracellular, they respond only to ligands which are introduced to the cell, especially (but 
not exclusively) those produced by intracellular bacteria (Philpott et al., 2002;Girardin et 
al.,  2003c).  Hence,  the  epithelial  proinflammatory  responses  generally  occur  following 
epithelial damage, cellular invasion, tight junction disruption or translocation of bacterial 
products across the epithelial layer. Responses to normal bacterial flora of the gut lumen 
are  therefore  limited  in  the  healthy  gut.  Dysregulation  of  PRR  signalling  can  be 
detrimental  to  the  host.  Inflammatory  disorders  of  the  human  gastrointestinal  tract  are 
thought to be related PRR activation by the normal bacterial flora of the gut (Farrell and 
LaMont, 2002;Inohara et al., 2003). Conversely, transient activation of PRR signalling is 
proposed to be required for development of the normal gut (Rakoff-Nahoum et al., 2004). 
It must be noted that the above observations pertain to the distribution of PRRs expressed 
by human IECs. It remains to be determined if bovine IECs show similar patterns of PRR 
presentation. 
 
The  result  of  PRR  activation  is  the  production  of  proinflammatory  immune  effectors 
including  cytokines,  chemokines  and  antimicrobial  peptides.  These  molecules  act  to 
activate responsive components of the immune system including phagocytic and antigen-  54 
presenting cells (e.g. neutrophils, macrophages and dendritic cells). The action of these 
components of innate immunity is important for the priming of adaptive responses such as 
humoral immunity, in the form of specific antibodies produced by B-lymphocytes and cell-
mediated immunity dependent on the action of T-lymphocytes (reviewed in Lanzavecchia 
and Sallusto, 2007). In the case of non-invasive bacteria such as EHEC, B-cell-produced 
antibodies are arguably more significant in the host response to colonisation. Antibodies 
are  composed  of  immunoglobulin  proteins  (Ig).  The  most  important  antibodies  with 
respect  to  microbial  infections  are  IgG  (serum  antibodies),  IgA  (mucosal  secretory 
antibodies)  and  IgM  (B-cell  surface-presented  antibodies,  important  in  early  stages  of 
infection).  Antibodies  may  act  to  inhibit  the  functions  of  invading  microorganisms  by 
binding to presented epitopes. Antibodies coating the surface of  a microorganism may 
interfere with its binding to host cells, preventing invasion or close adherence and also 
increase  the  likelihood  of  macrophage  mediated  phagocytosis,  as  macrophages  carry 
receptors  for  the  conserved  domain  (Fc)  of  antibodies.  Antibodies  also  induce 
complement-mediated killing of microorganisms and infected cells, as the complement C1 
complex binds to the Fc component of antibodies bound to the surface of bacterial cells. 
Complement consists of a cascade of proteins which facilitate the killing of cells via the 
formation of a membrane attack complex (reviewed in Janeway et al., 2001). 
As IgA is most predominant at the mucosal surface, it is important in the recognition of 
microorganisms which are present at these sites. Secretory IgA is produced in response to 
the  resident  gut  microflora  which  may  be  important  for  the  prevention  of  invasion  by 
normally non-pathogenic microorganisms and also may aid biofilm formation (Johansen et 
al.,  1999;Bollinger  et  al.,  2003;Macpherson  and  Uhr,  2004;Bollinger  et  al.,  2006). 
Secretory  IgA  also  aids  sampling  of  gut  bacteria  by  M-cells  (Corthesy,  2007).  The 
secretory IgA response may also be also important in resistance to invasion by enteric 
pathogens and the action of their toxins (Uren et al., 2005;Wijburg et al., 2006). Serum 
IgG functions by binding antigens which are transferred into the bloodstream although IgG 
may  be  present  at  the  mucosal  surface  especially  in  cases  where  tissue  damage  has 
occurred. 
As set out in earlier sections, the human and bovine host produce both serum (IgG) and 
mucosal (IgA) antibodies against multiple components of E. coli O157:H7. Identification 
of bacterial components recognised by host antibodies has recently been enhanced by the 
adoption  of  high-throughput  proteomic  techniques  such  as  PELS  (Proteomics-based   55 
Library Screening) (John et al., 2005;Kudva et al., 2006). There have been several efforts 
to produce a vaccine effective against E. coli O157:H7 (as denoted in Section 1.3.4). The 
detection of specific antibodies against key components of EHEC by the host indicates that 
those  components  are  expressed  by  the  bacterium  in  vivo  and  recognised  by  the  host; 
hence,  detection  of  specific  antibodies  produced  by  the  host  in  response  to  EHEC 
colonisation may give rise to candidate targets for vaccine development.   56 
1.6  Aims 
 
The above summarises the current knowledge regarding the danger to human health posed 
by EHEC, its asymptomatic existence in the bovine gut and the intricate mechanisms of its 
interactions with the host. In order to explore these issues further the work performed in 
this study aimed to: 
 
1)  Characterise the responses of bovine and human epithelial cell lines to exported 
products of E. coli O157:H7 and further characterise the action of the StcE protease 
(Chapter 3). 
 
2)   Define the genotypes of resident E. coli of the bovine gastrointestinal tract and 
relate these genotypes to colonisation patterns (Chapter 4). 
 
3)   Assess the inhibitory activity of bovine E. coli isolates against E. coli O157:H7 in 
order to predict whether these strains may have applicability as probiotic agents 
(Chapter 5). 
 
4)  Evaluate  the  genotypic  variation  among  Scottish  EHEC  isolates  and  assess  the 
potential  acquisition  of  additional  virulence  factors  by  outbreak-related  E.  coli 
O157 isolates (Chapter 6).  
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2.1  Source of materials 
 
All  chemicals  and  reagents  were  purchased  from  Sigma-Aldrich  (Poole,  Dorset,  UK) 
unless  otherwise  stated.  All  PCR  primers  were  obtained  from  MWG-Biotech.  Purified 
recombinant StcE (rStcE) in phosphate-buffered saline (PBS) was provided by Rodney 
Welch (University of Wisconsin, Madison). 
 
2.2  Bacterial strains 
 
Bacterial strains used as reference isolates for this study are listed in Table 2.1. Bovine E. 
coli strains isolated during this study or provided by Stuart Naylor (Scottish Agricultural 
College) or Neil Paton (Moredun Research Institute) are described in detail in Chapter 4.  
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Reference 
number 
Strain/serotype (original designation)  Supplier  Applications  
MCI 0010  E. coli O157:H7 (WallaWalla3)  M. Reynolds, Emory University, Atlanta 
 
Antimicrobial susceptibility testing (Chapter 5) 
MCI 0011  E. coli O80  M.J. Woodward VLA Weybridge 
 
O-RFLP reference (Chapter 4) 
MCI 0022  E. coli O43:H28  M. Stevens, IAH Compton 
 
O-RFLP reference (Chapter 4) 
MCI 0024  E. coli O157:H7 (NCTC12900)  A. Best, VLA  Wild type parent strain of MCI 0025 (Chapter 3) 
Antimicrobial susceptibility testing (Chapter 5) 
MCI 0025  E. coli O157 ∆fliC (DM4)  A. Best, VLA 
 
fliC mutant strain of MCI0024 (Chapter 3) 
MCI 0045  E. coli O157:H7 (EDL933)  G. Pόsfai, Institute of Biochemistry, 
Szeged, Hungary. 
O-RFLP reference (Chapter 4) 
H-RFLP reference (Chapter 4) 
Positive  control  for:  stx1,  stx2,  eae  (γ),  espP,  escN, 
espA, ehxA (Chapters 4 & 6). 
Microarray control strain (Chapters 4 & 6) 
Antimicrobial susceptibility testing (Chapter 5) 
Subtractive hybridization driver strain (Chapter 6) 
MCI 0050  E. coli O26 (MPRL4269)  MPRL, Aberdeen 
 
O-RFLP reference (Chapter 4) 
MCI 0052  E. coli O5:H- (95-4107/291D18)  T. Besser, WSU 
 
O-RFLP reference (Chapter 4) 
MCI 0053  E. coli O111:H21 (DEC/15A)  T. Besser, WSU 
 
O-RFLP reference (Chapter 4) 
MCI 0066  E. coli O157:H7 (WallaWalla1)  M. Reynolds, Emory University, Atlanta 
 
Wild-type parent strain of MCI 0010 
MCI 0070  E. coli O116:H21 (EH42)  E. Hartland, University of Melbourne 
 
O-RFLP reference (Chapter 4) 
MCI 0071  E. coli O130:H11 (EH43)  E. Hartland, University of Melbourne 
 
O-RFLP reference (Chapter 4) 
MCI 0072  E. coli O1:H7 (EH69)  E. Hartland, University of Melbourne 
 
O-RFLP reference (Chapter 4) 
MCI 0076  E. coli O103:H2 (PMK5::∆stx)  M. Stevens, IAH, Compton  O-RFLP reference (Chapter 4) 
Positive control for: eae (ε) (Chapter 4)   60 
MCI 0078  E. coli O157:H7 (Sakai::∆stx)  C.Sasakawa, University of Tokyo  O-RFLP reference (Chapter 4) 
Microarray control strain (Chapters 4 & 6) 
Antimicrobial susceptibility testing (Chapter 5) 
MCI 0132  E. coli O9:K30 (EC46/04)  R. M. La Ragione, VLA 
 
O-RFLP reference (Chapter 4) 
MCI 0133  E. coli O149:K91 (EC439/04)  R. M. La Ragione, VLA 
 
O-RFLP reference (Chapter 4) 
MCI 0134  E. coli O147:K89 (EC1203/04)  R. M. La Ragione, VLA 
 
O-RFLP reference (Chapter 4) 
MCI 0191  E. coli O157:H7 (85-170)  M. Stevens, IAH Compton  Antimicrobial susceptibility testing (Chapter 5) 
 
MCI 0200  E. coli O157:H7 (TUV933-0)  D. Miller, Bristol University  O-RFLP reference (Chapter 4) 
Antimicrobial susceptibility testing (Chapter 5) 
MCI 0234  E. coli O157 (SERL5)  L. Allison, SERL 
 
Positive control for: stx2 (Chapters 4 & 6) 
MCI 0236  E. coli O157 (SERL7)  L. Allison, SERL 
 
Positive control for: stx1, stx2 (Chapters 4 & 6) 
MCI 0246  E. coli O162 (SERL17)  L. Allison, SERL 
 
O-RFLP reference (Chapter 4) 
MCI 0247  E. coli O113 (SERL18)  L. Allison, SERL 
 
O-RFLP reference (Chapter 4) 
MCI 0248  E. coli O177 (SERL19)  L. Allison, SERL 
 
O-RFLP reference (Chapter 4) 
MCI 0249  E. coli O118 (SERL20)  L. Allison, SERL 
 
O-RFLP reference (Chapter 4) 
MCI 0254  E. coli K12 (MG1655)  M. Hough, Edinburgh University  O-RFLP reference (Chapter 4) 
Microarray control strain (Chapters 4 & 6) 
 
MCI 0255  E. coli K12 (NCTC10418)  M. Hough, Edinburgh University 
 
Antimicrobial susceptibility testing (Chapter 5) 
MCI 0278  E. coli O127:H6 (E2348/69)  D. Gally, Edinburgh University  O-RFLP reference (Chapter 4)  
Positive control for: eae (α1), espA, escN (Chapter 4). 
MCI 0279  E. coli O157:H7 (TT12B)  D. Gally, Edinburgh University  O-RFLP reference (Chapter 4) 
Antimicrobial susceptibility testing (Chapter 5) 
 
MCI 0291  E. coli O44:H18 (EAggEC 042)  A. Scott-Tucker, University of 
Birmingham 
O-RFLP reference (Chapter 4) 
Positive control for: aat (Chapters 4)   61 
 
MCI 0296  E. coli O157:H- (NCTC13125)  R. M. La Ragione, VLA 
 
O-RFLP reference (Chapter 4) 
MCI 0478  Shigella sonnei (539)  I.R. Henderson, University of 
Birmingham 
 
Positive control for: ipaH (Chapter 4) 
MCI 0479  E. coli O78:H11 (H10407)  I.R. Henderson, University of 
Birmingham 
 
O-RFLP reference (Chapter 4) 
MCI 0480  E. coli O6:K5:H1 (DSM 6601)  Ardeypharm, Germany  O-RFLP reference (Chapter 4) 
Positive control for: neuB (K5 capsule) (Chapter 4) 
 
MCI 0481  E. coli O6:K?:H1 CFT073  D. Gally, Edinburgh University 
 
O-RFLP reference (Chapter 4) 
MCI 0482  E. coli O18:K1:H7 (RS218)  D. Gally, Edinburgh University 
 
Positive control for: kfiC (K1 capsule) (Chapter 4) 
MCI 0652  E. coli O78:K80  F. Dziva, IAH, Compton 
 
O-RFLP reference (Chapter 4) 
MCI 0662  E. coli O4:K6 (J96)  D. Gally, Edinburgh University 
 
O-RFLP reference (Chapter 4) 
MCI 0663  E. coli O6:K15:H31 (536)  D. Gally, Edinburgh University 
 
O-RFLP reference (Chapter 4) 
MCI 0685  E. coli O101 (EC25/06)  R. M. La Ragione, VLA 
 
Positive control for: F5, F41 (Chapter 4) 
MCI 0686  E. coli O9 (EC92/07)  R. M. La Ragione, VLA 
 
Positive control for: F5, F41 (Chapter 4) 
DNA5  E. coli O84:H4 (4795/87)  R. M. La Ragione, VLA 
 
eae (ζ), escN (Chapter 4) 
DNA6  E. coli O145:H4 (7476197)  R. M. La Ragione, VLA 
 
eae (ι), escN (Chapter 4) 
DNA7  E. coli O125:H- (CF/11201)  R. M. La Ragione, VLA 
 
eae (η), escN (Chapter 4) 
DNA8  E. coli O118:H5 (6044/95)  R. M. La Ragione, VLA 
 
eae (κ), escN (Chapter 4) 
DNA9  E. coli O111:H8 (CL37)  R. M. La Ragione, VLA 
 
eae (θ), escN (Chapter 4) 
Table 2.1: Reference strains used in this study: Bovine gastrointestinal E. coli isolates are described in Chapter 4. A full list of EHEC isolates is given in Table 6.1.  62 
2.3   Microbiological techniques 
 
2.3.1   Bacterial culture  
 
2.3.1.1 General culture and maintenance of E. coli isolates 
 
All culture media prepared in-house were sterilised by autoclaving at 15 psi for 15 minutes at 
121˚C  prior  to  use.  All  non-presterilised  heat-sensitive  additive  solutions,  including 
antibiotics,  were  passed  through  a  Millipore  0.22µM  filter  and  added  to  media  after 
autoclaving,  once  media  had  cooled  to  below  55˚C.  Selective  antimicrobial  substances 
employed  included  ampicillin,  streptomycin,  cefixime  and  potassium  tellurite.  Stock 
ampicillin solution (50mg/ml) was prepared in water, filter-sterilised and diluted in media to 
give a final concentration of 50µg/ml. Stock streptomycin (10mg/ml) was prepared in water 
and  diluted  in  media  to  give  a  final  concentration  of  25µg/ml.  Cefixime-tellurite  solution 
(Oxoid)  was  prepared  according  to  the  manufacturers  instructions  and  added  to  media  as 
required,  to  give  final  concentrations  of  cefixime,  2.5µg/ml;  and  potassium  tellurite, 
0.05µg/ml. 
 
E. coli was resuscitated on Luria-Bertani (LB: 1% w/v Bacto-tryptone, 0.5% w/v Bacto-yeast 
extract 1.5% w/v Bacto-agar) medium or nutrient agar (NA; Oxoid, Basingstoke, Hampshire) 
overnight at 37°C. Subculture was generally performed in LB broth (as LB medium without 
agar). Minimal essential medium-HEPES modification (MEM-HEPES, M7278 Sigma) was 
used when bacteria were to be cultured for addition to cultured cell lines. Broth cultures were 
incubated at 37˚C with 200rpm shaking.  
 
Selective indicator media employed for isolation of E. coli and verification of culture purity 
included  Tryptone/bile-salts/X-glucuronide  (TBX)  medium  and  Sorbitol  MacConkey  Agar 
(SMAC) and were both supplied by Oxoid. 
 
To select transformants carrying cloned plasmids, S-Gal/LB Agar Blend (Sigma C-4478) was 
employed. One sachet was added to 500ml distilled water before autoclaving. Ampicillin was 
included at a final concentration of 50µg/ml.   63 
 
2.3.1.4 Long term storage of E. coli isolates 
 
Glycerol stocks of E. coli isolates were prepared by mixing 500µl of E. coli overnight culture 
with  500µl  sterile  LB  containing  30%  v/v  glycerol  in  a  1.5ml  sterile  centrifuge  tube  or 
Cryovial. Alternatively, 5 colonies of a pure overnight culture on LB or NA medium were 
transferred to a Protect vial (Prolabs, Neston, Wirral, UK) using a sterile disposable plastic 
loop. The vial was vortexed briefly and the liquid removed and discarded. Glycerol stocks and 
Protect vials were stored at -70°C until required. 
 
2.3.2 Isolation and enumeration of E. coli from cattle 
 
Isolation  of  E.  coli  associated  with  gastrointestinal  mucosal  surfaces  followed  a  protocol 
adapted from Naylor  et al. (2003). Sections of the gastrointestinal tract (roughly 20cm in 
length)  were  removed  from  the  animal  post  mortem.  Tract  portions  were  opened 
longitudinally and visible gastrointestinal contents were carefully shaken off (or gently rinsed 
off  with  sterile  PBS  where  this  was  not  possible).  The  mucosal  layer  was  parted  from 
underlying connective tissue and rinsed gently but thoroughly with sterile PBS. Three 1cm
2 
pieces of tissue were cut from the mucosal layer and added to 5ml aliquots of sterile PBS. 
Tubes containing tissue sections in PBS were held on ice for no more than one hour before 
further processing. For bacterial enumeration tissue sections in aliquots of PBS were vortexed 
for one minute and serial tenfold dilution was performed using sterile PBS. Spread plates on 
TBX medium (Oxoid) were prepared in triplicate using 100µl of the undiluted sample and 
diluted samples. The resulting plates were incubated at 37°C overnight. Blue (glucuronidase 
positive) and white (glucuronidase negative) colonies were counted. The vast majority of E. 
coli isolates (96-97%) produce an active glucuronidase enzyme, although certain serotypes 
(including strains of serotype O157:H7) are glucuronidase negative (Ratnam et al., 1988). β-
glucuronidase activity has been found to be restricted to the genera Escherichia, Shigella and 
Salmonella  among  the  Enterobacteriaecae  (Kilian  and  Bulow,  1979);  hence,  detection  of 
glucuronidase activity is an important (though not absolute) indicator that a bacterial isolate is 
likely to belong to Escherichia or related genera. The dilution yielding plates with the highest 
number of colonies (where that number was less than 1000) were used to calculate the average   64 
number of E. coli per 100µl of the undiluted sample. At least 18 colonies were picked per site 
for each animal (where 18 colonies were available) and transferred to 10ml aliquots of LB. 
The ratio of blue:white colonies picked was made to reflect the ratio of blue:white colonies 
obtained at each site. The colonies in LB were incubated overnight at 37°C with 200rpm 
shaking. These cultures were used to prepare glycerol stocks (Section 2.3.4.1) and genomic 
DNA (Section 2.6.1). 
 
To visualise mucosal tissue morphology at the sites sampled, two additional pieces of tissue 
were taken from each site, adjacent to the sections taken for microbiological examination. One 
was preserved in a 10ml aliquot of formal saline and the other was placed in a plastic tissue 
cassette with one drop of OCT (TissueTek) and transferred to liquid nitrogen. Snap-frozen 
OCT-embedded tissue was subsequently stored at -70˚C. Further processing of formal-saline-
fixed  tissue  was  performed  by  the  Pathology  Unit,  Moredun  Research  Institute.  Tissue 
sections were stabilised in plastic cassettes, embedded in paraffin wax and used to prepare 
haematoxylin  and  eosin-stained  sections  according  to  standard  methodology.  Slides  were 
visualised using an Olympus BX50 microscope and an Olympus DP70 camera. Cell
F Imaging 
Software (Olympus) was used to convert images to the TIFF file format. 
 
Sampling of E. coli from live cattle was performed by insertion of a swab into the anus of the 
animal and gently rubbing this against the recto-anal mucosa for approximately 5 seconds. 
Swabs were used to prepare streak plates on TBX medium using standard methodology. 
 
E. coli isolates provided by Stuart Naylor were isolated from necropsy tissue sections by the 
method described above, except that “colony sweeps” were provided, whereby colonies from 
TBX-agar plates were gathered using a sterile spreader and transferred directly to glycerol 
stocks. Individual isolates were derived from these mixtures in the course of this study, by 
performing streak plates on TBX-agar. Strains provided by Neil Paton were isolated from live 
cattle  by  rectal  mucosal  swab  (described  above)  or  by  faecal  “free-catch”  whereby  faecal 
matter was caught in a clean glove on emergence from the animal. Swabs or faecal matter 
were used to prepare streak plates on CT-SMAC and individual sorbitol-fermenting (pink) 
colonies were selected and used to prepare glycerol stocks or Protect vials as set out in Section 
2.3.1.4. 
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2.3.3  Cell lines and culture conditions 
 
2.3.3.1 T84 
 
The  T84  cell  line  was  obtained  from  the  European  Collection  of  Cell  Cultures  (ECACC, 
Salisbury, England); originally derived from a lung metastasis of colon carcinoma in a 72 year 
old male (Murakami and Masui, 1980). T84 cells were grown in a 1:1 mixture of Dulbecco’s
 
modified Eagle medium (DMEM, Sigma: D6546) and Nutrient Mixture Ham's F12 (Sigma 
N4888) supplemented
 with 10% (v/v) gamma irradiated heat-inactivated foetal bovine
 serum 
(FBS, BioSera) and 2mM  L-glutamine. Cells were maintained in a humidified
 atmosphere 
containing 5% CO2 at 37°C. 
 
2.3.3.2 Caco-2 
 
The Caco-2 cell line was provided by ECACC and was originally derived from a primary 
colonic tumour (Fogh et al., 1977). Caco-2 cells were maintained in DMEM supplemented L-
glutamine  (2
  mM)  and  10%  FBS.  Cells  were  maintained  in  a  humidified
  atmosphere 
containing 5% CO2 at 37°C. 
2.3.3.3  EBL 
 
The epithelial bovine lung (EBL) cell line was kindly provided by John March (MRI) and was 
originally  obtained  from  the  Deutsche  Sammlung  von  Mikroorganismen  und  Zellkulturen 
GmbH (DMSZ). The cell line was originally isolated from lung of a 7-month-old bovine fetus 
(Rutter and Luther, 1984). EBL cells were maintained in Eagles Minimal Essential Medium 
(EMEM, Sigma: M2279) supplemented with 10% FBS and 2mM  L-glutamine. Cells were 
maintained in a humidified atmosphere containing 5% CO2 at 37˚C. 
 
2.3.4  Preparation of bacterial conditioned medium (supernatants) 
 
Single colonies of LB-grown bacteria were picked and used to inoculate 10ml aliquots of 
MEM-HEPES or MEM-HEPES including streptomycin. These were incubated overnight at 
37˚C  200rpm  shaking.  Cultures  were  subsequently  diluted  1:10  in  fresh  MEM-HEPES  (±   66 
streptomycin 25µg/ml) (prewarmed to 37˚C) and incubated at 37°C with 200rpm shaking. 
OD600 of mid-log and late-log phase cultures was determined to be approximately 0.35 and 0.6 
respectively; estimated by the construction of growth curves. Upon reaching this absorbance, 
cultures  were  centrifuged  at  5000g  for  10  minutes  at  4˚C  and  the  supernatant  harvested. 
Supernatant  samples  were  filter-sterilised  using  Millipore  disposable  0.22µm  low  protein 
binding filters. 7ml aliquots were stored at -70˚C until required.  
 
E. coli O157 (fliC-) MCI 0025 was grown in MEM-HEPES containing 25µg/ml streptomycin. 
When bacterial supernatants from streptomycin sensitive strains were used, streptomycin was 
added to the supernatants after filtering, to ensure that all challenge materials contained an 
equal amount of streptomycin. Streptomycin was also included in the control media (MEM-
HEPES) used in subsequent sections to determine basal responses.  
 
2.3.5  Stimulation of cultured cell lines cells using bacterial supernatants 
 
Cell monolayers (T84 or EBL) were grown in 24-well tissue culture plates until the first day 
after they became fully confluent. Prior to challenge all material to be added to the cells was 
prewarmed to 37˚C. Residual cell medium was removed from the cell culture plate and each 
well was washed twice in serum-free cell culture medium. Cell culture medium was replaced 
with bacterial conditioned medium or sterile MEM-HEPES (25µg/ml streptomycin) diluted 
1:1 in sterile serum-free cell culture medium. Untreated wells incubated with sterile serum-
free cell culture medium alone were included to assess plate-plate variation and edge-effects. 
Challenges were carried out for 24 hours, after which time, the medium was drawn off and 
stored at -70°C until required. 
 
2.3.6  Challenge of cultured cell lines cells using live bacteria 
 
EBL-cell monolayers were grown in 12-well tissue culture plates until the first day after they 
became fully confluent. Medium was removed and replaced with serum-free medium 24 hours 
prior to challenge. Bacteria were grown and subcultured in MEM-HEPES (± streptomycin 
25µg/ml)  as  detailed  in  Section  2.3.4.  Subcultured  bacteria  were  grown  to  mid-log  phase 
(OD600=0.35). Prior to challenge all material to be added to the cells was prewarmed to 37˚C.   67 
Residual cell medium was removed from the cell culture plate and each well was washed 
twice in serum-free cell culture medium (prewarmed to 37°C). For challenge with a MOI of 
100 bacteria per cell the volume in the wells was adjusted to 800µl using serum-free cell 
culture medium. 200µl bacterial culture was added to the cells and the plates were incubated at 
37˚C until the specified timepoint.  
 
For live-challenge timecourse experiments, medium containing bacteria was removed at the 
specified timepoints. Bacteria and cell debris were removed by passing the sample through a 
0.22µM filter and the samples stored at -20˚C until analysed by ELISA (Section 2.5.2). 
 
A method based on the gentamicin protection assay (Tang et al., 1993) was also employed, 
whereby live challenges were carried out as above. After 1 hour or 3 hours, cell medium was 
removed and the cells washed twice with serum-free culture medium. 1ml serum-free cell 
culture medium containing 100µg/ml gentamicin was added to each well. Cells were incubated 
until the total time after the addition of the bacteria had progressed to 24 hours. After this 
time, culture medium was drawn off, centrifuged and the supernatant transferred to a fresh 
tube. Samples were stored at -20˚C until required for analysis by ELISA (Section 2.5.2). 
 
2.3.7  Treatment of cultured cell lines with the StcE protease 
  
Three-day post-confluent Caco-2 cells were prepared and maintained in 6-well tissue culture 
plates according to Section 2.3.3.2. Medium was removed and replaced with medium lacking 
foetal bovine serum 24 hours prior to treatment. Cells were treated with 25µg/ml rStcE in 
serum-free Caco-2 cell medium for 4h at 37°C in a humidified atmosphere containing 5% 
CO2.  Cells  treated  with  a  similar  volume  of  PBS  were  used  as  a  negative  control.  Cell 
monolayers were treated with 150µl 2D lysis buffer per well (8M Urea, 4% (w/v) CHAPS, 
40mM  Tris,  including  Protease  Inhibitor  Cocktail  (1  tablet  to  10ml  buffer)  Boehringer 
Manheim) and samples were analysed by 2-DGE as described in Section 2.4.3. 
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2.4  Proteomic techniques 
 
2.4.1  SDS-PAGE  
 
Two  glass  plates  were  clamped  together  vertically  and  a  resolving  gel  comprising 
acrylamide:N,N’-methylenebisacrylamide  (37.5:1,  10%  w/v),  Tris  (375mM,  pH8.8).  SDS 
(0.1%  w/v),  ammonium  persulphate  (APS,  0.025%  w/v)  and  N,N,N’,N’-
tetramethylethyldiamine  (TEMED,  0.005%  v/v),  was  poured  between  them,  leaving 
approximately 3cm between the surface of the gel and the top of the glass plates. SDS (200µl, 
0.1% w/v) was layered on top of this to produce a smooth level surface and exclude air. When 
polymerisation  of  the  separating  gel  was  complete  the  layer  of  SDS  was  removed  and  a 
stacking  gel  composed  of  acrylamide:N,N’-methylenebisacrylamide  (37.5:1,  3%  v/v),  Tris 
(125mM, pH6.8), SDS (0.1% w/v), APS (0.1%w/v) and TEMED (0.14% v/v) was poured 
above the resolving gel. A plastic comb was inserted into the stacking gel to form wells for the 
loading of samples. Following polymerisation of the stacking gel, the comb was removed and 
the assembled gel placed in a Biorad Mini-Protean III™ electrophoresis tank. Both reservoirs 
were then filled with 1X running buffer (25mM Tris, 192mM glycine, 0.1% SDS). Once the 
separating and stacking gels were prepared, protein samples were mixed 3:1 with 4X Laemmli 
sample buffer (250mM Tris, pH 6.8, 40% v/v glycerol, 8% w/v SDS, 520mM dithiothreitol 
(DTT), 0.01% w/v bromophenol blue) or prepared in 1X Laemmli sample buffer, boiled for 10 
minutes, then chilled on ice. Samples and molecular weight markers (PageRuler: Fermentas) 
were loaded into the wells of the gel using gel loading tips. A current was passed across the 
gel at a constant voltage of 135V at room temperature until the dye front had reached the 
bottom of the resolving gel. 
2.4.2  Non-denaturing Polyacrylamide gel electrophoresis (Acidic conditions) 
 
Acidic native gel electrophoresis was performed essentially as SDS-PAGE, with the following 
alterations  to  buffers  and  conditions.  Resolving  gel  was  composed  of  acrylamide:N,N’-
methylene-bisacrylamide (37.5:1, 10% v/v), Acetate-KOH (34mM, pH4.3), glycerol (11.5% 
v/v), APS (0.12% w/v) and TEMED 0.15%. 300µl of n-butanol was layered on top of this to 
produce a smooth level and exclude air. Once the resolving gel was fully polymerised, the n-
butanol  was  removed  and  stacking  gel  (3%  v/v  acrylamide:N,N’-methylene-bisacrylamide   69 
(37.5:1), 62mM Acetate-KOH (pH6.8), 0.1% v/v APS, 0.1% v/v TEMED) was added and a 
plastic  comb  inserted.  Running  buffer  (348mM  β-alanine,  20.5%  acetic  acid,  pH4.3)  was 
added to both reservoirs of the electrophoresis tank. Samples were mixed 1:8 with dissolving 
buffer (37% v/v glycerol, 64mM Acetate-KOH, pH6.8, including a trace amount of Methyl 
green)  and  kept  on  ice.  Protein  ladder  was  prepared  by  combining  equal  amounts  of  α-
Lactalbumin,  carbonic  anhydrase,  chicken  egg  albumin  and  bovine  serum  albumin  and 
combining this mixture with an equal volume of dissolving buffer. Samples and protein ladder 
were loaded into the wells and a current of 135V was passed across the gel with reverse 
polarity for approximately 1.5hrs at 4°C. 
 
2.4.3  2D Gel Electrophoresis (2-DGE) 
 
The  method  used  for  2-DGE  was  based  on  that  recommended  by  Amersham  Bioscience. 
Commercially-available precast gels were used for both the first and second dimensions which 
were carried out using an IPGphor isoelectric focusing unit (first dimension) and a flat-bed 
Multiphor (second dimension). Commercially-available 18 cm pH3-10 non-linear immobilised 
pH gradient (IPG) strips were employed (Amersham Biosciences). The second dimension was 
performed using 12.5% Ettan DALT Gels. 
 
Samples  (prepared  according  to  Section  2.3.7)  were  treated  with  the  2-D  Clean-Up  kit 
(Amersham Biosciences) according to the manufacturer’s instructions. Briefly, 100µl aliquots 
of  protein  sample  were  mixed  with  300µl  precipitant  solution,  vortexed  thoroughly  and 
incubated  on  ice  for  15  minutes.  300µl  co-precipitant  was  added  and  the  mixtures  were 
vortexed  briefly.  Tubes  were  centrifuged  at  12,000g  in  a  microcentrifuge  for  5  minutes. 
Supernatant was completely removed, aided by a brief pulse-centrifuge to recover residual 
liquid for removal. 40µl of co-precipitant was carefully layered on the pellet and the tubes left 
on ice for 5 minutes. Tubes were centrifuged again for 5 minutes at 12,000g. Liquid was 
carefully removed without disturbing the pellet. 25µl distilled water was added, dispersing the 
pellet. 1ml chilled wash buffer (-20˚C) and 5µl wash additive were added to each pellet and 
tubes  were  vortexed  for  10  seconds.  Tubes  were  incubated  at  -20˚C  for  30  minutes  with 
intermittent  vortexing.  Tubes  were  centrifuged  at  maximum  speed  in  a  microcentrifuge 
(17,000g) for 5 minutes. Wash buffer was discarded and pellets allowed to air dry briefly, 
before  resuspension  in  100µl  2D  rehydration  solution  (8M  urea,  2%  (w/v)  CHAPS,  0.2%   70 
(w/v) DTT, 1% (v/v) IPG buffer and 0.002% (w/v) bromophenol blue). The resultant mixture 
was vortex for 30 seconds and subsequently centrifuged to reduce foam. 
 
Duplicate 1µl and 5µl aliquots were transferred to 1.5ml centrifuge tubes and analysed using 
the 2D Quant Kit (Amersham) according to the manufacturer’s instructions. Briefly, a set of 
BSA standards was prepared, from 0-25µg. 500µl precipitant was added to each sample and 
standard.  Tubes  were  vortexed  and  left  at  room  temperature  for  2-3  minutes.  500µl  co-
precipitant was added to each tube and the tubes were vortexed briefly then centrifuged at 
10,000g for 5 minutes. All visible supernatant was removed from each tube and 100µl copper 
solution was added, along with 400µl distilled water. 1ml colour reagent was added to each 
tube and mixed quickly by vortexing. Absorbance at 480 nm was determined, using water as a 
reference. A standard curve was plotted and the protein concentration of the original sample 
was predicted using this curve. 
 
The  volume  of  each  original  sample  was  adjusted  using  rehydration  solution  to  give 
approximately 250µg protein in 400µl rehydration solution, which was used to rehydrate IPG 
strips. IPG strips were rehydrated for a minimum of 12 hours in a DryStrip reswelling tray 
(Amersham). Strips were subsequently transferred to universal IPG Strip holders and then 
placed on an IPGphor. 
 
Isoelectric focusing was carried out using a gradually increasing voltage, 30V for the first 
hour, 150V for the second hour; then the voltage was doubled every hour until the 6
th hour 
(2400V).  8000V  were  applied  thereafter,  until  approximately  80kVh  had  been  applied  to 
strips. At this point strips were stored at -80°C until electrophoresis in the second dimension 
could be carried out. Strips were removed from -80°C storage and allowed to warm up to 
room temperature. A two step equilibration process was performed, using equilibration buffer 
(an aqueous solution containing 50 mM Tris-HCl, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% 
(w/v) SDS and 0.002% (w/v) bromophenol blue). Strips were incubated at room temperature 
for 20 minutes on a shaking platform with in equilibration buffer containing dithiothreitol (1% 
w/v).  This  equilibration  buffer  was  discarded  and  replaced  with  fresh  equilibration  buffer 
containing iodoacetamide (4% w/v) and incubated for a second 20 minute period. 
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First dimension strips were then removed from the equilibration buffer and carefully blotted to 
remove  excess  traces  of  buffer  before  being  placed  onto  the  polyacrylamide  for 
electrophoresis. Electrophoresis was carried out at 600V, 20 mA, 40 W for 30 minutes. The 
first dimension strips were removed from the gel and discarded. Electrophoresis was then 
continued at 600 V, 40 mA, 40 W until the tracking dye had migrated to the anodic buffer 
strip. Gels were stained with colloidal coomassie according to Section 2.4.3 
 
2.4.4  Polyacrylamide Gel Staining 
 
In order to visualise all protein bands/spots after PAGE, gels were fixed in 50% v/v methanol, 
10% v/v acetic acid in distilled water for at least 30 minutes. Staining was carried out using 
Genomic Solutions Colloidal Coomassie solution in 20% v/v methanol overnight. Gels were 
destained in 25% methanol for at least 4 hours. For visualisation of glycosylated proteins after 
SDS-PAGE,  gels  were  stained  using  the  GelCode  Glycoprotein  Staining  Kit  (Pierce 
Biotechnology) according to the manufacturer’s instructions. All incubations were carried out 
at room temperature with gentle agitation on a rocking platform. Briefly, gels were fixed in 
100ml of 50% (v/v) methanol for 30 minutes, washed twice for 10 minutes in 3% (v/v) acetic 
acid and subsequently transferred to 25ml Oxidising solution for 15 minutes. Gels were then 
washed 100ml 3% acetic acid three times for 5 minutes each time and subsequently transferred 
to 25ml GelCode Glycoprotein Staining Reagent for 15 minutes, followed by 25ml reducing 
solution for 5 minutes. Gels were washed for at least one hour in 3% acetic acid, then for at 
least one hour in distilled water.  
 
2.4.5  MALDI-TOF mass spectrometry 
 
MALDI-TOF  mass  spectrometry  was  carried  out  at  the  Moredun  Proteomics  Facility 
according  to  standard  methodology.  Briefly,  protein  bands  from  the  SDS-page  gels  were 
treated with 100mM ammonium bicarbonate/50% acetonitrile three times. They were then 
dehydrated in 100% acetonitrile for 10mins and dried for 20mins under a vacuum, followed by 
incubation  with  10mM  DTT  in  100mM  ammonium  bicarbonate  at  56ºC  for  1hr.  The 
supernatant was then removed and the bands incubated in a solution of 55mM iodoacetimide 
in 100mM ammonium bicarbonate, in the dark for 30mins. The supernatant was removed and   72 
bands  were  treated  with  100mM  ammonium  bicarbonate/50%  acetonitrile,  dehydrated  and 
dried as previous steps. The bands were subjected to trypsinolysis and analysed by matrix 
assisted  laser  desorption  ionisation-time  of  flight-mass  spectrometry  (MALDI-TOF-MS). 
Resultant  peptide  profiles  were  compared  predicted  patterns  using  the  MASCOT  search 
engine (Matrix Science Inc) to search the NCBI non-redundant and Swissprot databases. 
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2.5  Immunochemical Techniques 
 
2.5.1  Western Blotting 
 
Immediately  following  SDS-PAGE,  proteins  in  gels  were  transferred  onto  Hybond-C 
membranes (Millipore) by electrophoretic blotting. The gel was pressed against a piece of 
nitrocellulose membrane which had been pre-soaked in transfer buffer (25mM Tris, 192mM 
glycine, 20% v/v methanol) and supported between two Whatmann 3MM papers and two 
sponge pads. This assembly was placed in a BioRad Mini Trans-Blot™ tank which was filled 
with transfer buffer (25mM Tris, 192mM Glycine, 20% v/v Methanol). Transfer was carried 
out by applying a current of 240mA for 1h 45min. Tanks were cooled by the inclusion of ice 
packs containing transfer buffer, frozen at -20˚C prior to use. 
 
Membranes  were  blocked  for  at  least  2  hours  in  Tris-buffered  saline/Tween-20  (TBS-T: 
20mM Tris/HCl, 150mM NaCl, pH7.2, 0.03%v/v Tween-20) including skimmed milk powder 
(Marvel™,  5%  w/v).  Primary  antibody  was  diluted  to  the  appropriate  concentration  (see 
below)  in  TBS-T/Marvel™  (0.5%  w/v)  and  membranes  were  incubated  in  this  solution 
overnight with constant agitation at 4
oC. The membranes were then washed with TBS-T for 
approximately 1.5 hours, changing the buffer every 15 min. Horseradish peroxidise (HRP) -
conjugated  secondary  antibodies  were  diluted  to  the  appropriate  concentration  in  TBS-
T/Marvel™  (0.5%w/v)  and  incubated  for  2  hours  with  the  membranes,  which  were  then 
washed.  Membranes  were  then  developed  using  the  enhanced  chemiluminesence  (ECL) 
system  (Amersham).  X-ray  film  (Kodak)  was  exposed  to  the  membranes,  which  were 
developed using an X-ray developer.  
 
Two different primary/secondary  antibody  combinations were employed during this study; 
Firstly: the goat anti-human-C1-esterase inhibitor whole antiserum (Sigma, C8159) used at a 
working  dilution  of  1/400,  followed  by  HRP-conjugated  rabbit  anti-goat  IgG  secondary 
antibody (Sigma, A5420) at a working dilution of 1/5000.  
 
Secondly,  whole  bovine  mucosal  scrapings  from  calf  experimentally  infected  with  E.  coli 
O157:H7 (MCI 0010) were provided by Dr Arvind Mahajan. The mucosa was scraped using a   74 
glass  slide  and  the  scrapings  (approximately  50mg)  were  suspended  in  5  ml  of  ice  cold 
phosphate  buffered  saline  (PBS,  pH  7.2)  plus  protease  inhibitor  cocktail  (Complete-Mini, 
Roche, Mannheim, Germany), vortexed and clarified by centrifugation at 16,000g and 4 °C for 
15 min. This solution was used as a primary antibody at a working dilution 1/10 in TBS-T. 
Blots probed with this mixture were probed with HRP-conjugated anti-bovine IgA (Serotec) at 
a working dilution of 1/1000. 
 
2.5.2  Enzyme-linked Immunosorbent Assay (ELISA) 
 
The  Human  IL-8  ELISA  Duoset  (R&D  Systems)  was  employed  according  to  the 
manufacturer’s instructions. 96-well EIA/RIA stripwell plates (Costar) were coated overnight 
in the Capture Antibody (4.0 µg/ml in PBS, 100µl/well). Liquid from the wells was removed 
by  aspiration  and  each  well  was  washed  3  times  with  400µl  PBS,  containing  0.05%  v/v 
Tween-20.  Residual  washing  buffer  wash  removed  by  blotting  on  clean  tissue  paper.  The 
plates were then blocked using PBS containing 1% w/v BSA (300µl/well) for a minimum of 1 
hour;  then  aspiration  and  washing  was  carried  out  as  before.  Samples  of  cell  culture 
supernatant (generated as detailed in Section 2.3.5 and 2.3.6) were added in 100µl volumes 
and incubated for 2 hours at room temperature. IL-8 standards were also included in serial 1:1 
dilutions in Reagent Diluent (0.1%w/v BSA, 0.05% v/v Tween-20, 20mM Tris Base, 150mM 
NaCl)  from  2000  to  62.5pg/ml.  Three  wells  containing  reagent  diluent  alone  were  also 
included. Wells were aspirated and washed as before and the Detection Antibody (20ng/ml in 
Reagent  Diluent)  was  added  (100µl/well).  Plates  were  incubated  for  2  hours  at  room 
temperature, then plates were aspirated and washed as before. To each well was added 100µl 
Streptavidin-HRP (diluted 1:200 in Reagent Diluent). The plate was incubated for 20 minutes 
in the dark. The plate was aspirated and washed as before. 100µl Substrate solution (60ng/ml 
Tetramethyl  benzidine  in  acetate:citrate  buffer  pH5.5,  0.04%  v/v  hydrogen  peroxide)  was 
added to each well and the plate again incubated in the dark for 20 minutes. 50µl stop solution 
(10%w/v sulphuric acid) was then added to each well and the plate read at 450nm using the 
ELx808IU  Ultra  Microplate  Reader  (BIO-TEK  Instruments  Inc.).  A  standard  curve  was 
constructed and a third order polynomial trendline was fitted to the datapoints using Microsoft 
ExCel.  The  equation  generated  was  used  to  convert  absorbance  readings  to  concentration 
figures.   75 
2.6  Genomic Techniques 
 
2.6.1  Preparation of bacterial DNA 
 
2.6.1.1  DNeasy blood and tissue kit (QIAGEN) 
 
To obtain high purity bacterial genomic DNA required for DNA microarray hybridisation, the 
DNeasy  blood  and  tissue  kit  was  employed  according  to  the  manufacturer’s  instructions. 
Briefly, bacterial isolates were cultured overnight in LB. Two 1.5ml aliquots from each strain 
were harvested by centrifugation at 8,000g for 5 minutes. The supernatant was discarded and 
pellets were resuspended in 180µl Buffer ATL. 20µl proteinase K was added and the tubes 
were mixed thoroughly using a vortex mixer. Tubes were incubated at 56˚C for 3h. After this 
period, tubes were allowed to cool to room temperature. 1µl RNase A (100mg/ml, QIAGEN) 
was added to each tube, mixed thoroughly by vortexing and incubated for 2 minutes at room 
temperature. 200µl Buffer AL and 200µl absolute ethanol were added to each sample and 
these were mixed thoroughly by vortexing. The mixtures were subsequently transferred to a 
DNeasy Mini Spin column, placed in a 2ml collection tube. Columns were centrifuged at 
6,000g (8,000rpm) for 1 minute in a microcentrifuge. Flow-through was discarded and the 
columns  were  washed  using  500µl  Buffer  AW1  and  secondly  using  500µl  Buffer  AW2, 
centrifuging at 6000g (8,000rpm) discarding flow-through after each wash. After the second 
wash,  the  columns  were  replaced  in  the  collection  tube  and  centrifuged  at  20,000g 
(14,000rpm) for 2 minutes to remove residual wash buffer from the column. The columns 
were  placed  in  sterile  1.5ml  centrifuge  tubes.  For  each  strain  (represented  by  2  columns 
containing genomic DNA) 200µl AE buffer was added to the first column, DNA was eluted by 
centrifugation at 6,000g (8,000rpm) for 2 minutes. The eluted sample from the first column 
was transferred to the second column and used to elute the second column in the same way. 
Thus, 2 columns were eluted with one volume of AE buffer, which resulted in an optimal yield 
of DNA required for DNA microarray (Section 2.6.6). DNA samples were stored at -20˚C 
until required. 
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2.6.1.2  Wizard genomic DNA kit (Promega) 
 
For the production of high concentrations of high molecular weight bacterial genomic DNA 
suitable  for  Long-template  PCR  (Section  2.6.4.1)  and  genomic  subtractive  hybridisation 
(Section  2.6.8)  the  Wizard  genomic  DNA  purification  kit  was  utilised  according  to  the 
manufacturer’s  instructions,  with  some  modifications.  For  each  isolate,  1.5ml  of  a  10ml 
overnight  culture  in  LB  was  pelleted  by  centrifugation  at  10,000g  for  2  minutes.  The 
supernatant  was  removed  and  discarded.  The  pellet  was  thoroughly  resuspended  in  300µl 
Nuclei Lysis Solution by gentle pipetting. The mixture was incubated at 80°C for 5 minutes to 
lyse the cells. The mixture was cooled to room temperature and 1µl RNase A was added. The 
tubes were inverted 2-5 times to mix and left at room temperature for 5-15 minutes. To the 
lysate,  100µl  Protein  Precipitation  Solution  was  added  and  the  mixture  was  immediately 
vortexed  for  20  seconds  and  transferred  to  ice and  allowed  to  stand  for  a  minimum  of  5 
minutes. The mixture was centrifuged at maximum speed (17,000g) in a microcentrifuge for 5 
minutes  at  4°C.  The  supernatant  was  transferred  to  a  clean  tube  containing  300µl  room 
temperature isopropanol and mixed thoroughly until the DNA formed a visible mass. The 
DNA was pelleted by centrifugation at 13000g for 2 minutes. The supernatant was removed 
and  replaced  with  750µl  of  room  temperature  70%  v/v  ethanol.  The  tubes  were  inverted 
several times to wash the DNA pellet and the inside of the tube. The tubes were centrifuged at 
13,000g  for  2  minutes  to  recover  the  DNA  pellet.  The  ethanol  was  then  aspirated  and 
discarded and the pellet was allowed to air-dry until all visible ethanol had evaporated. The 
pellet was rehydrated by the addition of 100µl TE buffer (Sigma, 10mM Tris, 1mM EDTA, 
pH8.0) and the tube was gently tapped to aid dispersion of the pellet. Rehydration was allowed 
to continue overnight at room temperature. Purified DNA was subsequently stored at 4°C or -
20°C. To increase the yield of DNA produced using this procedure (required for genomic 
subtractive  hybridisation)  a  scaled-up  protocol  was  adopted.  The  same  procedure  was 
performed as in the small-scale protocol except for the following alterations. 50ml Falcon 
centrifuge tubes were used throughout. All centrifugation steps were carried out in a Sigma 
4K15 centrifuge at 5,000g. 10ml overnight culture was processed. Lysis was carried out using 
6ml Nuclei Lysis Solution. Lysate was treated with 10µl RNase A. Protein precipitation was 
carried out using 2ml Protein Precipitation Solution. DNA was precipitated in 6ml isopropanol 
and the pellet washed in 10ml 70% v/v ethanol. DNA was rehydrated in 200µl TE buffer. 
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2.6.1.3  Rapid genomic DNA preparation 
 
Although the Wizard genomic DNA kit provided chromosomal DNA of high purity, it was 
found not to contain detectable levels of pO157 plasmid DNA when analysed by PCR for the 
espP gene. Therefore, to provide template DNA suitable for screening bacterial isolates for 
virulence  factor-encoding  genes  and  for  a  rapid  method  of  PCR-screening  of  transformed 
clones,  a  third  method  was  adopted.  Briefly,  single,  well-isolated  bacterial  colonies  were 
picked  from  overnight  cultures  on  LB  medium,  nutrient  agar  or  S-gal-ampicillin  medium 
(Section 2.3.1.1). Each colony was resuspended in 50µl well-mixed Instagene Chelex Matrix 
(BioRad) by vigorous vortexing for 10 seconds. The mixture was heated to 100°C in a heating 
block for 10 minutes. The mixture was allowed to cool briefly and vortexed again for 10 
seconds.  Samples  were  stored  at  -20˚C  until  required.  Before  each  use,  samples  were 
centrifuged at 12,000g for 1 minute. 
 
2.6.1.4  Isolation of Plasmid DNA 
 
Plasmid DNA from bacteria transformed with cloning vectors was isolated using the Wizard 
SV  miniprep  kit  (Promega)  according  to  the  manufacturers’  instructions.  Briefly,  10ml 
overnight bacterial culture, grown in LB containing 50µg/ml ampicillin (Section 2.3.1.1) was 
centrifuged at 13,000g for 5 minutes in a microcentrifuge. The supernatant was discarded and 
the pellet resuspended in 250µl cell resuspension solution. To this was added 250µl of cell 
lysis solution and the tube was vortexed thoroughly to mix. 10µl alkaline protease solution 
was added to this mixture and this was inverted several times to mix. 350µl Neutralisation 
solution was added and the mixture was vortexed vigorously for 10 seconds. The resultant 
lysate was transferred to a spin column and centrifuged for 1 minute at 13,000g. The flow-
through was discarded and 750µl wash buffer was added to the column. This was centrifuged 
again at 13,000g and the resultant flow-through discarded. This washing step was repeated 
using 250µl wash buffer; centrifugation was carried out at 13,000g for 2 minutes. The column 
was transferred to a sterile 1.5ml centrifuge tube and plasmid DNA was eluted by addition of 
100µl nuclease-free water to the column and centrifugation for 1 minute at 13,000g. Plasmid 
DNA samples were stored at -20˚C until required. 
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2.6.2  Spectrophotometric analysis of DNA 
 
Purified DNA was quantified by measurement of absorbance at 260nm using a Nanodrop ND-
1000  spectrophotometer.  Absorbance  ratios  (260/280nm  and  260/230nm)  were  used  to 
determine DNA purity. 
 
2.6.3  PCR-analysis of E. coli isolates 
 
PCR  primers  were  obtained  from  MWG-Biotech  (where).  Primers  used  in  this  study  are 
detailed  in  Table  2.2.  All  PCR  reactions  were  carried  out  using  Thermo-Hybaid  thermal 
cyclers. PCR mixes and cycling conditions are detailed in Table 2.3. Results of PCR analysis 
were visualised by agarose gel electrophoresis (Section 2.6.5).   79 
 
Target gene     Sequence  Reference 
chuA  chuF  GACGAACCAACGGTCAGGAT  Clermont et al.  
   chuR  TGCCGCCAGTACCAAAGACA  (2000) 
yjaA  yjaF  TGAAGTGTCAGGAGACGCTG  Clermont et al.  
   yjaR  ATGGAGAATGCGTTCCTCAAC  (2000) 
TSPE4.C2  tspF  GAGTAATGTCGGGGCATTCA  Clermont et al.  
   tspR  CGCGCCAACAAAGTATTACG  (2000) 
stx (RFLP)  LinF  GAACGAAATAATTTATATGT  Bastian et al.  
   LinR  TTTGATTGTTACAGTCAT  (1998) 
stx1  stx1F  ATAAATCGCCATTCGTTGACTAC  Aranda et al. 
   stx1R  AGAACGCCCACTGAGATCATC  (2004) 
stx2  stx2F  GGCACTGTCTGAAACTGCTCC  Aranda et al. 
   stx2R  TCGCCAGTTATCTGACATTCTG  (2004) 
ipaH  ipaF  GTTCCTTGACCGCCTTTCCGATACCGTC  Aranda et al. 
   ipaR  GCCGGTCAGCCACCCTCTGAGAGTAC  (2004) 
aat  aatF  CTGGCGAAAGACTGTATCAT  Aranda et al. 
   aatR  CAATGTATAGAAATCCGCTGTT  (2004) 
bfpA  bfpF  AATGGTGCTTGCGCTTGCTGC  Aranda et al. 
   bfpR  GCCGCTTTATCCAACCTGGTA  (2004) 
eae  eaeF  CTGAACGGCGATTACGCGAA  Aranda et al. 
   eaeR  CCAGACGATACGATCCAG  (2004) 
eae (RFLP) 
 
 
eaeVF  AGYATTACTGAGATTAAG  Ramachandran 
   eaeVR  AAATTATTYTACACARAY  et al. (2003) 
   eaeZetaVR  AGTTTATTTTACGCAAGT    
   eaeIotaVR  TTAAATTATTTTATGCAAAC    
espP  espPF  AAACAGCAGGCACTTGAACG  McNally et al.  
  
espPR  AGACAGTTCCAGCGACAACC 
 
(2001) 
espP (RFLP)  PRFLPf  AAACAGCAGGCACTTGAACG  Brunder et al. 
   PRFLPr  GGAGTCGTCAGTCAGTAGAT  (1999) 
escN  escNf  CGCCTTTTACAAGATAGAAC  Kyaw et al. 
   escNr  CATCAAGAATAGAGCGGAC  (2002) 
cdtB  cdtF  AGCACCCGCAGTATCTTTGA  Janka et al. 
   cdtR  AGCCTCTTTTATCGTCTGGA  (2003) 
 
cnf  cnfF  CTGGACTCGAGGTGGTGG   Blanco et al. 
   cnfR  CTCCTGTCAACCACAGCC  (1996) 
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fimA  fimF  CGACGCATCTTCCTCATTCTTCT  Nowrouzian  
   fimR  ATTGGTTCCGTTATTCAGGGTTGTT  et al. (2001) 
 
sfaD/E  sfaF  CTCCGGAGAACTGGGTGCATCTTAC  Nowrouzian  
   sfaR  CGGAGGAGTAATTACAAACCTGGCA  et al. (2001) 
papC  papF  GACGGCTGTACTGCAGGGTGTGGCG  Nowrouzian  
   papR  ATATCCTTTCTGCAGGGATGCAATA  et al. (2001) 
draA  draF  GCCAACTGACGGACGCAGCAC  Nowrouzian  
   draR  CCCCAGCTCCCGACATCGTTTTT  et al. (2001) 
neuB  neuF  CTACCCCTTTTGACGAAGAC  Nowrouzian  
   neuR  ACACACCTGACCCCAATAC  et al. (2001) 
kfiC  kfiF  GCCACCAACTGTCGCAAAA  Nowrouzian  
   kfiR  TGTCGCCCAAACAAAAAGATT  et al. (2001) 
iutA  iutF  GGCTGGACATCATGGGAACTGG  Nowrouzian  
   iutR  CGTCGGGAACGGGTAGAATCG  et al. (2001) 
ehxA  ehxF  ATGACAGTAAATAAAATAAAGAAC  Cookson et al.  
   ehxR  TCAGACAGTTGTCGTTAAAGTTG  (2007) 
F5 (K99)  F5F  TATTATCTTAGGTGGTATGG  Franck et al. 
   F5R  GGTATCCTTTAGCAGCAGTATTTC  (1998) 
F17  F17F  GCAGAAAATTCAATTTATCCTTGG  Bertin et al. 
   F17R  CTGATAAGCGATGGTGTAATTAAC  (1996) 
F41  F41F  GCATCAGCGGCAGTATCT  Franck et al. 
   F41R  GTCCCTAGCTCAGTATTATCACCT  (1998) 
espA  espAF  TGAGGCATCTAARGMGTC  China et al. 
   espAaR  GCTGGCTATTATTGACCG  (1999) 
   espAgR  ATCACGAATACCAGTTACCA    
   espAbR  TGCCTTTCTTATTCTTGTCA    
H-RFLP  F-FLIC1  ATGGCACAAGTCATTAATACCCAAC  Fields et al.  
  
R-FLIC2  CTAACCCTGCAGCAGAGACA 
 
(1997) 
O-RFLP  O482  CACTGCCATACCGACGACGCCGATCTGTTGCTTGG  Coimbra et al. 
   O412  ATTGGTAGCTGTAAGCCAAGGGCGGTAGCGT  (2000) 
mccH47  mccH47F  
 
CACTTTCATCCCTTCGGATTG 
Gordon & 
O'Brien 
   mccH47R   AGCTGAAGTCGCTGGCGCACCTCC  (2006) 
mccV  mccVF   CACACACAAAACGGGAGCTGTT 
Gordon & 
O'Brien 
   mccVR   CTTCCCGCAGCATAGTTCCAT  (2006) 
 
mccJ25  mccJ25F  TCAGCCATAGAAAGATATAGGTGTACCAAT 
Gordon & 
O'Brien 
  
mccJ25R  TGATTAAGCATTTTCATTTTAATAAAGTGT 
 
 
 
 
(2006)   81 
 
colB  ColBF   AAGAAAATGACGAGAAGACG 
Gordon & 
O'Brien 
   ColBR   GAAAGACCAAAGGCTATAAGG  (2006) 
colE2  ColE2F   TTTATGAGCGGTGGCGAT 
Gordon & 
O'Brien 
   ColE2R   TCGGGTTACTGCGTTGCTAA  (2006) 
colE7  ColE7F   CCCTCCCTGACTTGACAGAGAAAATAATGGCG 
Gordon & 
O'Brien 
  
ColE7R  
 
GCCTCTGTGTAATCACTAATACTATTTTTCAG 
 
(2006) 
 
Plasmid   M13F  GTAAAACGACGGCCAGT   
inserts  M13R  AACAGCTATGACCATG   
 
Table 2.2: Sequences of PCR primers used during this study. 
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Target 
gene(s) 
PCR Mix  Cycling Conditions 
chuA,  yjaA, 
TSPE4.C2 
12.5µl GoTaq Green Mastermix (Promega) 
0.5µM each of 6 primers  
Wizard genomic DNA:1µl 
Total volume: 25µl 
1 cycle 
94°C (2 min) 
30cycles: 
94°C (30s) 
55°C (30s)     
72°C (30s) 
1 cycle 
72°C (7min) 
 
stx1,  stx2, 
ipaH. 
0.1µM each of stx2F and stx2R primers 
0.12µM each of stx1F and stx1R primers 
0.05µM each of ipaF and ipaR primers 
5µl: 5X Q solution (QIAGEN) 
0.25µl Accuprime DNA polymerase 
2.5µl Accuprime buffer 
Total volume: 25µl 
1 cycle 
95°C (5 min) 
40 cycles 
95°C (45 s) 
50°C (1 min) 
72°C (1 min)  
1 cycle 
72°C (7 min) 
 
aat, bfpA, eae.  0.2µM each of aatF and aatR primers 
0.1µM each of eaeF, eaeR, bfpF and bfpR primers 
5µl: 5X Q solution (QIAGEN) 
0.25µl Accuprime DNA polymerase (Invitrogen) 
2.5µl Accuprime buffer (Invitrogen) 
Total volume: 25µl 
1 cycle 
95°C (5 min) 
40 cycles 
95°C (40 s) 
58°C (1 min) 
72°C (1 min)  
1 cycle 
72°C (7 min) 
 
espP  1µM each of primers espPF and espPR 
0.25µl HotStarTaq (QIAGEN) 
2.5µl 10X PCR Buffer (QIAGEN) 
0.1mM dNTPs (Roche Applied Sciences) 
Total volume: 25µl 
1 cycle 
95°C (15 min) 
30 cycles 
95°C (45s ) 
59°C (45s ) 
72°C (90s) 
1 cycle 
72°C (10min) 
 
escN  As  for  espP,  except  using  escNF  and  escNR 
primers 
1 cycle 
95°C (15 min) 
35 cycles 
95°C (1 min) 
54°C (40s ) 
72°C (1 min) 
1 cycle 
72°C (5 min) 
 
cdtB  0.5µM each of primers cdtF and cdtR 
0.25µl HotStarTaq (QIAGEN) 
2.5µl 10X PCR Buffer (QIAGEN) 
0.1mM dNTPs (Roche Applied Sciences) 
5µl: 5X Q solution (QIAGEN) 
Total volume: 25µl 
1 cycle 
95°C (15 min) 
30 cycles 
95°C (30s ) 
54°C (1 min) 
72°C (1 min) 
1 cycle 
72°C (5 min) 
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cnf  As for cdtB, except using cnfF and cnfR primers  1 cycle 
95°C (15 min) 
30 cycles 
95°C (1 min) 
55°C (1 min) 
72°C (1 min) 
1 cycle 
72°C (5 min) 
fimA,  sfaD/E, 
papC, draA 
0.45µM each of primers fimF, fimR, papF, papR, 
sfaF, sfaR, draF and draR 
0.25µl HotStarTaq (QIAGEN) 
2.5µl 10X PCR Buffer (QIAGEN) 
0.1mM dNTPs (Roche Applied Sciences) 
Total volume: 25µl 
1 cycle 
95°C (15 min) 
30 cycles 
95°C (1 min) 
55°C (1 min) 
72°C (1 min) 
1 cycle 
72°C (5 min) 
neuB,  kfiC, 
iutA 
0.45µM each of neuF, neuR, iutF and iutR. 
0.9µM each of primers kfiF and kfiR. 
0.25µl HotStarTaq (QIAGEN) 
2.5µl 10X PCR Buffer (QIAGEN) 
1.5µl MgCl2 (25mM) 
0.1mM dNTPs (Roche Applied Sciences) 
Total volume: 25µl 
As  fimA,  sfaD/E,  papC,  draA 
PCR. 
espA  1µM each of primers espAF, espAaR, espAgR and 
espAbR 
0.25µl HotStarTaq (QIAGEN) 
2.5µl 10X PCR Buffer (QIAGEN) 
0.1mM dNTPs (Roche Applied Sciences) 
Total volume: 25µl 
1 cycle 
95°C (15 min) 
30 cycles 
95°C (30s) 
48°C (30s) 
72°C (30s) 
1 cycle 
72°C (5 min) 
F5  0.4µM each of primers F5F and F5R 
Total volume: 25µl 
0.25µl HotStarTaq (QIAGEN) 
2.5µl 10X PCR Buffer (QIAGEN) 
0.1mM dNTPs (Roche Applied Sciences) 
Total volume: 25µl 
1 cycle 
95°C (15 min) 
25 cycles 
95°C (30s) 
50°C (45s) 
72°C (90s) 
1 cycle 
72°C (10 min) 
F17  0.45µM each of primers F17F and F17R 
0.25µl HotStarTaq (QIAGEN) 
2.5µl 10X PCR Buffer (QIAGEN) 
0.1mM dNTPs (Roche Applied Sciences) 
Total volume: 25µl 
1 cycle 
95°C (15 min) 
25 cycles 
95°C (2 min) 
50°C (1 min) 
72°C (1 min) 
1 cycle 
72°C (5 min) 
F41  As for F5, except using F41F and F41R primers  As F5 
 
mccJ25  0.2µM each of primers mccJ25F and mccJ25R 
12.5µl GoTaq Green Mastermix (Promega) 
Total volume: 25µl 
 
1 cycle 
94°C (4 min) 
25 cycles 
94°C (30s) 
55°C (30s) 
72°C (3 min) 
1 cycle 
72°C (3 min) 
mccV  As  mccJ25  except  using  mccVF  and  mccVR 
primers 
As mccJ25   84 
mccH47, colB  As  mccJ25  except  using  mccH47F,  mccH47R, 
colBF and colBR primers 
As mccJ25 
colE2  As  mccJ25  except  using  colE2F  and  colE2R 
primers 
As mccJ25 
colE7  As  mccJ25  except  using  colE7F  and  colE7R 
primers 
As mccJ25 
ehxA  As for F5, except using primers ehxF and ehxR 
 
1 cycle 
95°C (15 min) 
25 cycles 
95°C (45s) 
52°C (45s) 
72°C (2 min) 
1 cycle 
72°C (5 min) 
 
stx (RFLP)  0.5µM each of primers LinF and LinR 
0.2µl HotStarTaq (QIAGEN) 
2.5µl 10X PCR Buffer (QIAGEN) 
40µM dNTPs (Roche Applied Sciences) 
Total volume: 25µl 
1 cycle 
95°C (15 min) 
35 cycles 
94°C (45s) 
45°C (1 min) 
72°C (1 min) 
1 cycle 
72°C (10 min) 
 
eae (RFLP)  1µM  each  of  primers  eaeVF,  eaeVR,  eaeZetaVR 
and eaeIotaVR 
0.5µl MgCl2 (25mM) 
0.25µl HotStarTaq (QIAGEN) 
2.5µl 10X PCR Buffer (QIAGEN) 
0.1mM dNTPs (Roche Applied Sciences) 
Total volume: 25µl 
 
1 cycle 
95°C (15 min) 
35 cycles 
94°C (1 min) 
41°C (1 min) 
72°C (1 min) 
1 cycle 
72°C (10 min) 
 
espP (RFLP)  0.6µM each of primers PRFLPf and PRFLPr 
0.25µl HotStarTaq (QIAGEN) 
2.5µl 10X PCR Buffer (QIAGEN) 
0.1mM dNTPs (Roche Applied Sciences) 
Total volume: 25µl 
 
1 cycle 
95°C (15 min) 
30 cycles 
94°C (30s) 
56°C (1 min) 
72°C (2min 30s) 
1 cycle 
72°C (5 min) 
 
 
Table 2.3: PCR amplification conditions: 2µl Template DNA was included in each reaction prepared according 
to Section 2.6.1.3, unless stated otherwise. Reactions were made up to their respective total volumes using Sigma 
Ultrapure Water (molecular biology grade). 
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2.6.4  PCR-RFLP analysis of E. coli isolates 
 
2.6.4.1  Molecular serotyping 
 
Flagellar (H) antigen determination by PCR-RFLP was carried out employing a previously 
described method (Fields et al., 1997;Ramos Moreno et al., 2006). Genes encoding the FliC 
major flagellar protein were amplified using the primers F-FLIC1 and R-FLIC2 (Table 2.2). 
Amplification was carried out in 25µl volumes containing 1µM each primer, 1µl template 
DNA (prepared as set out in Section 2.6.1.2) 160µM dNTPs, 1.5mM MgCl2, 0.1µl GoTaq 
Flexi DNA polymerase and 1X Promega PCR buffer (colourless). PCR cycling parameters 
were as follows: 1 cycle (94°C/4 min) was followed by 35 cycles (94°C/30s, 60°C/1 min, 
72°C/2 min) and 1 cycle (72°C/5 min). After amplification, 5µl of the mixture was analysed 
by  agarose  gel  electrophoresis.  1µl  RsaI  restriction  enzyme  (Roche  Applied  Science)  was 
added  to  each  amplified  sample  and  mixed  by  pipetting.  Restriction  digest  mixtures  were 
incubated at 37°C for at least 3 hours. After this time, 8µl loading buffer was added and the 
resultant mixture was analysed by agarose gel elecrophoresis. Observed fragment sizes were 
compared to expected sizes, generated by in silico restriction analysis using the University of 
Alberta Sequence Manipulation Suite: 
http://www.ualberta.ca/~stothard/javascript/rest_digest.html. 
 
Somatic  (O)  antigen  determination  (O-RFLP)  was  attempted  by  the  method  proposed  by 
Coimbra et al. (2000). The rfb locus was amplified using the primers O-412 and O-482 (Table 
2.2).  Amplification  was  carried  out  in  25µl  volumes  containing  0.3µM  each  primer,  1µl 
template  DNA  (prepared  as  set  out  in  Section  2.6.1.2),  500µM  dNTPs,  0.375µl  Long 
Template DNA polymerase and 1X Long template PCR buffer 3. PCR cycling parameters 
were  as  follows:  1  cycle  (94°C/2  min)  was  followed  by  10  cycles  (94°C/10s,  64°C/30s, 
68°C/15 min) then 20 cycles (94°C/10s, 64°C/30s, 68°C/15 min with a 20s increment each 
cycle)  and finally 1 cycle (72°C/7 min). After amplication, 5µl 10X NEB restriction buffer 2, 
was added and the volume adjusted to 49.5µl with ultrapure water. To this 0.5µl (2.5U) MboII 
restriction enzyme was added. The mixture was thoroughly mixed and incubated at 37˚C for at 
least 3 hours. After this time the mixture was heated to 72˚C for 10 minutes to dissociate the 
enzyme  from  the  DNA.  Subsequently,  15µl  of  the  mixture  was  analysed  by  agarose  gel   86 
electrophoresis.  Isolates  representing  unknown  O-types  were  compared  with  those  of  the 
available reference types (detailed in Table 2.1). Selected isolates with a pattern that did not 
match the reference types were submitted to the Health Protection Agency, Laboratory of 
Enteric Pathogens (Colindale Avenue, London) for serological O-antigen determination. 
 
2.6.4.2  PCR-RFLP analysis of candidate virulence factor-encoding genes 
 
PCR  amplification  was  carried  out  as  detailed  in  Table  2.3.  7µl  aliquots  of  the  amplified 
products of the stx (RFLP) PCR (Table 2.3) were mixed with 1.25µl NEBuffer 3, 4µl distilled 
water and 0.25µl (2.5U) HincII (New England Biolabs). 7µl aliquots of the amplified products 
of the espP (RFLP) PCR were mixed with 1µl SureCut Buffer A, 1.7µl distilled water and 
0.3µl (3.33U) AluI (Roche Applied Science). Similarly 7µl aliquots of the amplified products 
of the ehx PCR were mixed with 1µl SureCut Buffer B, 1.7µl distilled water and 0.3µl (3.33U) 
TaqI (Roche Applied Science). Each of these mixtures were incubated at 37°C for 3 hours and 
subsequently analysed by agarose gel electrophoresis. 
 
2.6.5  Agarose gel electrophoresis 
 
Samples resulting from DNA isolation, PCR and restriction digest were analysed by agarose 
gel electrophoresis according to standard methodology. Gel Red (Biotium Inc) was included in 
gels as per the manufacturers instructions. The percentage of agarose used depended on the 
size of fragments expected. For applications resulting in fragments below 500bp, 2% agarose 
gels were employed, whereas when fragments were expected greater than 500bp, 1% agarose 
gels were employed. Where fragments of a range of sizes were expected, 1.5% agarose gels 
were utilised. 
 
2.6.6  Genomic microarray 
 
2.6.6.1  Composition of the microarray 
 
Pre-printed microarray slides were provided by Dr Wu Guanghui of the Veterinary Laboratory 
Agency, Weybridge, Surrey. The array comprised the Array-ready Oligo Set for the E coli   87 
genome  Version  1.0  (Operon)  containing  5978  70-mer  probes  representing  open  reading 
frames (ORFs) of three E. coli strains, MG1655, O157:H7 (EDL933) and O157:H7 (Sakai).  
In addition, 110 Oligos representing genes encoded on plasmids pO157 and pOSAK1 were 
also included on the array. The composition, printing and validation of the array are detailed in 
Wu  et  al.  (2008)  and  (Carter  et  al.,  2008).  Oligonucleotides  were  set  out  on  the  slide  in 
triplicate  on  each  slide,  arranged  in  21  x  21  subgrids.  Spacing  between  spots  was 
approximately 0.21 µm and the average diameter of spots was approximately 120 µm. 
 
2.6.6.3 Genomic DNA preparation, Labelling and hybridisation 
 
As a control sample the DNA from three sequenced strains (MG1655, EDL933 and Sakai) 
was  mixed,  each  strain  contributing  a  third  of  the  total  DNA  (i.e.  0.66  µg  each).  Two 
micrograms of the control or test DNA (from a single strain) was labelled using the protocol of 
the Institute of Food Research (http://www.ifr.bbsrc.ac.uk/Safety/Microarrays/protocols.html) 
with some minor adjustments. Briefly, 2 µg of genomic DNA in 23.5 µl of nuclease-free water 
was mixed with 20 µl of 2.5X random primer–reaction buffer mix from the BioPrime DNA 
labelling system (18094-011; Invitrogen). The mixture was boiled for 5 min and cooled on ice 
for 5 min. Then, 5 µl of 10X deoxynucleoside triphosphates (1.2 mM each dATP, dGTP and 
dTTP and 1.1 mM dCTP; Amersham Biosciences) and 0.5 µl of Cy5 or Cy3 dCTP (1 mM 
stock; Amersham Biosciences) were added. Finally, 1 µl of Klenow enzyme from the kit was 
added and the reaction was carried out at 37°C for 1.5 h. Excess Cy3 and Cy5 dCTP were 
removed  from  the  labeled  DNA  with  a  MinElute  PCR  purification  kit  (28006;  Qiagen). 
Hybridization was performed with a protocol similar to the one developed by the BµG@S 
group  (http://bugs.sgul.ac.uk/bugsbase/index.php).  The  slide  was  submerged  in 
prehybridization solution (3.5X SSC (1X SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 
0.1% sodium dodecyl sulfate (SDS) and 10 mg/ml bovine serum albumin) at 65°C for 20 min. 
Then, it was rinsed in 400 ml of water for 1 min and followed by 400 ml of propan-2-ol for 1 
min before being dried by centrifugation at 1,500 rpm (480g) for 5 min. The labeled DNA was 
prepared in hybridization solution (4X SSC, 3% SDS), heated at 95°C for 2 min and allowed 
to  cool  at  room  temperature  before  being  added  to  a  slide  covered  with  a  LifterSlip. 
Hybridization was carried out in a Genetix hybridization chamber and incubated at 65°C in a 
hybridization oven for 16 to 20 h. After the hybridization, the slide was washed twice gently in   88 
wash buffer A (1X SSC, 0.05% SDS) at 65°C for at least 5 min each time. The slide was then 
washed in 400 ml wash buffer B (0.06X SSC) for 2 min at room temperature. 
 
2.6.6.4 Data acquisition and analysis 
 
The processed slides were scanned using a GenePix 4000B scanner (Axon Instruments, Inc) 
and data was compiled using GenePix Pro 4.1.  A spot was determined to be present if a 
minimum  65%  of  its  pixels  have  intensities  greater  than  the  background  plus  2  standard 
deviations. The resultant data was normalised per spot by dividing signal (532nm wavelength, 
Cy3)  intensity  by  control  (635nm  wavelength,  Cy5)  intensity.  Per-chip  normalisation  was 
performed using a set of genes present in a single copy in each of the three control strain 
genomes. Cut-off values were determined according to Carter et al. (2008). Pixel intensity 
values  below  0.25  were  marked  absent,  those  above  0.5  were  marked  present  and  those 
between 0.25 and 0.5 were considered to be ambiguously detected. 
 
2.6.7  Virulence gene nanoarray 
 
A miniaturised DNA Microarray described by Anjum et al. (2007) was used, comprising 39 
oligonucleotide probes complementary to virulence factors, 7 complementary to bacteriocin 
genes  and  15  control  genes.  The  method  set  out  by  (Ballmer  et  al.,  2007)  was  used  for 
multiplex linear DNA amplification and labelling. Briefly, for each assay, 1µg  DNA prepared 
by the DNeasy method was combined with 1 µl 10X ThermoPol amplification buffer (New 
England Biolabs), 1 µl deoxynucleoside triphosphate mixture (1 mM each dATP, dCTP and 
dGTP; 0.65 mM dTTP), 0.35 µl biotin-16-dUTP (Roche Applied Science), 1 µl mixture of the 
60  oligonucleotide  primers  described  by  Anjum  et  al.  (2007)  at  a  final  concentration  of 
0.135µM and 0.1 µl Therminator DNA polymerase (New England Biolabs) in a total volume 
of 10µl.  
 
The linear amplification steps comprised 5 min at 96°C, followed by 45 cycles of 62°C/20s, 
72°C/40s  and  96°C/60s.  Printed  ArrayTubes  obtained  from  Clondiag  were  placed  in  a 
thermomixer (Eppendorf) and washed with 500 µl of deionized water for 5 min at 55°C (550 
rpm) then with 500 µl hybridization buffer 1 (Clondiag) for 5 min at 30°C and (550 rpm). 10µl   89 
of the labeled DNA was diluted with 90 µl hybridization buffer 1, denatured for 5 min at 
95°C, cooled on ice for 2 min and then added to the ArrayTube.  
 
The  hybridization  was  carried  out  at  55°C  and  with  shaking  at  550  rpm  for  1  h.  After 
hybridization the ArrayTubes were washed for 5 minutes in each of three wash solutions: the 
first using 500 µl 2X SSC (0.3M NaCl, 0.03M sodium citrate, pH 7.0) containing 0.2% w/v 
SDS at 40°C then with 500 µl 2X SSC at 30°C, followed by 500 µl 0.2X SSC at 30°C, with 
each step performed for at 550 rpm. The arrays were blocked using 100 µl 6X SSPE solution 
(60 mM sodium phosphate, 1.08 M NaCl, 6 mM EDTA, pH 7.4) containing 0.005% Triton X-
100 and milk powder (2% w/v) for 15 min at 30°C (550 rpm). 100µl 200pg/µl Peroxidase-
streptavidin conjugate (Sigma) in 6X SSPE–Triton X-100 was added to each tube and the 
mixture was incubated for 15 min at 30°C and 550 rpm. ArrayTubes were washed using 500µl 
2X SSC containing 0.01% (v/v) Triton X-100 at 30°C, 500 µl 2X SSC at 20°C and 500µl 0.2X 
SSC at 20°C, for 2 min each, with each step repeated once.  
 
100µl True Blue peroxidase substrate (Kirkegaard & Perry Laboratories) was added to the 
ArrayTubes and signals were detected with the ATR01 ArrayTube reader (Clondiag). Signals 
were recorded at 25°C for 5 min and analyzed by using the IconoClust, version 2.2, software 
(Clondiag). Images were examined for smudging and debris leading to false positives and 
these were removed from the analysis. Values for 1-(mean pixel intensity/background pixel 
intensity) were calculated and a cut-off applied, whereby values above 0.3 were designated 
positive, while values below 0.1 were considered negative. Values between 0.1 and 0.3 were 
considered to be ambiguous. 
 
2.6.8  Subtractive hybridisation 
 
DNA was prepared using the Wizard genomic DNA kit (Section 2.6.1.2). This DNA was used 
for genomic subtractive hybridisation, using the PCR-select Bacterial Genome Subtraction Kit 
(Clontech) according to the manufacturer’s instructions. In each case, genomic DNA from a 
genome-sequenced  E.  coli  O157:H7  EDL933  (MCI0045)  was  used  as  the  driver  DNA. 
Genomic DNA from strains MCI 0453, MCI 0489, MCI 0507 were used individually as tester 
DNA. Briefly, tester and driver DNA samples (2-10µg) were digested to completion in 50µl 
reaction volume including 1.5µl RsaI restriction enzyme, 5µl 10X RsaI Restriction Buffer. The   90 
reaction  was  stopped  by  the  addition  of  2.5µl  0.2M  EDTA  (pH  8.0)  and  50µl 
phenol:chloroform:isoamyl  alcohol  (25:24:1)  was  added.  The  mixture  was  vortexed  and 
centrifuged at 14,000g for 10 minutes at room temperature. The aqueous layer was recovered 
and added to 50µl chloroform:isoamyl alcohol (24:1) and centrifuged as before. The aqueous 
layer was recovered to a clean tube. DNA was precipitated by the addition of 0.5 volume of 
ammonium  acetate  and  2.5  volumes  of  95%  ethanol.  After  vortexing  briefly,  precipitated 
DNA was pelleted by centrifugation. The supernatant was removed and the pellet washed by 
the addition of 200µl 80% ethanol. Pellets were recovered by centrifugation, the ethanol was 
removed and pellets were air-dried briefly. Digested precipitated DNA was resuspended in 
nuclease-free water. DNA concentration was determined using a Nanodrop spectrophotometer 
(Section 2.6.2) and adjusted to 120ng/µl with nuclease free water. A 1µl aliquot of each tester 
DNA was mixed with 2µl Adaptor 1 and another 1µl aliquot mixed Adaptor 2R. To these 
mixtures  were  added  4µl  sterile  distilled  water,  2µl  5X  Ligation  buffer  and  1µl  T4  DNA 
Ligase (400U). After overnight incubation at room temperature, 1µl 0.2M EDTA (pH 8.0) was 
added and samples were heated to 72˚C to stop the reaction and inactivate the ligase.  
 
At this point, ligation and digestion efficiency was determined by the method prescribed by 
the manufacturer. Briefly, each adaptor-ligated tester DNA sample was used as template DNA 
for PCR-amplification using a primer complementary to the E. coli 23S rRNA gene and a 
primer  complementary  to  sequence  carried  on  the  adaptor  (both  supplied  with  the  kit).  A 
reaction whereby the DNA was amplified using two internal 23S rRNA primers was included 
as a positive control. Ligation efficiency was considered to be adequate if the intensity of the 
band generated by the adaptor-specific primer/23S rRNA primer amplification was greater 
than 25% of that generated by amplification using the two internal 23S rRNA primers. If the 
amplification using the adaptor-specific primer/23S rRNA primer generated larger products 
than the expected 374bp band, the restriction digest was considered to be incomplete. 
 
Two rounds of hybridisation of the adaptor-ligated tester DNA to driver DNA were performed 
as follows: 1µl of each of the adaptor-ligated tester DNA samples were mixed individually 
with 2µl RsaI digested driver DNA (120ng/µl) and 1µl 4X hybridisation buffer. The samples 
were overlayed with one drop of mineral oil (molecular biology grade) and centrifuged briefly. 
The mixtures were incubated at 98°C for 90 seconds and 63°C for a further 90 minutes, in a 
Thermo Hybaid thermal cycler.   91 
 
In a sterile tube, a further 1µl RsaI-digested driver DNA (120ng/µl) was mixed with 1µl 2X 
hybridisation  buffer.  One  drop  of  mineral  oil  was  added  and  the  mixture  was  briefly 
centrifuged and incubated at 98°C for 90 seconds in a thermal cycler. The two completed first 
hybridisation samples were mixed with the denatured driver DNA, taking care not to allow the 
two first hybridisations samples to mix before they were in contact with the fresh denatured 
driver DNA. After mixing, the second hybridisation was carried out overnight at 63°C in a 
thermal cycler. After this period, 200µl Dilution Buffer was mixed with to the hybridised 
samples and the mixture was heated for a further 7 minutes at 63°C to eliminate non-specific 
hybridisation. 
 
The hybridised samples were used as template DNA for two rounds of PCR-amplification. 
The first round utilises a PCR primer complementary to both ends of the two adaptors. The 
second round employs nested primers, complementary to areas within the adaptors between 
the binding sites for the primary PCR primer. 
 
After the two rounds of amplification, the PCR products were cloned into pGEM-T vector 
using pGEM-T vector System II (Promega) according to the manufacturer’s instructions. 3µl 
of the mixture of products from the secondary PCR were mixed with 1µl (50ng) pGEM-T 
vector,  5µl  2X  Rapid  Ligation  Buffer  and  1µl  T4  DNA  Ligase  (Promega).  The  ligation 
mixtures were incubated at room temperature overnight. 50µl chemically competent E. coli 
JM109 cells (Promega) were defrosted on ice for each of the transformation reactions to be 
performed. 2µl of the ligation mixture was added to one 50µl aliquot of JM109 cells, which 
was mixed by vigorously tapping the tube and left on ice for 20 minutes. Cells were heat-
shocked for 45-50 seconds in a water-bath set to 42°C and returned to ice for 2 minutes. 950µl 
room temperature SOC-medium was added and the mixture incubated at 37°C for 1.5 hours. 
100µl aliquots were spread onto S-gal agar containing 50µg/ml ampicillin (Section 2.3.1.1) 
and incubated overnight at 37°C. For each of the test strains 250-300 colonies were picked 
from the resultant plates and transferred into either 50µl Instagene Chelex Matrix (BioRad) or 
10ml LB broth. Those in LB broth were incubated overnight at 37°C with 200rpm shaking and 
the  culture  processed  using  the  Wizard  SV  Plus  Miniprep  Kit  (Section  2.6.1.4)  to  yield 
isolated plasmid DNA. Those picked into Instagene Chelex matrix were replica-plated onto 
LB agar containing 50µg/ml ampicillin for short-term storage and the tubes containing the   92 
bacteria in Instagene Chelex Matrix were processed as Section 2.6.1.3 to prepare template 
DNA for PCR. Potential clones were screened for inserts using M13 universal primers. 1µl 
DNA (either isolated plasmid or Instagene-treated sample) included in a mixture comprising 
0.3µM  M13F  and  M13R  primers  (Table  2.2),  0.1mM  of  each  dNTP,  1.5mM  MgCl2,  5µl 
GoTaq Flexi 5X Colourless PCR Buffer, 0.2µl GoTaq Flexi DNA Polymerase (Promega). The 
cycling protocol comprised 1 cycle of 5 minutes at 94°C, then thirty cycles of the following: 
94°C for 15 seconds, 51°C for 30 seconds and 90 seconds at 72°C. This was followed by a 
final  elongation  step  at  72°C  for  10  minutes.  The  resulting  fragments  were  analysed  by 
agarose gel electrophoresis. Any clones yielding no amplicon or more than one amplicon were 
removed from further analysis. 
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2.6.8.1  Verification of subtracted library by Southern Hybridisation. 
 
The DIG High Prime DNA Labelling and Detection Starter Kit II (Roche) was used according 
to the manufacturer’s instructions: 
 
2.6.8.1.1  DNA Labelling 
 
1µg of the DNA to be used as the probe in a volume of 16µl was denatured in a boiling water 
bath for 10 minutes; then immediately chilled on ice for 2 minutes. 4µl DIG-High Prime was 
added, mixed briefly by vortexing and the tube centrifuged briefly to collect the contents at the 
base. This mixture was incubated overnight at 37°C. Subsequently 2µl 0.2M EDTA (pH 8.0) 
was  added  and  the  mixture  heated  to  65°C  to  stop  the  reaction.  Labelling  efficiency  was 
determined by preparing a serial dilution of the mixture and transferring 1µl spots of diluted 
samples to Whatman Supercharged Nytran Nylon Membranes. Membranes were fixed by UV 
treatment for 2 minutes each side in a UV crosslinker, while kept moist by filter paper soaked 
in 10X SSC buffer. Membranes were rinsed in distilled water and allowed to air-dry. Once 
dry, the membranes were incubated for 2 minutes in Maleic Acid Buffer (0.1 M Maleic acid, 
0.15 M NaCl; adjusted to pH 7.5 using solid NaOH) followed by 30 minutes in 1X Blocking 
Buffer (prepared by diluting 10X Blocking Buffer in Maleic Acid Buffer) then for 30 minutes 
in Antibody Solution (Anti-Digoxygenin-Alkaline Phosphatase Conjugated Antibody diluted 1 
in 10,000 in Blocking Buffer). Membranes were washed twice for 15 minutes in Washing 
Buffer (0.1 M Maleic acid, 0.15 M NaCl; pH 7.5; 0.3% (v/v) Tween 20) and equilibrated in 
Detection Buffer (0.1 M Tris-HCl, 0.1 M NaCl, pH 9.5). Each membrane was placed in an 
exposure cassette and 1ml CSPD (chloro-5-substituted adamantyl-1,2-dioxetane phosphate) 
solution  was  applied  to  the  surface  of  each  membrane.  Membranes  were  covered  with 
transparent plastic and the CSPD was spread across the surface. Excess CSPD was squeezed 
out gently and removed using tissue. Membranes were incubated at room temperature for 5 
minutes. X-ray film was exposed to the membrane and developed using an X-ray developer. 
Labelling efficiency was considered sufficient if spots of 1pg/µl DNA were visible after 40 
minutes of exposure. 
 
   94 
2.6.8.1.2  Hybridisation 
 
5µl aliquots of the PCR products generated by M13 PCR (Section 2.6.8) were combined with 
5µl  aliquots  of  0.6M  NaOH.  2µl  amounts  of  this  mixture  were  spotted  onto  Whatman 
Supercharged Nytran Nylon Membranes. Membranes were neutralised in 0.5M Tris HCl (pH 
7.5) for 4 minutes, then washed in distilled water. Membranes were allowed to dry briefly and 
exposed to UV light in a UV light-box. Dry membranes were stored at 2-8°C between two 
sheets of filter paper. DIG Easy Hyb (DEH) solution was preheated to 65°C in a hybridising 
oven. Membranes were prehybridised in prewarmed DEH solution for one hour with constant 
agitation. DNA probes (Section 2.6.8.1.1) were denatured for 5 minutes in a boiling water bath 
and transferred immediately to ice. 10µl probe was added to 25ml prewarmed DEH solution. 
Liquid  was  removed  from  the  membranes  and  replaced  with  the  probe  in  DEH  solution. 
Membranes were incubated in probe/DEH mixture at 65°C overnight in sealed containers with 
constant  agitation.  Washing  was  subsequently  carried  out,  firstly  using  ample  2X  SSC 
containing 0.1% (w/v) SDS at room temperature with one change of buffer and secondly, 
using ample prewarmed 0.5X SSC containing 0.1% (w/v) SDS at 68°C for 5 minutes. All 
subsequent steps were carried out at room temperature. Membranes were washed briefly in 
Wash Buffer at room temperature then transferred to 50ml 1X Blocking Buffer. Membranes 
were incubated in Blocking Buffer for 3 hours at room temperature after which time the liquid 
was removed and replaced with 20ml Antibody Solution. Antibody Solution was removed and 
replaced with Wash Buffer and two 15 minute washes were carried out. Washing Buffer was 
replaced  with  Detection  Buffer  and  incubated  for  5  minutes  at  room  temperature  with 
agitation.  Membranes  were  placed  in  film  cassettes,  overlaid  with  CSPD  solution.  A 
transparent plastic sheet was placed on the surface of the membrane and air bubbles were 
carefully smoothed out. X-Ray film was exposed for 1-24h and developed using an X-ray 
developer. Images were scanned using a GelDoc Imager and converted to tagged image format 
files (.tif). Resulting images were imported into the Total Lab Array (Progenesis) program. 
Grids  were  fitted  to  the  spots  and  pixel  intensity  was  calculated  and  normalised  against 
background. Data generated was exported to Microsoft ExCel. Spots representing each clone 
in the library were ranked according to their intensity and the lowest intensity spots were 
chosen for sequencing.  
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2.6.8.2  Sequence-analysis of subtracted libraries 
 
DNA-sequencing was performed using DNA prepared using the Wizard SV Plus Miniprep Kit 
(Section  2.6.1.4).  Sequencing  was  carried  out  at  MWG  Biotech,  using  the  T7  universal 
forward primer. Database searches were performed using the Basic Local Alignment Tool 
(BLAST) (Altschul et al., 1997;Zhang et al., 2000). Gene accession numbers and Protein ID 
of genes or predicted genes covered in the most significant BLAST-N hit were recorded. If no 
significant hits were returned by BLAST-N, BLAST-X searches were performed to predict 
any translated proteins from the region identified. 
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2.7  Competition analysis 
 
2.7.1  Preparation of soft agar lawns of bacteria 
 
LB  containing  0.7%  Agar  No.1  (Oxoid)  was  melted  and  cooled  to  40˚C.  65µl  overnight 
culture of the sensitive strain was added to 4ml molten soft agar and poured onto preset hard 
nutrient agar plate (Oxoid) and allowed to set. 10µl spots of bacterial supernatant or lysate, 
filter  paper  discs  (prepared  as  described  in  the  following  sections)  or  section  of 
polyacrylamide  gel, were gently placed on the surface of the lawn. Plates were incubated 
overnight at 37˚C. 
 
2.7.2  Preparation of filter paper disc containing bacterial lysate 
 
Overnight streak plates of E. coli isolates were prepared on LB agar. Filter paper discs of 7mm 
diameter were soaked in chloroform for 10 seconds and then laid onto a single, well-isolated 
colony. Chloroform was allowed to evaporate and discs were kept at 4°C until used as detailed 
in Section 2.7.1. 
 
2.7.3  Mitomycin C-induced supernatant/lysate preparation 
 
An adaptation of the method described by (Gordon et al., 1998) was employed to recover 
bacterial products containing potential inhibitory substances. Briefly, overnight culture was 
diluted 1:10 in LB and incubated at 37˚C, 200rpm shaking for 1hr. Mitomycin C was added to 
a final concentration of 0.1-0.2µg/ml and incubated for a further 4hr at 37˚C, 200rpm shaking. 
Culture was centrifuged at 10 000g for 5mins and the supernatant from this was added to 1/20 
volume  of  chloroform  to  kill  viable  cells.  Alternatively,  to  recover  a  cell  lysate  bacterial 
culture without prior centrifugation was added to 1/20 volume of chloroform then centrifuged 
for 2 minutes at a minimum of 5000g. 100µl aliquots were plated onto a sterile LB plate to 
ensure  no  viable  organisms  were  present.  In  order  to  recover  bacterial  products  at  higher 
concentrations, an Amicon Ultra-15 filter (Ultra-Cel 5kDa or 3kDa cut-off, Millipore) was   97 
used according to manufacturer’s instructions to give a 60-fold concentration. Supernatants 
were stored at 4˚C until required. 
 
2.7.5  Bacterial competition assays 
 
At each time-point in the competitive assays described in this section (competitive growth, 
competitive exclusion with supernatants and competitive adherence) samples containing live 
bacteria were removed and used to prepare serial 1 in 10 dilutions in sterile PBS. Three 100µl 
aliquots of each dilution were used to prepare three spread-plates on SMAC or TBX medium. 
Plates were incubated overnight at 37˚C. 
 
2.7.5.1  Competitive Growth Assay 
 
Overnight  LB  cultures  of  the  two  strains  to  be  co-cultured  were  prepared.  OD600  was 
determined to ensure both cultures had grown to the same extent. 50µl of each culture was 
added to 10ml of LB and incubated continually at 37˚C, 200rpm shaking.  
 
2.7.5.2  Competitive exclusion with supernatant 
 
Supernatant, prepared as described in Section 2.7.3, was filtered with a 0.22µm filter unit 
(Millex  GV  Millipore).  50µl  of  MCI  0200  was  added  to  10ml  of  a  1:1  mixture  of  test 
supernatant and LB and incubated at 37˚C, 200rpm shaking.  
 
2.7.5.3  Competitive adherence 
 
EBL cells were grown to confluence in 12-well tissue culture plates. 24hr prior to challenge, 
the cell culture medium was removed and replaced with fresh culture medium with or without 
serum.  1hr  prior  to  challenge,  the  volume  in  each  well  was  adjusted  to  500µl.  Overnight 
cultures of strains to be tested for competitive adherence were prepared in 10ml aliquots of 
MEM-HEPES  (Section  2.3.1.1).  Cultures  were  diluted  tenfold  in  sterile  MEM-HEPES, 
prewarmed  to  37˚C  and  were  subsequently  incubated  at  37˚C,  200rpm  shaking  until 
OD600=0.35, which was determined to be approximately 3.85x10
7cfu/ml (± 2.39x10
6cfu/ml;   98 
n=56). 250µl aliquots of culture of each of the two strains to be assayed for competition were 
added to each of two wells. This translated to a total multiplicity of infection of 100 bacteria 
per cell (MOI=50 bacteria of each strain per cell). Plates containing bacteria and cells were 
incubated at 37˚C in a humidified atmosphere containing 5% CO2. Wells were washed three 
times with 1ml PBS to remove non-adherent bacteria. 100µl of TritonX-100 (0.05%) was 
added to lyse the cells and the monolayers were solubilised, aided by scraping with a 1ml 
rubber syringe insert. Lysates were used to prepare serial tenfold dilutions and spread-plates as 
detailed in Section 2.7.5. 
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2.8  Data analysis 
 
Histograms were prepared using Microsoft ExCel, showing the mean ± standard error of the 
mean (unless stated otherwise). Values in the text are also given as mean ± standard error of 
the  mean.  Assessments  of  significant  differences  between  means  were  carried  out  by 
performing a Student’s t-test using the Minitab software, where a P-value less than 0.05 is 
considered significant. 
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3.1  Introduction 
 
As explained in Section 1.3, E. coli O157:H7 poses a significant threat to human health but 
may exist in the bovine host without clinical signs of disease. Work presented in this chapter 
was designed to investigate the differential interactions of factors exported by E. coli O157:H7 
with the bovine and human host, generally employing cultured epithelial cell lines for this 
purpose. Detection of differential responses of epithelial cells to EHEC could lead to further 
explanation of the different outcomes of EHEC colonisation of the bovine and human host and 
could have implications for the control and treatment of EHEC infection. Within the bovine 
host E. coli O157:H7 is generally described as a commensal organism, in that it normally does 
not cause clinical symptoms and is frequently isolated from healthy cattle (Griffin and Tauxe, 
1991). Nevertheless, it has been noted that EHEC induces the formation of A/E lesions in the 
bovine gastrointestinal tract (Phillips et al., 2000;Naylor et al., 2005)  which is a function 
associated with pathogenicity in humans (See Section 1.4.1). 
 
In general, bacterial components which are exported from the bacterial cell cause the most 
profound  and  measurable  effects  in  the  host.  Exported  molecules  are  the  portion  of  the 
bacterium which is most accessible to recognition by the innate immune system since they 
come into direct physical contact with the host. Enterohaemorrhagic E. coli is no exception 
since it exports a wide variety of proteins with diverse biological functions. Exported proteins 
may be presented on the cell surface, secreted into the extracellular medium or injected into 
the host cell. EHEC secretes certain enzymes, toxins and effector proteins which may have 
specific effects upon host defence mechanisms. Proteases, such as EspP and StcE, may alter 
the functionality of host proteins involved in innate immunity (Brunder et al., 1997;Lathem et 
al.,  2004).  Certain  bacterial  exported  proteins  may  target  signal  transduction  pathways, 
subverting cellular responses to the bacterium,  such as those introduced by the T3SS and 
shiga-like toxin (described in Sections 1.4.1 and 1.4.2 respectively). In addition to secreted or 
injected  factors  many  exported  proteins  are  structural.  These  may  be  embedded  in  the 
membrane and include the components which make up complex extracellular appendages such 
as flagella and fimbriae. Proteins which make up extracellular appendages are often found in 
the  extracellular  medium  as  mechanical  shearing  of  these  structural  extremities  is 
commonplace. 
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Proinflammatory responses to EHEC during human infection are well characterised. Bacterial 
disruption of the epithelium causes proinflammatory cytokine release, especially via TLR5 
stimulation with bacterial flagellin and subsequent infiltration of neutrophils to the mucosal 
surface  (Berin  et  al.,  2002;Dahan  et  al.,  2002;Miyamoto  et  al.,  2006).  Proinflammatory 
responses  during  colonisation  of  the  bovine  gastrointestinal  tract  are  yet  to  be  fully 
determined, although disruption of the epithelial layer by the formation of A/E lesions is likely 
to induce some level of proinflammatory cytokine release 
 
Production of proinflammatory cytokines is an important part of the host immune response to 
bacterial infection.  Interleukin-8 (IL-8) is a stereotypical proinflammatory  cytokine, which 
acts to recruit neutrophils to the site of infection and promotes their infiltration (Savkovic et 
al.,  1996).  IL-8  is  produced  in  response  to  many  cellular  stressors,  such  as  heat  shock, 
irradiation,  oxidative  stress,  cytotoxic  drugs,  reactive  oxygen  species  and  cellular  injury. 
Bacterial products may cause IL-8 production by activation of pattern recognition receptors 
(PRRs) as described in Section 1.5.3. Bacteria may also induce inflammation as a consequence 
of cellular injury (Naito and Yoshikawa, 2002) and further inflammation may occur due to 
secondary  infection  in  regions  of  barrier  disruption  caused  by  the  primary  pathogen.  The 
release of proinflammatory cytokines, such as TNFα, induces production of proinflammatory 
cytokines by other cells and thereby the stress signal is amplified. 
 
Flagellin has an established role as a major inducer of epithelial IL-8 secretion through the 
TLR5 pathway, as described in Section 1.5.3. This response has been shown both in vitro and 
in  vivo  to  enteric  pathogens,  including  EHEC,  EPEC,  EAggEC  and  Salmonella  enteritica 
Serovar Typhimurium (Gewirtz et al., 2001b;Berin et al., 2002;Zhou et al., 2003;Khan et al., 
2004;Miyamoto  et  al.,  2006;Gobert  et  al.,  2008).  Flagellin  from  S.  enteritica  Serovar 
Typhimurium has been recently shown to inhibit production of IL-10 by mouse macrophages 
(Vicente-Suarez  et  al.,  2007).  The  epithelial  proinflammatory  response  to  live  bacteria  is 
unlikely to be solely dependent on flagellin, especially as IL-8 production in Caco-2 cells in 
response to both C. rodentium and EPEC is upregulated by treatment with ∆fliC bacterium, 
albeit to a lesser extent than the response elicited by flagellated bacteria (Khan et al., 2008). 
Nevertheless, the dominance of flagellin as an elicitor of IL-8 secretion highlights the potential 
importance of flagellin in the progression of EHEC induced disease, particularly as levels of 
serum IL-8 have been shown to positively correlate, while levels of IL-10 negatively correlate,   103 
with the risk of development of HUS in children affected by EHEC (Westerholt et al., 2000). 
Conversely,  constant  low  level  stimulation  of  PRRs,  such  as  TLR5,  by  bacteria  of  the 
gastrointestinal microflora has been shown to be important in the maintenance of a healthy gut 
(Rakoff-Nahoum et al., 2004).  
 
It  may  be  beneficial  to  the  bacterium  to  limit  proinflammatory  responses  by  reducing 
infiltration  of  neutrophils  and  thereby  reduce  the  proportion  of  bacteria  eliminated  by 
phagocytosis. The action of T3SS in EHEC and EPEC results in inhibition of IL-8 secretion in 
human IECs (Zhou et al., 2003;Rogers et al., 2003;Hauf and Chakraborty, 2003;Sharma et al., 
2005). In this way, inflammation can be described as a “net effect” of bacterial pro- and anti-
inflammatory stimuli and highlights the antagonism of the bacterium and the host response. 
 
Thus,  the  proinflammatory  response  is  strongly  linked  to  the  action  of  bacterial  flagellin 
during enteric infection and there is some antagonism between pro- and anti-inflammatory 
molecules produced by EHEC. It is not yet determined whether the reasons for decreased 
pathogenicity  of  EHEC  O157:H7  in  the  bovine  host  compared  with  the  human  host  may 
include differential proinflammatory responses between the two species although this remains 
a possibility.  
 
 
Many EHEC-exported components have been shown to exert specific effects upon the host 
(discussed in detail in Section 1.4). The StcE protease is an example of a secreted protein with 
roles in the subversion of host immunity. StcE was first identified by Paton & Paton (2002) in 
their analysis of the immunodominant antigens of E. coli O157:H7 by screening an E. coli 
O157:H7 cosmid library against sera from HUS patients. One of the antigens discovered had 
not  previously  been  functionally  characterised.  The  antigen  was  termed  “TagA”  for  its 
homology with ToxR-regulated lipoprotein TagA encoded by Vibrio cholerae. The immune 
recognition of this protein during human infection has been confirmed (John et al., 2005), but 
was not identified in a screen for E. coli O157:H7 immunogens in colonised cattle (Kudva et 
al., 2006).  
 
Lathem et al. (2002) identified that the TagA homologue was responsible for the aggregation 
of Jurkat cells, using a minitransposon mutagenesis screen and further related the effect to the   104 
protein’s ability to cleave C1-esterase inhibitor. The TagA homologue was henceforth termed 
secreted protease of C1 esterase inhibitor from EHEC (StcE). Cleavage of C1-INH by StcE 
was later found to increase the complement inhibition mediated by C1-INH (Lathem et al., 
2004).  C1-INH  is  an  inhibitor  of  the  complement  cascade,  which  is  a  group  of  proteases 
whose  activation  triggers  a  cascade  of  protease  activation  by  cleavage,  resulting  in  the 
formation  of  the  membrane  attack  complex  which  facilitates  the  killing  of  infected  cells 
(Janeway  et al., 2001). Increased inhibition of complement would prolong the survival of 
infected cells, hence allowing the bacterium to persist on the mucosal surface.  
 
StcE also cleaves human mucin 7 and gp340 and decreases the viscosity of salivary mucous 
(Grys et al., 2005;Grys et al., 2006). Cleavage of mucins could allow the bacterium to access 
the epithelium, where it binds and forms microcolonies necessary for successful colonisation. 
StcE is well conserved among E. coli O157:H7 strains and homologues have been identified in 
a number of members of the Gammaproteobacteria, including E. coli serotypes O55 and O103, 
Shigella  boydii,  Shewanella  baltica,  Aeromonas  spp.  and  Photobacterium  profundum  
(Lathem  et  al.,  2003;Vezzi  et  al.,  2005;Seshadri  et  al.,  2006);  publicly  available  genome 
sequences  stored  on  the  NCBI  database).  The  StcE  homologue  in  Aeromonas  hydrophila 
shares only 65% amino acid identity with StcE yet it retains activity against C1-INH (Pillai et 
al., 2006). 
 
The main objective of this work was to further investigate the roles of extracellular factors 
which may benefit E. coli O157:H7 in its interactions with the host, focusing on extracellular 
factors which modulate host innate immunity and on the epithelial proinflammatory response 
to such factors. Another objective was to characterise the response of bovine epithelial cells to 
E. coli O157:H7 compared with the response to other bovine commensal E. coli. In order to 
perform this analysis, cell lines representing the human and bovine epithelium were chosen. 
At  the  time  that  this  study  was  conducted  no  cell  line  model  for  the  bovine  intestinal 
epithelium was available. Therefore, for the purposes of this analysis embryonic bovine lung 
(EBL) cells were utilised as a bovine epithelial cell line model. A related objective of this 
work was to characterise the function of the StcE protease in interactions with the epithelium 
and to establish a role for StcE in interactions with the bovine host.   105 
3.2  Results 
 
3.2.1  Analysis of bacterial modulation of the epithelial proinflammatory 
response 
 
3.2.1.1  Modulation of interleukin-8 production by the T84 cell line by 
bacterial extracellular products  
 
Bacterial supernatants from a wild type strain of a naturally occurring verotoxin-negative E. 
coli  O157:H7  (MCI  0024)  and  an  isogenic  fliC  mutant  of  this  strain  (MCI  0025)  were 
prepared  according  to  Section  2.3.4  and  used  to  stimulate  cultured  epithelial  cell  line 
monolayers for 24 hours. Initial results, presented in Figure 3.1, suggest that in the absence of 
flagellin, bacterial supernatant (obtained at late-log growth phase) suppressed the production 
of IL-8 in T84 cells to levels below that induced by sterile medium. Preliminary data also 
suggest that supernatant from the fliC mutant could suppress TNFα-induced IL-8 production, 
when  TNFα  was  included  at  25ng/ml  (Figure  3.2).  At  a  concentration  of  50ng/ml  TNFα 
appeared to overcome the suppressive effect. This suggests that the effect is dose-dependent. 
However, in this instance, supernatant from MCI 0024 did not upregulate IL-8 production 
above the basal level. 
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Figure 3.1: IL-8 response of T84 cells to bacterial supernatants: Preliminary data shows that in wells treated 
with bacterial supernatant from the FliC mutant, IL-8 production is below the level seen in those treated with 
sterile MEM-HEPES medium alone (n=3, P=0.025). IL-8 induction appears to be greater in response to early log 
phase culture supernatants, although this difference is not statistically significant. 
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Figure  3.2:  Effect  of  MCI  0025  supernatant  on  TNFα-induced  IL-8  production:  In  the  presence  of 
supernatant from the FliC
- bacterium, 25ng/ml TNFα  was seen to induce IL-8 production to a significantly 
decreased level (n=3 P = 0.015). IL-8 levels in response to MCI 0024 were not significantly greater than the basal 
level or that induced by MCI 0025 supernatant.   107 
Given  the  potential  biological  significance  of  the  apparent  suppressive  effect  indicated  in 
Figures 3.1 and 3.2, the initial experiment was repeated using a greater number of replicates 
(n=6). Results are presented in Figure 3.3(A). In this instance, supernatant from MCI 0024 
significantly  upregulated  IL-8  production  compared  with  unstimulated  cells  (P=0.001). 
MCI0025 supernatant also caused significant upregulation of IL-8 production compared with 
unstimulated  cells  (P=0.001)  but  to  a  significantly  reduced  extent  (P=0.016).  Hence,  the 
apparent suppressive effect shown in Figure 3.2 was not observed in further replication of the 
initial experiment. The results presented in Figure 3.3(B) show that MCI 0025 supernatant has 
no measurable effect on TNFα-induced IL-8 production, contrary to the initial result presented 
in Figure 3.3. 
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Figure 3.3: IL-8 response to bacterial supernatants: (A) Both MCI 0024 and MCI 0025 supernatant 
significantly increase IL-8 production above the basal level (n=6, P<0.05) (B) MCI 0025 supernatant did not 
appear to suppress TNFα-induced IL-8 production in this instance. 
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As the initial results apparently indicating a suppressive effect of bacterial supernatants on IL-
8 production were not reproduced in subsequent experiments, possible technical reasons were 
examined  for  these  potentially  anomalous  results.  One  possible  reason  for  the  observed 
suppression of IL-8 production is that the basal IL-8 levels of the control were misleadingly 
high.  This  could  be  a  positional  effect,  as  no  effort  was  made  to  randomly  distribute  the 
replicates  of  different  stimuli  on  the  plate  in  these  initial  assays.  To  assess  the  potential 
positional effect, a negative control of sterile serum-free culture medium (DMEM:Hams F12, 
2mm L-glutamine) was added to 4 corner wells and 2 centre wells on each of 6 plates and 
analysed  by  the  IL-8  ELISA  kit  after  24  hours  to  assess  edge-effects  and  plate-to-plate 
variation. IL-8 production by cells in corner wells was observed to be significantly greater 
than the IL-8 production by cells in wells at the centre of the plate (P=0.05; Figure 3.5). This 
compromises the validity  of the initial results shown in Figures 3.1  and 3.2, as in  earlier 
experiments it was assumed that basal IL-8 production does not vary significantly between 
regions of the tissue culture plate. Treatment and control wells were organised in a regular 
order in these initial experiments, with the control wells always placed in the first three wells 
of the plate (one corner well and two edge wells); whereas, in the experiments performed to 
generate data presented  in Figure 3.3,  a  greater number of  replicates were performed and 
treatments were positionally distributed about the tissue culture plate (according to the pattern 
displayed in Figure 3.4(B). This may have caused an unusually high apparent basal level of 
IL-8 production observed in Figures 3.1 and 3.2. This finding calls into question the validity of 
previous conclusions. 
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Figure  3.4:  Setup  method  for  IL-8  ELISA  challenges:  (A)  In  initial  challenges,  treatment  groups  were 
arranged in blocks of 3. Control wells were always the first three on the plate (blue). (B) In later challenges, 
treatment groups (n=6) were arranged in the pattern shown (blue=control, red=treatment #1, blue=treatment #2). 
The 4 corner wells and two of the centre wells (pink) were used to assess edge effects with the plate and were not 
exposed to stimuli. 
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Figure 3.5: Edge-effect on IL-8 production/secretion: T84 cells in corner wells of 24-well tissue culture plates 
(n=24) were found to secrete significantly more IL-8 than centre wells (n=12, P=0.05). 
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3.2.1.2  Proinflammatory responses of EBL cells to EHEC and bovine 
commensal E. coli 
 
The data presented in Section 3.2.1.1 provides further evidence of the role of flagellin in the 
initiation of a proinflammatory response. As yet unpublished data suggest that live E. coli 
O157:H7 fliC- (MCI 0025) induces IL-8 gene transcription to a lesser extent than the wild 
type  (MCI  0024)  and  that  IL-8  gene  transcription  is  decreased  in  response  to  a  bovine 
commensal  strain,  designated  E.  coli  MCI  0105,  compared  with  that  initiated  by  E.  coli 
O157:H7 in EBL cells (Paton N.; personal communication). In order to validate these findings 
using  a  proteomic  technique,  similar  experiments  were  carried  out  using  the  human  IL-8 
ELISA Duoset (R&D Systems). 
 
Confluent EBL-cell monolayers were challenged with live bacteria, including wild-type E. 
coli O157:H7 (MCI 0024), the fliC-mutant (MCI 0025) and a bovine  faecal isolate  (MCI 
0105) at an approximate MOI of 100 bacteria per cell, according to the method detailed in 
Section 2.3.6. Culture medium was removed at each timepoint and analysed using the IL-8 
ELISA kit, as set out in Section 2.5.2. None of the bacteria elicited a significant IL-8 response 
above the basal level. These data are not shown, as cells had totally lifted from the cell culture 
plate after 6 hours, suggesting that they had lost viability prior to producing detectable levels 
of IL-8. To protect cells from this effect an alternative protocol was adopted based on the 
gentamicin  protection  assay  (Tang  et  al.,  1993).  This  method  consists  of  a  brief  bacterial 
challenge,  followed  by  removal  and  eradication  of  residual  bacteria  by  the  addition  of 
gentamicin (detailed in Section 2.3.6). 
 
The  results  presented  in  Figure  3.6  show  that  at  a  MOI  of  100,  MCI  0025  induced  IL-8 
production to the greatest extent in the 1 hour-challenge procedure. In the 1 hour-challenged 
procedures  and  the  3  hour-challenged/MOI=100  procedure,  all  bacteria  upregulated  IL-8 
production above the control (P<0.05) except that the difference between the level induced by 
MCI  0024  (MOI=500/1h)  and  control  was  not  significant,  possibly  due  to  the  inherent 
variability displayed at the low absorbance values observed. No bacterium caused significant 
IL-8 upregulation compared with control in the 3 hour-challenged/MOI=500 procedure.   112 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: IL-8 responses of EBL cells to brief challenge with live bacteria followed by removal of the 
bacterial stimulus using gentamicin: (A) 1h bacterial challenge: IL-8 production appeared to be upregulated 
in response to all bacteria at both MOI tested, compared to control, except that the difference between MCI 0024 
(MOI=500) and control was not significant (n=6 in each case) (B) 3h bacterial challenge:  IL-8 production was 
significantly upregulated in response to each bacterium except MCI0024 compared to control after 3h pulse for 
the MOI of 100b/c (P<0.05) but no significant upregulation was observed at MOI of 500b/c (n=3 in each case). 
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To assess the effects of bacterial secreted factors on IL-8 production by EBL cells, 24 hour 
challenges using bacterial supernatants were performed. Supernatants were prepared at the late 
log growth phase in MEM-HEPES, as detailed in Section 2.3.4 and incubated with confluent 
EBL cell monolayers as set out in Section 2.3.5. Samples were analysed by IL-8 ELISA as 
described in Section 2.5.2. Data presented in Figure 3.7 suggest that supernatant from each 
bacterium significantly upregulated IL-8 production above the basal level (P<0.05 for each 
strain tested). Supernatant from the bovine commensal strain (MCI 0105) was observed to 
induce  IL-8  production  to  a  significantly  lower  level  than  supernatant  from  the  E.  coli 
O157:H7  strains.  There  was  no  significant  difference  in  the  level  of  IL-8  induced  by 
supernatants from the wild type and fliC mutant E. coli O157 strains. This could suggest that 
E. coli O157:H7 possesses factors other than flagellin which are capable of initiating an IL-8 
response in EBL cells, which may not be produced by E. coli MCI 0105. It is equally possible 
that MCI 0105 may produce factors which inhibit IL-8 production of EBL cells. 
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Figure  3.7:  IL-8  responses  of  EBL  cells  to  bacterial  supernatants:  IL-8  production  was  significantly 
upregulated in response to supernatants prepared from each bacterium. IL-8 production was upregulated to a 
significantly lower level by MCI 0105 than by MCI 0024 (P=0.002). 
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3.2.2  Functional analysis of the StcE protease 
 
The aim of the following experiments was to confirm and further establish a role for StcE in 
interactions with the host, focussing on the intestinal epithelium and to determine whether 
StcE has a role in interactions with the bovine host. For all experiments, recombinant StcE 
(rStcE) provided by Rodney Welch (University of Madison, Wisconsin) was utilised. 
 
3.2.2.1  Confirmation of activity of purified StcE protease 
 
The activity of the purified rStcE was confirmed by digestion of its known substrate: C1-
Esterase Inhibitor. The experiment was carried out as previously reported in Lathem et al. 
(2002) Briefly, 16µg purified human recombinant C1-INH (Europa Bioproducts: CP2041U) 
was incubated in 480µl AD buffer (20mM Tris, 100mM NaCl, 10% v/v Glycerol 0.01% v/v 
Tween-20 pH 7.5). To this, 4.8µg StcE or an equivalent volume of sterile PBS (11µl) was 
added. Aliquots (30µl) were removed at each timepoint and subjected to SDS-PAGE (Section 
2.4.1). A Western blot was performed by the method set out in Section 2.5.1, using the anti-C1 
Esterase Inhibitor primary antibody and the HRP-conjugated Rabbit anti-Goat IgG secondary 
antibody. As shown in Figure 3.8, levels of a degradation product (60-65kDa) were seen to 
increase over time. Further bands of lower molecular weight can be seen when exposure time 
is increased, which could suggest that StcE may cleave C1-INH at more than one site. These 
results confirm activity of the purified protease against its known substrate. 
 
In an attempt to reproduce the effects of StcE on human salivary mucins and further confirm 
the activity of the purified protein, the procedure set out in Grys et al. (2005) was carried out. 
If the effects demonstrated by Grys et al. could be confirmed by this method it was envisaged 
that further analysis of the effects of StcE on bovine mucins would be assessed. A 100µl 
aliquot of human buccal saliva was collected from the author and incubated with 5µg rStcE in 
a total volume of 115µl for 4 hours at room temperature. A control sample, in which rStcE was 
replaced with an equal volume of sterile PBS (15µl) was prepared and treated identically. 
Samples  (5-20µl)  were  subjected  to  SDS-PAGE  and  stained  using  first  the  Glycoprotein 
Staining  Kit  (Pierce)  and  subsequently  with  Colloidal  Coomassie  (as  described  in  Section 
2.4.4). No bands were visualised after glycoprotein staining (data not shown) suggesting either   116 
that  the  saliva  contained  no  salivary  glycoproteins  or  that  these  glycoproteins  were  not 
mobilised under the electrophoresis conditions employed. The resultant image produced after 
Coomassie  staining  is  presented  in  Figure  3.9.  No  clear  differences  were  observed  in  the 
protein profiles between rStcE-treated and untreated saliva samples, except for 2 bands present 
in rStcE treated profiles. These were excised and both analysed by MALDI-TOF to determine 
if either of these bands may be degradation products of a larger salivary protein affected by 
StcE;  however,  results  of  MALDI-TOF  analysis  and  subsequent  Mascot  database  search 
suggest that both bands are fragments of the StcE protease itself and that the smaller of the 
two bands is StcE lacking the C-terminal domain, as no peptides covering this region were 
detected (Appendix I). This could suggest that StcE could undergo cleavage or be expressed in 
both full length and truncated forms. It is not yet determined whether the shorter form has 
similar activity to the full length StcE protease. A similar doublet of bands was noted by 
Lathem et al. (2002) in a Western blot image after probing E. coli O157:H7 supernatants with 
an anti-StcE antibody. The authors termed this band “non-specific” but presented no evidence 
to confirm this assumption. 
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Figure 3.8: Confirmation of activity of rStcE: (A) C1-INH degradation is exhibited in the production of a 60 
kDa band (denoted by a white arrow) increasing with time when incubated with rStcE. (B) A control confirms 
that rStcE is necessary for the pattern shown (* - the sample for 180 minutes was mistakenly loaded twice in this 
gel. (C) The effect is visualised on coomassie stained SDS-PAGE gel. A band at approximately 60 kDa is present 
in lane containing C1-INH treated with StcE for 300 minutes (lane 2) which is absent in the lane containing 
untreated C1-INH (lane 1). 
 
Figure 3.9: Treatment of saliva with rStcE 
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Figure 3.9: Treatment of saliva with rStcE: Lathem et al. 
(2002) presented data showing cleavage of salivary proteins 
by  StcE.  A  similar  experiment  was  conducted  in  order  to 
attempt  to  reproduce  this  work  and  further  confirm  the 
activity of the recombinant StcE protein. No clear difference 
was  observed  in  the  protein  profiles  between  StcE  treated 
and untreated saliva samples except for 2 bands, denoted by 
the  arrows,  present  in  rStcE-treated  profiles.  These  were 
excised  and  both  confirmed  by  MALDI-TOF  as  the  StcE 
protease (Appendix I). 
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3.2.2.2  Affinity of anti C1-INH antibody for rStcE 
 
To determine if StcE affects bovine C1-INH, StcE was incubated with foetal bovine serum 
(FBS) which theoretically should contain the bovine C1-esterase inhibitor homologue. 2.5µg 
rStcE (or an equivalent volume of PBS) was incubated with 20µl FBS and made up to 127.5µl 
using AD buffer. The experiment was continued as described in Section 3.2.2. The resultant 
Western blot images (using the anti-C1 Esterase Inhibitor primary antibody HRP-conjugated 
Rabbit  anti-Goat  IgG  secondary  antibody)  are  shown  in  Figure  3.10.  The  success  of  this 
experiment was dependent upon the presence of bovine C1-INH in FBS and also that the 
antibody  may  have  affinity  for  bovine  C1-INH.  In  the  untreated  FBS,  the  anti  C1-INH 
antibody appears to have bound to a protein band less than 60kDa, which is unlikely to be C1-
INH. Bovine C1-INH primary sequence contains deletions totalling 32 amino acids (6.4% of 
the total length) when compared with human C1-INH. Therefore, bovine C1-INH in its intact 
glycosylated form (assuming that the glycosylation of bovine and human C1-INH is similar) is 
likely to have a molecular mass of approximately 93kDa. Presence of strong bands in the FBS 
incubated  with  rStcE  suggests  that  the  antibody  binds  to  rStcE.  The  cross-specificity  was 
confirmed in a separate blot in which rStcE alone was subjected to SDS-PAGE and Western 
blot, using the anti-C1 Esterase Inhibitor primary antibody HRP-conjugated Rabbit anti-Goat 
IgG secondary antibody. The resultant image is shown in Figure 3.10 (C).  
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Figure 3.10: Anti C1-INH Western blots showing treatment of foetal bovine serum with rStcE:  
(A) FBS treated with PBS alone: the strongest band visible is below 60kDa. (B) FBS treated with StcE: the band 
below  60  kDa  remains  unchanged.  Two  strong  bands  were  visible  at  approximately  100kDa,  close  to  the 
predicted size of rStcE (105kDa). Visible distortion of this gel is presumably due to the large amount of bovine 
serum albumin present in FBS. (C) A sample of rStcE alone subjected to SDS PAGE and Western blot probed 
with anti C1-INH antibody. The anti C1-INH antibody appears to bind to rStcE. 
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The  apparent  affinity  of  the  anti-C1INH  antibody  with  rStcE  could  be  an  artefact  due  to 
impurity of the primary antibody (whole goat antiserum). The anti-C1-INH antibody used by 
Lathem et al. (2002) was not available at the time that this study was conducted. It is possible 
that the antiserum could include anti-StcE antibodies as goats may be effectively colonised by 
EHEC (Heuvelink et al., 2002). Another possibility is that C1-INH has sufficient structural 
similarity  with  StcE  for  the  antibody  to  have  affinity  for  both  proteins.  However,  this  is 
unlikely, as the two proteins share only 5% amino acid identity as determined by ClustalW 
alignment (Larkin et al., 2007). 
 
3.2.2.3  Bovine Rectal Mucosal Immune Response to StcE 
 
To determine if StcE elicits a bovine mucosal immune response in vivo, a Western blot was 
carried out to establish the presence of IgA antibodies against StcE in mucosal material from a 
calf challenged with E. coli O157:H7. Samples of rStcE, H21 and H7 flagellin (1µg each) 
were subjected to SDS-PAGE in duplicate as described in Section 2.4.1. Western blotting was 
then carried out. Blots were probed using bovine mucosal material followed by anti bovine 
IgA-HRP secondary antibody, as described in Section 2.5.1. Mucosal material and flagellin 
samples were provided by Arvind Mahajan (University of Edinburgh).  
 
Results suggest that anti-StcE and anti-H7 IgA antibodies were present in the mucosal sample, 
whereas anti-H21 antibodies were not detected. A parallel Coomassie stained SDS-PAGE gel 
confirms the presence of each protein in sufficiency. The presence of anti-StcE IgA antibodies 
suggests that StcE is expressed at the mucosal surface and recognised by the bovine host. 
Negative controls whereby a similar blot would be probed with mucosal scrapings from an 
unchallenged animal and the same blot probed only with the secondary antibody would aid the 
confirmation of this effect.   121 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: Rectal mucosal scrapings from E. coli O157:H7 (stx-)-challenged calf contains anti-StcE IgA: 
1µg each of rStcE, H21 flagellin (negative control) and H7 flagellin (positive control) was subjected to SDS-
PAGE (A) Colloidal Coomassie stained gel confirms that each of the analysed proteins is present in abundance. 
(B) Western blot probed with mucosal material and anti bovine IgA suggests that bovine anti-StcE IgA is present 
in the mucosal material. Anti H7-flagellin IgA but not anti-H21 flagellin IgA is detected. 
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3.2.2.4  Assessment of StcE activity against Caco-2 Whole Cells 
 
Data presented in Grys et al. (2005) suggest that StcE affects the epithelial proteome. This 
observation  is  yet  to  be  confirmed  or  characterised  in  detail,  but  could  suggest  that  StcE 
affects proteins expressed by epithelial cells, either by proteolytic action or induction of a 
response from the cell, altering the protein expression profile. StcE is unlikely to activate the 
proinflammatory  signalling  pathway  leading  to  a  general  stress  response  as  treatment  of 
epithelial cells with rStcE does not lead to degradation of IκBα or phosphorylation of p38 
MAPK  (Cameron  P.  unpublished  observations)  and  also  does  not  lead  to  activation  of 
protease-activated  receptors  (PARs)  (Plevin  R.  unpublished  observations).  The  following 
experiment  was  conducted  to  attempt  to  characterise  the  effects  of  StcE  on  the  epithelial 
proteome. 
 
Three day confluent Caco-2 cells were treated with StcE protease according to Section 2.3.7 
and  2D  gel  electrophoresis  was  carried  out  as  detailed  in  Section  2.4.3.  Microscopic 
examination of rStcE-treated cells revealed no obvious morphological alterations compared 
with untreated cells (not shown). The resulting gel images are presented in Figure 3.12. No 
gross  differences  between  rStcE-challenged  and  control  cell  proteomes  were  observed. 
Although  good  separation  of  protein  spots  was  achieved,  consistent  differences  between 
proteomes of StcE-treated cells compared with untreated cells were not detected. Variation in 
spot intensities between the two replicates was considerable (observed using the Phoretix 2D 
Software)  meaning  that  an  impractical  number  of  replicates  of  the  procedure  would  be 
required to identify consistent differences. 
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Figure 3.12: Analysis of effects of StcE the Caco2 cell proteome: Caco2-cells were treated with rStcE or an equivalent volume of sterile PBS. 2 replicates of rStcE treated 
(right) and untreated (left) Caco2 cell proteomes separated by 2D gel electrophoresis are shown. Inconsistencies in resultant gel patterns between replicates, such as those 
caused by horizontal streaking or poorly resolved spots meant that an impractical number of replicates would have been required to detect subtle differences. 
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3.3  Discussion 
 
Data  presented  here  provides  further  evidence  that  flagellin  is  the  major  proinflammatory 
stimulus  among  exported  proteins  of  E.  coli  O157:H7  recognised  by  the  human  cultured 
epithelial T84 cell line. The inflammatory response of the epithelium to bacterial flagellin has 
been reported by others (Gewirtz et al., 2001b;Berin et al., 2002;Zhou et al., 2003;Khan et al., 
2004;Miyamoto et al., 2006). 
 
Suppression  of  inflammatory  cytokine  production  in  response  to  flagellin-free  bacterial 
supernatants  was  initially  suspected.  Suppression  of  proinflammatory  signalling  has  been 
noted  as  a  function  of  the  T3SS  of  both  EPEC  and  EHEC  (Zhou  et  al.,  2003;Hauf  and 
Chakraborty, 2003). On further investigation, the initial result was shown to be anomalous and 
it was shown that supernatant from fliC mutant actually upregulated IL-8 production in T84 
cells to above the basal level. Exported proinflammatory stimuli other than flagellin have also 
been detected by others in EPEC supernatants, although the additional stimuli responsible for 
this effect have not been identified (Sharma et al., 2005;Khan et al., 2008). 
 
Analysis of the effect of position in 24-well tissue culture plates on IL-8 secretion by T84 cells 
lead to the discovery that cell medium from corner wells of the plate contained significantly 
more  IL-8  than  those  at  the  centre  of  the  plate.  This  is  an  effect  which  was  likely  to  be 
responsible  for  the  early  anomalous  results  and  should  be  considered  in  any  further 
experimental design where this cell culture system was used.  The effect could be due to 
different levels of gaseous exchange at the two positions on the plate, resulting in different 
oxidative environments.  
 
Evidence presented here does not suggest that the IL-8 response of EBL cells to bacteria and 
bacterial products depends on flagellin, contrary to the effects shown for the response of T84 
human epithelial cell lines. This could suggest that there may be other, as yet unidentified, 
secreted factors capable of IL-8 induction in EBL cells present in bacterial supernatants. 
 
Bacterial  supernatants  of  a  bovine  commensal  E.  coli  isolate  (MCI  0105)  induced  IL-8 
production to a lesser extent than E. coli O157:H7. Genomic analysis of this isolate, presented 
in Chapter 4, suggest that this isolate resembles E. coli K12, in that it lacks much of the   125 
genomic content possessed by E. coli O157:H7. E. coli O157:H7 could produce additional 
factors capable of stimulating IL-8 production in EBL cells or the commensal strain could 
produce factors which may counteract the effect or both. There was no identifiable difference 
in the response of EBL cells to any of the live bacteria tested, including the bovine commensal 
isolate.  This  suggests  that  the  IL-8  response  of  this  epithelial  cell  line  to  live  bacteria  is 
independent  of  flagellin  and  is  not  a  specific  to  EHEC  strains;  however,  there  may  be  a 
differential response to the extracellular products of EHEC versus commensal strains. The 
factor(s) responsible for this differential response remain to be elucidated. 
 
It has not yet been determined whether EBL cells respond in a similar way to bacteria as 
intestinal epithelial cells. Human IECs are unresponsive to TLR2 and TLR4 ligands and only 
express TLR5 at the basolateral surface (described in detail in Section 1.5.2). It remains to be 
established whether bovine IECs share this pattern of TLR responsiveness. The presentation of 
PRRs by EBL cells has not yet been characterised; therefore, it cannot be determined whether 
EBL cells would be expected to respond in a similar manner to bacterial products as intestinal 
epithelial cells. Further analysis of the responses of bovine intestinal epithelial cells should be 
conducted using a system which is more likely to represent gastrointestinal epithelial cells, 
such as an immortalised intestinal epithelial cell line. The responses of the lung epithelium 
(generally an almost sterile environment) are likely to differ significantly from those of the 
intestinal epithelium, especially as E. coli is not generally tolerated in the airways of healthy 
animals and man and can cause pneumonia in susceptible hosts (reviewed in Russo & Johnson 
2000). However, HeLa  cells (derived from the  cervix) and HEp-2 cells (derived from the 
larynx)  have  been  heavily  relied  upon  for  the  modelling  of  EHEC  intestinal  colonisation 
(Sperandio et al., 2003;Grys et al., 2005;Rendon et al., 2007) and it was envisaged that EBL 
cells could provide an accessible model with which hypotheses may be generated for testing in 
more characteristic (but more complex to implement) model systems representing the bovine 
gastrointestinal epithelium more accurately. Primary bovine rectal epithelial cells are one such 
possibility for this purpose. 
 
In every case, the levels of IL-8 induction in EBL cells were at the very minimum detectable 
by  the  human  IL-8  ELISA  kit,  which  highlights  a  major  limitation  in  this  analysis.  The 
antibodies provided with the human kit are likely to have a decreased affinity for bovine IL-8 
(human and bovine  IL-8 share only 77% amino acid identity, as determined by ClustalW   126 
alignment  of  the  two  sequences).  No  antibodies  against  bovine  IL-8  are  currently 
commercially available. 
 
An  objective  of  this  analysis  was  to  examine  further  the  function  of  the  StcE  protease, 
especially its role in interaction with the epithelium and to determine if StcE has a role in 
interaction with the bovine host. Observations presented in this chapter suggest that cattle 
challenged with E. coli O157:H7 produce IgA antibodies against StcE. Although the results 
presented here do not resolve the function of StcE within the bovine host, the production of 
IgA antibodies to StcE suggest that StcE is expressed and recognised during colonisation. 
However, further confirmatory examination is required in order to verify this result (as set out 
in Section 3.2.2.3). 
 
The  activity  of  purified  recombinant  StcE  was  confirmed  by  digestion  of  its  established 
substrate (human C1-INH). However, alterations to the proteomic profile of salivary proteins 
(as reported by Grys et al., 2005) were not detected when visualisation was attempted using 
SDS-PAGE; however, visualisation of the digestion of mucin 7 and gp340 by immunoblotting 
was not performed. An attempt was made to determine whether StcE affects bovine C1-INH. 
The assay for this relied upon both the affinity of anti human C1-INH antibodies for bovine 
C1-INH and the presence of C1-INH in commercially available foetal bovine serum. This 
cross specificity was not observed but undesirable was affinity was observed between the C1-
INH antibody and recombinant StcE, making the resultant Western blot image more difficult 
to interpret. If purified bovine C1-INH can be sourced the effect of StcE on bovine C1-INH 
may be established. Lathem et al. (2002) noted that the aggregative effects of StcE on human 
T-cells, attributed to the cleavage of C1-INH, occurred when either human or bovine serum 
was present, which suggests that StcE does indeed have the same effect of C1-INH. It remains 
to be established if StcE affects bovine T-cells in the same way.  
 
An  effort  was  made  to  determine  whether  StcE  affects  proteins  expressed  by  a  human 
epithelial cell line using 2D electrophoresis. This technique did not yield potential substrates, 
meaning that analysis by this method was aborted due to the variation in spot intensity and 
specific areas of poor resolution on the gels. New substrates may only be identified using this 
technique if StcE was to affect one of the more abundant proteins in the sample, which must 
also be within the resolvable molecular weight range of the technique (<150kDa). As proposed   127 
StcE substrates described to date are in the high molecular weight range, it is unlikely that the 
method above will allow easy identification of any further StcE substrates. 
 
In summary, data presented here reaffirms that flagellin elicits a significant proinflammatory 
cytokine  response  in  T84  cells.  The  IL-8  response  of  EBL  cells  to  bacteria  and  bacterial 
products does not appear to be flagellin-dependent. The role of StcE protease in the bovine 
host is not yet fully characterised. Observations presented here suggest a secretory antibody 
response at the mucosal surface, suggesting that the effects of this protein during colonisation 
of the bovine gastrointestinal tract are worthy of further investigation. Although no definitive 
conclusions  may  be  drawn  from  this  analysis,  the  data  presented  here  support  the 
multifactorial basis of E. coli-host interactions. 
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4.1  Introduction 
 
As discussed in detail in Chapter 1, the prevalence of EHEC in ruminant hosts facilitates 
transmission of EHEC to humans (Borczyk et al., 1987;Griffin and Tauxe, 1991;Gansheroff 
and O'Brien, 2000). E.  coli O157:H7 has been  found to exhibit preference for  an area of 
lymphoid-follicle  dense  mucosal  tissue,  proximal  to  the  recto-anal  junction  (RAJ)  and  is 
restricted to this area when the organism persists in the bovine host (Naylor et al., 2003). The 
understanding of the factors involved in E. coli tissue tropism could lead to the realisation of 
interventions for control of pathogenic E. coli in ruminants. 
 
E. coli O157:H7 also exhibits specific tissue tropism during the course of human infection. 
The bacterium has been observed to colocalise  with Peyer’s patches, which are lymphoid 
follicle-dense regions of the terminal ileum,  as  has been noted  for other enteropathogenic 
bacteria (Jensen et al., 1998;Phillips et al., 2000;Vazquez-Torres and Fang, 2000;Chong et al., 
2007). It is not yet determined what role (if any) the lymphoid follicle-dense nature of bovine 
rectal mucosal tissue has on the enhanced colonisation at this site, although the cellular surface 
molecules presented at lymphoid follicle dense sites are different to those presented at non-
lymphoid sites, especially due to the presence of large aggregations of cells involved in host 
immunity (described in Section 1.5.2). It is also possible that the physiochemical environment 
at the RAJ is optimal for bacterial growth and persistence. Aeration of the site could increase 
bacterial growth, as E. coli growth rate in culture is increased with greater aeration. Aeration 
has  been  shown  to  cause  upregulation  of  adhesin  genes  in  E.  coli  O157:H7  and  E.  coli 
O157:H-  (James  and  Keevil,  1999;Musken  et  al.,  2008).  Consequently,  greater  levels  of 
oxygen at the RAJ may aid both proliferation and adherence of the bacterium. 
 
The  prevalence  of  E.  coli  of  EHEC-related  genotypes  in  ruminants  has  been  investigated 
extensively.  This  has  generally  been  by  detection  of  EHEC-related  genes,  such  as  those 
encoding  verotoxin,  intimin  and  enterohaemolysin  and  detection  of  EHEC-associated 
serotypes among bovine isolates. Extensive studies using such methodology has been carried 
out in a number of geographical locations (Cobbold and Desmarchelier, 2000;Aktan et al., 
2004;Blanco et al., 2004;Fukushima and Seki, 2004;Blanco et al., 2005;Aidar-Ugrinovich et 
al.,  2007;Ishii  et  al.,  2007).  These  approaches  selectively  target  EHEC-related  organisms 
without comparing this to the E. coli population as a whole.   130 
 
Sparse information is available on the specific gastrointestinal localisation of E. coli subtypes 
other than E. coli O157:H7. Colonisation of the ovine host by E. coli O26 was examined by 
experimental infection of weaned lambs (Aktan et al., 2007). The organism was found to be 
most prevalent at sites in the upper GIT, including the ileum and persistence at these sites was 
observed up to 38 days post inoculation. An organism identified as E. coli ONT:H25, which 
encodes eae type β, stx type 1 and enterohaemolysin, was found to show preference for the 
bovine terminal rectum in healthy cattle (Sheng et al., 2005). Thus, there is evidence that there 
may  be  strain-specific  differences  in  colonisation  patterns  in  ruminants;  however,  to  date 
analysis has largely focussed on the tropism of EHEC-related organisms while knowledge is 
sparse regarding the distribution of other E. coli within the bovine GIT.  
 
Several factors produced by EHEC have been linked to adherence to cells and hence have 
potential roles in colonisation and persistence in the bovine host. Bacterial outer membrane 
protein  intimin  has  an  established  role  in  gastrointestinal  colonisation  of  host  animals, 
especially in concert with the translocated intimin receptor (Tir) (Tzipori et al., 1995;Fitzhenry 
et al., 2002;Cornick et al., 2002;Vlisidou et al., 2006;Sheng et al., 2006b). Intimin-exchange 
studies suggest that intimin γ produced by E. coli O157:H7 defines both host specificity and 
tissue tropism of E. coli O157:H7 (Phillips and Frankel, 2000;Hartland et al., 2000;Fitzhenry 
et al., 2002). Given the established role of intimin as an adhesin, it is logical to predict that the 
subtypes of intimin may be involved in tissue tropism of intimin-encoding bacteria. It has been 
noted that E. coli O157:H7 forms A/E lesions at the bovine terminal rectum, dependent on the 
T3SS (Naylor et al., 2005). 
 
Besides intimin other bacterial molecules have been proposed to aid adherence or define the 
preference shown by E. coli O157:H7 for the bovine terminal rectum. Long polar fimbriae 
have been suggested to define E. coli O157:H7 colonisation of human ileal Peyer’s patches 
and therefore could be important in defining localisation to lymphoid follicles (Fitzhenry et 
al., 2006), although LPF have not yet been shown to be important for tissue tropism of EHEC 
in the bovine host. A study by Dziva et al. (2004), employing signature tagged mutagenesis, 
reaffirmed the role of LEE-encoded T3SS-effector proteins and revealed an array of additional 
factors influencing colonisation of experimentally infected calves including non-LEE-encoded 
putative  T3SS  effector  proteins  and  putative  fimbrial  loci.  A  similar  study  revealed  an   131 
analogous group of factors aiding gastrointestinal colonisation by E. coli O26:H- (van Diemen 
et al., 2005). Factors encoded on pO157 have also been implicated in bacterial colonisation of 
the bovine GIT (Sheng et al., 2006b) et al 2006). The EspP protease has been established as a 
determinant of adherence to cultured bovine rectal epithelial cells (Dziva et al., 2007). The 
action of verotoxin has also been proposed to aid gastrointestinal colonisation. Robinson et al. 
(2006) determined that verotoxin increases the surface expression of nucleolin by enterocytes 
in mice. As nucleolin is proposed to be a cellular receptor for bacterial intimin (Sinclair and 
O'Brien, 2002), it is by this mechanism that Stx is proposed to increase EHEC adherence to 
enterocytes. Although several candidate factors have been proposed, no single factor has been 
definitively  linked  to  colonisation  of  the  bovine  terminal  rectum  above  other  sites  in  the 
bovine GIT.  
 
The  objectives  of  this  line  of  investigation  were  two-fold:  Firstly,  to  perform  genomic 
characterisation  of  E.  coli  of  the  bovine  GIT,  with  a  view  to  prediction  of  diversity  and 
potential  pathogenicity  of  bovine  resident  E.  coli.  This  was  performed  using  molecular 
analysis by PCR to detect virulence, putative adhesin-encoding genes and to assign isolates to 
phylogenetic  groups.  To  complement  this  approach  comparative  genome-indexing  by 
microarray  was  also  performed  on  selected  isolates.  The  second  major  objective  was  to 
determine the colonisation patterns of resident E. coli of the bovine gastrointestinal tract, by 
sampling from selected sites and characterisation of strains recovered from different sites. Five 
gastrointestinal locations were selected for this purpose (Figure 4.12). Enumeration data was 
combined with molecular typing results in order to deduce links between specific genotypes 
and  colonisation  patterns.  If  colonisation  patterns  of  bovine  resident  E.  coli  could  be 
established, those which exhibit a similar colonisation pattern to E. coli O157:H7 may have 
applicability as probiotic agents (discussed further in Chapter 5) as they may be more adept at 
competition with E. coli O157:H7 at its preferred site of colonisation. A major goal of this 
analysis was to establish whether E. coli O157:H7 is unique in its specific tissue tropism or if 
other E. coli share this site-preference. This type of analysis would allow E. coli O157:H7 to 
be placed in context among E. coli of the bovine gastrointestinal tract and further elucidate the 
complex interactions between E. coli and the bovine host. 
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4.2  Results 
 
4.2.1  Molecular analysis of bovine E. coli isolates 
 
4.2.1.1  Bacterial strains 
 
For each of the molecular techniques used in this study, reference strains of known genotype 
were utilised. These strains are summarised in Table 2.1 (Materials and Methods). 
 
A prototype panel of bovine resident E. coli was provided by Neil Paton (MRI) and Stuart 
Naylor (SAC). These had been isolated by 3 methods, as set out in Section 2.3.2, namely: (i) 
faecal “free catch”, (ii) recto-anal mucosal swab and (iii) PBS-washing of necropsy sections. 
Strains provided by N. Paton were originally isolated from 7 animals by method (i) and 12 
different animals by method (ii), using CT-SMAC as a selective medium. Pooled colonies 
from TBX plates (Section 2.3.2) were provided by S. Naylor. They were prepared by method 
(iii) and were originally derived from 14 animals which had been orally challenged with E. 
coli  O157:H7  (∆stx,  MCI  0010)  but  were  not  apparently  effectively  colonised  by  this 
organism  (S.  Naylor  personal  communication).  There  was  a  possibility  that  the  challenge 
strain  was  out-competed  by  bovine  intestinal  bacteria  and  that  among  the  E.  coli  isolates 
derived from these animals there may be a strain which is able to compete effectively with E. 
coli O157:H7 in vivo, that may have applicability as a probiotic agent (investigated further in 
Chapter 5), assuming that intra-E. coli competition was the reason for poor colonisation by the 
challenge  strain  in  these  animals.  From  each  sweep,  individual  colonies  were  selected  at 
random  for  analysis  for  molecular  serotyping  (Section  4.2.1.2).  A  full  list  of  isolates  is 
included in Appendix II. 
 
Three isolates were selected from each animal for molecular H-typing except from animals 7 
and 493 where only 2 and 1 isolates were provided respectively. Molecular O-typing was 
subsequently performed on all isolates, except for the isolate derived from animal 493 (MCI 
0354), one colony from animal 740 (MCI 0369) and one colony from animal 583 (MCI 0379). 
In these cases, molecular H-type distinguished these isolates from others derived from that   133 
animal (MCI 0369 and MCI 0379) and from all others among that group of animals (MCI 
0369). 
 
4.2.1.2  Molecular serotyping of bovine E. coli isolates 
 
As highlighted in Section 1.2.1, E. coli may be categorised into over 180 different O-serotypes 
and more than 50 H-serotypes. Hence, there are more than 9000 combinations of O/H types 
which  are  theoretically  possible.  This  means  that  serotyping  is  a  powerful  method  for 
subspecific classification of E. coli. As serological methods of O and H antigen determination 
remain laborious and expensive, molecular methods were adopted to group E. coli isolates by 
serotype. 
 
Molecular H-typing (H-RFLP) by the method of Fields et al (1997) and Ramos Moreno et al. 
(2006) (described in Section 2.6.4.1) was performed on each of the bovine resident E. coli 
isolates described in Section 4.2.1.1. Examples of H-RFLP and O-RFLP patterns are presented 
in Figures 4.1 and 4.2 respectively and results for all isolates analysed are given in Appendix 
III. 
 
In the majority of cases, H-RFLP patterns were matched to expected patterns described in 
Ramos Moreno et al. (2006) or to theoretical patterns predicted by in silico digestion of all full 
length E. coli fliC-gene sequences available on the NCBI database, using the University of 
Alberta Sequence Manipulation Suite: 
http://www.ualberta.ca/~stothard/javascript/rest_digest.html.  A  table  of  predicted  restriction 
fragment patterns is included in Appendix III. 
 
From the 32 animals from which isolates were derived (representing 96 isolates in total) 14 
different  H-RFLP  patterns  were  identified,  with  3  amplified  but  unmatchable  and  3  not 
amplified by the PCR, suggesting that these isolates were H- or carry a fliC gene of a variant 
type not amplifiable using the method described here. Patterns matching H35 and H21 were 
most prevalent, found in isolates from 10 animals each.  A pattern matching H19NM was 
exhibited by isolates from 4 animals, H4 and H8 in 3 animals and H31 in 2 animals. All other 
patterns were observed in single animals.  
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Molecular O-typing (O-RFLP) was performed using the method of Coimbra et al. (2000). O-
RFLP patterns obtained could not be related to the O-patterns set out in Coimbra et al. due to 
extensive variance in actual patterns compared with the schematic representation presented in 
that paper as illustrated in Figure 4.2 (B). Hence, it was not possible to derive a meaningful 
database of reference patterns from the information included in the paper. However, O-RFLP 
patterns could be matched to each other (where multiple representatives of one unknown O-
pattern were obtained). It was also possible to assign a theoretical O-type to isolates which 
yielded an O-RFLP pattern which matched that of a reference isolate of serotype previously 
determined  using  conventional  serological  methods.  Where  isolates  yielded  an  O-RFLP 
pattern  which  could  not  be  matched  to  a  known  serotype,  an  arbitrary  “Or”  number  was 
assigned (see Table 4.2) which should not be confused with the “R” patterns given in Coimbra 
et al. It was interesting to note that by this method, an isolate designated O5 by serological O-
typing (MCI 0052) exhibited the same pattern as an isolate designated O113 (MCI 0247). The 
patterns more closely resemble that of O113 given in the paper. Confirmation by serotyping 
would be required to eliminate the possibility that the original serotype-designation was at 
fault. 
 
From the 32 animals analysed, 28 distinct O-RFLP patterns were observed, with Or11 found 
in 4 animals; Or4, Or7, Or14, Or17 and a pattern matching that of serologically typed MCI 
0319 (O146) each appeared in 3 animals. Or14 matched an isolate of serotype O45, while Or4, 
Or7 and Or17 matched to isolates which were untypeable by the serological method. All other 
types occurred in single animals only, with five isolates not yet defined (ND) the H-types of 
which suggested that they differed from other isolates from the same animals.   135 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Example image showing H-RFLP analysis: (A) Uncut fliC gene amplicons were between 1000-
2000bp in length. (B) H-RFLP patterns after RsaI treatment. This image is an example showing a subset of the H-
RFLP types observed. Numbers shown correspond to arbitrary MCI reference numbers for each strain (Tables 
2.1, 4.2 and 4.5). MCI 0045 (E. coli O157:H7 EDL933) was included in each gel as a reference of known H-type 
(H7) H-RFLP profiles for all bovine isolates are presented in Appendix III. 
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Figure 4.2: O-RFLP analysis: (A) Example of restriction patterns obtained from reference isolates and bovine 
isolates of unknown serotype. The bands for MCI 0045 (E. coli O157:H7) and MCI 0053 (E. coli O111:H21) 
appear fainter due to lower concentration of template DNA was lower than expected in this instance. Resultant 
images for all isolates are presented in Appendix III. (B) The image (left) shows the O-RFLP pattern obtained 
from 7 E. coli O157 isolates (MCI reference numbers correspond to those given in Table 2.1) compared with the 
expected pattern from Coimbra et al. (2000). The bands circled in red highlight the difficulties faced  when 
attempting to match patterns to the published reference patterns. 
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4.2.1.3  PCR analysis of selected genes 
 
From the isolates described in Section 4.2.1.1, one representative isolate of each O/H-RFLP 
pattern combination from each animal was further characterised by PCR-based screening for 
selected  factors  which  were  chosen  on  the  basis  that  the  detection  of  each  would  allow 
placement  of  the  organism  into  a  phylogenetic  group  or  aid  assignation  of  a  predicted 
pathotype, allowing anticipation of the potential hazard to humans and animals posed by each 
strain. PCR primers were chosen based on published studies and are summarised in Table 2.2 
(Materials & Methods). 
 
Detection of the gene encoding intimin (eae) was performed using a method adapted from 
Aranda et al. (2004). This was performed in concert with detection of the aat gene, indicative 
of  enteroaggregative  adherence,  present  in  90%  of  human  EAEC  isolates  (Schmidt  et  al., 
1995b)  and  the  gene  encoding  bundlin  (bfpA),  the  major  structural  subunit  of  the  bundle 
forming  pilus  indicative  of  localised  adherence  exhibited  by  “typical”  human  EPEC 
(Donnenberg et al., 1992). In optimising the assay, it was found that the eae primers would 
amplify the EPEC eae (α1) gene to a lesser extent than eae (γ) of EHEC, even though the 
primers  matched  identically  with  the  primer  sites  given  in  the  E.  coli  E2348/69  genome 
sequence 
(ftp://ftp.sanger.ac.uk/pub/pathogens/Escherichia_Shigella/E2348_array_chromo.embl).  A 
possible reason for the faint band observed could be that there is some interference between 
the the eae primers and other primers or amplified products in the reaction, possibly due to the 
amplification of the bfpA gene which is also encoded by this EPEC strain. Nevertheless, the 
band for eae (α1) was visible and the assay was considered sufficient for the detection of these 
genes (see Figure 4.4). A triplex PCR, also adapted from Aranda et al. was used to detect 
genes  encoding  IpaH  associated  with  the  invasive  mechanism  of  EIEC  and  Shigella  spp. 
(Sethabutr et al., 1993), along with stx1 and stx2 genes, encoding shiga-like/vero-toxins. The 
method of Lin et al. (1993) was adopted as a complementary approach for stx-gene detection, 
allowing further subtyping of stx genes, according to the method presented in Bastian et al. 
(1998).  PCR-RFLP  was  employed  to  determine  the  subtype  of  intimin  encoded  using  the 
method of Ramachandran et al. (2003). 
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Assays to detect genes encoding two key components of the T3SS; escN and espA, by the 
methods of Kyaw et al. (2003) and China et al. (1999) respectively, were assessed. The escN 
PCR assay was successfully employed to amplify the gene from a range of diverse T3SS 
encoding E. coli strains. The espA PCR failed to amplify the espA gene from EPEC (MCI 
0278) and was therefore discarded. 
 
Plasmid-borne EHEC-encoded putative virulence factor-encoding ehxA and espP genes were 
detected using previously published methods (McNally et al., 2001;Cookson et al., 2007). The 
method for ehxA gene detection included an RFLP-typing scheme. It must be noted that the 
ehxA restriction patterns could not be related to those presented in Cookson et al. (2007) 
possibly due to incomplete digestion of amplified fragments. However all ehxA positive E. 
coli isolates exhibited one of two patterns (designated “106*” and “319*”, after MCI 0106 and 
MCI  0319  respectively)  distinct  from  the  pattern  yielded  by  E.  coli  O157:H7  MCI  0045 
(Figure 4.5). The method of Brunder et al. (1999) allowed espP typing to be performed. To 
date, 4 main groups of EspP protein have been determined (designated α, β, γ and δ). EspP of 
types α and γ are proteolytically active, while EspP of types β and δ have been found to be 
inactive against pepsin A (Brockmeyer et al., 2007). 
 
Genes encoding components of cytolethal distending toxin (cdtB), cell necrotising factor (cnf), 
F5 (K99), F17 (gafD) and F41 fimbriae were detected according to published methods (Blanco 
et al., 1996;Bertin et al., 1996b;Franck et al., 1998;Janka et al., 2003). Cytolethal distending 
toxin (CDT) causes cytopathic effects on human endothelial cells, by triggering cell cycle 
arrest (Comayras et al., 1997). Functional CDT has been found to be produced by ExPEC of 
both the human and bovine host and diarrhoeagenic E. coli including sorbitol-fermenting E. 
coli  O157:H-  (Pickett  et  al.,  1994;Scott  and  Kaper,  1994;Peres  et  al.,  1997;Janka  et  al., 
2003;Toth et al., 2003;Bielaszewska and Karch, 2005). Cell necrotising factors, CNF-1 and 
CNF-2 induce rearrangement of the actin cytoskeleton, possibly facilitating endocytosis of 
bacteria (De Rycke et al., 1990;Oswald et al., 1994). CNF, along with CDT, is produced by 
the majority of ExPEC strains (reviewed in De Rycke et al., 1999). The role of CNF in enteric 
pathogenesis remains unclear as CNF has been found in E. coli isolated from both healthy and 
diarrhoeic  cattle  (Blanco  et  al.,  1998a;Blanco  et  al.,  1998b;Orden  et  al.,  1999).  The 
elaboration of F17 fimbriae is a common feature of CNF-2 producing bacteria. F17 fimbriae 
producing E. coli have been related to bovine neonatal diarrhoea and septicaemia (Shimizu et   139 
al., 1987;Lintermans et al., 1988). K99 (F5) and F41 fimbriae have been related to ETEC 
which cause diarrhoea in cattle (Acres, 1985;Güler et al., 2008). 
 
Multiplex PCRs described by Nowrouzian et al. (2001) were also performed in order to detect 
genes encoding several adhesins (papC, fimA, sfaD/E, draA and iutA) and capsular antigen-
related  proteins  (neuB  and  kfiC).  The  papC  gene  encodes  the  P-fimbrial  usher  protein,  a 
chaperone which aids the formation of P-fimbriae (Dodson et al., 1993). The neuB and kfiC 
genes are encoded by the K1 and K5 operons respectively. P-fimbriae as well as K1 and K5 
capsular antigens have been identified in persistent colonists of the human intestine (Tullus et 
al.,  1992;Adlerberth  et  al.,  1998;Nowrouzian  et  al.,  2001).  The  fimA  gene  encodes  the 
structural subunit of Type I fimbriae which are encoded by the majority of E. coli  strains and 
are proposed to enhance adherence to a variety of tissues (Krogfelt et al., 1990). 
 
The sfaD/E genes (carried on the operon encoding S-fimbriae), the draA gene, which encodes 
the  Dr  haemagglutinin  and  iutA,  which  encodes  the  aerobactin  receptor  (which  aids  iron 
acquisition), are commonly found in ExPEC. Each of these factors has been put forward as 
enhancers of  cellular  adherence and have been  identified as markers of persistence in the 
human  intestine  (Adlerberth  et  al.,  1995;Nowrouzian  et  al.,  2001).  Neither  their  role  in 
interactions of E. coli with the bovine host nor their carriage among bovine E. coli isolates 
have been examined in detail. 
 
The triplex PCR described by Clermont et al. (2000) was used to assign isolates to the 4 the 
four most common phylogenetic groups (A, B1, B2 and D, although groups C and E also 
exist) of those determined by MLST and MLEE (see Section 1.2) based on the carriage of 
three genomic loci: chuA, yjaA and TSPE4.C2;. Virulent extra-intestinal strains are reported to 
belong mainly to group B2 and D (Bingen et al., 1998;Picard et al., 1999;Johnson and Stell, 
2000). The majority of virulent EHEC belong to Group A or Group E although the majority of 
other STEC are members of group B1 (Escobar-Paramo et al., 2004;Girardeau et al., 2005). E. 
coli O157:H7 belongs to Group E, but would be identified as belonging to Group D by the 
method of Clermont et al.  
 
PCR assays were verified before proceeding with the analysis, using at least one positive and 
negative control (listed in Table 2.1, Materials & Methods). Example images of the results of   140 
PCR-characterisation are shown in Figures 4.3-4.5. Results for all isolates are summarised in 
Table 4.2 and images supporting these results are included in Appendix IV.  
 
Of the 46 isolates analysed, 34 isolates were found to encode the fimA gene. 14 isolates were 
found to encode one or more verotoxin gene. Aerobactin receptor gene (iutA) was amplified 
from 16 isolates. 13 isolates were found to encode gafD and cdtB was also detected in 13 
isolates, of which 12 also encoded cnf. Intimin and escN genes were detected in 6 isolates. The 
enterohaemolysin gene (ehxA) was detected in 7 isolates and 4 isolates were found to encode 
the espP gene. These data are included in a summary of E. coli genotypes, discussed further in 
Section 4.2.3. 
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Figure 4.3: Verification of single-factor PCR assays: Reference strains of known genotype were used to assess 
the sensitivity and specificity of PCR-based gene detection assays. In all cases shown, amplification of single 
genes from reference isolates occurred as expected, while bands were absent from negative controls. No positive 
control was available for gafD prior to commencing this work. Numbers correspond to MCI reference numbers 
given in Table 2.1 (Materials & Methods). Results for all strains are provided in Appendix III. 
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Figure 4.4: Verification of multiplex PCR assays: Multiplex PCR assays were carried out using template DNA 
from reference isolates with known genotype. In all cases, PCR amplification resulted in bands at the expected 
sizes, without non-specific amplification. No positive control for the draA haemagglutinin gene was available 
during this study. Images of PCR detection of genes from all bovine isolates are included in Appendix III. 
Numbers correspond to MCI reference numbers given in Table 2.1 (Materials & Methods).  
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Figure 4.5: PCR-RFLP analysis of stx genes: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Types  Fragment sizes (bp)  Pattern 
stx1  705, 158, 32   A 
stx2  555, 262, 62   B 
stx2c/stx2d  555, 324, 16   C 
stx2e  555,340    D 
stx2vO111/stx2vOX392  880, 15   E 
stx2e/stx2f  521,374  F 
stx2g  902 (uncut)  G 
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B  Figure 4.5: PCR-RFLP analysis of stx genes: (A) HincII-digested 
RFLP patterns obtained from stx-encoding bovine E. coli isolates. MCI 
0319 (stx1) and MCI 0234 (stx2 and stx2c/d) are included as reference 
patterns.  Numbers  correspond  to  MCI  reference  numbers  given  in 
Tables 4.2, 4.5 and Appendix II (B) Expected patterns, adapted from 
Bastian et al. (1998) and updated by in silico digestion using sequences 
available from the NCBI and the Sequence Manipulation Suite: 
http://www.ualberta.ca/~stothard/javascript/rest_summary.html  
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Figure 4.6: PCR-RFLP analysis of plasmid-encoded EHEC virulence factors: (A) TaqI restriction digestion of ehxA amplicons yielded two distinct patterns, designated 
“106” and “319”. MCI 0045 was included as a reference pattern, but gave a fainter pattern. The central panel shows the MCI 0045 pattern more clearly with increased exposure 
(B) AluI restriction digestion of espP amplicons yielded patterns which were matched to those given by Brunder et al. (1999). Numbers correspond to MCI reference numbers 
given in Tables 4.2, 4.5 and Appendix II. (C) Expected RFLP patterns of espP subtypes, along with the associated serotypes given by Brunder et al. (1999) and formulated by 
in silico restriction analysis using the sequence manipulation suite: (http://www.ualberta.ca/~stothard/javascript/rest_digest.html). 
espP type  Expected 
fragment sizes 
(bp) 
Associated 
serotypes 
A 
(αO157) 
773, 677, 420, 
57, 21. 
O157:H7 
B (αO26)  677, 420, 422, 
351, 48, 30 
O26:H11/ H-, 
O145:H-, 
O111:H-. 
C (β)  677, 498, 422, 
351   
O22:H8, 
O69:H-, 
Orough:H11. 
D 
(γO77/δ) 
849, 677, 422  O55:H-, 
O52:H19, 
O8:H19. 
E (γO128)  819, 677, 422, 
30 
O128:H8. 
F  1778, 170  ONT:H14. 
G  677, 420, 360, 
350, 220 
O98:H8. 
αO157 #2  422,420, 400, 
351, 48,30 
O157:H7. 
vO113  887, 516, 400, 
145 
O113:H21. 
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Figure 4.7: PCR-RFLP analysis of intimin-encoding genes: (A) Verification of eae-RFLP protocol: The primers designed by Ramachandran et al (2003) amplified gene 
fragments from all of the reference types available apart from eae type η. All yielded expected patterns, as described by Ramachandran et al. (2003) (B) Analysis of eae genes 
carried by bovine E. coli isolates. Deduced eae types are included in Tables 4.2 and 4.5. 
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Ref. No.  Animal 
Isolation 
method 
O-type/O-RFLP 
type 
H-RFLP-
type  Lineage  ipaH  stx  espP  escN  eae  cdtB  cnf  fimA  papC  iutA  ehxA  gafD 
MCI 0104  7  FFC  Or1  H35  D  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0105  9  FFC  ONT (Or2)  H34  B1  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0106  10  FFC  ONT (Or3)  H-/NT  A  -  -  B  +  θ  -  -  +  -  -  106*  - 
MCI 0108  8  FFC  ONT (Or4)  H4  B1  -  -  -  -  -  +  +  -  -  +  -  + 
MCI 0109  11  FFC  ONT (Or4)  H4  B1  -  -  -  -  -  +  +  -  -  +  -  + 
MCI 0110  14  FFC  O26  H11  B1  -  A  B  +  β  -  -  +  -  +  106*  - 
MCI 0114  11  FFC  Or5  H4  B1  -  -  -  -  -  +  +  -  -  +  -  + 
MCI 0120  13  FFC  Or6  H35  B1  +/-  -  -  -  -  -  -  +  -  -  -  - 
MCI 0121  9  FFC  ONT (Or7)  H+(NT)8  D  -  -  -  -  -  +  -  +  -  -  -  - 
MCI 0122  7  FFC  O116  H25  B1  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0160  100742  RS  Or9  H31  B1  -  -  -  -  -  +  +  +  +  +  -  + 
MCI 0162  400211  RS  O43 (Or10)  H35  B1  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0164  500348  RS  Or11  H14  B1  -  -  -  -  -  +  +  +  -  +  -  + 
MCI 0165  400396  RS  Or11  H-/NT  B2  -  -  -  -  -  +  +  -  -  +  -  + 
MCI 0167  400385  RS  Or12  H35  B1  -  -  -  +  β  -  -  +  -  -  -  - 
MCI 0168  400211  RS  Or10  H35  B1  -  -  -  +  β  -  -  +  -  -  -  - 
MCI 0169  500340  RS  Or13  H35  B1  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0170  300741  RS  Or11  H21  B1  -  -  -  -  -  -  -  +  -  -  -  + 
MCI 0171  300741  RS  ONT (Or4)  H35  B1  -  -  -  +  β  -  -  +  -  -  -  - 
MCI 0172  400376  RS  Or11  H-/NT  B2  -  -  -  -  -  +  +  -  -  +  -  + 
MCI 0173  500340  RS  O45 (Or14)  H35  B1  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0174  600341  RS  ONT (Or7)  H21  B1  -  -  -  -  -  +  +  +  -  +  -  + 
MCI 0176  300395  RS  O45 (Or14)  H35  B1  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0177  600341  RS  ONT (Or7)  H21  B1  -  -  -  -  -  +  +  +  -  +  -  + 
MCI 0179  600747  RS  Or15  H19NM  B1  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0181  600747  RS  O45 (Or14)  H30  A  -  -  -  -  -  -  -  -  +  -  -  - 
MCI 0182  300744  RS  Or16  H21  B1  -  -  -  -  -  -  -  +  -  -  -  -   147 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.2: Results of molecular typing of E. coli isolates: Isolates which yielded a band of similar molecular weight and intensity to the reference strains are noted with a ‘+’. 
Those yielding a band of lower intensity, suggesting either artifactual non-specific amplification or polymorphisms in the primer-binding site are denoted ‘+/-’. RFLP-patterns 
are included for eae, stx, espP and ehxA. No isolates were found to carry genes encoding aat, bfpA, F5, F41, sfaD/E, kfiC, neuB or draA and hence, these genes are omitted from 
the table.  
Notes: “Lineage”= Phylogenetic group determined by method of Clermont et al. (2000)..ND=not determined, NT=Untypeable. Isolation method: FFC: faecal free-catch, RS: 
recto-anal mucosal swab TS: tissue section from terminal rectum. 
For stx, espP, eae and ehxA, RFLP patterns are also given. For ehxA: type 106* and 319* were assigned to isolates which exhibited ehx-RFLP patterns indistinguishable from 
MCI 0106 and MCI 0319 respectively. 
a: an amplicon of the expected size was produced by the method of Aranda et al. (2004) but not by the method of Ramachandran et al. (2003). Therefore this isolate may be 
intimin positive, but it is untypeable by the methods described here. 
Ref. No.  Animal 
Isolation 
method 
O-type/O-RFLP 
type 
H-RFLP-
type  Lineage  ipaH  stx  espP  escN  eae  cdtB  cnf  fimA  papC  iutA  ehxA  gafD 
MCI 0308  824  TS  ONT (Or17)  H8  B1  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0311  540  TS  Or18  H-/NT  A  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0319  540  TS  O146  H21  B1  -  A  -  -  -  -  -  +  -  +  319*  - 
MCI 0327  593  TS  O146  H21  B1  -  A  -  -  -  -  -  +  -  +  319*  - 
MCI 0344  541  TS  Or19  H32  A  -  D  -  -  -  -  -  +  -  -  -  - 
MCI 0345  541  TS  Or18  H35  A  -  -  -  +  +(NT
a)  -  -  -  -  -  -  - 
MCI 0354  493  TS  ND  H29  B1  -  G  -  -  -  -  -  -  -  -  -  - 
MCI 0356  710  TS  O45 (Or14)  H21  B1  -  A+D  -  -  -  +  +  -  -  +  -  + 
MCI 0362  739  TS  Or20  H21  B1  -  -  -  -  -  +  +  -  -  +  -  + 
MCI 0368  740  TS  Or21  H48  B1  -  A  -  -  -  -  -  +  -  -  -  - 
MCI 0369  740  TS  ND  H31  D  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0373   824  TS  Or22  H8  B1  -  D  -  -  -  -  -  +  -  -  -  - 
MCI 0377  583  TS  ONT (Or17)  H-/NT  B1  -  -  -  -  -  -  -  +  -  -  -  - 
MCI 0378  583  TS  Or23  H21  B1  -  D  -  -  -  +  +  -  -  +  -  + 
MCI 0386  587  TS  O146  H21  B1  -  A  -  -  -  -  -  +  -  +  319*  - 
MCI 0392  566  TS  Or24  H21  B1  -  A  G  -  -  -  -  -  -  -  -  - 
MCI 0398  586  TS  Or25  H19NM  B1  -  G  -  -  -  -  -  +  -  -  319*  - 
MCI 0404  825  TS  Or26  H19NM  B1  -  A  -  -  -  -  -  +  -  -  319*  - 
MCI 0410  826  TS  Or27  H19NM  B1  -  D  C  -  -  -  -  +  -  -  -  -   148 
 
4.2.1.4  Extended Genotyping of E. coli isolates using microarrays 
 
To obtain extended genotypic information and relate this to PCR-based characterisation, five 
bovine commensal E. coli were selected (based on their pathotype, as predicted by virulence 
factor  PCR)  for  extended  spectrum  virulence  gene  detection  using  a  miniaturised  DNA 
microarray  (ArrayTube  system,  Clondiag)  designed  and  tested  by  Anjum  et  al.  (2007) 
(described in Section 2.6.7). Genes that were detected using the array are summarised in Table 
4.3. The full list of oligonucleotides included in the ArrayTube is given in Appendix V. For 
each of the genes represented in both the nanoarray and the PCR-screen, the results of gene-
detection by these methods were in agreement. 
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Isolate  Factors detected by PCR  Factors detected by 
nanoarray 
Predicted 
pathotype 
E. coli ONT (Or2):H34 
(MCI 0105) 
 
fimA.  gad, rrl.   Non-
pathogenic  
E. coli ONT (Or3):H-/NT 
(MCI 0106) 
eaeθ, espP, fimA, ehxA (type 
106). 
 
rrl, eae, ehxA.  Atypical 
EPEC  
E. coli ONT (Or4):H4 
(MCI 0108) 
cdtB, cnf, iutA, F17 (gafD)  gad, rrl, cdtB, cnf1, F17-G, 
iss. 
 
ExPEC 
E. coli O26:H11  
(MCI 0110) 
stx1/stx1v, eaeβ, escN, espP 
(type B), ehxA (type 106), 
iutA, fimA. 
 
rrl, cba, eae, espB, ehxA, 
iss, stx1. 
EHEC 
E. coli O146:H21  
(MCI 0319) 
stx1/stx1v, iutA, ehxA (type 
319), fimA. 
gad, rrl, celB, ehxA, 
iss, mchB, mchC, mchF, 
senB, stx1. 
STEC* 
 
Table 4.3: Gene detection using the ArrayTube nanoarray compared with gene detection by PCR: In all 
cases, virulence factors detected by nanoarray were in agreement with those detected by PCR. * MCI 0319 is 
designated as a predicted STEC (shiga-toxigenic E. coli) as it encodes genes for Shiga-like toxin not genes 
encoding intimin and proteins associated with a functional  T3SS. Shiga-toxigenic intimin/T3SS-negative E. coli 
strains have been noted to cause haemorrhagic colitis and HUS (Banatvala et al. 2001).   150 
Figure 4.8: Images resulting from virulence gene nanoarray 
MCI 0319 
MCI 0108 
MCI 0110 
MCI 0105  MCI 0106 
Figure 4.8: Images resulting from virulence gene nanoarray: Oligos described in Appendix V were included in triplicate. Bottom left: The grid shown 
corresponds to the positions of the oligonucleotides, the numbers shown referring to those shown in Table A5 (c = HRP control spots). Where areas of 
smudging occurred, due to particulate matter, results for oligonucleotides affected were omitted from subsequent analysis.   
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In order to obtain a broader view of the genomes of the strains analysed by nanoarray, a pan-
genomic  microarray  was  utilised,  as  described  in  Section  2.6.6,  which  comprised 
oligonucleotides  representing  the  genomes  of  two  sequenced  E.  coli  O157:H7  isolates 
(EDL933 and Sakai) and that of prototypic laboratory isolate E. coli K12 MG1655. Examples 
of resultant array images are presented in Figure 4.9. A schematic diagram summarising the 
microarray  results  is  presented  in  Figure  4.10.  As  shown  in  Figure  4.10  the  backbone 
component, common to E. coli O157:H7 and E. coli K12 MG1655, is conserved among the 
strains analysed. Greater heterogeneity is observed in the portion of the genome present in E. 
coli O157:H7 but not E. coli K12, including oligonucleotides representing regions which are 
designated “O-islands”. The presence and absence of each O-island is examined in more detail 
in Figure 4.10.  
 
It can be seen from this analysis that isolates encoding EHEC-related genes (MCI 0106, MCI 
0110  and  MCI  0319)  carry  the  largest  proportion  of  the  O157-specific  sequences  of  the 
isolates analysed here. MCI 0108 (ExPEC-like strain) was found to be devoid of almost all of 
the  genes  encoded  on  the  major  O-islands.  MCI  0105,  which  was  predicted  to  be  non-
pathogenic (as it was negative for all of the virulence factor-encoding genes), was positive for 
more than 50% of the oligonucleotides representing O-islands 7, 30, 36 44, 102 and 115, 
although the functions of the genes encoded on these regions are not defined. As would be 
expected of intimin-encoding strains, MCI 0106 and MCI 0110 were positive for more than 
50%  of  the  oligonucleotides  representing  the  LEE  and  also  O-islands  71  and  122.  These 
islands  are  conserved  among  pathogenic  EHEC  and  both  encode  T3SS-effector  proteins 
(Karmali et al., 2003;Tobe et al., 2006;Coombes et al., 2008). MCI 0110 and MCI 0319, 
which both encoded stx1, were both positive for the majority of oligonucleotides representing 
O-islands 51, 52 and 76. Once again, the functions of the genes encoded on these islands are 
largely  unknown.  Although  MCI0319  encodes  stx1,  it  was  negative  for  much  of  the 
oligonucleotides  representing  the  stx1  bacteriophage.  This  highlights  the  diversity  of 
bacteriophages which carry stx genes, as has been noted by others, especially among those 
carried by bovine STEC (Besser et al., 2007). MCI 0110 (predicted EHEC as it encodes eae 
and stx) was the only strain tested which carries a significant proportion of O-island 50. Again, 
this island is largely composed of genes of unknown function. As the bovine isolates were 
observed to only encode small parts of many islands, this suggests that many of the O-islands 
may be mosaic, as noted by others (Perelle et al., 2003;Shen et al., 2004;Bielaszewska et al.,   152 
2007a;Bielaszewska  et  al.,  2007b),  suggesting  that  some  of  the  larger  O-islands  are  the 
product of multiple smaller acquisitions, rather than wholesale acquisitions of entire genomic 
islands. 
 
Although MCI 0106 and MCI 0110 were both found to encode espP and ehxA genes by PCR 
(both of these genes are carried on pO157 in E. coli O157:H7), these strains were only positive 
for  a  small  proportion  (approximately  one  quarter:  Figure  4.11)  of  the  oligonucleotides 
representing  pO157.  Both  strains  were  positive  for  katP  and  oligonucleotides  representing 
genes  flanking  espP  (locus  tags  L7013-L7029).  The  probes  representing  espP  were 
ambiguously positive in MCI 0106, suggesting some diversity in the espP gene encoded by 
this strain. Operons encoding enterohaemolysin were detected in MCI 0106, 0110 and 0319 
which corroborates the results of the ehxA PCR. 
 
The isolates analysed herein were positive for many of the oligonucleotides representing the 
K-islands, which comprise the portion of E. coli K12 genome which is absent from E. coli 
O157:H7 (Perna et al., 2001). MCI 0108, MCI 0110 and MCI 0319 were each positive for 
approximately 40% of these oligonucleotides, whereas MCI 0105 and MCI 0106 were each 
positive for approximately 30%. K12-specific regions conserved in all strains include parts of 
K-islands 77, 121, 142, 166, 172, 183 and 192, which contain genes which have only putative 
or unknown functions assigned, K-island 108 which encodes genes involved in molybdate 
metabolism, and K-island 153 which encodes a malate synthase and glycolate oxidase genes. 
MCI 0108 and MCI 0110 were positive for a cluster of genes involved in citrate dependent 
iron transport. 
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Figure 4.9: Example images resulting from genomic microarray hybridisations 
Figure 4.9: Example images resulting from 
genomic  microarray  hybridisations:  Each 
panel  shows  one  block  of  5978 
oligonucleotides.  Three  of  these  blocks  are 
printed  on  each  array,  meaning  that  3 
replicates of each oligo are included on each 
slide. Grossly, it can be seen from this image 
that E. coli O157:H7 (MCI 0066) is positive 
for much of the O157-specific content, while 
predicted  non-pathogenic  strain  MCI  0105 
lacks many of these genes (evidenced by the 
propensity of red spots in the upper part of 
each  block,  where  the  O157-specific 
oligonucleotides  were  situated),  whereas 
predicted  EHEC-like  strain  (MCI  0110)  is 
positive for many of these oligonucleotides. 
MCI 0066  MCI 0105 
MCI 0110   154 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: Results of O157/K12 microarray analysis of bovine commensal E. coli: the Venn diagram above shows the numbers of oligonucleotides specific to each of the 
three control strains represented on the array and those common to two or all three isolates. Each oligonucleotide is represented by a vertical bar, the topmost bar coloured 
according to the Venn diagram (the grey area at the rightmost end of the bar corresponds to the genes encoded on pO157) and subsequent bars coloured by presence or absence 
in each strain analysed (yellow: present, blue: absent, grey: ambiguous). It can be seen that the core genome component is broadly conserved in each strain, whereas the O157-
specific component (the rightmost third of the bars) shows heterogeneous carriage across the bovine isolates analysed. The numbers to the right correspond to MCI reference 
numbers (Tables 2.1 and 4.2). 
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Figure 4.11: O-island scan of bovine commensal E. coli: For each of the O-islands of greater than 5kbp that were represented on the array (excluding all oligonucleotides 
predicted to hybridise to multiple locations on the genomes of any of the control strains), the proportion of oligonucleotides giving a positive result for each strain was 
determined. It can be seen that a typical human E. coli O157:H7 strain (WallaWalla1, MCI 0066) was positive for the majority of O-islands, while these genes are carried more 
variably by other bovine resident E. coli. (a: the stx2 encoding bacteriophage, b: stx1 encoding bacteriophage, c: sites containing genes encoding non-LEE-encoded T3SS-
effectors, d: the LEE, e: operons encoding long polar fimbriae). pO157 is included in this scan as it is another significant genomic element present in E. coli O157:H7 but 
absent  from the E. coli K12 MG1655 genome. Colours: blue: <25% oligos positive, light blue: 25-50% positive, green: 50-90% positive, yellow: >90% positive. 
  O-island 
  1  7  8  9  14  17  20  28  30  35  36  44  45  47  50  51  52  55  70  71  76  79  84 
MCI 0066  100  100  100  100  100  100  100  100  100  100  100  100  80  100  100  94  100  100  100  95  100  94  91 
MCI 0105  40  73  33  14  86  100  0  0  80  0  54  50  0  0  14  0  20  14  0  5  0  19  0 
MCI 0106  40  67  17  14  0  0  0  0  80  0  58  63  83  0  29  35  32  14  0  75  4.2  38  0 
MCI 0108  40  13  25  14  0  100  0  0  40  0  0  6.3  0  0  0  0  32  14  0  5  25  6.3  9.1 
MCI 0110  40  43  8.3  0  0  100  0  0  40  0  83  75  12  0  71  82  60  14  0  85  79  0  9.1 
MCI 0319  40  70  17  14  0  100  0  0  80  0  63  38  44  0  29  59  64  14  0  5  54  19  0 
size (kbp)  6.5  36  23  6.1  5.3  5.3  8.1  25  12  14  39  45  62  32  47  16  54  6.7  7.9  58  21  45  14 
oligos  5  30  12  7  7  6  5  5  5  14  24  16  41  27  21  17  25  7  7  20  24  16  11 
                          a              c       
   
  O-island 
  90  93  95  102  108  115  122  123  138  139  140  141  144  145  148  153  154  162  166  167  172  173  pO157 
MCI 0066  100  75  100  100  100  100  100  100  100  100  89  100  100  100  95  100  100  100  100  90  58  100  99 
MCI 0105  0  6.3  0  33  0  50  12  0  0  20  11  0  100  38  0  17  0  100  0  10  8.3  0  23 
MCI 0106  0  19  100  33  14  80  76  0  0  30  0  0  100  100  71  17  0  50  100  10  13  0  23 
MCI 0108  0  6.3  100  33  0  0  24  0  0  100  0  0  100  38  0  33  0  100  0  10  8.3  0  21 
MCI 0110  0  56  0  47  29  45  76  0  0  10  0  0  100  100  62  33  0  100  86  10  17  0  28 
MCI 0319  0  25  0  33  0  50  18  0  0  30  0  0  100  100  2.4  17  0  100  0  0  13  0  18 
size (kbp)  5.1  49  6.2  13  22  17  23  7.3  15  6.6  9.1  5.9  6.1  5.4  43  7.4  6.9  5.5  6.3  9.3  44  5.6  92 
oligos  3  16  6  15  14  20  17  6  18  10  9  6  2  8  42  6  6  2  7  10  24  3  97 
    b        c  c  c        e      d    e               156 
4.2.2  Distribution of bovine resident E. coli in the bovine GIT 
 
In order to obtain a profile of the E. coli present at different sites in the bovine GIT, five sites 
were chosen for the isolation of mucosa-associated E. coli by necropsy sampling as set out in 
Section 2.3.2. The selected sites are highlighted in Figure 4.12 including (1) terminal rectum 
(TR), within 5cm of the RAJ, (2) the proximal rectum (PR) between 15 and 20cm from the 
RAJ, (3) a site in the distal colon (DC) approximately one metre from the rectum (4) a site at 
the proximal colon (PC) at a flexure close to the caecum, (5) the terminal ileum (IL), 10-20cm 
from the ileocaecal junction. In the initial animals, which were used to optimise techniques 
(described in Section 4.2.2.1), site 3 (colon) was not sampled. In the first animal, only sites 1, 
2 and 4 were sampled. Sites 3 and 5 were added to give increased coverage of regions of the 
lower GIT in the animals for which enumeration data was included in the analysis of E. coli 
prevalence at each location. 
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Figure 4.12: Representation of bovine gastrointestinal tract, showing the sites of E. coli necropsy sampling: 
Each of the sites analysed in this study is circled in red in the diagram above, including: TR: Terminal rectum, 
PR: Proximal rectum, DC: Distal colon, PC: Proximal colon and IL: Ileum (redrawn from Dyce et al., 1987). 
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4.2.2.1  Optimisation of viable counts 
 
Four animals (which showed no signs of diarrhoeal illness and had not been treated with 
antibiotics) which were to undergo routine disposal were analysed in order to assess and refine 
techniques for bovine E. coli isolation. The first was a milking cow of approximately seven 
years, used to pilot two techniques of isolating mucosa-associated E. coli. As well as the 
technique set out in Section 2.3.2, a second method was assessed for its applicability for this 
purpose, whereby a sterile swab was vigorously rubbed across a defined area (5cm x 5cm) of 
the mucosal tissue. The method set out in Section 2.3.2 proved more practical for this purpose 
as wrinkling of the tissue made measurement of the area to swab more difficult and saturation 
of  the  swab  was  not  always  even.  For  this  first  animal,  count  data  was  not  obtained  as 
insufficient countable replicates of the spread plates were prepared. However, this animal was 
used to provide isolates for analysis of the numbers of different E. coli serotypes present 
within one animal (see Section 4.2.2.3). 
 
The three further animals (two milking cattle of approximately 29 months and a four week old 
male calf) were used to determine the expected range of E. coli colonisation density which 
could be expected to be found allowing refinement of the methodology. 
 
The data obtained indicated that the two milking cows were moderately colonised at all sites 
sampled (in the range of 10
2-10
3cfu/cm
2). The young calf exhibited heavy colonisation at the 
rectum  (10
5-10
6  cfu/cm
2)  and  low  numbers  of  E.  coli  at  the  proximal  colon  and  ileum 
(approximately 10
2 cfu/cm
2). 
 
4.2.2.2  Enumeration of mucosa-associated E. coli at selected GIT sites in 
a panel of healthy weaned calves 
 
Eleven calves, aged between 4 and 8 months which showed no signs of diarrhoeal disease and 
had not been treated with antibiotics were used to obtain mucosally-associated E. coli. Tissue 
sections  from  the  five  sites  detailed  in  Figure  4.11  were  taken  and  E.  coli  was  isolated 
according to the method detailed in Section 2.3.2.  
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Animal 300710 was excluded from the analysis as the counts were universally low.  Resultant 
bacterial counts from other animals were transformed by the dilution factor of the countable 
plates (those exhibiting less than 500 colonies) to give a value for cfu/100µl of the liquid in 
which  the  tissue  was  suspended,  which  would  contain  the  bacteria  removed  from 
approximately 2mm
2 of tissue surface by the vigorous vortexing (described in Section 2.3.2). 
The data was transformed using the following equation: log10(c+1), where c=cfu/100µl. The 
addition of the constant (+1) allows zero values to be retained after the transformation. The 
data  was  imported  into  the  GenStat  program  and  a  restricted  maximum  likelihood  model 
(REML) was fitted to the data, using “site” as a fixed factor and “replicate tissue section 
within site” and “animal” as random factors. Site within animal was identified as having a 
significant effect on the number of E. coli recovered (F=0.050), meaning that colonisation was 
not uniform across the sites analysed. The terminal rectum and proximal colon appeared to be 
most heavily colonised of the sites analysed, although not to a significant extent over the other 
sites (Figure 4.14). 
 
The  terminal  rectum  and  ileum  were  presupposed  to  be  areas  of  lymphoid  follicle-dense 
mucosal tissue, with the proximal rectum and colon likely to be less densely populated with 
lymphoid tissue. To validate this presumption and to affirm that sampling was performed at 
the same sites in each animal, 1cm
2 pieces of tissue were fixed in formal saline, embedded in 
paraffin  wax  and  sections  of  tissue  taken  for  haematoxylin  and  eosin  (H  &  E)  staining 
(performed at Moredun Research Institute: Pathology Department). Images representative of 
each site are presented in Figure 4.13.   160 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13: Mucosal morphology at sites selected for the isolation of resident E. coli (part 1):  TR: terminal 
rectum, within 5cm of the recto-anal junction (RAJ): the principle site of colonisation for E. coli O157:H7. 
Lymphoid follicles (LF) are present at high density at this site. An LF is shown here extending through the 
lamina muscularis (LM) into the lamina propria (LP). PR: proximal rectum (15cm proximal to the RAJ), 
lymphoid follicles are less frequent at this site. TS: tela submucosa, E: epithelium.
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Figure 4.13: Mucosal morphology at sites selected for the isolation of resident E. coli (part 2): proximal colon (PC) and distal colon (DC) are both primarily involved in 
the absorption of water and solutes from the gut lumen. Similarly to the proximal rectum, these sites are not densely populated with LFs. The terminal ileum is a site of 
particularly high LF density, a site including ileal Peyer’s patches. The image shows an LF which extends into the lamina propria to the mucosal surface. 
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Figure 4.14: Viable counts of E. coli from each gastrointestinal site analysed: Mean ± SEM of count data 
from animals described in Section 4.2.2.2 (n=10) are shown as predicted by REML analysis using the GenStat 
program. These data suggest that E. coli may be generally more prevalent at the TR and PC than the other sites 
analysed. (TR: terminal rectum, PR: proximal rectum, DC distal colon, PC: proximal colon, IL: ileum). 
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4.2.2.3  Characterisation of mucosa-associated E. coli of the bovine 
gastrointestinal tract 
 
The first animal studied was used to obtain an indication of the number of different E. coli 
serotypes that may be present within one animal, (Figure 4.9). From this animal, 54 colonies 
from each intestinal site were chosen for analysis by molecular H-typing. 
 
From all other animals, 18 colonies were picked from plates representing each site, except in 
the cases where CFU counts from particular sites were so low that there were insufficient 
colonies available for selection (in such cases all available colonies were taken for analysis). 
Where blue (glucuronidase-positive) and white (glucuronidase-negative) colonies were present 
on  TBX  medium,  proportions  of  blue:white  colonies  picked  were  made  to  reflect  the 
proportions of these present on the plate. The full list of strains recovered from the animals 
analysed in this study is given in Appendix II. 
 
When glucuronidase-negative (white colonies on TBX) organisms were selected for analysis, 
they normally exhibited no growth in LB. When the organism did grow in LB and sufficient 
DNA  was  obtained  (determined  by  nanodrop),  amplification  of  the  rfb  locus  for  O-RFLP 
failed in each case. It was therefore deduced that these were colonies of an organism other 
than E. coli and therefore discounted from the viable count data and no further characterisation 
of  these  organisms  was  performed.  It  was  important  to  attempt  to  characterise  these 
glucuronidase-negative  organisms,  considering  that  E.  coli  O157:H7  is  generally 
glucuronidase-negative;  however,  the  vast  majority  (96-97%)  of  E.  coli  strains  are 
glucuronidase positive (Ratnam et al., 1988). 
 
For five of the total number of animals utilised in this study rectal swabs were taken and 
plated onto TBX agar 3 weeks prior to euthanasia. Three colonies from each animal were 
included in the molecular characterisation, to assess whether particular E. coli subtypes had 
persisted. 
 
Molecular H-typing (H-RFLP) was used as a preliminary method used to predict the number 
of  different  serotypes  present  within  an  animal.  This  procedure  was  performed  for  each 
selected colony as set out in Section 2.6.4.1. For each of the H-RFLP-patterns found, three   164 
colonies exhibiting this pattern from each gastrointestinal site were chosen for molecular O-
typing (O-RFLP). When no amplicon was generated by H-RFLP, six of these colonies were 
chosen for O-RFLP when available. If the O-RFLP patterns of the three (or six) chosen of a 
particular H-RFLP type were indistinguishable, it was assumed that all isolates of that H-type 
bear the same O-type within that animal. Where more than one O-RFLP pattern was identified 
for one H-RFLP pattern in one animal, it was necessary to obtain O-RFLP patterns for all 
isolates  bearing  that  H-RFLP  pattern  within  that  animal.  O-RFLP  patterns  and  H-RFLP 
patterns obtained from each animal are included in Table 4.5. 
 
The molecular serotype analysis of E. coli isolated from the first animal is presented in Figure 
4.15. It was observed that a single serotype was most prevalent at each of the sites analysed, 
making up 76-82% of the E. coli recovered from each site (79.6% of the total E. coli recovered 
from that animal). A second serotype was present at lower levels (13-17% at each site, 14.8% 
overall). In total, five different serotypes were identified among isolates from this animal, 
although three of these serotypes combined comprised less than 5% of the E. coli sampled 
from this animal. This was found to be typical of other animals analysed (Table 4.4). For the 
remaining animals analysed, molecular serotype data was combined with viable count data in 
order to examine the colonisation patterns for each serotype identified. Where isolates of a 
particular serotype were isolated from more than one colony from each animal, these were 
considered to be significantly present in the animal. Relative proportions of each serotype 
were predicted by multiplying total E. coli count (cfu/cm
2) by the proportion of recovered 
colonies exhibiting this serotype. These data are presented in Table 4.4. The mean number of 
E.  coli  types  detected  within  an  animal  was  calculated  as  2.571  (±  0.453,  n=14,  min=1, 
max=7). 
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Figure 4.15: Pie charts showing distribution of E. coli subtypes within one animal: At each site analysed one 
serotype  (ONT  (Or4):H37,  represented  by  isolate  MCI  0430)  predominates,  with  a  second  type  (Or57:H7, 
represented by isolate MCI 0435) making up a smaller but significant proportion of the E. coli population. This is 
in agreement with the numbers of E. coli subtypes recovered from the rest of the panel of animals (Section 
4.2.2.3 and Table 4.4). 
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Table  4.4: 
Distribution of E. coli in the bovine GIT
ANIMAL  TYPE  TR  PR  DC  PC  IL  RT  ANIMAL  TYPE  TR  PR  DC  PC  IL  RT 
04097  Or29:H19NM  352.9  846.6  *  2523  73.41  No  700217  Or41:H25  2296  68.06  0  0  0  Yes 
   Or30:H8  117.6  0  *  137.3  14.68  No     O103:H2  1722  68.06  0  0  0  Yes 
   TOTAL  500  888.9  *  2883  102.8       Or17:H8  1148  22.69  0  0  0  Yes 
02757  O103:H36  119  343.4  *  1455  357.1  No     Or7:H+(NT)2  0  45.37  36.36  1158  233.3  No 
   Or29:H19NM  47.62  156.1  *  783.3  642.9  No     ~O147:H-/NT  0  22.69  0  0  0  No 
   TOTAL  250  655.6  *  2350  1500       Or10:H2  0  45.37  27.27  2027  700  No 
600096  O26:H+(NT)1  2E+06  1E+06  *  138.9  50  Yes     Or42:H16NM  0  0  18.18  1737  933.3  No 
   Or35:H20  5E+05  0  *  0  0  Yes     TOTAL  5167  272.2  100  5211  1983   
   TOTAL  2E+06  1E+06  *  138.9  50    400354  Or7:H+(NT)2  848.1  524.5  7.407  6228  59.72  No 
200927  Or7:H+(NT)2  58833  4728  3465  22891  0  No     Or45:H2  318.1  0  0  0  0  Yes 
   TOTAL  58833  4728  3850  24417  0       Or47:H40  0  0  37.04  566.2  119.4  No 
601223  Or7:H+(NT)2  100  233.3  2317  438.9  1078  No     TOTAL  1272  572.2  66.67  6794  238.9   
   TOTAL  100  233.3  2317  438.9  1078    301437  Or47:H40  45804  5627  49238  41839  921.8  No 
300710  Or7:H+(NT)2  27.78  22.22  50  38.89  27.78  No     TOTAL  48667  6378  59086  44300  1006   
   TOTAL  27.78  22.22  50  38.89  27.78    401473  Or41:H25  305.6  0  0  0  0  Yes 
300129  Or37:H+(NT)1  14383  0  0  0  0  Yes     Or10:H2  55.56  0  0  774.1  0  No 
   Or35:H49  9589  651.9  2261  30904  2050  No     Or46:H2  27.78  686.3  127.8  1161  369.4  No 
   Or14:H-/NT  0  217.3  174  0  128.1  No     Or52:H+(NT)2  0  915  553.7  3870  1355  No 
   TOTAL  28767  977.8  2783  32722  2178       Or53:H9  0  114.4  0  774.1  0  No 
300136  Or37:H+(NT)1  6224  0  0  0  0  Yes     TOTAL  388.9  1944  766.7  6967  2217   
   Or14:H-/NT  4841  3932  687.5  9018  10144  No  200522  Or7:H+(NT)2  2872  256.5  447.2  1662  117.3  No 
   Or38:H+(NT)1  691.5  245.8  437.5  1932  2029  No     Or52:H+(NT)2  1045  615.7  511.1  1477  93.83  No 
   TOTAL  11756  4178  1000  10950  12172       TOTAL  4178  872.2  1150  3139  211.1   
700140  Or39:H+(NT)2  2201  2311  3080  1818  5906  No     <10               
   Or37:H+(NT)1  593.8  0  0  0  0  Yes     11-100               
   Or36:H47  0  0  0  699.1  0  No     101-1000             
   TOTAL  2672  2311  3272  2517  6644       1001-10000             
  * = site was not analysed         10001-100000             
              >100001              
Table 4.4: Distribution of E. coli in the bovine 
GIT: Proportion of each type of E. coli present at 
each site in each animal sampled was calculated 
and multiplied by the total count at each site to 
give  predicted  density  (cfu/cm
2).  Isolates  which 
colonised at the rectum at greater than two-fold 
density  at  the  rectum  than  other  sites  were 
considered  to  be  candidate  rectal  tropic  strains 
(RT).    167 
PCR-screening for selected genes was carried out on two representatives of each molecular 
serotype from each animal; one isolate from two separate sites where strains of this serotype 
were isolated from more than one site in an animal. The pair of isolates chosen was always 
from the two sites where the organism was recovered that were spatially furthest away from 
each other (the terminal rectum and the ileum in most cases). PCR characterisation was carried 
out  as  Section  4.2.1.3  and  example  images  are  presented  in  Figures  4.3-4.7.  Results  of 
molecular  characterisation  of  these  isolates  by  PCR  are  summarised  in  Table  4.5  with 
supporting imaged included in Appendix IV. The genes detected in each of the paired isolates 
were identical in each case and for simplicity; results from one representative of each paired 
isolate are included in Table 4.5. The full list of isolates is given in Appendix II.   168 
 
Ref. No.  Animal 
Isolation 
method 
O-type/O-
RFLP type 
H-RFLP-
type  Lineage  ipaH  stx  espP  escN  eae  cdtB  cnf  fimA  sfaD/E  neuB  iutA  ehxA  gafD 
MCI 0430  001  TS  ONT (Or4)  H37  A  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0435  001  TS  Or57  H7  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0437  001  TS  Or28  H39  A  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0439  001  TS  O43 (Or10)  H2  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0441  001  TS  O149*  H8  B1  -  stx2NT
d  -  -  -  -  -  +  -  -  -  -  - 
MCI 0454  04097  TS  O139 (Or29)  H19NM  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0455  04097  TS  Or30  H8  B1  -  A+D+B  C  -  -  -  -  +  -  -  -  319*  - 
MCI 0457  04097  TS  Or31  H10  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0464  04097  TS  Or34  H25  B2  -  -  -  -  -  -  -  -  -  -  -  -  - 
MCI 0465  02757  TS  O103  H36  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0468  02757  TS  ND  H-/NT  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0475  02757  TS  O139 (Or29)  H19NM  A  -  -  -  -  -  -  -  -  -  -  -  -  - 
MCI 0483  600096  TS  O26  H+(NT)1  B1  +/-  -  D  +  β  -  -  +  -  -  -  106*  - 
MCI 0487  600096  TS  O18ac (Or35)  H20  B1  -  A+D+B  D  -  -  -  -  +  -  -  -  319*  - 
MCI 0490  200927  TS  ONT (Or7)  H+(NT)2  B1  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0494  200927  TS  Or36  H47  B1  -  -  -  -  -  +  +  +  -  -  +  -  - 
MCI 0496  601223  TS  ONT (Or7)  H+(NT)2  B1  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0501  300710  TS  ONT (Or7)  H+(NT)2  B1  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0512  300129  TS  O18ac (Or35)  H49  B1  -  -  -  -  -  +  -  +  -  -  -  -  - 
MCI 0517  300129  TS  Or37  H+(NT)1  B1  -  B  C  -  -  -  -  +  -  -  -  319*  - 
MCI 0518  300129  TS  O45 (Or14)  H-/NT  B2  -  -  -  -  -  +  +  -  -  -  +  -  + 
MCI 0521  300129  TS  ONT (Or7)  H5  B2  -  A  -  -  -  +  +  -  +  +  +  -  - 
MCI 0522  300129  TS  Or39  H+(NT)2  B1  -  A  +/-
c  -  -  +  +  +  -  -  -  -  + 
MCI 0653  300129  TS  Or57  H-/NT  B1  -  B  C  -  -  -  -  +  -  -  -  319*  - 
MCI 0654  300129  TS  Or39  H-/NT  B1  -  A  +/-
b  -  -  +  +  -  -  -  -  -  + 
MCI 0655  300129  TS  O18ac (Or35)  H49  B1  -  -  -  -  -  +  -  -  -  -  -  -  - 
MCI 0656  300129  TS  Or39  H49  B1  -  A  +/-
c  -  -  +  +  -  -  -  -  -  +   169 
 
 
Ref. No.  Animal 
Isolation 
method 
O-type/O-
RFLP type 
H-RFLP-
type  Lineage  ipaH  stx  espP  escN  eae  cdtB  cnf  fimA  sfaD/E  neuB  iutA  ehxA  gafD 
MCI 0523  300136  TS  O45 (Or14)  H-/NT  B2  -  -  -  -  -  +  +  -  -  -  +  -  + 
MCI 0528  300136  TS  Or37  H+(NT)1  B1  -  B  C  -  -  -  -  +  -  -  -  319*  - 
MCI 0529  300136  TS  O15 (Or38)  H+(NT)8  D  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0534  700140  TS  Or37  H+(NT)1  B1  -  B  C  -  -  -  -  +  -  -  -  319*  - 
MCI 0535  700140  TS  Or39  H+(NT)2  B1  -  A  NEW
c  -  -  +  +  +  -  -  -  -  + 
MCI 0540  700140  TS  Or26  H+(NT)9  B1  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0541  700140  TS  Or36  H47  B1  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0543  700140  TS  Or40  H+(NT)3  B1  -  -  -  -  +/-
a  +  +  +  -  -  +  -  + 
MCI 0544  700217  TS  O43 (Or41)  H25  B1  -  -  +/-
b  +  -  +  -  +  -  -  -  106*  - 
MCI 0546  700217  TS  Or17  H8  B2  -  C  G  -  -  -  -  +  -  -  -  -  - 
MCI 0549  700217  TS  O103  H2  B1  -  -  -  +  ε  -  -  +  -  -  -  106*  - 
MCI 0551  700217  TS  ONT (Or7)  H+(NT)2  B1  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0557  700217  TS  O43 (Or10)  H2  B1  -  -  -  -  -  -  -  +  -  -  -  -  + 
MCI 0561  700217  TS  O118 (Or42)  H16NM  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0564  700217  TS  Or43  H+(NT)7  B1  -  -  -  -  -  -  -  +  -  -  -  -  + 
MCI 0566  700217  TS  Or44  H8  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0657  700217  TS  ~O147  H-/NT  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0658  700217  TS  O103  H2  B1  -  -  -  +  -  -  -  +  -  -  -  106*  - 
MCI 0567  400354  TS  Or45  H2  B1  -  C  -  -  -  -  -  +  -  -  -  -  - 
MCI 0568  400354  TS  ONT (Or7)  H+(NT)2  B1  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0573  400354  TS  Or46  H2  B1  -  -  -  -  -  -  +  +  -  -  -  -  - 
MCI 0574  400354  TS  O149  H12  D  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0575  400354  TS  O58 (Or47)  H40  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0578  400354  TS  Or48  H+(NT)4  B1  -  -  -  -  -  -  -  -  -  -  -  -  + 
MCI 0579  400354  TS  -
e  H5  B2  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0580  400354  TS  ONT (Or7)  H+(NT)2  B1  -  -  -  -  -  -  -  -  -  -  -  -  + 
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Ref. No.  Animal 
Isolation 
method 
O-type/O-
RFLP type 
H-RFLP-
type  Lineage  ipaH  stx  espP  escN  eae  cdtB  cnf  fimA  sfaD/E  neuB  iutA  ehxA  gafD 
MCI 0581  301437  TS  O58 (Or47)  H40  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0586  301437  TS  O149*  H12  D  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0589  301437  TS  Or49  H5  B2  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0590  301437  TS  Or50  H16NM  A  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0591  301437  TS  O45 (Or14)  H-/NT  B2  -  -  -  -  -  +  +  -  -  -  +  -  + 
MCI 0593  301437  TS  Or51  H-/NT  A  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0594  401473  TS  O43 (Or41)  H25  B1  -  -  +/-
b  +  -  +  -  +  -  -  -  106*  - 
MCI 0595  401473  TS  O43 (Or10)  H2  B1  -  -  -  -  -  -  -  +  -  -  -  -  + 
MCI 0597  401473  TS  Or46  H2  B1  -  -  -  -  -  -  +  +  -  -  -  -  - 
MCI 0602  401473  TS  O147 (Or52)  H+(NT)2  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0606  401473  TS  O118 (Or42)  H16NM  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0608  401473  TS  Or46  H-/NT  B2  -  -  -  -  -  +  +  -  -  -  +  -  + 
MCI 0611  401473  TS  Or53  H9  A  -  -  -  -  -  -  -  -  -  -  +  -  + 
MCI 0613  401473  TS  O147 (Or52)  H-/NT  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0614  401473  TS  O5/O113  H-/NT  A  -  +
f  -  -  -  -  -  -  -  -  -  -  - 
MCI 0659  401473  TS  Or17  H8  B1  +/-  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0615  200522  TS  ONT (Or7)  H+(NT)2  B1  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0619  200522  TS  O147 (Or52)  H-/NT  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0621  200522  TS  O147 (Or52)  H+(NT)2  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0625  200522  TS  Or54  H25  B1  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0626  200522  TS  Or48  H5  B2  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0627  200522  TS  Or46  H2  B1  -  -  -  -  -  -  +  +  -  -  -  -  - 
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Ref. No.  Animal 
Isolation 
method 
O-type/O-
RFLP type  H  Lineage  ipaH  stx  espP  escN  eae  cdtB  cnf  fimA  sfaD/E  neuB  iutA  ehxA  gafD 
MCI 0628  700217  RS  ONT (Or17)  H8  B1  -  C  G  -  -  -  -  +  -  -  -  -  - 
MCI 0629  700217  RS  Or55  H+(NT)5  D  -  -  +/-
b  -  -  -  -  +  -  -  -  -  - 
MCI 0631  400354  RS  Or55  H+(NT)5  D  -  -  +/-
b  -  -  -  -  +  -  -  -  -  - 
MCI 0632  400354  RS  Or56  H2  B1  -  C  -  -  -  -  -  +  -  -  -  -  - 
MCI 0635  301437  RS  O80  H+(NT)6  D  +/-  -  B  +  γ  -  -  +  -  -  +  106*  - 
MCI 0637  301437  RS  Or50  H16NM  A  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0638  401473  RS  Or55  H+(NT)5  D  -  -  +/-
b  -  -  -  -  +  -  -  -  -  - 
MCI 0640  401473  RS  O118 (Or42)  H16NM  B1  -  -  -  -  -  -  -  +  -  -  -  -  - 
MCI 0641  200522  RS  Or54  H25  B1  -  -  -  -  -  +  +  +  -  -  +  -  + 
MCI 0642  200522  RS  Or55  H+(NT)5  D  -  -  +/-
b  -  -  -  -  +  -  -  -  -  - 
MCI 0644  200522  RS  -
e  H2  B1  -  A  A  +  -  -  -  +  -  -  +  106*  - 
Table 4.5: Molecular analysis of bovine E. coli isolates isolated during the course of this study: Isolates which yielded a band of similar molecular weight and intensity to 
the reference strains are noted with a ‘+’. Those yielding a band of lower intensity, suggesting either artifactual non-specific amplification or polymorphisms in the primer-
binding site are denoted ‘+/-’. RFLP-patterns are included for eae, stx, espP and ehxA. No isolates were found to carry genes encoding aat, bfpA, F5, F41, sfaD/E, kfiC, neuB or 
draA and hence, these genes are omitted from the table.  
Notes: “Lineage”= Phylogenetic group determined by  method of Clermont et al. (2000). Isolation methods: F=faecal, RS=rectal swab, TS=Tissue section. ND=not  yet 
determined, NT=Untypeable, NA=not amplified.  
For stx, espP, eae and ehxA, RFLP patterns are also given. For ehxA: type 106* and 319* were assigned to isolates which exhibited ehx-RFLP patterns indistinguishable from 
MCI 0106 and MCI 0319 respectively. 
a: an amplicon of the expected size was produced by the method of Aranda et al. (2004) but not by the method of Ramachandran et al. (2003). Therefore this isolate may be 
intimin positive, but it is untypeable by the methods described here. 
b: an amplicon of the expected size was produced by the method of McNally et al. (2001) but not by the method of Brunder et al. (1999). Therefore this isolate may be espP 
positive, but it is untypeable by the methods described here. 
c: espP RFLP-pattern did not match any of those given by Brunder et al. (1999) 
d: stx2 positive by the method of Aranda et al. (2004) but the stx RFLP-pattern did not match any of those given by Bastian et al. (1998)  
e: O-RFLP-PCR yielded no amplicon. 
f: this isolate was found to be stx positive but the stx type remains to be determined.   172 
4.2.3  Associations between E. coli subtypes and colonisation patterns 
 
In order to predict associations between virulence factor genes among bovine GIT-resident E. 
coli and to give an overview of the genotypic nature of bovine E. coli isolates PCR-analysis 
data was combined from the two samples shown in Tables 4.2 and 4.4. In total, data from 132 
E. coli isolates from 47 animals were included in this analysis, representing 67 O-RFLP types 
and 37 H-RFLP types. In total, 93 distinct O/H combinations were observed. Serologically 
untypeable isolates exhibiting O-RFLP pattern Or7 and a pattern corresponding to O45 (Or14) 
were  the  most  commonly  isolated  O-RFLP  types  (recovered  from  9  and  7  animals 
respectively). 
 
Organisms  which  yielded  no  amplicon  after  fliC  PCR  were  recovered  from  13  animals, 
suggesting either that the strains encode no fliC gene or encode a variant fliC gene which is 
not amplified by the procedure described here. Ramos Moreno et al. (2006) noted that this 
protocol does not amplify fliC H17, H53 or H54. Eight fliC sequences that did not match 
reference  types  were  identified,  designated  H+(NT1-NT8).  Isolates  giving  a  pattern  that 
matched H21, H+(NT2) and H19NM were recovered from 10, 7 and 6 animals respectively.  
 
The fimA gene was most commonly detected, occurring in 80.3% of strains. 32.6% of strains 
analysed were found to encode fimA and no other factor. Next most commonly detected were 
cdtB and gafD, each detected in 31.8% of isolates, then iutA and cnf, each detected in 30.3% 
of isolates, with all 4 of these genes present in 23.5% of E. coli analysed.  
 
One or more genes encoding verocytotoxin were detected in 32 of the isolates analysed (24%). 
Of these strains, 16 carried genes with an RFLP pattern matching stx1, 6 strains exhibited a 
pattern matching stx2, 4 strains exhibited a pattern matching stx2c/d and 7 strains exhibited a 
pattern matching stx2e and 2 strains yielded amplicons which were not cut suggesting stx2g. 
One strain (MCI 0441)  gave a pattern which did not match reference patterns, possibly a 
previously undescribed variant stx gene and one strain was stx positive but not yet typed (MCI 
0614). Two strains (MCI 0455 and MCI 0487) were found to carry three different stx variant 
genes. The carriage of three stx subtypes by bovine isolates has been noted previously (Bertin 
et  al.,  2001).  Twenty  strains  (15.2%)  were  found  to  encode  ehxA,  11  of  which  were 
provisional type 319 and 9 of type 106.    173 
 
18 strains (13.6%) were found to encode espP, of which 6 were of RFLP type C, 3 each of 
types B and G, 2 of type D, one of type A and 2 were unmatchable to reference patterns (MCI 
0535, MCI 0656) with one yet to be determined (MCI 0522). RFLP-type C (likely to refer to 
espP  type  β)  is  one  of  the  types  found  to  be  proteolytically  inactive  against  pepsin  A 
(Brockmeyer et al. 2007). Whether EspP (β) has other functions has not been determined, but 
as this was the most common type found among this panel of bovine E. coli isolates, it may 
have  a  function  in  colonisation.  Conventional  EspP  (α)  has  been  implicated  in  cellular 
adherence in the bovine host (Dziva et al., 2007); however, proteolytic activity of the protease 
has not yet been shown to be necessary for EspP function as an adhesin. 
 
13  strains  (9.8%)  were  found  to  encode  escN  genes  and  10  strains  (7.6%)  were  found  to 
encode an eae gene, of which 5 were type β, one each were type γ, ε and θ and 2 were 
untypeable as the PCR described by Ramachandran et al. (2003) failed to amplify genes from 
these strains.  
 
Two strains were found to encode papC and only one strain (MCI 0521) was found to encode 
neuB  and  sfaD/E.  No  strains  were  found  to  encode  ipaH,  although  5  strains  yielded  an 
ambiguous faint band at the expected size. No strains were found to encode aat, bfpA, draA, 
kfiC or genes encoding F5 or F41 fimbrial subunits. 
 
Virulence factor-encoding genes detected in more than 10 isolates were included in a z-test, 
using a null hypothesis that the proportion of strains encoding gene 1 which also encode gene 
2 does not differ from the proportion of strains which encode gene 2 in the population as a 
whole. Results of the E. coli phylogenetic group determination by the method of Clermont et 
al. (2000) and the assignation of candidate rectal tropism (Table 4.4) were also included in the 
test for associations. The z-values were generated according to the binomial approximation of 
the normal distribution using the equation: 
 
(p- π) 
  √ [π(1- π)/n)] 
 
Z   =   174 
where π refers to the proportion of strains encoding gene 1 of the total sample and p is given 
by the proportion of strains also encoding gene 2 of the total number of strains encoding gene 
1. Z statistics were compared to  a standard table of Z values, to  give  P-values indicating 
whether  the  null  hypothesis  should  be  accepted.  P-values  less  than  0.05  were  considered 
significant, although P-values below 0.01 were returned for certain associations. As well as 
detecting  the  association  between  virulence  factors,  this  test  was  used  to  relate  virulence 
factors to colonisation patterns (determined to be rectally tropic or not rectal tropic) Results of 
this test are given in Table 4.5. 
 
The results of this analysis, presented in Table 4.5, indicate that there are positive associations 
between stx, ehxA and espP. Positive associations were also identified between espP and escN, 
eae and escN and eae and ehxA. Positive associations were also found between cdtB, cnf, iutA 
and gafD.Strains encoding espP, escN, eae or ehxA were more likely to encode fimA and less 
likely to encode cdtB or gafD. Strains encoding escN, eae or ehxA were also less likely to 
encode cnf. Strains encoding cdtB, cnf, iutA or gafD were significantly less likely to encode 
fimA. 
 
Candidate rectal tropic strains were found to be more likely to encode any of stx, espP, escN, 
fimA and ehxA and were less likely to encode cnf, iutA or gafD (P<0.01). Non-rectal tropic 
strains were significantly  more likely to encode cnf, iutA or gafD and were less likely to 
encode stx (P<0.01). 
 
The assignation of phylogenetic groups revealed that the vast majority (72.7%) of E. coli 
isolates analysed are of Group B1. Isolates encoding stx or espP were positively associated 
with  the  B1  phylogenetic  group.  It  was  also  clear  that  isolates  which  colonised  cattle  in 
significant  numbers  (those  designated  “RT:Yes”  [rectal  colonists]  or  “RT:No”  [those 
colonising other sites]; Table 4.5) were almost exclusively of the B1 phylogenetic group and 
were significantly more likely to encode stx, espP or ehxA. Phylogenetic Group A made up 
9.8% of the total number of isolates. The cdtB, cnf, fimA, iutA and gafD genes were detected 
less frequently among isolates of Group A. Group B2 accounted for 9.1% of isolates. Isolates 
of this phylogroup more often encoded cdt, cnf, iutA or gafD. The remaining 8.3% of isolates 
were of phylogenetic Group D. These isolates all encoded fimA, whereas stx, cnf and gafD   175 
were found significantly less frequently in these strains. Of the 10 isolates of this Group D, 
only 2 were found to encode factors other than fimA.   176 
 
  stx  espP  escN  eae  cdtB  cnf  fimA  iutA  ehxA  gafD  A  B1  B2  D 
RT: 
Yes 
RT: 
No 
stx    4.11  -0.44  -0.53  -1.38  -1.16  -1.37  -0.73  3.18  -1.82  -0.44  3.25  -0.34  -1  0.96  -1.41 
espP  7.8    2.17  1.75  -2.11  -1.88  2.22  -1.88  5.73  -2.11  -0.52  2.33  -0.43  -0.33  2.41  -0.1 
escN  -1.17  3.07    7.37  -2.29  -4.17  3.11  -0.99  6.75  -4.43  0.67  0.92  -1.1  -0.08  2.77  -1.23 
eae  -1.88  3.26  9.7    -3.04  -2.79  2.51  -0.04  4.35  -3.04  1.23  -0.6  -1.1  0.2  0.29  -2.2 
cdtB  -1  -0.8  -0.62  -0.62    7.95  -5.38  6.64  -1.3  7.17  -1.19  -0.29  1.77  -1  -0.34  0.81 
cnf  -0.89  -0.76  -1.19  -0.61  8.44    -4.61  7.18  -1.89  7.75  -1.19  -0.05  1.92  -0.7  -0.91  1.27 
fimA  -0.21  0.18  0.18  0.11  -1.15  -0.92    -0.79  0.46  -1.15  -0.28  1.23  -0.64  0.25  0.22  0.06 
iutA  -0.56  -0.76  -0.28  -0.01  7.05  7.18  -3.96    -0.02  6.7  -0.89  -1.15  1.92  -0.4  -0.91  1.27 
ehxA  5.38  5.11  4.25  2.08  -3.04  -4.17  5.1  -0.04    -4.43  -0.59  3.8  -1.1  -0.4  3.87  -0.94 
gafD  -1.31  -0.8  -1.19  -0.62  7.17  7.3  -5.38  6.32  -1.89    -0.9  0.24  1.49  -0.71  -0.91  1.41 
A  -1.17  -0.73  0.67  0.93  -4.43  -4.17  -4.86  -3.11  -0.93  -3.36             -0.91  -1.23 
B1  0.65  0.25  0.07  -0.03  -0.08  -0.01  1.59  -0.3  0.45  0.07             0.22  0.43 
B2  -1  -0.66  -1.19  -0.91  7.17  7.3  -12.2  7.3  -1.89  6.01             0.09  -2.2 
D  -3.2  -0.56  -0.09  0.18  -1.9  -2.92  5.1  -1.67  -0.76  -3.16             -0.91  -1.05 
RT: Yes  3.4  4.5  3.65  0.29  -1.64  -4.17  5.1  -4.17  8.09  -4.43  -1.19  3.8  0.11  -1      
RT: No  -2.05  -0.07  -0.67  -0.91  1.62  2.41  0.6  2.41  -0.81  2.83  -0.67  3.13  -1.1  -0.48      
 
Table 4.6: Test for association between genotypes and colonisation characteristics among bovine E. coli isolates: Z-test was carried out as detailed in Section 4.2.3. Where 
Z>1.96, genes/characteristic vertical column are significantly more likely to occur in strains which also attain the gene/characteristic in the horizontal row (P<0.05). Where Z<-
1.96, genes/characteristics given in the vertical column are significantly less likely to occur in strains which also attain the gene/characteristic in the horizontal row (P<0.05). 
Where Z>2.58 or where Z<-2.58, the significance of positive or negative association increases (P<0.01). Positive associations are highlighted in dark green (P<0.01) and light 
green (P<0.05). Negative associations are highlighted in red (P<0.01) and orange (P<0.05). Grey denotes that there was no statistically significant interaction between the two 
characteristics. White spaces denote characteristics that are mutually exclusive and invalid for comparison. 
A/B1/B2/D – refers to the phylogenetic group, as determined by the methods of Clermont et al. (2000). 
RT:Yes/RT:No  – refers to strains identified as potentially rectal tropic (Table 4.4).   177 
4.3  Discussion 
 
The  first  objective  of  this  analysis  was  to  conduct  genotypic  characterisation  of  selected 
resident E. coli of the bovine GIT, in order to determine whether E. coli O157:H7 represents a 
typical or an atypical gastrointestinal colonist of cattle. PCR and microarray analysis revealed 
that  E.  coli  of  the  bovine  GIT  represent  a  heterogeneous  group,  based  on  the  carriage  of 
virulence factors and genomic regions. CGI microarray confirmed that the core component of 
the E. coli genome, present in E. coli O157:H7 and E. coli K12 MG1655 is well conserved 
among bovine isolates, but that the O157- and K12- specific genomic regions (the O-islands 
and K-islands) are areas of heterogeneity. A large proportion of these genomic islands are 
comprised of bacteriophage or prophage-related elements (Perna et al., 2001;Hayashi et al., 
2001b). It has been well documented that genomic diversification in E. coli, including  the 
acquisition of factors which could lead to increased virulence, is largely dependent on the 
recombination  events  performed  by  bacteriophages,  although  the  majority  of  transduced 
elements remain cryptic (Ogura et al., 2006;Tobe et al., 2006).  
 
The role of bacteriophages in virulence factor gene transduction is further evidenced by the 
widespread  prevalence  of  stx  genes  among  bovine  isolates,  as  stx  genes  are  carried  on 
temperate bacteriophages (Konowalchuk et al., 1977;Scotland et al., 1983). 24.2% of strains 
isolated in this study were found to encode stx. Strains encoding stx were isolated from 24 of 
the 47 animals (51.1%). This highlights the potential biohazard posed by faecal matter from 
healthy cattle. Varied estimates of the prevalence of STEC in cattle have been made: Previous 
studies have found STEC to be present in 0-71% of animals (Wilson et al., 1992;Cerqueira et 
al., 1999) and 0-100% of herds (Wilson et al., 1992;Cobbold and Desmarchelier, 2000;Thran 
et al., 2001a;Jenkins et al., 2002). In weaned beef cattle, similar to those analysed in this 
study, estimates of the proportion of shedding animals range from 5.8% to 70% (Pradel et al., 
2000;Thran et al., 2001b). Comparisons of the prevalence observed with this study with those 
identified in other studies is complicated by the fact that the methods used to identify the 
prevalence  of  STEC  vary  from  study  to  study  and  most  are  based  on  faecal  sampling 
techniques which have been shown to yield different populations of E. coli to those isolated 
directly  from  mucosal  surfaces  (Greenquist  et  al.,  2005).  It  must  be  noted  that  the  major 
objective of this study was to link genotype with colonisation site, rather than survey the 
genotypes of E. coli present in cattle.   178 
 
PCR-based detection of discriminative factors revealed that bovine resident E. coli broadly 
cluster into 3 main groups, carrying:- 
 
1)  fimA and none of the additional virulence factor-encoding genes tested for in the PCR-
screen (matches genotypic pattern of non-pathogenic E. coli) 
2)  a combination of cdt, cnf, iutA and gafD (ExPEC related genes) 
3)  combinations of stx, ehxA, escN and eae and fimA (genes associated with EHEC and 
EPEC strains). 
 
In assigning E. coli to these groups, it must be remembered that the virulence factors detected 
in this study represent only a subset of the virulence factors encoded by E. coli and that even 
the strains assigned to group 1 may carry virulence factors which are not detected in the gene-
screening procedure described in this study and must still be considered potential pathogens 
before more extensive characterisation is carried out. 
 
It is tempting to assume that isolates of group 3 are generally present in healthy cattle, but 
absent  from  healthy  humans,  as  these  include EHEC  which  are  known  human  pathogens. 
However, this is not yet proven. Sampling and detection of EHEC-related virulence factors 
among E. coli of the human gastrointestinal tract has not been performed to a great extent, 
although it has been shown that E. coli O157:H7 can exist in the human GIT without overt 
clinical manifestations, especially in those who face increased likelihood of exposure to E. coli 
O157:H7,  such  as  individuals  involved  with  regular  contact  with  cattle  or  environments 
contaminated by cattle (Wilson et al., 1996;Silvestro et al., 2004). 
 
Strains encoding cdtB, cnf and gafD (F17 fimbriae) were found to constitute a large proportion 
of the E. coli population detected in animals analysed in this study. Strains encoding these 
factors have been linked to cases of enteric disease in calves (Shimizu et al., 1987;Lintermans 
et al., 1988;Orden et al., 1999).  The prevalence of such strains among the natural microbiota 
of  the  healthy  animal  has  been  noted  by  others  (Blanco  et  al.,  1998a;Blanco  et  al., 
1998b;Güler  et  al.,  2008)  strongly  suggests  that  these  strains  function  as  opportunistic 
pathogens, relying on a compromised host for pathogenesis and are non-pathogenic under 
normal circumstances.    179 
 
The panel of E. coli described here were devoid of aat genes, which corroborates the finding 
that EAEC are generally not detected in ruminants (Cassar et al., 2003). The bfpA gene was 
not detected in any isolates suggesting that “typical” EPEC are not regularly found in cattle; 
however, atypical EPEC-like strains (those encoding eae but not bfpA or stx) represented 6.8% 
of the strains isolated. Atypical EPEC are more closely related to EHEC than to conventional 
EPEC strains such as EPEC O127:H6 (Trabulsi et al., 2002). Strains encoding F5 (K99) and 
F41 fimbriae, common among bovine ETEC pathogens (Section 4.2.1.3) were not found. This 
could suggest that these strains persist in a reservoir other than the bovine gut and are unlikely 
colonise asymptomatically. 
 
The genes put forward as mediators of persistence of E. coli strains in humans (Nowrouzian et 
al., 2001) related to the formation of P and S fimbriae, along with capsular antigens K1 and 
K5 were rarely detected among the isolates analysed. This could suggest that mechanisms of 
E.  coli  persistence  in  ruminants  differ  from  persistence  in  the  human  GIT,  although 
characterisation of the capsular antigens of strains analysed here was not performed during 
this study. It may be that K1 and K5 capsular antigens are common only among human E. coli 
isolates, while other as yet undefined capsular antigen-types may have a role in colonisation of 
the bovine GIT, although genes likely to encode K1 and K5 capsular  antigens have been 
detected in the genomes of E. coli related to cases of bovine mastitis and therefore are likely to 
have originated from bovine faeces (Kaipainen et al., 2002). The aerobactin-receptor gene 
(iutA) was found to be prevalent among bovine E. coli isolates, which might suggest that the 
mechanisms of iron acquisition could also be important in colonisation of cattle. In each case, 
detection  of  an  individual  virulence  factor  does  not  directly  implicate  that  factor  in 
colonisation of the bovine gastrointestinal tract, but the relation of these factors to colonisation 
patterns may suggest that the factors may be worthy of further investigation to determine the 
role in colonistation (if any) that these factors fulfil. The genes detected in this study may also 
be markers for other as yet undefined factors which define the colonisation pattern. Further 
genomic and functional analysis of these strains may reveal the true factors which confer the 
colonisation patterns observed.  
 
It must be noted that gene detection by PCR is fallible. While attempts were made to conduct 
analysis using previously validated PCR primer sets and conditions, differing specificities of   180 
PCR reactions are unavoidable. In general, probe-based methods are more reliable for gene 
detection than PCR-based methods. Both false-negative and false-positive results are more 
likely with PCR. False-negative results may be obtained with as little as a single nucleotide 
change  at  a  primer-binding  site  while  false-positive  results  can  be  obtained  due  to  cross 
contamination or by non-specific priming and amplification of irrelevant genomic loci. PCR 
does however provide an accessible, low cost,  high throughput method of gene detection, 
requiring little downstream analysis or sophisticated equipment. Gene detection by microarray 
and nanoarray partially corroborated PCR results, but absolute genotyping of bovine isolates 
would only be possible by more extensive methodology, such as whole genome sequencing. 
 
The second major objective of this study was to assess the colonisation patterns of bovine 
resident E. coli. The data obtained suggest that colonisation is non-uniform. E. coli was found 
in greater numbers at the terminal rectum and proximal colon. As mentioned previously, E. 
coli  O157:H7  colocalises  to  lymphoid  follicle-dense  regions  in  both  human  and  bovine 
infections, namely the recto-anal junction in cattle and the ileal Peyer’s patches in humans. 
Data  presented  here  appears  to  suggest  that  the  terminal  ileum  is  generally  less  densely 
colonised by E. coli in cattle than other sites, although this region is densely populated by 
lymphoid follicles (as is the terminal rectum). Thus, if E. coli shows a general preference for 
lymphoid follicle-dense regions, other factors could act to prevent E. coli from establishing at 
the  ileum.  The  ileum  may  present  an  unfavourable  physiochemical  environment  for  the 
persistence of E. coli at this site. It is possible that E. coli is not tolerated by the host immune 
system at the ileum, especially as the level of cells associated with host immunity are found in 
great numbers at this site. Ileal colonisation may be a function associated exclusively with 
virulence: it is clear that ileal colonisation in humans is important for the pathogenesis of E. 
coli O157:H7 so prevention of ileal colonisation could be an important mechanism by which 
cattle generally resist EHEC pathogenesis. The gastrointestinal location of E. coli O157:H7 in 
humans  carrying  the  organism  asymptomatically  remains  to  be  determined,  although  it  is 
feasible that the organism is carried at sites other than the ileum in these individuals. 
 
The major limitation of this analysis is that sampling of sites in the upper regions of the bovine 
gastrointestinal tract is only possible to perform at a single timepoint (post-mortem) without 
resorting  to  invasive  sampling  procedures.  Initial  colonisation  of  sites  in  the  upper 
gastrointestinal sites by E. coli O157:H7 has been noted (Cray, Jr. and Moon, 1995;Brown et   181 
al., 1997;Dean-Nystrom et al., 1998a;Laven et al., 2003), while persistence has been related to 
colonisation at the terminal rectum (Naylor et al., 2003;Low et al., 2005;Lim et al., 2007) (as 
described in Section 1.3.3). In all cases, it is impossible to determine whether the E. coli 
isolated during this study represent persistent colonists or were carried transiently. However, 
calves that were sampled by rectal swabbing 3 weeks prior to euthanasia were found not to 
contain the strains of E. coli which were found to be abundant at post mortem, suggesting that 
strain-turnover of E. coli in the bovine GIT is a fairly rapid occurrence; however, the method 
of rectal swabbing was not consistent with the sampling of rectal tissue sections, in that PBS 
washing was not performed. It is possible that the strains isolated by rectal swab represent 
transient  faecal  bacteria  and  true  resident  isolates  may  have  been  missed  in  this  initial 
isolation. Others have found that resident E. coli strains of the human GIT have persisted for 
more than 3 years (Wold et al., 1992;Nowrouzian et al., 2003). As yet analysis of persistence 
of E. coli strains in cattle has focussed on E. coli O157:H7 (Akiba et al., 2000;Lejeune et al., 
2004).   
 
In  a  few  cases,  colonisation  patterns  of  E.  coli  isolates  were  apparently  conserved  when 
isolates that were indistinguishable by molecular analysis were found in multiple animals. 
These included the organisms designated E. coli Or37:HNT1 represented by isolates MCI 
0517, MCI 0528 and MCI 0534 (stx2+, ehxA: type 319, fimA+) which were found only in the 
rectum in three animals. Similarly, isolates designated E. coli O43(Or41):H25 (escN+, cdtB+, 
ehxA: type 106) represented by isolates MCI 0544 and MCI 0594, were recovered from two 
animals, restricted to the rectum in each case. In the youngest animal analysed, an organism 
designated E. coli O26:HNT1 MCI 0483 (escN+, eaeβ, espP: type D, fimA+, ehxA: type 106) 
was found at 10000-fold density at the rectum than at the proximal colon or the ileum. This 
observation is in keeping with the findings of Shaw et al. (2004) who noted that shedding of 
E. coli O26 was especially associated with very young calves. 
 
The strains described in the paragraph above represent the most promising candidate rectal 
tropic E. coli strains recovered during the study, which may be worthy of further investigation. 
Although rectal colonisation is only predicted for these organisms and not yet confirmed by 
rechallenge and reisolation, it is interesting to note that prevalence at the rectum above other 
sites correlated positively with the carriage of stx, eae, escN, espP and ehxA genes. Carriage of 
stx or eae was found to negatively associate with strains showing no apparent site-preference.   182 
These  observations  contrast  with  finding  that  isolates  encoding  ExPEC-related  virulence 
factors and those encoding no detected virulence factors except for fimA were found to be 
evenly distributed between the sites analysed. The most obvious example of this was ExPEC-
related E. coli ONT (Or7):HNT2 (cdtB+, cnf+, fimA+, iutA+, gafD+) which was recovered 
from five animals and was not found to associate with any site in preference to others. To 
refine knowledge regarding the colonisation pattern of each organism oral challenges of calves 
may be a suitable method. Such methodology may also give important information on the 
colonisation  behaviour  of  strains  to  be  assessed  for  utility  as  a  probiotic  organism  (as 
discussed further in Chapter 5). 
 
It is possible that strains of EHEC-related genotypes are highly adherent and that they encode 
factors which aid colonisation and persistence at the terminal rectum. EHEC factors involved 
in the pathogenic process in humans could be the same factors required for colonisation of the 
bovine terminal rectum, as has been suggested  for intimin, Shiga-like toxin and the EspP 
protease (Robinson et al., 2006;Sheng et al., 2006b;Dziva et al., 2007). The trait could depend 
on other, as yet uncharacterised factors associated with EHEC-related genotypes. It is equally 
plausible that strains of EHEC-related genotypes lack factors allowing them to colonise and 
persist  at  sites  other  than  the  terminal  rectum  in  the  bovine  host,  while  strains  of  other 
genotypes are able to colonise these regions effectively or may be tolerated by the host. E. coli 
O157:H7  has  been  observed  to  form  T3SS-dependent  A/E-lesions  at  the  bovine  terminal 
rectum (Naylor et al., 2005). It could also be that the host responds more aggressively to A/E-
lesion-forming or shiga-toxigenic bacteria at sites in the upper gastrointestinal tract, while 
such strains are tolerated at the bovine terminal rectum. To date, no extensive analysis has 
been conducted of the persistence of non-EHEC- related E. coli in ruminants. 
 
To  summarise,  data  presented  in  this  chapter  highlights  the  diversity  and  potential 
pathogenicity of E. coli of the bovine GIT. There is some evidence to suggest that E. coli 
generally  colonises  the  terminal  rectum  and  proximal  colon  to  a  greater  extent  than  the 
proximal  rectum,  distal  colon  or  ileum.  EHEC-related  genotypes  were  most  strongly 
associated  with  colonisation  of  the  terminal  rectum  above  other  sites  in  the  bovine 
gastrointestinal tract, while strains of ExPEC-related or those lacking established virulence 
factors generally exhibited a more even distribution throughout the gastrointestinal tract.   183 
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5.1  Introduction 
 
As mentioned previously, the bovine gastrointestinal tract (specifically the bovine terminal 
rectum) provides a reservoir for E. coli O157:H7. It is envisaged that effective control of 
EHEC colonisation of cattle could prevent or reduce transmission to man and hence reduce the 
incidence of disease in humans. Efforts have been made to reduce prevalence of EHEC in 
finished food products. Improved detection methods have been developed and the adoption of 
these  methods  may  prevent  contaminated  articles  reaching  the  consumer  (Bennett  et  al., 
1996). Pre-harvest control would be ideal, as human EHEC infections have also been related 
to contact with farm animals or environments contaminated with animal faeces. Numerous 
strategies have been put forward to reduce the carriage of E. coli O157:H7 by cattle and are 
currently being evaluated for that purpose (discussed in detail in Section 1.3.4). 
 
The application of bacteriocin-producing E. coli has recently been proposed as an option for 
reduction of EHEC prevalence in cattle (Zhao et al., 1998;Tkalcic et al., 2003;Zhao et al., 
2003;Schamberger  et  al.,  2004).  Bacteriocins  are  molecules  produced  by  one  bacterium, 
which  may  inhibit  another  susceptible  bacterium.  Bacteriocins  include  medium  to  large 
proteins (colicins) and small peptides (microcins). 
 
More than 25 different E. coli colicins have been characterised to date, with molecular masses 
ranging from 29-75kDa (Cursino et al., 2002). Colicins are normally encoded on plasmids 
which also encode proteins conveying immunity to the colicin encoded (Hardy et al., 1973). 
Expression  of  colicins  is  induced  by  stressors  such  as  a  lack  of  nutrients  and  bacterial 
detection of DNA damaging agents triggering the SOS response system. Most colicins are not 
normally  secreted  and  are  generally  released  on  lysis  of  a  colicin  producing  cell,  often 
facilitated by a lysis protein which co-expressed with the functional colicin. Colicins may 
target specific receptors on sensitive strains and active uptake by Ton or Tol translocation 
systems has been observed (Cascales et al., 2007). 
 
Microcins can be distinguished from colicins due to their low molecular weight (<10kDa) 
(Asensio  and  Pérez-Díaz  1976).  Microcin  production  and  immunity  genes  may  be 
chromosomally or plasmid-encoded (Duquesne et al., 2007). The synthesis of the majority of 
microcins occurs in the stationary growth phase and has not been found to be induced by   185 
agents that trigger the SOS response. Microcin release is not lethal to the producer as specific 
export systems are utilised (Hwang et al., 1997;Delgado et al., 1999;Pavlova and Severinov, 
2006). 
 
It was envisaged that strains acquired from the bovine host may be suitable candidates for 
investigation as potential probiotic organisms. These strains are likely to colonise the bovine 
GIT  effectively  without  pathogenesis  as  all  were  isolated  from  healthy  animals.  As 
competition at the mucosal surface is manifested in a number of different ways; the simplest 
form being “niche-occupation” by growth, competition for nutrients and binding surfaces, it 
was hypothesised that E. coli isolated from the bovine host (particularly those colonising the 
bovine terminal rectum) may have increased persistence and occupation of the niche colonised 
by E. coli O157:H7 (i.e. the bovine terminal rectal mucosal epithelium). Bacterial isolates 
studied include a group of strains provided by Stuart Naylor (MCI 0308-MCI 0412) from 
animals  in  which  E.  coli  O157:H7  (MCI  0010)  was  found  to  colonise  poorly  after  oral 
challenge (Stuart Naylor, Personal Communication). It was deduced that the E. coli present in 
these animals may have prevented EHEC colonisation, although there are many other factors 
which could have acted against establishment of EHEC colonisation in this instance.  
 
Screening for bacteriocin-encoding genes by PCR was performed to predict the carriage of 
bacteriocins likely to be effective against E. coli O157:H7. Colicin E7 and microcins H47, J25 
and V and have previously been shown to inhibit the growth of E. coli O157:H7 (Sable et al., 
2000;Schamberger  and  Diez-Gonzalez,  2004;Abercrombie  et  al.,  2006)  and  hence  were 
targeted in the PCR-based gene-screening procedure. Colicin B and E2 were also screened for 
as these have been identified as common colicins of E. coli isolates (Schamberger and Diez-
Gonzalez, 2004). Analysis also included in-vitro competition assays, to determine the potential 
inhibitory  activity  of  each  potential  organism.  The  data  presented  in  Chapter  4  aids  the 
selection of an organism likely to effectively colonise the bovine GIT and the pathotyping 
information was used as a predictor of the potential biosafety of each prospective strain. 
 
Note: The work presented in this chapter represents the collaborative efforts of the author and 
Joanna  Laing  (BSc,  University  of  Edinburgh).  The  author  and  Joanna  invested  equal 
intellectual and practical input into the production of the results presented herein.   186 
5.2  Results 
 
5.2.1  Detection of bacteriocin-encoding genes by PCR  
 
Detection  of  six  bacteriocin  genes  was  performed  by  PCR  using  previously  described 
oligonucleotide primers (Gordon and O'Brien, 2006). Eighty-eight bovine E. coli isolates were 
screened  for  genes  encoding  colicins  B,  E2  and  E7  and  microcins  H47,  V,  J25  by  PCR. 
Results are summarised in Table 5.1 and supporting images are included in Appendix II. Ten 
strains (11.4%) possessed the genes for a colicin or a microcin. The most commonly detected 
genes were those encoding colicin E2 and microcin H47, each detected in 6 strains (6.8%). 
Colicin B was detected in 3 strains (3.4%). Microcin V, J25 or colicin E7 genes were not 
confidently detected, although no positive controls were available at the start of this study. 
PCR for microcin V yielded a faint band of the expected size from MCI 0345, which could 
suggest  carriage  of  this  gene,  although  sequencing  would  be  required  to  verify  this 
observation.  Of  the  10  bacteriocin-encoding  strains,  5  were  positive  for  two  bacteriocins; 
microcin H47 in combination with either colicin E2 (3 strains) or Colicin B (2 strains). 
 
The fragments amplified by the colicin E2 and microcin H47 primers from MCI0410 and 
MCI0319 respectively were sequenced to confirm their identity. In both cases, sequences were 
obtained that were highly homologous with the target gene. The sequence generated from the 
colicin E2 PCR product suggested that more then one gene may have been amplified in the 
PCR reaction, as “double sequence” was observed. This could suggest that multiple colicin E2 
homologues may be encoded in the genome of MCI0410. 
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Bovine E. coli isolate  mccH47  mccV  colB  colE2 
MCI 0104  -  -  -  - 
MCI 0105  -  -  -  - 
MCI 0106  -  -  -  - 
MCI 0108  -  -  -  - 
MCI 0109  -  -  -  - 
MCI 0110  -  -  -  - 
MCI 0114  -  -  -  - 
MCI 0120  -  -  -  - 
MCI 0121  -  -  -  - 
MCI 0122  -  -  -  - 
MCI 0160  -  -  -  - 
MCI 0162  -  -  -  - 
MCI 0164  -  -  -  - 
MCI 0165  -  -  -  - 
MCI 0167  -  -  -  - 
MCI 0168  -  -  -  - 
MCI 0169  -  -  -  - 
MCI 0170  -  -  -  - 
MCI 0171  -  -  -  - 
MCI 0172  -  -  -  - 
MCI 0173  -  -  -  - 
MCI 0174  -  -  -  - 
MCI 0176  -  -  -  - 
MCI 0177  -  -  -  - 
MCI 0179  -  -  -  - 
MCI 0181  -  -  -  - 
MCI 0182  -  -  -  - 
MCI 0308  -  -  -  - 
MCI 0319  +  -  -  + 
MCI 0327  +  -  -  + 
MCI 0344  -  -  -  - 
MCI 0345  -  +/-  -  - 
MCI 0354  -  -  -  - 
MCI 0356  -  -  -  - 
MCI 0362  -  -  -  - 
MCI 0368  -  -  -  - 
MCI 0369  -  -  -  - 
MCI 0377  -  -  -  + 
MCI 0378  -  -  -  - 
MCI 0379  -  -  -  - 
MCI 0382  -  -  -  - 
MCI 0386  +  -  -  + 
MCI 0392  +  -  -  - 
MCI 0398  -  -  -  - 
MCI 0404  -  -  +  + 
MCI 0410  -  -  +  + 
MCI 0430  -  -  -  - 
MCI 0435  -  -  -  - 
MCI 0437  -  -  -  - 
MCI 0439  -  -  -  - 
MCI 0441 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
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Bovine E. coli isolate  MccH47  MccV  ColB  ColE2 
MCI 0454  -  -  -  - 
MCI 0455  -  -  -  - 
MCI 0465  -  -  -  - 
MCI 0483  -  -  -  - 
MCI 0487  -  -  -  - 
MCI 0490  -  -  -  - 
MCI 0496  -  -  -  - 
MCI 0501  -  -  -  - 
MCI 0512  -  -  -  - 
MCI 0517  -  -  -  - 
MCI 0518  -  -  -  - 
MCI 0523  -  -  -  - 
MCI 0528  -  -  -  - 
MCI 0529  -  -  -  - 
MCI 0534  -  -  -  - 
MCI 0535  -  -  -  - 
MCI 0541  -  -  -  - 
MCI 0544  +  -  -  - 
MCI 0546  -  -  -  - 
MCI 0549  -  -  -  - 
MCI 0551  -  -  -  - 
MCI 0557  -  -  -  - 
MCI 0561  -  -  -  - 
MCI 0564  -  -  -  - 
MCI 0568  -  -  -  - 
MCI 0575  -  -  -  - 
MCI 0581  -  -  -  - 
MCI 0586  -  -  -  - 
MCI 0594  +  -  -  - 
MCI 0595  -  -  -  - 
MCI 0597  -  -  +  - 
MCI 0602  -  -  -  - 
MCI 0606  -  -  -  - 
MCI 0608  -  -  -  - 
MCI 0611  -  -  -  - 
MCI 0615  -  -  -  - 
MCI 0621  -  -  -  - 
Total  6  1 (+/-)  3  6 
         
 
Table 5.1: PCR-based screening of bovine E. coli isolates for bacteriocin-encoding genes: No strains were 
found to be positive for MccJ25 or ColE7 and hence these genes were omitted from the table. The band observed 
from MCI 0345 for MccV was faint and hence considered ambiguous (+/-). Mcc: microcin, Col: colicin, +: 
detected, -: not detected.   189 
5.2.2  In vitro inhibition assays 
 
5.2.2.1  Lawn-inhibition assays 
 
Two  methods  were  evaluated  to  obtain  bacterial  products  for  testing  against  potentially 
sensitive  bacteria  (as  set  out  in  Section  2.7).  Bacterial  supernatants  were  recovered  by 
centrifugation and 10µl spots of this preparation were overlaid onto bacterial lawns. A second 
method employing filter-paper discs soaked in chloroform and laid onto bacterial colonies was 
performed in order to recover intracellular bacterial products as certain bacteriocins are non-
secreted (as explained in Section 5.1). For the 5 strains tested initially, the supernatant method 
proved more sensitive as the lysate disc and was adopted as it proved less laborious. Results of 
the initial assessment of these methods are presented in Figure 5.1.  
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Figure 5.1: Assessment of methods for bacterial inhibitory activity detection: The upper images show the 
lysate-disc method of inhibition assessment, while the lower panels show the results of the supernatant spot-on-
lawn method. Products from MCI 0255 were used as negative controls in each case. The rightmost panel shows 
the greater sensitivity of the spot on lawn method, as a zone of inhibition is observed for unconcentrated MCI 
0410 supernatant on a MCI 0200 lawn, while no such zone of inhibition was observed using the filter-paper disc 
method. Within the area of inhibition caused by MCI 0404 breakthrough colonies were observed, which could 
suggest that the test strain may have acquired resistance to the inhibitory activity of MCI 0404 supernatant. 
 
 
 
 
 
 
MCI 0255  MCI 0377  MCI 0392  MCI 0404  MCI 0410 
MCI 0410/ 
MCI 0200   191 
In total, nineteen strains were identified from which supernatant or bacterial lysate inhibited 
lawns of laboratory strain MCI 0255 (listed in Table 5.2). For these strains mitomycin C-
induced culture was prepared and either culture supernatant or whole bacterial culture was 
centrifuged into chloroform to produce a supernatant/lysate mixture (Section 2.7.3, Materials 
& Methods). These products were concentrated 60-fold using an Amicon 3kDa-cutoff filter 
and tested against the panel of E. coli strains listed in Table 5.2. In all cases, supernatant and 
lysate prepared in the same manner from MCI 0255 was used as a negative control. 
 
No single isolate was found to be able to cause clear zones of inhibition on all of the O157:H7 
strains tested, which suggests that sensitivity to inhibitory compounds is not uniform among E. 
coli  O157:H7  subtypes.  This  could  indicate  differing  sensitivities  to  inhibitory  substances 
among E. coli O157:H7 strains. Three potentially non-pathogenic bovine E. coli isolates (MCI 
0105,  MCI  0308  and  MCI  0430)  were  also  tested  for  sensitivity  to  bacterial  products,  to 
determine whether inhibitory E. coli strains would affect the natural microflora of the bovine 
GIT. 
 
Initially, the best candidate for further inhibition studies proved to be MCI0410 as it was the 
only organism from which unconcentrated supernatant produced a visible zone of inhibition 
on a lawn of E. coli O157:H7 (MCI 0200) and concentrated supernatant inhibited four of the 
six E. coli O157:H7 (∆stx) strains. However, MCI 0410 supernatant inhibited MCI 0105 and 
MCI 0308, which are likely to be non-pathogenic members of the bovine gastrointestinal flora. 
Strains MCI 0483 and MCI 0512 exhibited greater selectivity against E. coli O157 strains 
tested. MCI 0483 and MCI 0512 were isolated long after work commenced using MCI 0410. 
The analysis which follows pertaining to MCI 0410 is yet to be performed for MCI 0483 or 
MCI 0512.   192 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.2: Activity of bacterial products on a panel of E. coli isolates: Strains tested for sensitivity are denoted by their MCI reference number, which corresponds to Table 
2.1. Bacterial products are denoted by the MCI reference number and “S” or “L” to indicate whether bacterial supernatant or lysate was used as the test substance. Clear 
inhibition,  indicating  that  the  substance  was  bactericidal  is  indicated  with  a  “+”  sign;  substances  giving  a  turbid  zone  of  inhibition,  indicating  that  the  substance  was 
bacteriostatic, are denoted “+/-”. 
       Bacterial lawn 
      K12 lab strain  Bovine resident E. coli isolates  E. coli O157:H7 (∆stx) isolates 
      255  105  308  430  10  24  78  191  200  279 
255L  -  -  -  -  -  -  -  -  -  - 
255S  -  -  -  -  -  -  -  -  -  - 
165S  +  -  -  -  -  -  -  +/-  -  - 
170S  +  -  -  -  -  -  -  +/-  -  - 
171S  +  -  -  -  -  -  -  -  -  +/- 
172L  +  -  -  -  -  -  -  -  -  - 
172S  +  -  -  -  -  -  -  +/-  -  - 
180S  +  -  -  -  -  +/-  -  -  -  +/- 
379S  +  -  -  -  +/-  +  -  -  -  - 
398S  +  +/-  -  -  -  +  -  -  -  - 
404S  +  +  +  -  +  -  -  -  -  - 
410S  +  +/-  +  -  +  +  -  +  +/-  - 
436S  +  -  -  -  -  -  -  -  -  - 
437S  +  +/-  -  -  -  +/-  -  -  -  - 
483L  +  -  -  +/-  +  +  +  +/-  +/-  + 
512L  +/-  -  +/-  -  +/-  -  +/-  +/-  +/-  +/- 
523S  +  -  -  -  -  -  -  -  -  - 
544S  +  -  -  -  -  -  -  -  -  - 
549S  +  -  -  -  -  -  -  -  -  - 
557S  +  -  -  -  -  -  -  -  -  - 
575S  +  +/-  -  -  -  -  -  -  -  - 
  
615S  +/-  -  -  +  -  -  -  -  -  -   193 
PCR-screening results suggested that MCI 0410 carries at least one copy of a colicin E2-like 
gene. Colicin E2 has a pI value of 7.63 (Herschman and Helsinki, 1967) and therefore, in 
order to attempt to separate inhibitory substances (possibly including a colicin E2-like protein) 
while retaining their activity, acidic polyacrylamide gel electrophoresis was employed for the 
analysis of concentrated supernatant from MCI 0410 under non-denaturing conditions. The 
lane containing MCI 0410 supernatant was cut into 2-3mm sections and placed on lawns of 
MCI 0255 and MCI 0200. None of the excised bands caused inhibition of MCI 0200 while all 
excised bands (including the the negative control, taken from a clean area of the gel) inhibited 
MCI 0255. This suggests that the acid contained in the gel is sufficient to inhibit MCI 0255 
and would mask any inhibitory action of proteins contained within the gel slices. Therefore the 
procedure  was  repeated  using  SDS-PAGE.  This  method  would  normally  be  expected  to 
denature the proteins. However, certain proteins may retain their activity after SDS-PAGE 
(Bischoff et al., 1998). MCI 0410 supernatant produced an intense band at approximately 
62kDa after SDS-PAGE as shown in Figure 5.3. Only gel sections taken from this large band 
produced a clear zone of inhibition on a lawn of MCI 0255 while other bands and the negative 
control did not. However, this band was not observed to inhibit a lawn of MCI 0200. No 
comparatively intense bands were seen in the SDS-PAGE pattern of MCI 0165, 0170 or 0172 
and no bands from these gels showed inhibition of MCI 0255 lawns (not shown). 
 
The  peptide  mass  fingerprint  of  the  62kDa  band  was  determined  by  MALDI-TOF  mass 
spectrometry  and  searched  against  the  MASCOT  database.  The  most  significant  hit  was 
colicin E2 (Mowse score =180, P<0.05, Figure 5.4). 
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Figure 5.2: Analysis of MCI 0410-secreted proteins: (A) Banding pattern of the secreted products of MCI 
0410 when separated by SDS-PAGE. The band denoted with the arrow was cut out of the gel and placed on soft 
agar lawns of MCI 0200 and MCI 0255. (B) Inhibition of MCI 0255 bacterial lawn was observed (top left) 
whereas the negative control using a piece of clean SDS-PAGE gel caused no inhibition (top right). Inhibition of 
MCI 0200 was not detected (bottom left). 
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Figure 5.3: Results of MALDI-TOF analysis of the band resulting from SDS-PAGE of MCI 0410 secreted 
protein: The most significant hit was against E. coli colicin type E2, giving 42% coverage and a MOWSE score 
of 180. 
 
 
 
 
 
 
 
 
 
Match to: CEA2_ECOLX Score: 180 Expect: 3.3e-13 
Colicin-E2 - Escherichia coli 
 
Nominal mass (Mr): 61592; Calculated pI value: 9.02 
NCBI BLAST search of CEA2_ECOLX against nr 
 
Taxonomy: Escherichia coli 
 
Number of mass values searched: 92 
Number of mass values matched: 29 
Sequence Coverage: 42% 
 
Matched peptides shown in Bold Red 
 
     1 MSGGDGRGHN TGAHSTSGNI NGGPTGLGVG GGASDGSGWS SENNPWGGGS  
    51 GSGIHWGGGS GHGNGGGNGN SGGGSGTGGN LSAVAAPVAF GFPALSTPGA  
   101 GGLAVSISAG ALSAAIADIM AALKGPFKFG LWGVALYGVL PSQIAKDDPN  
   151 MMSKIVTSLP ADDITESPVS SLPLDKATVN VNVRVVDDVK DERQNISVVS  
   201 GVPMSVPVVD AKPTERPGVF TASIPGAPVL NISVNNSTPE VQTLSPGVTN  
   251 NTDKDVRPAG FTQGGNTRDA VIRFPKDSGH NAVYVSVSDV LSPDQVKQRQ  
   301 DEENRRQQEW DATHPVEAAE RNYERARAEL NQANEDVARN QERQAKAVQV  
   351 YNSRKSELDA ANKTLADAIA EIKQFNRFAH DPMAGGHRMW QMAGLKAQRA  
   401 QTDVNNKQAA FDAAAKEKSD ADAALSAAQE RRKQKENKEK DAKDKLDKES  
   451 KRNKPGKATG KGKPVGDKWL DDAGKDSGAP IPDRIADKLR DKEFKNFDDF  
   501 RKKFWEEVSK DPDLSKQFKG SNKTNIQKGK APFARKKDQV GGRERFELHH  
   551 DKPISQDGGV YDMNNIRVTT PKRHIDIHRG K 
   196 
5.2.3  In vitro competitive assays 
 
The media employed to distinguish E. coli O157:H7 from the bovine isolates used in these 
assays  were  Sorbitol-McConkey’s  (SMAC)  agar  and  Tryptone-Bile  salts-X-glucuronide 
(TBX). The E. coli O157:H7 isolate employed in this procedure (MCI 0200) is non-sorbitol-
fermenting and glucuronidase negative and therefore produces brown colonies on SMAC and 
white colonies on TBX. The vast majority of E. coli other than conventional E. coli O157:H7 
isolates are sorbitol-fermenting and glucuronidase positive, producing pink colonies on SMAC 
and blue colonies on TBX. Hence, E. coli O157 incubated with a second E. coli isolate may be 
distinguished and  enumerated from  a mixed culture using these indicator-media.  For  each 
triplicate plating exercise, at least one plate of each medium-type was employed, in order to 
confirm that the organism had not gained the ability to ferment sorbitol or to produce active 
glucuronidase during the course of the assay. Acquisition of both characteristics during the 
assay is unlikely.  
 
5.2.3.1  Competitive co-culture 
 
In all assays performed, there was a significant difference (P<0.05) between the number of 
viable  MCI  0200  when  grown  on  its  own  (1.05x10
9  ±  1.3x10
8  cfu/ml;  n=6  after  4hrs) 
compared  to  growth  in  the  presence  of  a  second  E.  coli  isolate.  However,  there  was  no 
significant difference (P>0.05) in the number of MCI 0200 when grown in the presence of any 
bovine isolate compared to growth in the presence of a laboratory strain (MCI 0255) (see 
Figure 5.5). When coincubated with MCI 0255, MCI 0200 grew to a density of 4.11x10
8 
cfu/ml (±7.39x10
7cfu/ml; n=6) within four hours. Similar growth levels were observed when 
grown with MCI 0410 (3.09x10
8 ±1x10
8cfu/ml; n=9), MCI 0170 (4.66x10
8 ±1.1x10
8cfu/ml; 
n=6) or MCI 0172 (3.66x10
8 ± 4.19x10
7cfu/ml, n=6). 
 
 
 
 
 
   197 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Competitive co-culture: Growth of E. coli O157:H7 (MCI 0200) with a second strain significantly 
decreases the growth of MCI 0200. However, there is no significant difference between the growth of E. coli 
MCI 0200 with MCI 0410 compared with MCI 0200 grown with MCI 0410. 
 
 
5.2.3.2  Growth of E. coli O157:H7 in MCI0410 supernatant 
 
MCI 0200 grew to a density of 1.1x10
9 ± 7.8x10
7 cfu/ml within 4 hours when grown in LB 
without another strain. When grown in a 1:1 mixture of sterile LB medium:MCI 0255 culture 
supernatant, density of MCI 0200 growth was significantly reduced at the 4 hour timepoint 
(3.91x10
7cfu/ml,  ±1.13x10
7cfu/ml;  n=12).  When  grown  in  the  presence  of  MCI  0410 
supernatant, numbers of MCI 0200 declined slightly in the first hour followed by a gradual 
incline to 5.9x10
6cfu/ml (±4.42x10
6cfu/ml; n=12) by 4hrs. Although MCI 0200 seems to be 
suppressed  to  a  greater  extent  by  MCI0410  supernatant  than  MC0255  supernatant,  the 
difference is not statistically significant (p>0.05).  
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Figure 5.5: Growth of MCI 0200 in 50% MCI 0410 supernatant in LB: Although MCI 0410 supernatant 
appeared to reduce the number of MCI 0200 more so than the supernatant of MCI 0255, the difference was not 
significant (P>0.05). Data shown is the average of two separate experiments (± SEM n=6 for each experiment). 
 
5.2.3.3  Competitive adherence to EBL cells 
 
E. coli O157:H7 (MCI0200) was coincubated with a panel of bovine E. coli isolates (MCI 
0165, 0170, 0172 and 0410) on EBL cell monolayers (as described in Section 2.7.5.3) to 
predict their ability to reduce the numbers of E. coli O157:H7 binding to bovine epithelial 
cells (shown in Figure 5.7). 
 
When added to EBL cells without a competitor, the number of viable adherent MCI 0200 was 
1.1x10
5  ±
 1.3x10
4 cfu/cm
2. When coincubated with MCI 0165, 0170 or 0172 there was no 
significant  difference  in  the  number  of  adherent  MCI  0200  compared  with  MCI  0200 
incubated  without  a  second  strain  (P>0.05).  When  coincubated  with  MCI  0410,  however, 
there  was  a  significant  difference  (P<0.05)  in  that  no  adherent  MCI  0200  colonies  were 
detected. It must be noted that overnight cultures of MCI 0255 failed to grow in MEM-HEPES 
(the medium chosen for growth of E. coli isolates for addition to cell monolayers), therefore 
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the assay lacked the laboratory strain (a likely non-competitive E. coli strain)  as a negative 
control; however, MCI0410 performed better than any of the other bovine isolates tested for 
inhibition of MCI0200 (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Competitive adherence between MCI 0200 and bovine isolates: The number of viable MCI 0200 
from the lysate was counted on SMAC after one hour of challenge and represented as colony forming units 
(CFU) per cm
2 (+1 SEM). When coincubated with MCI 0165, MCI 0170 or MCI 0172, there was no significant 
difference in the number of adherent MCI 0200 CFU compared with control (MCI 0200 incubated with cells 
only). When co-incubated with MCI 0410 complete inhibition was observed, in that no colonies of MCI 0200 
were recovered from the cell monolayer. 
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5.3  Discussion 
 
Data  presented  above  represents  the  initial  in  vitro  assessment  of  E.  coli  strains  for 
applicability as probiotic agents. E. coli MCI 0410 appeared to be a good initial candidate as 
supernatants from this organism caused zones of inhibition on lawns of E. coli O157:H7 and 
also that out-competed a strain of E. coli O157:H7 in adherence to monolayers of a bovine 
epithelial cell line. However, PCR-screening data presented in Chapter 4, revealed that this 
strain carries genes encoding EHEC virulence factors, including espP (β) and a subtype of 
stx2. As verotoxin positive E. coli present a significant health risk, the strain would provide 
limited worth as a probiotic organism in its current form. It is conceivable that virulence gene-
knockout organisms may be created and evaluated for probiotic potential. Alternatively, genes 
encoding  competitive  factors  could  be  cloned  into  E.  coli  isolates  with  less  pathogenic 
potential. 
 
Strains isolated later in the study may be better candidates for the development of a probiotic 
organism. MCI 0483 (E. coli O26:H+(NT1), escN+, eaeβ+, espP+, ehxA+) performed most 
impressively against the panel of E. coli O157:H7 strains and did not cause clear inhibition of 
any of the E. coli isolates predicted to be non-pathogenic except for the laboratory strain MCI 
0255. However, E. coli O26 isolates are recognised human pathogens and verotoxin producing 
E. coli O26 isolates are common (Goldwater and Bettelheim, 1998). It has been documented 
that E. coli O26 is prevalent in young calves but isolated less often in older cattle (Shaw et al., 
2004). As MCI 0483 was isolated from a young calf, this organism may be less effective in the 
colonisation  of  older  animals.  Products  from  strain  MCI  0512  (E.  coli  O18ac:H49  cdt+, 
fimA+) caused partial inhibition of most of the E. coli O157:H7 strains tested. Although the 
zone of inhibition observed appeared more turbid than that caused by MCI 0410 or MCI 0483 
at the concentrations tested, suggesting that the inhibition caused may be easier to for E. coli 
O157:H7 to overcome, this strain may be a good candidate for further investigation as its lack 
of  virulence  factor-encoding  genes  detected  could  suggest  that  the  organism  has  a  lower 
probability of pathogenesis than the other isolates obtained. 
 
Data presented in this chapter highlights the competitive fitness of potentially pathogenic E. 
coli strains. Competitive factors such as colicins and microcins may increase environmental 
persistence  of  pathogenic  bacteria  and  facilitate  transmission  to  humans.  This  means  that   201 
caution  should  be  exercised  in  designing  probiotic  strategies  for  the  control  of  E.  coli 
O157:H7 in cattle. Although numerous studies support the efficacy of competitive E. coli for 
use  as  a  probiotic  organism  (Zhao  et  al.,  1998;Tkalcic  et  al.,  2003;Zhao  et  al., 
2003;Schamberger et al., 2004), none appear to have considered the interaction of a probiotic 
organism with the indigenous microflora after release into the cattle population. It has been 
widely documented that E. coli have the ability to acquire genomic regions, especially by the 
action  of  bacteriophages  (Dobrindt  and  Hacker,  2001;Pallen  and  Wren,  2007).  This  is 
manifested most devastatingly in the acquisition of stx-encoding genes, which are carried on 
lysogenic  lambdoid  bacteriophages  (Smith  et  al.,  1983;O'Brien  et  al.,  1984).  If  a  hyper-
competitive E. coli strain were to be released into the environment, it must be proven to resist 
acquisition of the stx-encoding bacteriophage and other virulence factors. Another potential 
problem  with  the  administration  of  a  competitive  microorganism  to  cattle  is  that  genes 
conferring  the  competitive  advantage  may  be  transferred  to  a  pathogenic  microorganism. 
Either of these occurrences could lead to the emergence of a hyper-competitive organism with 
potential  pathogenicity.  The  insertion  of  bacteriophages  similar  to  the  stx-encoding 
bacteriophages lacking the stx genes into normal stx-insertion sites (such as at the yehV or 
wrbA sites) may prevent insertion of further stx-encoding bacteriophages (Serra-Moreno et al., 
2007); however, insertion of stx-phages has been found to occur at other genomic loci (Besser 
et al., 2007) and it is not unlikely that undescribed variant forms of stx-encoding phages may 
insert at unknown genomic sites. Ensuring that the probiotic strain lacks the yaeT protein, 
which is exploited as a receptor by stx-encoding bacteriophages may reduce the likelihood of 
stx-gene acquisition (Smith et al., 2007). The diversity of stx-encoding bacteriophages (Shaikh 
and  Tarr,  2003;Muniesa  et  al.,  2004;Besser  et  al.,  2007)  coupled  with  the  limited 
understanding  of  the  full  range  of  the  modes  of  action  of  virulence  factor-encoding 
bacteriophages means that it would be a major undertaking to produce a strain resistant to all 
types  of  horizontal  gene  transfer.  With  public  resistance  to  the  application  of  genetically 
modified organisms to food products, it may prove more simple to screen further isolates for 
suitability until a naturally occurring strain is identified which has efficacy against EHEC, 
lacks virulence properties and is resistant to acquisition of virulence factors or transduction of 
competitive factors to other organisms. 
 
Data presented above suggests that the sensitivity of E. coli O157:H7 to inhibitory compounds 
produced by E. coli isolates differ between strains of E. coli O157:H7. Activity of inhibitory   202 
substances  against  potential  non-pathogenic  bovine  E.  coli  isolates  was  also  detected  for 
certain  E.  coli  isolates,  including  MCI  0410.  Further  effects  of  the  disruption  of 
gastrointestinal microflora are not yet established; however, as the gastrointestinal microbiota 
is  important  for  the  health  of  the  animal  (Section  1.5.1)  the  predicted  disruption  to  this 
population should be considered in the design of probiotic strategies. 
 
In determining the probiotic potential of E. coli MCI 0410, it was noted that competition 
seemed to be most significantly increased when the organism was co-incubated with bovine 
epithelial cells, which could highlight the role of host cells in the activation of the competitive 
nature of E. coli. However, incubation with cultured cells was carried out in entirely different 
medium to competitive growth in liquid culture and the effects of components of the bacterial 
growth medium would need to be examined in order to validate this observation. 
 
In summary, data presented above provide an indication that strains isolated during this study 
could have inhibitory activity against E. coli O157:H7. However, virulence factor detection 
shows  that  some  of  these  isolates  are  potentially  pathogenic  meaning  that  certain  isolates 
would not be directly applicable in their current form. Nevertheless, certain isolates identified 
in  this  study  may  be  worthy  of  further  investigation  with  a  view  to  developing  probiotic 
control strategies against E. coli O157:H7.   203 
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6.1  Introduction 
 
As described in Chapter 1, EHEC infection of humans is often related to contact with bovine 
faecal  material,  especially  through  contamination  of  food  products  or  direct  contact  with 
bovine faeces (Mead et al., 1997;Locking et al., 2001;Strachan et al., 2006). Scotland has 
frequently been the setting for outbreaks of human EHEC-infection and E. coli O157 infection 
has been more frequent in Scotland compared with the rest of the UK since 1988, as shown in 
Figure 1.1 (Lynn et al., 2005). Incidence of E. coli O157 infection in Scotland peaked in 1996, 
when a large outbreak of E. coli O157:H7 occurred, related to contamination of cooked meat 
products with material from raw meat in a Wishaw butchery (The Pennington Group, 1998). 
 
At the beginning of this study, genome sequences for two strains of E. coli O157:H7 had been 
published. The first was strain EDL933, isolated from one of the earliest recognised outbreaks 
of human E. coli O157:H7 infection, which was linked to a fast food chain in Oregon. During 
this outbreak at least 47 people became infected (Riley et al., 1983;Perna et al., 2001). The 
second published genome was that of strain RIMD 0509952, which was isolated from an 
outbreak in Sakai, Japan, during which over 6000 schoolchildren were affected by EHEC 
disease (Watanabe et al., 1996;Hayashi et al., 2001b). Since then a large-scale sequencing 
project  of  E.  coli  O157:H7  genomes  has  begun  at  the  J.  Craig  Venter  Institute 
(http://msc.jcvi.org/o157h7/index.shtml accessed 10/08/2008). 
 
The  objectives  of  work  presented  in  this  Chapter  were  to  predict  the  diversity  of  EHEC 
genomes  and  establish  whether  the  strains  of  E.  coli  O157  related  to  human  disease  in 
Scotland differ from reference strains on the genomic level.  
 
Targeted analysis of individual virulence factor genes was initially carried out in order to 
predict the distribution of alleles of these genes among EHEC isolates. Genes encoding Shiga-
like toxin and the EspP protease were chosen, firstly as they each have proposed roles in the 
progression and severity of human infection (O'Brien and Holmes, 1987;Brunder et al., 1997) 
and secondly that these genes were the most common EHEC-virulence factor-encoding genes 
detected among bovine E. coli isolates (Chapter 4). This analysis may facilitate preliminary 
comparisons of the bovine “predicted-EHEC” population with those directly implicated in 
cases of human infection.    205 
 
A pan-genomic approach was adopted, including whole genome microarray to predict areas of 
genome-diversity  in  pathogenic  E.  coli  O157  strains.  Isolates  related  to  significant  recent 
outbreaks in Scotland were selected for identification of genomic portions present in Scottish 
isolates which are absent in genome-sequenced strains, using a technique termed suppressive 
subtractive hybridisation (SSH).  
 
Suppressive subtractive hybridisation (SSH) is a method whereby the sequences present in one 
population  of  DNA  (the  “tester”)  but  absent  in  another  (the  “driver”)  may  be  selectively 
amplified. In this instance, genomic DNA from a genome-sequenced strain of E. coli O157:H7 
(EDL933, MCI 0045) was used as the driver and genomic DNA from three strains related to 
outbreaks in Scotland were individually used as tester DNA populations. The first tester strain 
was an isolate related to the Wishaw outbreak of 1996 (MCI 0489). This strain was included 
to represent Scottish E. coli O157 which were prevalent in the mid 1990s, when incidence of 
E.  coli  O157  infection  was  at  its  peak  (Lynn  et  al.,  2005).  E.  coli  O157  MCI  0453  was 
selected as a representative of E. coli O157 strains most frequently related to incidence of 
human infection in Scotland recently. MCI 0453 is of phage type 21/28, which accounts for 
44% of identified cases of E. coli O157 infection in Scotland in 2007 (Locking et al., 2006). 
This particular strain caused HUS in two children in the same household and infected their 
mother. MCI 0507 was chosen as a representative of sorbitol-fermenting E. coli O157, which 
is an emerging group of human pathogens. This isolate was related to an outbreak in a Fife 
Nursery in 2006, during which there were 14 confirmed cases of EHEC infection (Health 
Protection Scotland, 2007).  
 
SSH-analysis was carried out to predict whether Scottish E. coli O157 isolates carry additional 
virulence factors. Strains encoding novel virulence factors could theoretically contribute to the 
increased prevalence of E. coli O157 infection in Scotland, although other factors such as 
increased likelihood of contact with cattle due to the rural environment and increased cattle 
population present in Scotland (Strachan et al., 2006), coupled with the increased observed 
prevalence of E. coli O157:H7 in Scottish cattle herds (Synge et al., 2003) are likely to be 
important in the increased incidence of human EHEC infection in Scotland.   206 
6.2  EHEC strains used in this analysis 
 
Bacterial isolates used in this study are summarised in Table 6.1. These include 48 isolates 
provided  by  Lesley  Allison  at  the  Scottish  E.  coli  Reference  Laboratory  (SERL,  Western 
General Hospital, Edinburgh) which are related to human disease in Scotland and 10 isolates 
from other sources.  
 
Ref No  Strain  Source  Phage Type  Intimin  Verotoxin  Details 
MCI 0033  E. coli O157:H7 
319 
Human  2  +  2+, 2c+  Redhouse dairy 
outbreak (1994) 
MCI 0047  E. coli O157:H7 
(MPRL 6303) 
Bovine  32  ND 
 
2+  unknown 
MCI 0048  E. coli O157:H7 
(MPRL 6043) 
Bovine  2  ND  2+  unknown 
MCI 0049  E. coli O157:H7 
(MPRL 6409) 
Bovine  49  ND  2+  Northern Ireland 
MCI 0050  E. coli O26 (MPRL 
4269) 
Human  ND  ND  -  unknown 
MCI 0051  E. coli O26 (MPRL 
4270) 
Human  ND  -  1+  Monkland 
s Outbreak (HUS) 
MCI 0064  E. coli O157:H7 
(NCTC12900) 
Human  ND  +  -  Public Health 
Laboratory, Austria, 
(1992) 
MCI 0066  E. coli O157:H7 
(WallaWalla1) 
Human  25 
g  +  2+  Washington State 
Outbreak, (1986) 
MCI 0218  E. coli O157:H7 
(84-289) 
Human  5 
g  +  2+  Ottawa (1987, 
Nursing home, HUS) 
MCI 0230  E. coli O157 
(SERL1) 
Bovine  21/28  +  2+  Outbreak Y-1 (2004, 
Dumfries & 
Galloway) 
MCI 0233  E. coli O157 
(SERL4) 
Bovine  21/28  +  2+  Outbreak Y-2 (2004) 
 
MCI 0234  E. coli O157 
(SERL5) 
Human  21/28  +  2+  Outbreak Y-2 
(2004, Dumfries & 
Galloway, 13 year 
old) 
MCI 0235  E. coli O157 
(SERL6) 
Human  21/28  +  2+  Outbreak Y-2 
(2004, Foreign 
patient
d, 3 year old, 
HUS) 
MCI 0236  E. coli O157 
(SERL7) 
Human  8  +  1+, 2+  Outbreak Y-3 (2000, 
Lothian, 13 year old) 
MCI 0238  E. coli O157 
(SERL9) 
Human  21/28  +  2+  Sporadic case (2004, 
Tayside, 62 year old, 
HUS) 
MCI 0239  E. coli O157 
(SERL10) 
Human  14  +  1+, 2+  Sporadic case (2004, 
Lothian, 40 year old, 
BD) 
MCI 0240  E. coli O157 
(SERL11) 
Human  33  +  1+, 2+  Sporadic case (2004, 
Ayrshire & Arran, 63 
year old, BD) 
MCI 0241  E. coli O157 
(SERL12) 
Human  31  +  2+  Sporadic case
b (2004, 
Lothian, 4 year old)   207 
MCI 0242  E. coli O157 
(SERL13) 
Human  21/28  +  2+  Outbreak Y-4, (2001, 
Greater Glasgow & 
Clyde, 11 year old, 
HUS) 
MCI 0245  E. coli O26 
(SERL16) 
Human  ND  +  1+  Sporadic case (2002) 
MCI 0246  E. coli O162 
(SERL17) 
 
Human  ND  -  1+  Sporadic case (2002) 
MCI 0247  E. coli O113 
(SERL18) 
Human  ND  -  2+  Sporadic case (2003) 
MCI 0248  E. coli O177 
(SERL19) 
Human  ND  +  2+  Sporadic case (2003) 
MCI 0249  E. coli O118 
(SERL20) 
Human  ND  -  1+, 2+  Sporadic case (2004) 
MCI 0280  E. coli O157:H7 
(TT12A) 
Human  ND  +    1+, 2+  Sporadic case (1992, 
Japan, HC) 
MCI 0444  E. coli O157
a 
SERL H1410 
Human  RDNC  +  2+  Sporadic case (2002) 
MCI 0445  E. coli O157
a 
SERL H 2687 
Human  RDNC  +  2+  Sporadic case (2003) 
MCI 0446  E. coli O157 SERL 
H 7370 
Human  8  +  1+, 2+  Sporadic case (2003)
c 
MCI 0447  E. coli O157 SERL 
H 7436 
Human  8  +  1+, 2+  Sporadic case (2003)
c 
MCI 0448  E. coli O157 SERL 
H7483 
Human  8  +  1+, 2+  Sporadic case (2003)
c 
MCI 0449  E. coli O157 SERL 
H 10080 
Human  21/28  +  2+  Sporadic case (2006)
e 
MCI 0450  E. coli O157 SERL 
H 10744 
Ovine  21/28  +  2+  Recent outbreak 
(2006) 
MCI 0451  E. coli O157 SERL 
H 10645 
Human  21/28  +  2+  Recent outbreak 
(2006) 
MCI 0452  E. coli O157 SERL 
H 10746 
Soil  21/28  +  2+  Recent outbreak 
(2006) 
MCI 0453  E. coli O157 SERL 
H 10873 
Human  21/28  +  2+  Familial outbreak 
(2006, HUS) 
MCI 0489  E. coli O157 SERL 
H 1477 
Human  2  +  2+  Wishaw Outbreak 
(1996, 65 year old, 
fatal) 
MCI 0507  E. coli O157
a 
SERL H8478 
Human  RDNC      Nursery Outbreak 
(2006, Fife) 
MCI 0665  E. coli O103 SERL 
XH2644G 
Human  ND  -  1+  Sporadic case (2005) 
MCI 0666  E. coli ONT SERL 
XH6233T 
Human  ND  -  2+  Sporadic case (2005) 
MCI 0667  E. coli O145 SERL 
XH6741H 
Human  ND  +  2+  Sporadic case (2006) 
MCI 0668  E. coli O26 SERL 
XH7788D 
Human  ND  +  1+, 2+  Sporadic case (2006) 
MCI 0669  E. coli O179 SERL 
XH8074K 
Human  ND  -  2+  Sporadic case (2006) 
MCI 0670  E. coli O111 SERL 
XH8352A 
Human  ND  +  1+, 2+  Sporadic case (2006) 
MCI 0671  E. coli O26 SERL 
XH9606R 
 
Human  ND  +  1+, 2+  Sporadic case (2006) 
MCI 0672  E. coli O113 SERL 
XH9674W 
Human  ND  +  1+, 2+  Sporadic case (2006)   208 
MCI 0673  E. coli O26 SERL 
XH10413N 
Human  ND  +  1+  Sporadic case (2006) 
MCI 0674  E. coli O26 SERL 
XH10544D 
Human  ND  +  1+  Sporadic case (2006) 
MCI 0675  E. coli ONT SERL 
XH10638L 
Human  ND  +  1+  Sporadic case (2006) 
MCI 0676  E. coli ONT SERL 
XH10743A 
f  ND  +  1+, 2+  Sporadic case (2006) 
MCI 0677  E. coli ONT SERL 
XH10745C 
f  ND  +  1+  Sporadic case (2006) 
MCI 0678  E. coli ONT SERL 
XH10917E 
Human  ND  -  2+  Sporadic case (2006) 
MCI 0679  E. coli ONT SERL 
XH11142L 
Human  ND  +  1+  Sporadic case (2007) 
MCI 0680  E. coli O103 SERL 
XH11266N 
Human  ND  +  1+  Sporadic case (2007) 
MCI 0681  E. coli O26 SERL 
XH11904R 
Human  ND  +  1+  Sporadic case (2007) 
MCI 0682  E. coli O26 SERL 
XH11946B 
Human  ND  +  1+  Sporadic case (2007) 
MCI 0683  E. coli O26 SERL 
XH12037J 
Human  ND  +  1+  Sporadic case (2007) 
MCI 0684  E. coli O103 SERL 
XH12243P 
Human  ND  +  1+  Sporadic case (2007) 
MCI 0695  E. coli O76 SERL 
XH12464R 
Human  ND  -  1+  Sporadic case (2007) 
 
a: Sorbitol-fermenting E. coli O157 isolates 
b: Patient had visited the farm that had been related to outbreak Y-1 
c: indistinguishable by PFGE (L. Allison, Pers. Comm.) 
d: The foreign patient acquired the infection in Scotland (L. Allison, Pers. Comm.) 
e: Recurrent clone (L. Allison, Pers. Comm.) 
f: Veterinary isolates 
g: determined by Ratnam et al. (1988) 
 
Table 6.1: Bacterial isolates used in this study: Where known, details including phage type (for O157 isolates), 
verotoxin type and case information are included (HUS: haemolytic uraemic syndrome, BD: bloody diarrhoea, 
HC:  haemorrhagic  colitis.  RDNC:  phages  reacted  but  did  not  conform  to  any  known  pattern,  ND:  not 
determined/unknown).   209 
6.3  Results 
 
6.3.1  Virulence factor-typing by PCR-RFLP of disease associated EHEC 
isolates 
 
Previously  published  methods  of  PCR-RFLP-typing  of  stx  and  espP  genes  described  in 
Section 2.6.3 (Bastian et al., 1998;Brunder et al., 1999) were adopted to obtain the allelic 
profile for these genes among the isolates included in this study (listed in Table 6.1). Resultant 
patterns and deduced stx and espP types are shown in Figures 6.1 and 6.2 and summarised in 
Table 6.2. 
 
Of the 26 non-sorbitol-fermenting E. coli O157 isolates included in the analysis, 24 were of 
espP pattern A. Pattern A corresponds to the espP type α allele which is commonly encoded 
by E. coli O157:H7 (Brockmeyer et al., 2007). All three sorbitol-fermenting E. coli O157 
isolates yielded no amplicon. Nine of the ten E. coli O26 isolates yielded espP pattern B, 
which  relates  to  the  EspP  type  α  gene  which  is  commonly  encoded  by  E.  coli  O26 
(Brockmeyer et al., 2007). No amplicon was generated from one E. coli O157 isolate (MCI 
0239) and another (MCI 0064)  yielded  espP type which could not be related to expected 
patterns given in Figure 4.6, which suggest that this isolate encodes a previously undescribed 
variant of EspP. Of the 18 representatives of other EHEC serotypes, espP amplicons were 
generated from 5 strains, including E. coli O103 (MCI 0665), E. coli O145 (MCI 0667), E. 
coli O177 (MCI 0248) and E. coli ONT (MCI 0679) which exhibited pattern B (espPαO26) and 
E.  coli  O179  (MCI  0669)  which  yielded  pattern  C,  which  corresponds  to  proteolytically 
inactive  EspP  type  β.  These  observations  reflect  the  prevalence  and  types  of  espP  genes 
detected  in  EHEC  isolates  given  in  Brockmeyer  et  al.  (2007)  in  which  espP  genes  were 
detected in the genomes of 62.5% of STEC isolates. Presence or absence of the espP gene and 
the subtypes carried was found to be serotype-specific. 
 
Although the stx genes  were detected in a  greater number of the EHEC isolates analysed 
herein, greater levels of heterogeneity were detected in the stx alleles than was identified in 
espP  alleles.  Of  the  26  non-sorbitol-fermenting  E.  coli  isolates,  19  yielded  a  pattern 
corresponding  to  stx2c/d.  Of  stx2c/d  -encoding  E.  coli  O157  strains, thirteen  also  appear  to 
encode a copy of the conventional stx2 gene, including all three of the phage type 2 isolates   210 
and 7 of the 10 phage type 21/28 isolates as stx2c. A further five stx2c/d -encoding isolates also 
carry a gene for stx1, including all four of the strains of phage type 8. One strain was observed 
to encode only stx2c/d (MCI 0241). All three sorbitol-fermenting E. coli O157 strains were 
found to encode stx2. Of the ten E. coli O26 isolates analysed, 9 were found to carry stx1. Of 
those, 2 were also found to carry stx2.  
 
Compared  against  the  espP  and  stx  gene  subtypes  identified  in  bovine  isolates,  the  most 
striking  difference  is  the  absence  of  the  stx2/stx2c/d  (pattern  A  +  B)  genotype  among  the 
bovine isolates whereas this is one of the most common patterns observed among the human 
EHEC isolates. Certain bovine isolates exhibited a pattern suggesting that three different stx-
encoding  alleles  were  carried  (stx1/stx2/stx2e)  which  has  previously  been  observed  among 
bovine STEC (Bertin et al., 2001). 
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Figure  6.1:  stx-RFLP  patterns  visualised  by  agarose  gel  elecrophoresis:    Numbers  above  each  lane 
correspond to MCI reference numbers given in Table 6.1. RFLP-pattern assignations are given beneath each lane, 
corresponding to Figure 4.7. MCI 0319 was used as a reference pattern for stx1 (see Chapter 4). 
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Figure 6.2: Determination of espP RFLP-types 
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Figure 6.2: Determination of espP RFLP-types: 
Strain (corresponding to MCI-Reference number) is 
given above gel lane. MCI 0045 was included on 
each gel as a reference pattern for espP pattern A. 
Patterns were matched to those listed in Figure 4.6 
and  pattern  assignations  are  given  beneath  each 
lane. Strains not shown were those which yielded no 
amplicon after PCR. 
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    stx-RFLP pattern  espP-RFLP pattern 
Serotype  Number 
analysed 
-  A 
stx1 
B 
stx2 
C 
stx2c/d 
D 
stx2e 
G 
stx2g 
A
+
B 
A
+
C 
A
+
D 
A
+
D
+ 
B 
B 
+ 
C 
A
+
G 
NEW*  A 
espPαO157 
B 
espPαO26 
C 
espPβ 
NEW*  - 
O157 (nSF)  26
  1  0  3  1  0  1  2  5  0  0  13  0  0  24  0  0  1  1 
O157 (SF)  3  0  0  3  0  0  0  0  0  0  0  0  0  0  0  0  0  0  3 
O26  10  1  7  0  0  0  0  2  0  0  0  0  0  0  0  9  0  0  1 
O103  3  0  3  0  0  0  0  0  0  0  0  0  0  0  0  1  0  0  2 
O113  2  0  0  0  1  0  1  0  0  0  0  0  0  0  0  0  0  0  2 
O111  1  0  0  0  0  0  0  1  0  0  0  0  0  0  0  0  0  0  1 
O118  1  0  0  0  0  0  0  0  0  0  0  0  1  0  0  0  0  0  1 
O145  1  0  0  1  0  0  0  0  0  0  0  0  0  0  0  1  0  0  0 
O162  1  0  1  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  1 
O177  1  0  0  0  1  0  0  0  0  0  0  0  0  0  0  1  0  0  0 
O179  1  0  0  0  1  0  0  0  0  0  0  0  0  0  0  0  1  0  0 
O76  1  0  1  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  1 
ONT  6  0  3  0  0  0  3  0  0  0  0  0  0  0  0  1  0  0  5 
 
TOTAL 
(EHEC) 
 
57  2  15  7  4  0  5  5  5  0  0  14  1  0  24  13  1  1  18 
 
Bovine 
isolates** 
 
132  101  13  4  4  4  2  0  0  1  2  0  0  1  1  3  7  1  120 
 
Table 6.2: Summary of stx and espP RFLP-types: Patterns observed after espP and stx RFLP were matched to those given in Figures 4.6 and 4.7. Numbers of isolates 
bearing each RFLP-pattern for each serotype were compiled in the table above, with “-” referring to isolates yielding no amplified fragment from the PCR for each factors. SF: 
sorbitol fermenting, nSF: non sorbitol fermenting. 
*  Pattern does not conform to any predicted genotype. 
**Assorted serotypes, as described in Chapter 4.   214 
6.3.2  Analysis of E. coli O157 isolates by genomic microarray 
 
Eleven isolates were selected for analysis by genomic microarray, using the method set out in 
Section 2.6.6. The isolates represented four outbreaks and four sporadic cases of disease, the 
available  details  of  which  are  given  in  Table  6.1.  From  one  of  the  outbreaks  two 
epidemiologically-linked isolates (a bovine isolate linked to the cases of human infection and 
a corresponding human isolate from the same outbreak, namely MCI 0233 and MCI 0234 
respectively) were included to predict whether the epidemiological investigation carried out by 
the  SERL  had  been  successful  in  identifying  two  strains  with  conserved  genomic 
characteristics. MCI 0066 was included in this analysis as a representative American E. coli 
O157:H7 strain, isolated during a foodborne EHEC outbreak in Washington State in 1986 
(Ratnam et al., 1988) 
 
Although the vast majority of oligonucleotides representing the genomes of E. coli O157:H7 
EDL933 and E. coli O157:H7 Sakai were found to be present in the genomes of the Scottish 
E.  coli  O157  isolates,  the  results  of  the  genomic  microarray  analysis  identified  several 
genomic  regions  encoded  by  reference  E.  coli  O157:H7  isolates  which  were  absent  or 
divergent  among  the  Scottish  E.  coli  O157  isolates.  The  most  notable  absences  are 
summarised in Figures 6.4 and 6.5. Figure 6.4 illustrates the diversity among stx-encoding 
bacteriophages carried in the genomes of E. coli O157 strains. Regions of the stx1 phage were 
found  to  be  absent  in  the  two  strains  which  were  found  to  encode  stx1  (MCI  0236  and 
MCI0239). However, regions of this phage were apparently present in strains without stx1, 
suggesting that there may be regions homologous to the stx1 phage present elsewhere on the 
genome, possibly among variant stx2-encoding bacteriophages. The two strains which were 
found to encode a conventional stx2EDL933 gene and were also found to be positive for the 
majority (but not all) of the oligonucleotides representing the stx2 phage present in the genome 
of the reference E. coli O157:H7 strains. Strains MCI 0236 and MCI 0241 which encoded stx1 
along with variant stx2c/d were found to be negative for the entire stx2-encoding bacteriophage 
except  for  oligonucleotides  representing  the  stx2  gene  itself.  Copies  of  the  conventional 
stx2EDL933 gene were not detected in these strains by PCR-RFLP analysis (presented in Section 
6.3.1).  
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Diversity was also exhibited within certain O-islands; the largest of these diverse regions are 
highlighted in Figure 6.5. Each of the isolates analysed was negative for a large portion of 
oligonucleotides representing genes carried on O-island 51, which are carried by a cryptic 
prophage element designated CP-933-C (Perna et al., 2001). MCI 0233 and MCI 0234 (bovine 
and human isolates respectively, epidemiologically linked to the same outbreak) were each 
negative for O-island 76 in its entirety. O-island 76 is also comprised of a cryptic prophage 
element, CP933-T. MCI 0066 and MCI 0241 were both negative for the majority of O-island 
172,  which  covers  a  putative  insertion  element.  Further  diversity  was  restricted  to  small 
genomic regions and individual genes– also encoded on O-islands. All of the Scottish isolates 
analysed were negative for oligonucleotides representing genes z1797 and z1799 carried on O-
island 50 (both encoding proteins involved in bacteriophage function). MCI 0236 and MCI 
0239 alone were positive for oligonucleotides representing genes z2200 and z2201 (putative 
fimbrial component-encoding genes carried on O-island 61) and oligonucleotides representing 
genes z5087, z5089 and z5094, which encode putative prophage-related proteins, carried on 
O-island 148 (the LEE). All strains were found to be positive for the vast majority of pO157-
encoded  genes,  except  for  oligonucleotides  representing  genes  L7071  and  L7072  (both 
hypothetical proteins).  
 
All strains were found to be negative for the majority of K-island-encoded genes, except that 
all strains were found to be positive for oligonucleotides representing genes b2361 and b2362 
which are both hypothetical proteins encoded on K-island 121. The vast majority of diverse 
regions described here are bacteriophage or prophage-related. This observation supports the 
notion that bacteriophages are the major agents of genome diversification among E. coli O157 
strains, as proposed by others (Bielaszewska et al., 2007a).   216 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3: Results of whole genome microarray analysis of E. coli O157 isolates: The Venn diagram above shows the numbers of oligonucleotides specific to each of the 
three control strains represented on the array and those common to two or all three of the control strain genomes. Each oligonucleotide is represented by a vertical bar, the 
topmost bar coloured according to the Venn diagram (the grey area at the rightmost end of the bar corresponds to the genes encoded on pO157) and subsequent bars coloured 
by presence or absence in each strain analysed (yellow: presence, blue: absence, grey: ambiguous). It can be seen from this representation that the Scottish E. coli O157 strains 
included in this analysis exhibit a similar pattern of gene conservation. 
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Figure 6.4: Diversity of stx-phage-encoded genes among E. coli O157 isolates 
 
 
 
 
stx1 phage  stx2 phage 
Figure  6.4:  Diversity  of  stx-phage-encoded 
genes  among  E.  coli  O157  isolates:  gene 
identifiers  (E.  coli  O157:H7  EDL933  genomic 
locus tags) are listed to the right of each diagram, 
with presence or absence of each oligonucleotide 
representing that gene for each strain given as a 
yellow (present), blue (absent), grey (ambiguous) 
or  black  (no  data  available)  block. 
Oligonucleotides  representing  the  stx1-phage 
were only partially present, even for MCI 0236 
and MCI 0239, which encode stx1 genes. It can 
be seen from this representation that although all 
of  the  isolates  are  positive  for  oligonucleotides 
representing stx2, the Scottish isolates lack some 
part of the stx2-phage encoded genes, especially 
in the case of MCI 0241 and MCI 0236. 
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Figure 6.5: Diversity of carriage of O-island-encoded genes among E. coli O157 isolates: gene identifiers (E. 
coli O157:H7 EDL933 genomic locus tags) are listed to the right of each diagram, with presence or absence of 
each  oligonucleotide  representing  that  gene  for  each  strain  given  as  a  yellow  (present),  blue  (absent),  grey 
(ambiguous) or black (no data available) block. It can be seen that all of the Scottish O157 isolates lack a major 
part of O-island 51. MCI 0233 and MCI 0234 are negative for O-island 76 in its entirety and MCI 0066 and MCI 
0241 lack the majority of oligonucleotides representing O-island 172. 
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6.3.3  Genomic subtractive hybridisation of Scottish outbreak-related E. coli 
O157 isolates 
 
Subtractive hybridisation was carried out according to Section 2.6.8 (Materials & Methods) 
resulting in three clone libraries corresponding to each of the tester strains (MCI 0453, MCI 
0489 and MCI 0507). Two hundred and eighty-eight colonies from each library were screened 
by Southern hybridisation (Section 2.6.8.1) using genomic DNA from the driver (MCI 0045) 
as a probe (not shown). The TotalLabArray program was used to assign a value for pixel 
density  to  each  resulting  spot.  For  the  clones  giving  the  lowest  intensity  spots  (likely  to 
represent  sequences  that  are  absent  in  the  EDL933  genome)  plasmid  DNA  was  purified 
(Section 2.6.1.4) and submitted for sequencing at MWG Biotech. Sequence data was edited to 
remove vector sequence and analysed by BLASTN. Those yielding no hit were analysed by 
BLASTX, to give predicted translated protein hits for each sequence. Sequencing was carried 
out in small batches until the same sequences were recovered multiple times, indicating that 
most of the unique sequences were likely to have been recovered. In total, 202 plasmids were 
chosen for sequencing from the three subtracted libraries (54 from MCI 0453, 59 from MCI 
0489 and 89 from MCI 0507). Sequencing was carried out in one direction, using the T7 
forward primer. The unique sequences identified in the genomes of MCI 0489, 0453 and 0507 
are summarised in Tables 6.3, 6.4 and 6.5 respectively. Sequences returning a BLAST hit of 
less than 90% identity to sequences in the NCBI database are given in full in Appendix VI. 
 
Pie charts presented in Figure 6.6 summarises the predicted functions of sequences returned 
for  each  of  the  three  tester  strains.    Predicted  bacteriophage-encoded  genes  were  most 
prevalent  among  the  sequences  obtained  for  each  strain.  Of  the  32,  40  and  42  sequences 
returned  for  MCI  0453,  MCI  0489  and  MCI  0507  respectively  18,  32  and  19  sequences 
returned hits related to bacteriophage or prophage genetic elements. 
 
In  addition  to  bacteriophage-related  elements,  sequences  returned  from  the  MCI  0453 
subtracted library also included three sequences which are homologous to Type IV secretion 
or  conjugation  apparatus.  Nine  matched  proteins  of  unknown  function  and  two  sequences 
were identified which returned no hits by BLAST-N or BLAST-X searching, which could 
represent previously undescribed genomic regions present in the genome of this isolate. 
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The sequences returned for MCI 0489 also include three which have similarity with proteins 
involved in DNA recombination, methylation and repair, one transcriptional regulator, one 
proposed to be involved in the ABC transport system and one matching a predicted protein of 
undetermined function.  
 
Among  the  sequences  identified  among  the  MCI  0507  subtracted  library,  five  sequences 
corresponded to miscellaneous metabolic functions. These included starvation sensing proteins 
including rspA and rspB. RspA senses homoserine lactone, which is produced during bacterial 
starvation and the starvation response renders the bacterium resistant to environmental stresses 
(Huisman and Kolter, 1994). Three were related to nucleotide binding and phosphorylation 
which  is  important  in  many  energy-dependent  cellular  processes.  Two  sequences  were 
identified  that  are  likely  to  be  related  to  conjugative  transfer  of  plasmid  DNA  and  two 
matched sequences of putative transcriptional regulators. Two sequences matching putative 
membrane  proteins  were  identified,  including  one  matching  an  autotransporter  protein 
encoded by E. coli HS (a human commensal E. coli isolate). Sequence encoding efa-1 was 
identified. Efa-1 (EHEC factor for adherence-1) has been previously described as a factor 
which increases the adherence of EPEC to cultured cells and has been implicated as a factor 
which inhibits lymphocyte proliferation (Nicholls et al., 2000;Klapproth et al., 2000). It has 
also previously been identified as a factor encoded by German isolates of sorbitol-fermenting 
E. coli O157:H- (Janka et al., 2005).   221 
Name  Size 
(bp) 
% ID  BLASTN Hit  Organism  Accession  Sequence 
begin 
Sequence 
end 
 
Protein ID 
w1A8  288  95  hypothetical protein: 
(putative Fels-1 prophage DNA or RNA 
helicases of superfamily II) 
 
Shigella dysenteriae Sd197  CP000034.1  1751820  1752108  ABB62028.1 
w1A9  308  97  "gpQ" 
 
Yersinia phage L-413C  AY251033.1 
 
1013  705  AAP04438.1 
w1C12  401  100  capsid protein small subunit, hypothetical 
protein 
 
E. coli O157:H7 strain EC970520  EF174158.1  7316  7717  ABM53631.1 
ABM53632.1 
w1C4  575  99  bacteriophage P4 DNA primease 
 
 
E. coli O157:H7 strain EC970520  EF174158.1  3513  2939  ABM53623.1 
w1D10  497  99  site-specific DNA-methyltransferase  S.  dysenteriae Sd197 
 
CP000034.1  1754612  1755109  ABB62032.1 
w1D11  >1200  93 
 
100 
 
 
98 
1-188: putative open reading frame 
 
271-699: hypothetical protein 
EcolO15_21403 (X) 
 
701-1029:hypothetical protein, hypothetical 
protein,adenine methylase, hypothetical 
protein  
 
Enterobacteria phage Nil2  
 
E. coli O157:H7 str.EC4501 
 
 
Stx2-converting bacteriophage 86 
AJ413274.1 
 
- 
 
 
AB255436.1 
8719 
 
1 
 
 
39988 
8907 
 
143 
 
 
39749 
CAC95099.1 
 
ZP_02788527 
 
 
BAF34069.1 
BAF34070.1 
BAF34071.1 
BAF34072.1 
 
w1E10  318  99  "orf31" (unknown product) 
 
Shigella flexneri bacteriophage V  U82619.2  23381  23064  AAL89433.1 
w1E8  491  98  Flanked by: ISSfl3 orfA and exonuclease I, 3 
--> 5 specific deoxyribophosphodiesterase. 
Contains: IntA insertion element 
 
S. flexneri 2a str. 2457T  AE014073.1  2070449  2070939  AAP17440.1 
AAP17439.1 
AAP16001.1 
w2C8  454  99  major capsid protein 
 
 
E. coli O157:H7 strain EC970520  EF174158.1  6298  6752  ABM53630.1 
w2E9  601  79  1-272: bacteriophage lambda NinG protein 
(X) 
 
283-588:hypothetical protein EcolO_07489 
(X) 
 
E. coli O157:H7 str. EC508 
 
 
E. coli O157:H7 str. EC508 
- 
 
 
- 
333 
 
 
59 
638 
 
 
149 
 
 
ZP_02823579 
 
 
ZP_02823580 
 
w2F3  249  90  hypothetical proteins (2). Phage p_Rha.  
 
S.  dysenteriae  Sd197  CP000034.1  1758074  1757827  ABB62034.1 
ABB62035.1 
 
w2F4  216  99  1-105: Present in EDL933 
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106-216: "gpQ" 
 
Yersinia phage L-413C  AY251033.1  593  708  AAP04438.1 
w2G10  688  85  1-93: Present in EDL933.  
 
94-688: "hkaK" (unknown function) 
 
 
 
Enterobacteria phage HK620 
  
 
AF335538.1 
 
 
 
5059 
 
 
4527 
 
 
AAK28859.1 
w2H7  250  100  repressor protein CI 
 
S.  dysenteriae Sd197  CP000034.1  1753860  1754109  ABB62031.1 
w3A11  427  95 
 
 
 
72 
1-201: hypothetical protein: (putative Fels-1 
prophage DNA or RNA helicases of 
superfamily II) 
 
"unnamed protein product" 
 
S.  dysenteriae Sd197,  
 
 
 
Photorhabdus luminescens subsp. 
Laumondii TTO1 
 
CP000034.1 
 
 
 
BX571868.1 
1751829 
 
 
 
315959 
1751628 
 
 
 
315698 
ABB62028.1 
 
 
 
CAE15290.1 
w3B2  285  91
a , 98
  3' flanking region (24bp deletion), 
hypothetical protein: phage p_Rha 
 
S.  dysenteriae  Sd197  CP000034.1  1757511 
1757592 
1757568  
1757831 
 
ABB62034.1 
w3B4  469  97  phage late control gene D protein, phage 
transcriptional activator (Ogr/Delta) 
 
E. coli E24377A (ETEC)  CP000800.1  1016222  1016691  ABV17526.1 
ABV16998.1 
w3C4  692  92  
 
 
72 
1-236:"eae-like protein"  
 
 
245-687 putative methyltransferase 
 
 
Enterobacteria phage phiV10 (of 
O157:H7) 
 
Salmonella typhi strain CT18 
DQ126339.2 
 
 
AL627268.1 
35895 
 
 
259815 
36131 
 
 
260181 
AAZ95934.1 
 
 
CAD05420.1 
w3C6  437  100  hypothetical protein EcolO_07509 (X)  E. coli O157:H7 str. EC508 
 
  16  125  ZP_02823583 
w3E6  297  98  site-specific DNA-methyltransferase  
 
S.  dysenteriae Sd197  CP000034.1  1754357  1754616  ABB62032.1 
w1B4  581  79  1-300: conserved hypothetical protein (X) 
 
448-581: Present in EDL933 
 
E. coli O157:H7 str. EC508      58  149  ZP_02823580 
w1B11  >969  100 
 
 
82 
1-660: RecT family protein (X) 
 
 
744-895:  Present in EDL933  
 
 
E. coli O157:H7 str. EC508    78  316  ZP_02825666 
w1C10  500  99  putative phage DNA primase (X) 
 
 
E. coli O157:H7 str. EC508      180  323  ZP_02823581.1| 
w1D6  493  99  DnaB analogue 
 
Enterobacteria phage Nil2  AJ413274.1  5697  5204  CAC95089.1 
w1F12  454  100  major capsid protein  E. coli O157:H7 strain EC970520  EF174158.1  6298  6752  ABM53630.1   223 
 
w1G2  306  97  1-237: "gpA"  
 
237-306: no significant hits (X) 
 
Yersinia phage L-413C  AY251033.1  28546  28783  AAP04475.1 
w1H6  568  97  flanked by: type II site-specific 
deoxyribonuclease and hypothetical protein, 
phage p_Rha 
 
S.  dysenteriae Sd197  CP000034.1  1757514  1756946  ABB62033.1 
ABB62034.1 
w1H8  >900  99  hypothetical protein, adenine methylase  Stx2-converting bacteriophage 86 
DNA 
 
AB255436.1  39111  39988  BAF34070.1 
BAF34071.1 
w2A4  >1000  99  predicted kinase inhibitor, predicted DNA-
binding transcriptional regulator 
 
E. coli W3110 DNA  AP009048.1  570305  571309    
w2B6  288  95  hypothetical protein: putative Fels-1 
prophage DNA or RNA helicases of 
superfamily II 
 
S.  dysenteriae Sd197  CP000034.1  1752108  1751821  ABB62028.1 
w2C11  >1000  93  
 
99 
 
 
99 
1-188: antA  
 
253-685: hypothetical protein 
ECH7EC4501_4951 (X) 
  
643-954: hypothetical protein, adenine 
methylase 
 
Enterobacteria phage Nil2 
 
E. coli O157:H7 strain EC4501 
 
 
Stx2-converting phage 86 
AJ413274.1 
 
 
 
 
AB255436.1 
8719 
 
1 
 
 
39988 
8907 
 
143 
 
 
39676 
CAC95099.1 
 
ZP_02788527.1 
 
  
BAF34072.1 
BAF34071.1 
w2D3  402  100 
 
97 
1-306: conserved hypothetical protein (X) 
 
307-402: hypothetical proteins (2) putative 
phage related helicases 
 
E. coli O157:H7 strain EC508 
 
S.  dysenteriae Sd197 
 
 
CP000034.1 
 
 
1752300 
 
 
1752204 
ZP_02823583.1 
 
ABB62028.1 
ABB62029.1 
w2G2  200  98  putative baseplate assembly protein 
 
E. coli APEC O1  CP000468.1  939608  939736  ABJ00305.1 
w2G12  245  100  PTS-dependent dihydroxyacetone kinase 
operon regulatory protein 
 
E. coli E24377A  CP000800.1  1341847  1342091  ABV20847.1 
w3B8  455  100  major capsid protein 
 
E. coli O157:H7 strain EC970520  EF174158.1  6298  6752  ABM53630.1 
w3E2  409  96  
 
 
73 
1-201 hypothetical protein  
 
 
148-409: unnamed protein product 
(both are phage related helicases) 
 
 
S.  dysenteriae Sd197 
 
 
P. luminescens subsp. laumondii 
TTO1 
CP000034.1 
 
 
BX571868.1 
1751829 
 
 
315959 
1751628 
 
 
315698 
ABB62028.1 
 
 
CAE15291.1   224 
w3F2  699  99  phage DNA packaging protein NU1-like 
protein 
 
E. coli O157:H7 strain EC970520  EF174158.1  7713  8412  ABM53633.1 
w3G10  245   
 
96 
1-63: Present in EDL933  
 
64-245: flanking sequence/Ogr (phage zinc 
binding transcriptional regulator) 
 
 
 
E. coli APEC O1 
 
 
CP000468.1 
 
 
2259200 
 
 
2259444 
 
 
ABJ00319.1 
 
w3H1  574  100  bacteriophage P4 DNA primease 
 
E. coli O157:H7 strain EC970520  EF174158.1  2939  3514  ABM53623.1 
w3H4  >1000  100  "w0048" (DNA breaking and rejoining 
enzyme) 
 
E. coli O157:H- plasmid pSFO157
b  AF401292.1  66718  67691  AAR00433.1 
a: % identity is calculated disregarding the 24bp deletion 
b: Also present in E. coli O157:H7 Sakai genome 
 
Table 6.3: Sequences identified in the SSH library of MCI 0453: A summary of the best BLASTN hits (or BLASTX hits where the hit is followed by the letter ‘X’) for each 
sequence in the subtracted library of MCI 0453 genomic fragments. Sequences which were identified multiple times were only included as a single entry on this table. Results 
are further summarised in pie charts (Figure 6.6). Where the best BLAST hit has less than 90% identity with the sequence obtained these sequences are given in full in 
Appendix VI. 
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Name  Size 
(bp) 
% ID  BLASTN Hit  Organism  Accession  Sequence 
begin 
Sequence 
end 
 
Protein ID 
d1A3  574  100  bacteriophage P4 DNA primease  E. coli O157:H7 strain EC970520 
 
EF174158.1  3513  2939  ABM53623.1 
d1C9  300  100  bacteriophage P4 DNA primease, hypothetical 
protein 
 
E. coli O157:H7 strain EC970520 
 
EF174158.1  2622  2926  ABM53623.1 
ABM53624.1 
d1D8  399  100  putative endolysin  E. coli O157:H7 Sakai 
 
BA000007.2  5051934  5051524  BAB38385.1 
d1F9  121  99  hypothetical protein  E. coli O157:H7 strain EC970520 
 
EF174158.1  6019  5898  ABM53628.1 
d1G4  614  0 
 
100 
 
 
99 
1-251: No significant hits 
 
260-614: hypothetical protein 
EcSMS35_A0078 (X) 
 
252-614: putative protein  
- 
 
E. coli SECEC SMS-3-5 
 
 
E. coli plasmid p1658/97 
 
- 
 
 
 
 
AF550679.1 
- 
 
39 
 
 
104777 
- 
 
154 
 
 
105141 
- 
 
YP_001739966 
 
 
AAO49623.1 
d1G9  250  94  hypothetical protein, putative virion 
morphogenesis protein 
E. coli O157:H7 Sakai 
 
BA000007.2  5058623  5058841  BAB38394.1 
BAB38395.1 
 
d1H10  500  80 
 
 
0 
1-103: rep protein 
 
 
104-500: no significant hits (X) 
 
Corynebacterium renale plasmid 
pCR1 
 
- 
X99132.2 
 
 
- 
613 
 
 
- 
716 
 
 
- 
CAA67573.2 
 
 
- 
 
d1H5  239  99  putative DNA circulation protein (phage-
related) 
 
E. coli O157:H7 Sakai 
 
BA000007.2  5067720  5067971  BAB38406.1 
d2B7  205  100  hypothetical protein   E. coli O157:H7 Sakai 
 
BA000007.2  5075563  5075768  BAB36395.1 
BAB34630.1 
 
d2G6    100 
 
100 
1-320: type IV secretion system protein VirB1 
 
315-531 hypothetical protein 
EschecoliO157_30031, (X) 
 
E. coli O157:H7 str. EC4115 
 
E. coli O157:H7 str. EC4115 
- 
 
- 
97 
 
1 
203 
 
60 
ZP_02771522 
 
ZP_02771521 
d2G9  600  75  Type IV conjugal transfer protein  Aeromonas veronii 
 
DQ890522.1  3375  2996  ABI83640.1 
d2H2  830  93  hypothetical protein, hypothetical protein 
(related to Gp11, bacteriophage Mu) 
E. coli O157:H7 Sakai 
 
BA000007.2  5048005  5048889  BAB38376.1 
BAB38377.1 
 
d3B10  882  99  1-264: present in EDL933 
 
265-882 hypothetical protein 
 
 
E. coli O157:H7 Sakai 
 
 
 
BA000007.2 
 
 
5077068 
 
 
5077950 
 
 
BAB38417.1   226 
d3F10  455  100  major capsid protein  E. coli O157:H7 strain EC970520 
 
EF174158.1  6298  6752  ABM53630.1 
d3G3  467  99  putative transcriptional regulator, putative 
endolysin 
 
E. coli O157:H7 Sakai 
 
BA000007.2  5051528  5051062  BAB38384.1 
BAB38385.1 
d3H2  284  100  phage transposase  E. coli O157:H7 Sakai 
 
BA000007.2  5043529  5043813  BAB38368.1 
d3H8  281  99  putative cI repressor protein, Stx2 converting 
phage II 
 
E. coli O157:H7 Sakai 
 
BA000007.2  1257594  1257313  BAB34608.1 
d1A1  300  100  putative DNA circulation protein  E. coli O157:H7 Sakai 
 
BA000007.2  5067720  5067971  BAB38406.1 
d1A2  397  99  unnamed protein product; psu gene product  Bacteriophage P4 
 
X51522.1  10773  11170  CAA35906.1 
d1B12  439  99  1-152 Present in EDL933  
 
152-440 hypothetical protein 
 
 
E. coli O157:H7 Sakai 
 
 
 
BA000007.2 
 
 
5076427 
 
 
5076866 
 
 
BAB38416.1 
d1C3  589  99  major capsid protein  E. coli O157:H7 strain EC970520 
 
EF174158.1  6298  6887  ABM53630.1 
d1D1  209  71  "traH"  E. coli plasmid R721 
 
AP002527.1  59100  58889  BAB12652.1 
d1D2  >975  96  locus 17899…18799  Salmonella enterica serovar Dublin 
plasmid pOU1115 
 
DQ115388.1  17899  18799  - 
d1F3  >900  95 
 
 
 
 
96 
143-676: gene 23 protein  
 
 
 
 
676- conserved hypothetical protein, 
hypothetical protein 
Enterobacteria phage Sf6 (Shigella 
flexneri) 
 
 
 
E. coli HS 
 
 
AF547987.1 
 
 
 
 
CP000802.1 
20706  
 
 
 
 
295965 
20173 
 
 
 
 
295579 
AAQ12213.1  
 
 
 
 
ABV04665.1 
ABV04666.1 
d1F7  >1048  76 
 
 
 
77 
1-607: “locus 690...1297”  
 
 
 
691-940 unnamed protein product, possible 
helicase. 
E. coli retronphage (phi)R73,  
 
 
 
Photorhabdus luminescens subsp. 
laumondii TTO1 
 
M64113.1 
 
 
 
BX571859.1 
 
690 
 
 
 
157011 
1297 
 
 
 
157295 
 
 
 
 
CAE12448.1 
d2B4  281  100  hypothetical proteins (2)  E. coli O157:H7 Sakai 
 
BA000007.2  5045477  5045758  BAB38371.1 
BAB38372.1 
d2B6  466  99  putative transcription regulator, putative 
endolysin 
 
 
E. coli O157:H7 Sakai 
 
BA000007.2  5051528  5051062  BAB38384.1 
BAB38385.1 
d2C2  314  99  phage transposase  E. coli O157:H7 Sakai  BA000007.2  5043529  5043813  BAB38368.1   227 
 
d2C7  401  100  hypothetical proteins (3) 
 
E. coli O157:H7 strain EC970520 
 
EF174158.1  2107  2508  ABM53621.1 
ABM53622.1 
ABM53624.1 
d2G1  615  94 
 
0 
1-364: putative protein, putative protein 
 
365-615: NO SIGNIFICANT HITS (X) 
 
E. coli plasmid p1658/97   AF550679.1  105141  104777  AAO49623.1 
AAO49624.1 
d2H12  >720  0  NO SIGNIFICANT HITS (X) 
 
              
d3D1  300  98  putative protein 
 
E. coli plasmid p1658/97  AF550679.1  105350  105138  AAO49623.1 
 
Table 6.4: Sequences identified in the SSH library of MCI 0489: A summary of the best BLASTN hits (or BLASTX hits where the hit is followed by the letter ‘X’) for each 
sequence in the subtracted library of MCI 0489 genomic fragments. Sequences which were identified multiple times were only included as a single entry on this table. Results 
are further summarised in pie charts (Figure 6.6). Where the best BLAST hit has less than 90% identity with the sequence obtained these sequences are given in full in 
Appendix VI. 
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Name  bp  % ID  homologue  organism  Accession 
number 
Sequence 
begin 
Sequence 
end 
Protein ID 
sf1-9  739  98  starvation sensing protein RspB (alcohol 
dehydrogenase-like) 
 
E. coli E24377A  CP000800.1  1778877  1779615  ABV20572.1 
sf1-52  688  99  site-specific recombinase, phage integrase 
family 
 
E. coli E24377A  CP000800.1  1001566  1000879  ABV17174.1 
sf1-54  468  97  putative bacteriophage protein 
 
S. dysenteriae Sd197  CP000034.1  553010  553477  ABB60777.1 
sf1-72  314  100  Efa1-Lymphostatin-like protein 
 
E. coli O157:H- 493/89  AJ459584.1  7357  7670  CAD30848.1 
sf1-79  656  99  predicted inner membrane protein, 
hypothetical protein with nucleoside 
triphosphate hydrolase domain 
 
E. coli W3110  AP009048.1  3131557  3130902  BAE77044.1 
BAE77045.1 
sf1-83  508  99  "w0003"  E. coli O157:H- pSFO157 
 
AF401292.1  2675  2168  AAR00439.1 
sfA-10  457  94  
 
 
80  
 
98 
 
 
81 
1-35:putative phage tail collar domain 
protein  
 
192-256: putative phage tail domain protein 
 
257-369: (present in EDL933) putative 
phage tail collar domain protein 
 
369-457: Gifsy-1 prophage proteins 
E. coli E24377A  
 
 
 
 
 
 
 
S. typhimurium LT2 
CP000800.1,  
 
 
 
 
 
 
 
AE008818.1 
852438 
 
 
1287369  
 
 
 
 
6044 
852473 
 
 
1287433  
 
 
 
 
5948 
ABV19732.1 
 
ABV21111.1 
 
 
 
 
 
AAL21482.1 
AAL21483.1 
 
sfA-17  223  97  Predicted phosphatase homologous to the 
C-terminal domain of histone macroH2A1 
(X) 
 
 Shigella dysenteriae 1012      116  200  ZP_00921526 
sfA-30  >1000  94  putative membrane protein, hypothetical 
protein 
E. coli E24377A  CP000800.1  1309747  1310729  ABV19698.1 
ABV18070.1 
 
sfA-55  244  89  putative bacteriophage protein  S. flexneri 2a str. 301  AE005674.1  914044  913801  AAN42512.1 
 
sfA-61  261  98  1-243: gpF1  E. coli APEC O1  CP000468.1  948432  948189  ABJ00313.1 
 
sfA-65  744  99  hypothetical proteins (x3)  E. coli strain EC970520   EF174158.1  1367  2110  ABM53619.1 
ABM53620.1 
ABM53621.1 
 
sfA-68  437  99  putative outer membrane autotransporter 
 
 
E. coli HS  CP000802.1  377328  376892  ABV04751.1   229 
sfA-83  284  97  antitermination protein Q 
 
S. flexneri bacteriophage V  U82619.2  33167  33450  AAL89448.1 
sfB-12  >1008  97  conserved hypothetical proteins (x2)  E. coli E24377A  CP000800.1  1306392  1307399  ABV20518.1 
ABV17372.1 
 
sfB-61  521  95  putative capsid protein of prophage  E. coli APEC O1  CP000468.1  1205015  1205535  ABJ00554.1 
 
sfB-77  >930  100  w0070, w0071  E. coli O157:H- plasmid pSFO157  AF401292.1  89907  90836  AAR00469.1 
AAR00487.1 
 
sfB-89  290  99  w0034  E. coli O157:H- plasmid pSFO157  AF401292.1  47832  48121  AAR00444.1  
 
sfB-96  520     1-470: NADH-ubiquinone oxidoreductase 
 
481-520: present in EDL933  
 
Roseobacter sp. SK209-2-6     118  225  ZP_01756926 
sf1-85  341     1-150: dihydroxyacetone kinase, 160-320 
dihydroxyacetone kinase subunit M 
 
99-341: present in EDL933 
 
 E. coli B7A,           ZP_00714922 
sfP-2  780  97  hypothetical protein, hypothetical protein  Citrobacter koseri ATCC BAA-895  CP000822.1  3274935  3274156  ABV14592.1 
ABV14593.1 
sfP-10  506  89  hypothetical protein 
 
C. koseri ATCC BAA-895  CP000822.1  3279503  3278998  ABV14597.1 
sf1-53  544  99  putative phage protein, predicted major 
capsid protein 
 
E. coli UTI89  CP000243.1  930348  929805  ABE06421.1 
ABE06422.1 
sf1-70  798  100  
 
98 
1-184: present in EDL933 
  
185-798:starvation sensing protein RspB, 
starvation-sensing protein RspA 
 
 
 
E. coli E24377A 
 
 
CP000800.1 
 
 
1780225 
 
 
1779612 
 
 
ABV20572.1 
ABV17062.1  
sf1-73  714  96  putative phage protein, hypothetical protein  E. coli UTI89  CP000243.1  935066  934354  ABE06425.1 
ABE06426.1 
sfP-5  814     1-292: Present in EDL933 292-814: ORF1, 
ORF2, ORF3, ORF4 and partial st55 
 
E. coli O157:H (non-motile) strain 
493/89 
AJ534392.1  3259  2743    
sf1-3  >822  99  PerC protein, hypothetical protein, 
hypothetical protein  
 
 
274-822: present in EDL933 
 
      5901  5083  ABM53627.1 
ABM53628.1 
ABM53629.1 
sf1-80  331  97  CI protein, hypothetical protein  E. coli O157:H7 Morioka V526 (Stx2 
converting phage II DNA) 
 
AP005154.1  43520  43190  BAC78103.1, 
BAC78104.1   230 
sf1-37  415  98  putative capsid protein gp7 of prophage 
 
E. coli UTI89  CP000243.1  1268235  1268649  ABE06799.1 
sf1-86  412  100  orf 31: unknown product 
 
S. flexneri bacteriophage V     23900  23489  AAL89433.1 
sf1-21  389    1-150: hypothetical protein gp80 
EcolO15_30564 
 
150-389:present in EDL933 
 
E. coli O157:H7 str. EC4501    171   395  ZP_02790314 
sf1-29  >1400  25 
 
 
 
86 
30-470: hypothetical protein  
 
600-750 present in EDL933 
  
779-810: putative protein encoded by 
prophage 
 
Methylobacterium nodulans  
 
 
 
Shigella boydii Sb227 
   451 
 
 
 
51 
640 
 
 
 
76 
ZP_02119661  
 
 
 
YP_408524 
sf1-38  295  99 
 
100 
1-230: putative repressor protein 
 
226-295 present in EDL933 
 
E. coli E24377A (ETEC)  CP000800.1  833710  833480  ABV17234.1 
sf1-5  699  99  hypothetical protein, phage DNA packaging 
protein NU1-like protein. 
 
E. coli O157:H7 strain EC970520  EF174158.1  7713  8412  ABM53632.1 
ABM53633.1 
sf1-66  380  98  e14 prophage; predicted DNA-binding 
transcriptional regulator  
 
E. coli APEC O1  CP000468.1  2949655  2949276  ABJ02081.1 
sfA-62  >1200  100  hypothetical protein EcolO15_29435 (X) 
 
E. coli O157:H7 str. EC4501    1  151  ZP_02790094 
sfA-77  >1200  86  65-1053: putative cytoplasmic protein 
(possibly zinc-chelating) 
 
S. typhimurium LT2  AE008824.1  17732  16857  AAL21628.1 
sfA-78  262  98  putative polysaccharide biosynthesis protein 
 
E. coli HS  CP000802.1  3176740  3177002  ABV07398.1 
sfB-33  283  97  antitermination protein Q  S. flexneri bacteriophage V 
 
U82619.2  33167  33450  AAL89448.1 
sfB-43  431  99  isocitrate dehydrogenase  E. coli BL21(DE3) 
 
AB064593.1  4926  4533  BAB61874.1 
sfB-56  489  99  Qin prophage; predicted protein, predicted 
S lysis protein 
E. coli K12 MG1655 
 
 
U00096.2  1638627  1638138  AAC74628.1 
AAC74629.2 
sfB-86  870  99  putative lipoprotein, conserved hypothetical 
protein 
E. coli E24377A (ETEC) 
 
CP000800.1  3466493  3465623  ABV20031.1 
Table 6.5: Sequences identified in the SSH library of MCI 0507: A summary of the best BLASTN hits (or BLASTX hits where the hit is followed by the letter ‘X’) for each 
sequence in the subtracted library of MCI 0507 genomic fragments. Sequences which were identified multiple times were only included as a single entry on this table. Results 
are further summarised in pie charts (Figure 6.6). Where the best BLAST hit has less than 90% identity with the sequence obtained these sequences are given in full in 
Appendix VI.   231 
 
 
Figure 6.6: Summary of the general functions of sequences identified by SSH in Scottish E. coli O157 isolates 
Figure 6.6: Summary of the general functions of sequences identified 
by SSH in Scottish E. coli O157 isolates: These charts show that a 
significant proportion of the genes identified by SSH are bacteriophage 
or prophage-related, evidenced by the blue regions of each pie chart, 
especially in the case of MCI 0489. Sequences related to proteins with 
the widest range of proteins were observed in the genome of MCI 0507, 
while  many  sequences  related  to  genes  of  unknown  function  were 
identified in the genome of MCI 0453.  
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6.4  Discussion 
 
Data  presented  in  this  chapter  highlights  the  diversity  of  EHEC  strains  related  to  human 
infection in Scotland. Typing of two of the established EHEC virulence factor-encoding genes 
by PCR-RFLP shows that the espP gene types appear to show serotype specificity, in that E. 
coli O157 isolates almost universally encode espPα type O157, whereas E. coli O26 isolates 
yielded a different pattern (corresponding to espPα type O26). espP genes were not detected in 
the genomes of the three sorbitol-fermenting E. coli O157 isolates. This distribution patterns 
of espP subtypes is in agreement with that observed by Brockmeyer et al. (2007) except that 
no amplicon was generated from one E. coli O157 isolate (MCI 0239) and that another E. coli 
O157:H7 isolate was found to encode an espP allele which gave a RFLP-pattern which did not 
match  any  predicted  pattern,  namely,  MCI  0064  (E.  coli  O157:H7  NCTC  12900).  As  a 
naturally  occurring  stx-negative  isolate,  MCI  0064  has  been  used  extensively  as  a  model 
organism of disease associated E. coli O157:H7 (Woodward et al., 2003;Best et al., 2005;La 
Ragione et al., 2005;Belfiore et al., 2007). As this work shows that the espP gene carried by 
this strain is atypical, it calls into question the applicability of this strain as a model for human 
EHEC, although this work does not address the expression or functionality of the espP type 
encoded by this isolate. Nevertheless, this result highlights the care which must be taken in 
selecting an isolate for use in animal studies. Any strain used as a model of human EHEC 
infection  should  be  well  characterised  to  verify  that  the  strain  is  representative  of  the 
infectious agent that it is designed to model. 
 
Genes encoding shiga-like toxin exhibit more heterogeneous carriage among Scottish EHEC 
isolates than that discovered for espP alleles. Among non-sorbitol-fermenting E. coli O157 
isolates seven different stx-genotypes were identified, the most common profile obtained was 
one suggesting that the isolates carried stx2 along with stx2c or stx2d. In total, 18 of the human 
EHEC isolates were predicted to carry stx2c/d-encoding genes, making this the most common 
allele detected. stx-genotypes appeared to associate with phage-types among the E. coli O157 
isolates analysed, with the majority of phage-type 21/28 carrying stx2 with stx2c/d whereas all 
isolates of phage type 8 exhibited a pattern corresponding to stx1 with stx2c/d.  
 
Unfortunately,  the  PCR-RFLP  assay  could  not  distinguish  stx2c  from  stx2d.  Analysis  of 
publicly  available  stx2c  and  stx2d  gene  sequences  (accession  numbers  EU086525.1  and   233 
EF584538.1) suggest that RsaI or AluI could be used to distinguish between these two alleles 
and resolve this issue. Stx2c and Stx2d differ in that Stx2d is activatable by elastase in intestinal 
mucous to a form which is 100-fold more verotoxic than conventional Stx2, whereas Stx2c has 
a similar level of toxicity as Stx2 (Melton-Celsa & O’Brien 1996, Melton-Celsa et al 2002). 
The prevalence of E. coli O157 isolates carrying stx2 and stx2c has been noted by others 
(Ziebell et al., 2008;Leotta et al., 2008;Uhlich et al., 2008) and the carriage of stx2 and stx2c 
genes  has  been  associated  with  increased  disease  severity  in  cases  of  E.  coli  O157:H7 
infection  (Caprioli  et  al.,  1995;Pierard  et  al.,  1998;Eklund  et  al.,  2002;Friedrich  et  al., 
2002;Persson et al., 2007) whereas Stx2d is generally encoded by non-O157 STEC such as E. 
coli O91:H21 (Gobius et al., 2003). Therefore, it is more likely that these strains carry the 
stx2c allele than the stx2d allele. The acquisition of a gene encoding stx2c in addition to stx2 
may have implications for the pathogenicity of E. coli O157:H7 and may be responsible for 
the increased pathogenicity of phage type 21/28 E. coli O157 isolates, noted by Lynn et al. 
(2005). Phage type 21/28 are also prevalent among the bovine E. coli O157 population which 
could contribute to their increased association with severe cases of human EHEC infection 
(Halliday et al., 2006). The association of phage type 8 with stx1/stx2c fits with two published 
observations. The first is that PT8 is associated with a lower relative risk of the development 
of HUS compared with other serotypes (Lynn et al., 2005) and secondly that stx1 is less toxic 
than stx2 or stx2c (Melton-Celsa and O'Brien, 1998). 
 
Genomic microarray analysis of E. coli O157 isolates shows the clonal nature of E. coli O157. 
However,  certain  regions  of  heterogeneity,  especially  among  bacteriophage  or  prophage-
related genes were found, highlighting the role of bacteriophages as mediators of genomic 
diversification  in  E.  coli  O157;  however,  bacteriophages  form  a  large  part  of  the  E.  coli 
O157:H7 genome and therefore are likely to feature in the diverse component regardless of 
their proposed role in eliciting such diversification. Twenty-four bacteriophage and prophage-
related  elements  were  identified  in  the  genome  of  E.  coli  O157:H7,  ranging  in  size  from 
7.5kbp to 61.6kbp and bacteriophages are proposed to constitute approximately half of the 
genomic content present in E. coli O157:H7 that is absent from the E. coli K12 MG1655 
genome (Perna et al., 2001;Hayashi et al., 2001b). Genomic subtractive hybridisation allowed 
the  detection  of  additional  genes  present  in  the  genomes  of  certain  E.  coli  O157  isolates 
related to cases of human disease. As many of these genomic regions are also bacteriophage-
related this provides further evidence to support the assertion that these are regions which are   234 
involved in genome diversification. The SSH results for MCI 0507 included genes associated 
with a more diverse range of biological functions than the resulting subtracted sequences from 
the two non-sorbitol-fermenting isolates (MCI 0489 and MCI 0453), highlighting additional 
differences between the genomes of sorbitol-fermenting E. coli O157 isolates and reference 
(non-sorbitol-fermenting) E. coli O157:H7 strains. Many of the sequences identified in the 
genome of MCI 0507 during this study were also identified in German isolates of sorbitol-
fermenting E. coli O157:H- by similar methods (Janka et al., 2005). These data, coupled with 
the conservation of stx types and the lack of espP genes, suggest that this strain of Scottish 
sorbitol-fermenting E. coli O157 are clonally related to European sorbitol-fermenting E. coli 
O157:H-.  
 
Genes encoding type IV secretion or conjugation apparatus were identified in the genome of 
MCI 0453. Type IV conjugation has been shown to mediate the horizontal transfer of genomic 
islands between bacteria (Juhas et al., 2007). Type IV secretion is also employed by organisms 
such  as  Helicobacter  pylori,  Bordatella  pertussis  and  Legionella  pneumophila  for  the 
secretion of virulence factors (Backert and Meyer, 2006). Either of these two features may aid 
the  pathogenic  function  of  the  strain,  either  by  facilitating  protein  export  or  increasing 
likelihood of horizontal gene transfer. Two sequences were also identified which relate to 
membrane  proteins,  including  an  autotransporter  protein  present  in  the  genome  of  human 
commensal  E.  coli  strain  HS.  The  presence  of  this  sequence  in  the  genome  of  a  human 
commensal E. coli isolates make the role of this protein in pathogenesis less likely; however, it 
has  not  been  determined  whether  E.  coli  HS  may  cause  disease  opportunistically. 
Autotransporter  proteins  related  to  virulence  have  been  identified  in  many  Gram  negative 
bacterial pathogens (reviewed in Henderson et al., 2004) and it is possible that this protein 
may  contribute  to  the  virulence  of  this  MCI  0453.  Extensive  expression  and  functional 
analysis would be required to test this possibility.  
 
As potential virulence factors were not apparent in the results of the SSH-screen, it is unlikely 
that increased incidence of disease in Scotland is due to acquisition of novel virulence factor-
encoding  genes;  however,  this  analysis  does  not  rule  out  differences  in  the  expression  of 
virulence factors. Also single or multiple nucleotide polymorphisms are not identified using 
the methods described here, but could have significant effects on the pathogenic functions of a 
microorganism. Several sequences were identified in the SSH-screen which were related to   235 
proteins of unknown function or returned no BLAST hits; hence, the possibility that these 
genes may have a bearing on bacterial pathogenesis may not be ruled-out. 
 
In summary, the EHEC strains analysed in this study exhibit some diversity with respect to the 
carriage  of  virulence  factor  gene  subtypes  and  gene-gains  and  gene-losses  identified  by 
microarray and SSH. Small-scale genome variation among E. coli O157 isolates was identified 
and  that  variation  was  largely  composed  of  phage  and  prophage-related  genetic  elements, 
further supporting the role of bacteriophages in genome diversification.   236 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7: General Discussion   237 
Enterohaemorrhagic E. coli (EHEC) represents a group of human pathogens which pose a 
significant threat to human health, of which E. coli serotype O157:H7 is the most frequently 
associated  with  human  EHEC  infection  and  also  often  resides  in  the  ruminant  gut.  The 
objectives of this work were to: 
 
1)  Characterise  the  roles  of  bacterial  exported  molecules  in  the  modulation  of  host 
immunity, focusing on interactions with the intestinal epithelium (Chapter 3). 
2)  Characterise the genotypes of E. coli of the bovine gastrointestinal tract and associate 
E. coli genotypes with preference for particular gastrointestinal locations (Chapter 4). 
3)  Evaluate the potential of E. coli of the bovine gastrointestinal tract for inhibition of 
pathogenic E. coli O157:H7 (Chapter 5). 
4)  Perform  genomic  characterisation  of  E.  coli  strains  significant  in  human  EHEC 
infection in Scotland (Chapter 6). 
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7.1  The role of EHEC-exported products in interaction with the 
host. 
 
Modulation of the host immune response is a feature of many bacterial pathogens and is also a 
feature  of  bacteria  which  exist  in  the  host  without  pathogenesis  or  even  benefit  the  host 
organism  (Lodinova-Zadnikova  and  Sonnenborn,  1997;Lodinova-Zadnikova  et  al., 
2003;Kamada  et  al.,  2008).  Differential  immune  responses  can  restrict  proliferation  of  a 
pathogenic  organism  within  the  host  but  may  exacerbate  the  tissue  damage  caused  by  a 
pathogen; hence, understanding of the host immune responses to E. coli O157:H7 could lead 
to  explanation  of  the  differential  levels  of  pathogenicity  of  the  bacterium  between  that 
observed in the human compared with the asymptomatic tolerance observed in the bovine host 
(Karmali et al., 1983b;Borczyk et al., 1987;Cray, Jr. and Moon, 1995). 
 
Data  presented  in  Chapter  3  reaffirms  the  role  of  bacterial  flagellin  in  the  inflammatory 
response of cells of a human intestinal epithelial cell line (T84). Although the results of initial 
experiments  suggested  a  suppressive  role  for  substances  present  in  bacterial  supernatants, 
subsequent  investigation  revealed  that  this  initial  finding  is  likely  to  be  anomalous  and 
confirmed that flagellin is indeed the major proinflammatory ligand secreted by EHEC, but 
also not the only factor exported by EHEC which induces IL-8 production by the human T84 
cells.  This  has  been  noted  by  others  for  a  variety  of  enteric  pathogens  (Sharma  et  al., 
2005;Khan et al., 2008); however, the identity of further proinflammatory ligands are yet to be 
determined. Furthermore, when a bovine epithelial cell line was assessed for responsiveness to 
bacterial  products,  the  proinflammatory  response  appeared  to  be  independent  of  flagellin. 
However,  there  are  several  key  points  to  note  in  the  interpretation  of  these  data.  Firstly, 
embryonic bovine lung (EBL) cells were chosen as a bovine epithelial cell line model. The 
responses of the lung epithelium compared with gastrointestinal responses are likely to differ, 
especially  as  E.  coli  is  not  generally  tolerated  in  the  lung  (Russo  and  Johnson,  2000). 
Secondly, the assay used to determine IL-8 production is based on a weak cross-reactivity 
between anti-human IL-8 antibodies provided in the IL-8 DuoSet ELISA (R & D Systems) 
and  bovine  IL-8.  Consequently,  the  observed  levels  of  IL-8  were  at  the  lower  limit  of 
detection using the ELISA kit, meaning that variation between replicates was often extensive. 
These  two  points  highlight  major  difficulties  faced  by  researchers  whose  goal  is 
characterisation of cellular responses of the bovine host or bovine cell line models. At the time   239 
of this study, no well-characterised bovine gastrointestinal epithelial cell line was available, 
compared with the plethora of human and mouse cell lines currently in circulation. Also, there 
are few commercially available antibodies for the analysis of bovine cellular responses. Given 
the number of publicly funded research groups dedicated to the analysis of ruminant cellular 
biology and immunology, it is hoped that a concerted collaborative effort will be made to 
make such reagents widely available. 
 
As  a  protease  secreted  by  E.  coli  O157:H7  with  some  well-characterised  functions  in  the 
human host, preliminary analysis was conducted to attempt to further characterise the function 
of StcE in bacterial interaction with the epithelium and predict the function of StcE protease in 
the bovine host. Confirmation of the activity of recombinant StcE (kindly provided by Rodney 
Welch of the University of Wisconsin, Madison) against its proposed substrates (human C1-
INH  and  salivary  glycoproteins)  (Lathem  et  al.,  2002,  Grys  et  al.,  2005)  was  attempted. 
Although digestion of human C1-INH was observed, its previously reported effects on the 
salivary proteome were not detected in this study. In order to determine if StcE affects bovine 
C1-INH; incubation of FBS with StcE was performed followed by Western blotting the using 
the anti-human C1-INH antibody. Both cross specificity of a human antibody with the bovine 
homologue and the presence of this homologue in commercially available FBS were required 
to visualise the result. As bovine C1-INH was not identifiable in the  resultant image this 
suggested either that the antibody failed to bind or that bovine C1-INH was not present; hence, 
it  was  not  possible  to  determine  whether  StcE  affects  bovine  C1-INH.  Data  obtained  by 
Lathem et al. (2002) suggest that the presence of FBS is sufficient to allow StcE-mediated 
aggregation of Jurkat cells and that this aggregation was due to StcE’s effect on C1-INH. 
Therefore, it is reasonable to postulate that StcE affects bovine C1-INH in the same way as 
human C1-INH. Although this analysis could not resolve the function of StcE in the bovine 
host, detection of anti-StcE IgA in mucosal scrapings from calves challenged with E. coli 
O157:H7 could suggest that StcE is expressed by the bacterium and recognised by the bovine 
immune  system  during  colonisation.  However,  further  investigation  would  be  required  to 
confirm this effect. 
 
In summary: the roles of bacterial products in mediation of the proinflammatory response are 
incompletely characterised. Data shown in Chapter 3 reaffirms the role of flagellin in the 
human epithelial proinflammatory response but leaves the possibility of the presence of other   240 
proinflammatory mediators in bacterial exported products. The role of the StcE protease in 
EHEC-interactions with the bovine host remain undetermined, although a secretory antibody 
response  could  suggest  that  it  is  expressed  by  the  bacterium  and  recognised  by  the  host 
immune system in colonisation of the bovine gastrointestinal tract.  
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7.2  E. coli of the bovine gastrointestinal tract 
 
As  explained  previously,  E.  coli  O157:H7  is  regularly  carried  in  the  bovine  gut.  Data 
presented in Chapter 4 shows that many non-O157 strains which carry genes encoding EHEC-
related virulence factors (especially stx and espP) are isolable from the bovine gut (Aktan et 
al., 2004;Shaw et al., 2004). No E. coli strains bearing an O-RFLP-pattern which matched that 
of E. coli O157 were isolated from animals used in this study. This would suggest that the 
prevalence of E. coli O157:H7 in incidence of human infection is not due to its prevalence in 
cattle above other serotypes which harbour EHEC-related genes (which were prevalent among 
the cattle analysed), suggesting that characteristics other than simply the carriage of the genes 
for the conventionally accepted virulence factors are involved in the increased association of 
E. coli O157:H7 with human infection. However, this study does not address the expression, 
secretion and regulation of these virulence factors by bovine isolates carrying these genes and 
in  all  cases  the  alteration  of  the  functions  of  each  virulence  factor  by  single  or  multiple 
nucleotide polymorphisms are possible. Furthermore, the animals analysed here represented a 
small  sample  from  a  restricted  geographic  area  and  could  not  therefore  be  considered 
representative of the Scottish cattle population as a whole. It is also feasible that many of the 
isolates  identified  as  carrying  EHEC-related  virulence  factors  may  be  capable  of  human 
infection, as has been noted for many non-O157 EHEC serotypes (as discussed in Section 1.3) 
and prevalence of non-O157:H7 serotypes could be underestimated due to isolation methods 
which  may  be  biased  toward  the  isolation  and  identification  of  E.  coli  O157:H7,  such  as 
methods  relying  on  cefixime-tellurite  resistance  and  non-sorbitol  fermentation  (March  and 
Ratnam, 1986) or those which rely on binding of the O-antigen such as latex agglutination or 
immunomagnetic separation (IMS) (March and Ratnam, 1989;Bennett et al., 1996). 
 
An  interesting  feature  of  the  carriage  of  E.  coli  O157:H7  by  the  bovine  host  is  that  the 
bacterium shows a preference for colonisation of the terminal rectum (Naylor et al., 2003). In 
order to predict whether this feature was specific to E. coli O157:H7 or if other E. coli strains 
also show preference for this site, isolation and enumeration of E. coli from selected sites in 
the  bovine  GIT  was  coupled  with  genotyping  methods  in  order  to  identify  associations 
between  genotypes  and  colonisation  patterns.  Overall  analysis  of  total  numbers  of  E.  coli 
present at each site suggested that E. coli presence was not uniform at the sites analysed and 
that the terminal rectum and proximal colon were the most heavily  colonised of the sites   242 
analysed. When enumeration data were combined with genotypic analysis it was revealed that 
strains exhibiting EHEC-related genotypes were significantly associated with colonisation at 
the rectum in greater numbers than other sites whereas those carrying ExPEC-related genes 
and those in which no virulence factors were identified (suggesting similarity with laboratory 
E. coli strains) exhibited an even distribution at each of the sites analysed. Other studies have 
related EHEC related genotypes with colonisation at the rectum; however, others have not 
considered  strains  other  than  EHEC-related  genotypes  colonising  without  apparent  site-
preference (Naylor et al., 2003;Low et al., 2005;Sheng et al., 2005). 
 
A limitation of the sampling methods employed in this analysis is that E. coli was sampled 
only at a single timepoint from each animal. As a temporal pattern of E. coli colonisation has 
been suggested for E. coli O157:H7, with initial colonisation observed at multiple sites and the 
greatest persistence observed at the rectum (Grauke et al., 2002;Naylor et al., 2003), high 
levels of E. coli genotypes recovered from the rectum could represent organisms at later stages 
of colonisation; however, in this study one particular genotype (E. coli ONT (Or7):HNT2: 
cdtB+, cnf+, fimA+, iutA+, gafD+) was recovered at high numbers at all sites sampled in five 
animals. Another genotype (E. coli Or37:HNT1 stx2+, ehx: type 319, fimA+) present only at 
the rectum of three animals suggests that genotype may be important in the definition of the 
gastrointestinal localisation of E. coli in the bovine host.  
 
There are a number of options for increasing the understanding of the issues addressed by this 
analysis. Methods for quantification of certain genotypes at certain locations could perhaps be 
enhanced by employing quantitative-PCR-based methodology, whereby total DNA would be 
obtained  from  a  fixed  region  of  tissue  and  the  copies  of  bacterial  genomes  estimated  by 
detection of certain genetic markers of representative genotypes (for example stx, espP, ehxA 
or eae for EHEC-related organisms or gafD, cdt or cnf for ExPEC-related organisms). Total 
numbers E. coli, using primer/probe sets for genes common to all E. coli (based on rRNA-
encoding genes), could be compared against numbers of E. coli of certain genotypes from a 
single sample. Results presented in Chapter 4 highlight the genes associated with particular 
colonisation patterns and these genes may be employed as targets for such an assay. 
 
To confirm that strains which were observed to be prevalent at the terminal rectum have a 
genuine preference for that site, conducting oral challenges of calves is an option in order to   243 
satisfy Koch’s postulates regarding the tropism of selected strains. This could be compared 
against a similar challenge using a strain which exhibited even colonisation at all of the sites.  
 
In order to identify the genes involved in definition of bacterial tropism, strains with defined 
colonisation  patterns  may  be  subjected  to  mutagenesis  screening  and  tested  for  altered 
colonisation patterns. The problem with this approach is that no robust methodology exists for 
the analysis of gastrointestinal colonisation patterns short of conducting animal challenges. If 
an in vitro assay could be developed for tissue tropism, perhaps employing in vitro organ 
culture (IVOC) coupled with an adherence assay, this would considerably aid such analysis. A 
similar method has been employed for the analysis of human tissue tropism of E. coli strains 
and may potentially be applied for analysis of E. coli-bovine host interactions (Chong et al., 
2007;Mundy et al., 2007). Identification of targets by this method would rely on a defined 
bacterial molecule-host cell receptor affinity and accounting for temporal and physiological 
reasons for rectal tropism (such as aeration at the site) would require modifications to such a 
technique which may prove impractical to incorporate. 
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7.3  Probiotic potential of E. coli 
 
Several studies have suggested a case for the application of probiotic strains of E. coli in order 
to  reduce  the  prevalence  of  E.  coli  O157:H7  in  cattle  (Zhao  et  al.,  1998;Tkalcic  et  al., 
2003;Zhao et al., 2003;Schamberger et al., 2004). It was envisaged that strains isolated from 
the bovine host during this study may have applicability as probiotic organisms and that data 
provided in Chapter 4 would aid selection of a strain which is able to colonise effectively at 
the terminal rectum and may therefore compete with E. coli O157:H7 at its preferred site in 
vivo. To this end, bovine E. coli isolates were tested in vitro for inhibition of E. coli O157:H7 
strains. Data presented in Chapter 5 shows that bacterial products from certain strains acted to 
inhibit E. coli O157:H7; however, of all strains which inhibited at least one strain of E. coli 
O157:H7,  none  were  observed  to  inhibit  all  of  the  E.  coli  O157:H7  strains  tested.  This 
suggests that susceptibility to allelopathic molecules produced by these strains varies among 
E. coli O157:H7 subtypes. The precise identities of the allelopathic molecules produced are as 
yet undetermined as PCR for genes encoding microcins and colicins known to inhibit E. coli 
O157:H7 largely returned negative results. This could indicate that previously undescribed 
inhibitory  molecules  are  produced  by  the  strains  identified  in  this  study  and  further 
investigation would be required to characterise these molecules in detail.  
 
It was envisaged that isolates which exhibited apparent rectal tropism (Chapter 4) may have 
applicability as they may compete with E. coli O157:H7 at the preferred site of colonisation in 
the bovine host; however, it became clear that the most promising rectal-tropic strains carried 
genes  encoding  EHEC-related  virulence  factors,  especially  Shiga-like  toxin.  Many  were 
excluded from further analysis due to this fact, particularly as those encoding stx may pose a 
significant  threat  to  human  health  and  must  be  handled  under  higher  containment  levels 
meaning  that  their  use  as  probiotic  organisms  would  not  be  advisable.  Although  certain 
isolates among those not encoding stx were found to inhibit strains of E. coli O157:H7, it is 
not  yet  known  whether  these  strains  may  potentially  undergo  lysogeny  by  stx-encoding 
bacteriophages if they were released into the environment. The acquisition of virulence factor-
encoding genes could increase the likelihood that isolates intended to be probiotic may emerge 
as pathogens themselves.  
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In summary, data presented in Chapter 5 shows that some of the strains used in this study have 
inhibitory  activity  against  E.  coli  O157:H7  although  this  is  unlikely  to  lead  directly  to  a 
probiotic  organism  for  application  to  reduce  the  prevalence  of  E.  coli  O157:H7.  Further 
resolution of the issues raised in this chapter could be gained firstly by identification of the 
allelopathic  molecules  produced  by  the  inhibitory  strains.  This  could  be  facilitated  by 
fractionation  of  bacterial  products  to  identify  inhibitory  fractions,  coupled  with  proteomic 
techniques such as MALDI-TOF in order to identify the molecules responsible. The isolation 
of further E. coli strains from cattle would provide a larger panel with an increased likelihood 
of containing one applicable as a probiotic agent. If a strain were to be identified which fills 
the criteria of (i) effective colonisation of cattle (especially at the terminal rectum) (ii) absence 
of virulence factors, (iii) resistance to acquisition of stx-encoding genes by phage transduction, 
(iv) specificity for inhibition of E. coli O157/EHEC, progression to identification of in vivo 
effectiveness is an option. These criteria eliminate the vast majority of naturally-occurring E. 
coli strains meaning that the search for a probiotic E. coli isolate becomes more complex.   246 
7.4  Genomic character of Scottish EHEC isolates 
 
The results of the characterisation of espP genes in EHEC isolates were largely as expected. It 
was notable that the majority of human EHEC isolates carrying an espP gene carried a subtype 
likely to encode an active form of the EspP protease, whereas a more diverse range of alleles 
were identified among the bovine E. coli isolates (although these data are likely to be affected 
by the inclusion of many  E. coli O157 and E. coli O26 isolates in the analysis). A large 
proportion of the non-O157 EHEC isolates were negative for the espP gene, which fits with 
the  observations  of  Brockmeyer  et  al.  (2007).  It  could  then  be  suggested  that  the  EspP 
protease is not absolutely necessary for EHEC pathogenicity; however, the possibility remains 
that  the  isolates  found  to  be  negative  for  this  gene  could  encode  a  protease  with  similar 
function which is not detected by the PCR-assay described here.  
 
The analysis of stx genes revealed that stx-encoding genes were almost ubiquitously carried by 
human  EHEC  isolates;  however,  the  diversity  observed  among  the  stx-genotypes  was 
extensive. The selective pressure for the emergence of variant stx genes may be maintained 
due to its antigenicity, as neutralising antibodies against Stx have been found to counteract the 
action of the toxin (Mukherjee et al., 2002;Orth et al., 2008). Many of the variant groups of 
Stx are antigenically non-cross-reactive, which could mean that production of a variant or 
multiple variants of Stx may allow evasion of host immune defences against EHEC infection. 
  
SSH and CGH microarray data presented in Chapter 6 suggest that the genomes of Scottish 
isolates  of  E.  coli  O157:H7  do  not  differ  greatly  from  reference  isolates,  including  the 
genome-sequenced American and Japanese isolates (EDL933 and Sakai) in terms of the gains 
and losses of entire genes or large gene fragments. It is hence unlikely that Scottish EHEC 
have  acquired  significant  virulence  factors  compared  with  strains  from  other  geographical 
locations. This could support the notion that the increased observed prevalence of E. coli O157 
infection  in  Scotland  may  depend  on  other  epidemiological  factors,  such  as  the  increased 
likelihood for contact with farm animals (Mead et al., 1997;Locking et al., 2001;O'Brien et 
al., 2001;Strachan et al., 2006) coupled with an increased observed prevalence of E. coli O157 
in farm animals in Scotland (Paiba et al., 2002). 
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It is envisaged that genotypic data presented here may be compared against clinical data from 
each incidence of infection in order to identify associations between genotypic traits and the 
severity of EHEC-induced infection. This process may be aided by extension and refinement 
of  the  genotyping  techniques  utilised  in  this  study.  Other  studies  have  been  successful  in 
identifying lineages of E. coli O157:H7 more closely associated with human disease (Kim et 
al., 1999;Lynn et al., 2005;Zhang et al., 2007), but have yet to identify the functions necessary 
for their varied association with human disease.    248 
7.5  Conclusions and Future Directions 
 
In summary: data presented in the above highlights several important features of E. coli as a 
bovine colonist and as a human pathogen. As delineated in Section 7.1 the mechanisms by 
which the human host recognises and responds to E. coli O157:H7 and the mechanisms by 
which E. coli O157:H7 acts to subvert the human host are only partially understood. The 
interactions between EHEC and the bovine host are even less well-characterised. Resolution 
of the nature of these interactions would be aided by the development and distribution of 
reagents for the study of bovine responses to EHEC, including immortalised cell lines and 
specific antibodies.  
 
Data presented in Chapter 4 highlights the genomic diversity of resident E. coli of the bovine 
gastrointestinal tract. Some evidence was observed that there is a general preference for the 
terminal rectum among E. coli with EHEC-related genotypes; however its is yet to be establish 
what factors either (i) generally restrict EHEC-related E. coli to the bovine rectum (prevent 
colonisation  at  other  sites)  or  (ii)  augment  adherence  or  proliferation  of  EHEC-related 
organisms at the rectum above other sites. It is possible that a combination of the two occurs 
and that multiple bacterial and host factors are involved.  
 
A related objective of this research was to identify a strain likely to have applicability as a 
probiotic organism. Although no such strain has yet been identified the findings presented in 
Chapter 4 regarding the virulence genes encoded by bovine resident E. coli, coupled with the 
abilities  of  E.  coli  to  transfer  genes  from  one  strain  to  another  (via  bacteriophages  or 
conjugative plasmids) provide a warning against proceeding with this type of work without 
conducting extensive characterisation of any candidate strain for administration to cattle.  
 
Data presented in Chapter 6 highlights the clonal nature of E. coli O157:H7, evidenced by the 
low level of detected genomic diversity. The observed diversity was generally identified in 
bacteriophage or prophage-related elements which reaffirms the role of these mobile elements 
in genome-diversification.    249 
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Appendix I    Analysis of rStcE by MALDI-TOF. 
 
Results of MALDI-TOF analysis of bands resulting from SDS-PAGE of rStcE (Figure 3.9) are 
presented in Figure A1. 
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Figure A1: Results of MALDI-TOF analysis of StcE bands separated by SDS-PAGE: The frame to the left shows the MASCOT result for the larger of the two bands 
analysed. Peptides were detected covering the protein intermittently from 25 residues from the N-terminus N-terminus to 7 residues from the C-terminus. The frame to the right 
shows the results from the lower molecular weight band. No peptides were detected covering the C-terminal 271 residues.
Match to: gi|52078252 Score: 105 Expect: 0.0001 
StcE' [Escherichia coli] 
 
Nominal mass (Mr): 95549; Calculated pI value: 6.15 
NCBI BLAST search of gi|52078252 against nr 
 
Taxonomy: Escherichia coli 
 
Variable modifications: Carbamidomethyl (C),Oxidation 
(M),Propionamide (C) 
Cleavage by Trypsin: cuts C-term side of KR  
unless next residue is P 
Number of mass values searched: 85 
Number of mass values matched: 23 
Sequence Coverage: 36% 
 
Matched peptides shown in Bold Red 
 
     1 ADNNSAIYFN TSQPINDLQG SLAAEVKFAQ SQILPAHPKE GDSQPHLTSL  
    51 RKSLLLVRPV KADDKTPVQV EARDDNNKIL GTLTLYPPSS LPDTIYHLDG  
   101 VPEGGIDFTP HNGTKKIINT VAEVNKLSDA SGSSIHSHLT NNALVEIHTA  
   151 NGRWVRDIYL PQGPDLEGKM VRFVSSAGYS STVFYGDRKV TLSVGNTLLF  
   201 KYVNGQWFRS GELENNRITY AQHIWSAELP AHWIVPGLNL VIKQGNLSGR  
   251 LNDIKIGAPG ELLLHTIDIG MLTTPRDRFD FAKDKEAHRE YFQTIPVSRM  
   301 IVNNYAPLHL KEVMLPTGEL LTDMDPGNGG WHSGTMRQRI GKELVSHGID  
   351 NANYGLNSTA GLGENSHPYV VAQLAAHNSR GNYANGIQVH GGSGGGGIVT  
   401 LDSTLGNEFS HEVGHNYGLG HYVDGFKGSV HRSAENNNST WGWDGDKKRF  
   451 IPNFYPSQTN EKSCLNNQCQ EPFDGHKFGF DAMAGGSPFS AANRFTMYTP  
   501 NSSAIIQRFF ENKAVFDSRS STGFSKWNAD TQEMEPYEHT IDRAEQITAS  
   551 VNELSESKMA ELMAEYAVVK VHMWNGNWTR NIYIPTASAD NRGSILTINH  
   601 EAGYNSYLFI NGDEKVVSQG YKKSFVSDGQ FWKERDVVDT REARKPEQFG  
   651 VPVTTLVGYY DPEGTLSSYI YPAMYGAYGF TYSDDSQNLS DNDCQLQVDT  
   701 KEGQLRFRLA NHRANNTVMN KFHINVPTES QPTQATLVCN NKILDTKSLT  
   751 PAPEGLTYTV NGQALPAKEN EGCIVSVNSG KRYCLPVGQR SGYSLPDWIV  
   801 GQEVYVDSGA KAKVLLSDWD NLSYNRIGEF VGNVNPADMK KVKAWNGQYL  
   851 DFSKPRSMRV VYK 
Match to: gi|52078252 Score: 52 Expect: 23 
StcE' [Escherichia coli] 
 
Nominal mass (Mr): 95549; Calculated pI value: 6.15 
NCBI BLAST search of gi|52078252 against nr 
 
Taxonomy: Escherichia coli 
 
Variable modifications: Carbamidomethyl (C),Oxidation 
(M),Propionamide (C) 
Cleavage by Trypsin: cuts C-term side of KR  
unless next residue is P 
Number of mass values searched: 75 
Number of mass values matched: 15 
Sequence Coverage: 22% 
 
Matched peptides shown in Bold Red 
 
     1 ADNNSAIYFN TSQPINDLQG SLAAEVKFAQ SQILPAHPKE GDSQPHLTSL  
    51 RKSLLLVRPV KADDKTPVQV EARDDNNKIL GTLTLYPPSS LPDTIYHLDG  
   101 VPEGGIDFTP HNGTKKIINT VAEVNKLSDA SGSSIHSHLT NNALVEIHTA  
   151 NGRWVRDIYL PQGPDLEGKM VRFVSSAGYS STVFYGDRKV TLSVGNTLLF  
   201 KYVNGQWFRS GELENNRITY AQHIWSAELP AHWIVPGLNL VIKQGNLSGR  
   251 LNDIKIGAPG ELLLHTIDIG MLTTPRDRFD FAKDKEAHRE YFQTIPVSRM  
   301 IVNNYAPLHL KEVMLPTGEL LTDMDPGNGG WHSGTMRQRI GKELVSHGID  
   351 NANYGLNSTA GLGENSHPYV VAQLAAHNSR GNYANGIQVH GGSGGGGIVT  
   401 LDSTLGNEFS HEVGHNYGLG HYVDGFKGSV HRSAENNNST WGWDGDKKRF  
   451 IPNFYPSQTN EKSCLNNQCQ EPFDGHKFGF DAMAGGSPFS AANRFTMYTP  
   501 NSSAIIQRFF ENKAVFDSRS STGFSKWNAD TQEMEPYEHT IDRAEQITAS  
   551 VNELSESKMA ELMAEYAVVK VHMWNGNWTR NIYIPTASAD NRGSILTINH  
   601 EAGYNSYLFI NGDEKVVSQG YKKSFVSDGQ FWKERDVVDT REARKPEQFG  
   651 VPVTTLVGYY DPEGTLSSYI YPAMYGAYGF TYSDDSQNLS DNDCQLQVDT  
   701 KEGQLRFRLA NHRANNTVMN KFHINVPTES QPTQATLVCN NKILDTKSLT  
   751 PAPEGLTYTV NGQALPAKEN EGCIVSVNSG KRYCLPVGQR SGYSLPDWIV  
   801 GQEVYVDSGA KAKVLLSDWD NLSYNRIGEF VGNVNPADMK KVKAWNGQYL  
   851 DFSKPRSMRV VYK 
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Appendix II  Bovine isolates employed during this study  
 
Table A1 shows the full list of bovine isolates provided by Neil Paton (all isolated by rectal 
swab or faecal free catch) and those pro or Stuart Naylor (all isolated from tissue sections). 
Table A2 lists the strains isolated during this study from tissue sections. Table A3 lists the 
strains  isolated  by  rectal  swabbing  of  animals  three  weeks  prior  to  euthanasia.    Isolation 
method/Site: FFC: faecal free-catch, RS: recto-anal mucosal swab TR: terminal rectum, PR: 
proximal rectum, DC: distal colon, PC: proximal colon, IL: ileum (refer to Figure 4.12 and 
Section 2.3.2 for a full description of sites and isolation methods). 
 
 
Animal 
Isolation/ 
Site  Colony  GLUC  SOR-F  H-pattern  O-pattern  Ref. No. 
7  FFC  3  ND  +  H35  Or1  MCI 0104 
7  FFC  2  ND  +  H25  O116  MCI 0122 
8  FFC  1  ND  +  H4  Or4  MCI 0108 
8  FFC  2  ND  +  H14  Or11  MCI 0123 
8  FFC  3  ND  +  H14  Or11  MCI 0124 
9  FFC  2  ND  +  H34  Or2  MCI 0105 
9  FFC  1  ND  +  H+(NT)  Or2  MCI 0115 
9  FFC  3  ND  +  H+(NT)  Or7  MCI 0121 
10  FFC  1  ND  +  H-/NT  Or3  MCI 0106 
10  FFC  2  ND  +  H-/NT  Or3  MCI 0111 
10  FFC  3  ND  +  H4  Or58  MCI 0112 
11  FFC  3  ND  +  H4  Or4  MCI 0109 
11  FFC  1  ND  +  H34  Or11  MCI 0113 
11  FFC  2  ND  +  H4  Or5  MCI 0114 
12  FFC  1  ND  +  H-/NT  Or3  MCI 0116 
12  FFC  2  ND  +  H-/NT  Or3  MCI 0117 
12  FFC  3  ND  +  H-/NT  Or3  MCI 0118 
13  FFC  1  ND  +  H14  Or11  MCI 0119 
13  FFC  3  ND  +  H14  Or11  MCI 0107 
13  FFC  2  ND  +  H35  Or6  MCI 0120 
14  FFC  1  ND  +  H11  O26  MCI 0125 
14  FFC  2  ND  +  H11  O26  MCI 0126 
14  FFC  3  ND  +  H11  O26  MCI 0110 
100742  RS  2  ND  +  H31  Or9  MCI 0160 
300395  RS  2  ND  +  H35  Or11  MCI 0166 
300395  RS  1  ND  +  H35  Or14  MCI 0176 
300395  RS  3  ND  +  H21  Or18  MCI 0180 
300741  RS  3  ND  +  H21  Or11  MCI 0170 
300741  RS  1  ND  +  H35  Or4  MCI 0171 
300744  RS  2  ND  +  H21  Or16  MCI 0182 
400211  RS  1  ND  +  H21  ND  MCI 0161   288 
400211  RS  3  ND  +  H35  Or10  MCI 0162 
400211  RS  2  ND  +  H35  Or10  MCI 0168 
400376  RS  2  ND  +  HNT  Or11  MCI 0172 
400385  RS  1  ND  +  H35  Or12  MCI 0167 
400396  RS  1  ND  +  HNT  Or11  MCI 0165 
500340  RS  3  ND  +  H35  Or13  MCI 0169 
500340  RS  1  ND  +  H35  Or14  MCI 0173 
500348  RS  2  ND  +  H14  Or11  MCI 0164 
600341  RS  3  ND  +  H21  Or7  MCI 0174 
600341  RS  2  ND  +  H21  Or7  MCI 0177 
600747  RS  2  ND  +  H19NM  Or15  MCI 0179 
600747  RS  1  ND  +  H30  Or14  MCI 0181 
824  TR  1  +  ND  H8  Or17  MCI 0308 
824  TR  2  +  ND  H8  Or17  MCI 0309 
824  TR  3  +  ND  H8  Or17  MCI 0310 
824  TR  4  +  ND  H8  Or22  MCI 0373 
824  TR  5  +  ND  H8  ND  MCI 0374 
824  TR  6  +  ND  H8  ND  MCI 0375 
824  TR  7  +  ND  H8  ND  MCI 0382 
824  TR  8  +  ND  H8  ND  MCI 0383 
824  TR  9  +  ND  H8  ND  MCI 0384 
540  TR  1  -  ND  H-/NT  Or18  MCI 0311 
540  TR  2  -  ND  H-/NT  Or18  MCI 0312 
540  TR  3  -  ND  H-/NT  Or18  MCI 0313 
540  TR  1  +  ND  H21  Or8  MCI 0319 
540  TR  2  +  ND  H21  Or8  MCI 0320 
540  TR  3  +  ND  H21  Or8  MCI 0321 
593  TR  1  +  ND  H21  Or8  MCI 0327 
593  TR  2  +  ND  H21  Or8  MCI 0328 
593  TR  3  +  ND  H21  Or8  MCI 0329 
541  TR  1  +  ND  H8  Or17  MCI 0333 
541  TR  2  +  ND  H8  Or17  MCI 0334 
541  TR  3  +  ND  H8  Or17  MCI 0335 
541  PC  1  +  ND  H32  Or19  MCI 0344 
541  PC  2  +  ND  H35  Or18  MCI 0345 
541  PC  3  +  ND  H32  Or19  MCI 0346 
493  TR  1  +  ND  H29  ND  MCI 0354 
710  PR  1  +  ND  H21  Or11  MCI 0356 
710  PR  2  +  ND  H21  Or11  MCI 0357 
710  PR  3  +  ND  H21  Or11  MCI 0358 
739  TR  1  +  ND  H21  Or20  MCI 0362 
739  TR  2  +  ND  H21  Or20  MCI 0363 
739  TR  3  +  ND  H21  Or20  MCI 0364 
740  TR  1  +  ND  H48  Or21  MCI 0368 
740  TR  2  +  ND  H31  ND  MCI 0369 
740  TR  3  +  ND  H48  Or21  MCI 0370 
583  TR  1  +  ND  H-/NT  Or17  MCI 0377 
583  TR  2  +  ND  H21  Or23  MCI 0378 
583  TR  3  +  ND  H8  ND  MCI 0379 
587  TR  1  +  ND  H21  Or8  MCI 0386   289 
587  TR  2  +  ND  H21  Or8  MCI 0387 
587  TR  3  +  ND  H21  Or8  MCI 0388 
586  TR  1  +  ND  H19NM  Or25  MCI 0398 
586  TR  2  +  ND  H19NM  Or25  MCI 0399 
586  TR  3  +  ND  H19NM  Or25  MCI 0400 
566  TR  1  +  ND  H21  Or24  MCI 0392 
566  TR  2  +  ND  H21  Or24  MCI 0393 
566  TR  3  +  ND  H21  Or24  MCI 0394 
825  TR  1  +  ND  H19NM  Or26  MCI 0404 
825  TR  2  +  ND  H19NM  Or26  MCI 0405 
825  TR  3  +  ND  H19NM  Or26  MCI 0406 
826  TR  1  +  ND  H19NM  Or27  MCI 0410 
826  TR  2  +  ND  H19NM  Or27  MCI 0411 
826  TR  3  +  ND  H19NM  Or27  MCI 0412 
 
Table A1: Summary of bovine isolates provided by Neil Paton and Stuart Naylor: (GLUC: glucuronidase 
positive (+)/negative (-), SOR-F: sorbitol-fermenting (+)/non-fermenting  (-), O-pattern: O-RFLP pattern, H-
pattern: H-RFLP-pattern.  
Isolation/Site: FFC: faecal free-catch, RS: recto-anal mucosal swab TR: terminal rectum, PR: proximal rectum, 
DC: distal colon, PC: proximal colon, IL: ileum. 
 
Animal  Site  GLUC  SOR-F  H-pattern  O-pattern  Ref. No.  #same O/H 
02757  TR  +  +  H19NM  Or29  MCI0466  4/21 
02757  TR  +  +  H36  O103  MCI0465  10/21 
02757  TR  +  +  H8  Or30  MCI0467  2/21 
02757  TR  -  -  NA  NA  NA  5/21 
02757  PR  +  +  H19NM  Or29  MCI0470  5/21 
02757  PR  +  +  H36  O103  MCI0469  11/21 
02757  PR  +  +  H8  Or30  MCI0471  1/21 
02757  PR  +  +  H29  Or59  NA  1/21 
02757  PR  -  -  NA  NA  NA  4/21 
02757  PC  +  +  H36  O103  MCI0473  13/21 
02757  PC  +  +  H19NM  Or29  MCI0474  7/21 
02757  PC  -  -  NA  NA  NA  1/21 
02757  IL  +  +  H36  O103  MCI0476  5/21 
02757  IL  +  +  H19NM  Or29  MCI0477  9/21 
02757  IL  -  -  NA  NA  NA  7/21 
04097  TR  +  +  H19NM  Or29  MCI0454  12/21 
04097  TR  +  +  H8  Or30  MCI0455  4/21 
04097  TR  +  +  H10  Or31  NA  1/21 
04097  TR  -  -  NA  NA  NA  4/21 
04097  PR  +  +  H19NM  Or29  MCI0458  20/21 
04097  PR  +  +  H29  Or32  MCI0459  1/21 
04097  PC  +  +  H19NM  Or29  MCI0460  14/21 
04097  PC  +  +  H8  Or30  MCI0462  1/21 
04097  PC  +  +  H7  Or33  MCI0461  1/21 
04097  PC  -  -  NA  NA  NA  5/21 
04097  IL  +  +  H19NM  Or29  MCI0463  5/21 
04097  IL  +  +  H25  Or34  MCI0464  1/21 
04097  IL  -  -  NA  NA  NA  14/2 
600096  TR  +  -  H+(NT)1  O26  MCI0483  14/18 
600096  TR  +  +  H20  Or35  MCI0487  4/18 
600096  PR  +  -  H+(NT)1  O26  MCI0484  18/18   290 
600096  PC  +  -  H+(NT)1  O26  MCI0485  12/18 
600096  PC  -  -  NA  NA  NA  6/18 
600096  IL  +  -  H+(NT)1  O26  MCI0486  5/11 
600096  IL  -  -  NA  NA  NA  6/11 
200927  TR  +  +  H+(NT)2  Or7  MCI0490  18/18 
200927  PR  +  +  H+(NT)2  Or7  MCI0491  18/18 
200927  DC  +  +  H+(NT)2  Or7  MCI0493  9/18 
200927  DC  +  +  H47  Or36  MCI0495  1/18 
200927  DC  -  -  NA  NA  NA  8/18 
200927  PC  +  +  H+(NT)2  Or7  MCI0492  15/18 
200927  PC  +  +  H47  Or36  MCI0494  1/18 
200927  IL  -  -  NA  NA  NA  18/18 
601223  TR  +  +  H+(NT)2  Or7  MCI0496  6/14 
601223  TR  -  -  NA  NA  NA  8/14 
601223  PR  +  +  H+(NT)2  Or7  MCI0497  16/18 
601223  PR  -  -  NA  NA  NA  2/18 
601223  DC  +  +  H+(NT)2  Or7  MCI0500  9/18 
601223  DC  -  -  NA  NA  NA  9/18 
601223  PC  +  +  H+(NT)2  Or7  MCI0498  9/18 
601223  PC  -  -  NA  NA  NA  9/18 
601223  IL  +  +  H+(NT)2  Or7  MCI0499  9/18 
601223  IL  -  -  NA  NA  NA  9/18 
300710  TR  +  +  H+(NT)2  Or7  MCI0501  3/18 
300710  TR  -  -  NA  NA  NA  15/18 
300710  PR  +  +  H+(NT)2  Or7  MCI0502  2/18 
300710  PR  -  -  NA  NA  NA  15/18 
300710  DC  +  +  H+(NT)2  Or7  MCI0505  3/10 
300710  DC  -  -  NA  NA  NA  7/10 
300710  PC  +  +  H+(NT)2  Or7  MCI0503  3/18 
300710  PC  -  -  NA  NA  NA  15/18 
300710  IL  +  +  H+(NT)2  Or7  MCI0504  3/18 
300710  IL  -  -  NA  NA  NA  15/18 
300129  TR  +  +  H49  Or35  MCI0512  6/18 
300129  TR  +  +  H+(NT)1  Or37  MCI0517  9/18 
300129  TR  +  +  -  Or57  MCI0653  1/18 
300129  PR  +  +  H49  Or35  MCI0513  12/18 
300129  PR  ÷  +  -  Or14  MCI0518  4/18 
300129  PR  +  +  H5  Or7  MCI0521  1/18 
300129  DC  +  +  H49  Or35  MCI0514  13/18 
300129  DC  +  +  -  Or14  MCI0519  1/18 
300129  DC  +  +  -  Or39  MCI0654  1/18 
300129  DC  -  -  NA  NA  NA  2/18 
300129  PC  +  +  H49  Or35  MCI0515  16/18 
300129  PC  +  +  H+(NT)2  Or39  MCI0522  2/18 
300129  IL  +  +  H49  Or35  MCI0516  16/18 
300129  IL  +  +  -  Or14  MCI0520  1/18 
300129  IL  -  -  NA  NA  NA  1/18 
300136  TR  +  +  -  Or14  MCI0523  7/18 
300136  TR  +  +  H+(NT)l  Or37  MCI0528  9/18 
300136  TR  +  +  H+(NT)8  Or38  MCI0529  1/18 
300136  TR  -  -  NA  NA  NA  1/18 
300136  PR  +  +  -  Or14  MCI0524  16/18 
300136  PR  +  +  H+(NT)8  Or38  MCI0530  1/18   291 
300136  PR  -  -  NA  NA  NA  1/18 
300136  DC  +  +  H+(NT)8  Or38  MCI0531  11/18 
300136  DC  +  +  -  Or14  MCI0525  7/18 
300136  DC  -  -  NA  NA  NA  2/18 
300136  PC  +  +  -  Or14  MCI0526  14/18 
300136  PC  +  +  H+(NT)8  Or38  MCI0532  3/18 
300136  PC  -  -  NA  NA  NA  1/18 
300136  IL  +  +  -  Or14  MCI0527  15/18 
300136  IL  +  +  H+(NT)8  Or38  MCI0533  3/18 
700140  TR  +  ÷  H+(NT)1  Or37  MCI0534  4/18 
700140  TR  +  +  H+(NT)2  Or39  MCI0535  14/18 
700140  PR  +  +  H+(NT)2  Or39  MCI0536  18/18 
700140  DC  +  +  H+(NT)2  Or39  MCI0537  16/18 
700140  DC  +  +  H+(NT)9  Or26  MCI0540  1/18 
700140  DC  -  -  NA  NA  NA  1/18 
700140  PC  +  +  H+(NT)2  Or39  MCI0538  13/18 
700140  PC  +  +  H47  Or36  MCI0541  5/18 
700140  IL  +  +  H+(NT)2  Or39  MCI0539  16/18 
700140  IL  +  +  H+(NT)3  Or40  MCI0543  1/18 
700140  IL  +  +  -  Or36  NA  1/18 
700217  TR  +  +  H25  Or41  MCI0544  8/18 
700217  TR  +  +  H8  Or17  MCI0546  4/18 
700217  TR  +  +  H2  O103  MCI0549  6/18 
700217  TR  +  +  H8  Or17  MCI0550  1/18 
700217  PR  +  +  H+(NT)2  Or7  MCI0551  2/18 
700217  PR  +  +  H2  O103  MCI0555  3/18 
700217  PR  +  +  -  ~O147  MCI0657  1/18 
700217  PR  +  +  H+(NT)2  Or7  MCI0556  2/18 
700217  PR  +  +  H25  Or41  MCI0545  3/18 
700217  PR  +  +  H2  Or10  MCI0557  2/18 
700217  PR  -  -  NA  NA  NA  6/18 
700217  DC  +  +  H+(NT)2  Or7  MCI0552  4/14 
700217  DC  +  +  H16NM  Or42  MCI0561  2/14 
700217  DC  +  +  H2  Or10  MCI0558  3/14 
700217  DC  +  +  H+(NT)7  Or43  MCI0564  2/14 
700217  DC  -  -  NA  NA  NA  3/14 
700217  PC  +  +  H+(NT)2  Or7  MCI0553  4/18 
700217  PC  +  +  H2  Or10  MCI0559  7/18 
700217  PC  +  +  H16NM  Or42  MCI0562  6/18 
700217  PC  +  +  H8  Or44  MCI0566  1/18 
700217  IL  +  +  H2  Or10  MCI0560  6/18 
700217  IL  +  +  H+(NT)2  Or7  MCI0554  2/18 
700217  IL  +  +  H16NM  Or42  MCI0563  8/18 
700217  IL  +  +  H+(NT)7  Or43  MCI0565  1/18 
700217  IL  -  -  NA  NA  NA  1/18 
400354  TR  +  +  H-  Or45  MCI0567  1/18 
400354  TR  +  +  H+(NT)2  Or7  MCI0568  8/18 
400354  TR  +  +  H2  Or46  MCI0573  3/18 
400354  TR  +  +  H2  Or60  not assigned
a  1/18 
400354  TR  -  -  NA  NA  NA  5/18 
400354  PR  +  +  H+(NT)2  Or7  MCI0569  11/18 
400354  PR  +  +  H12  ~O149  MCI0574  1/18 
400354  PR  -  -  NA  NA  NA  6/18   292 
400354  DC  +  +  H40  Or47  MCI0575  5/18 
400354  DC  +  +  H+(NT)2  Or7  MCI0570  1/18 
400354  DC  +  +  H+(NT)4  Or48  MCI0578  3/18 
400354  DC  -  -  NA  NA  NA  9/18 
400354  PC  +  +  H+(NT)2  Or7  MCI0571  11/18 
400354  PC  +  +  H40  Or47  MCI0576  1/18 
400354  PC  -  -  NA  NA  NA  6/18 
400354  IL  +  +  H40  Or47  MCI0577  6/18 
400354  IL  +  +  H+(NT)2  Or7  MCI0572  3/18 
400354  IL  +  +  NA  NA  NA  1/18 
400354  IL  +  +  H5  -  MCI0579  1/18 
400354  IL  +/-  +/-  H+(NT)2  Or7  MCI0580  1/18 
400354  IL  -  -  NA  NA  NA  6/18 
301437  TR  +  +  H40  Or47  MCI0581  16/18 
301437  TR  +  +  H12  ~O149  MCI0586  1/18 
301437  TR  -  -  NA  NA  NA  1/18 
301437  PR  +  +  H40  Or47  MCI0582  15/18 
301437  PR  +  +  H5  Or49  MCI0589  1/18 
301437  PR  +/-  +  H16NM  Or50  MCI0590  1/18 
301437  PR  -  -  NA  NA  NA  1/18 
301437  DC  +  +  H40  Or47  MCI0583  15/18 
301437  DC  +  +  H12  ~O149  MCI0587  1/18 
301437  DC  +  +  -  Or14  MCI0591  1/18 
301437  DC  +  +  -  Or51  MCI0593  1/18 
301437  PC  +  +  -  Or14  MCI0592  1/18 
301437  PC  +  +  H40  Or47  MCI0584  17/18 
301437  IL  +  +  H40  Or47  MCI0585  11/18 
301437  IL  +  +  H12  ~O149  MCI0588  1/18 
301437  IL  -  -  NA  NA  NA  6/18 
401473  TR  +  +  H25  Or41  MCI0594  11/18 
401473  TR  +  +  H2  Or10  MCI0595  2/18 
401473  TR  +  +  H2  Or46  MCI0597  1/18 
401473  TR  -  -  NA  NA  NA  4/18 
401473  PR  +  +  H2  Or46  MCI0598  6/18 
401473  PR  +  +  H+(NT)2  Or52  MCI0602  8/18 
401473  PR  +  -  H16NM  Or42  MCI0606  1/18 
401473  PR  +  +  -  Or46  MCI0608  1/18 
401473  PR  +  +  H9  Or53  MCI0611  1/18 
401473  PR  -  -  NA  NA  NA  1/18 
401473  DC  +  +  H+(NT)2  Or52  MCI0603  13/18 
401473  DC  +  +  H2  Or46  MCI0599  3/18 
401473  DC  +  +  H16NM  Or42  MCI0607  1/18 
401473  DC  +  +  -  Or46  MCI0609  1/18 
401473  PC  +  +  H+(NT)2  Or52  MCI0604  10/18 
401473  PC  +  +  H2  Or46  MCI0600  3/18 
401473  PC  +  +  H9  Or53  MCI0612  2/18 
401473  PC  +  +  H2  Or10  MCI0596  2/18 
401473  PC  +  +  -  Or46  MCI0610  1/18 
401473  IL  +  +  -  Or52  MCI0613  2/18 
401473  IL  +  +  H+(NT)2  Or52  MCI0605  11/18 
401473  IL  +  +  H2  Or46  MCI0601  3/18 
401473  IL  +  +  H8  Or17  MCI0659  1/18 
401473  IL  +  +  -  O5/O113  MCI0614  1/18   293 
200522  TR  +  +  H+(NT)2  Or7  MCI0615  11/18 
200522  TR  +  +  -  Or52  MCI0619  1/18 
200522  TR  +  +  H+(NT)2  Or52  MCI0660  4/18 
200522  PR  +  +  H+(NT)2  Or52  MCI0621  12/18 
200522  PR  +  +  H+(NT)2  Or7  MCI0661  5/18 
200522  PR  -  -  NA  NA  NA  1/18 
200522  DC  +  +  H+(NT)2  Or52  MCI0622  8/18 
200522  DC  +  +  H25  Or54  MCI0625  1/18 
200522  DC  +  +  H+(NT)2  Or7  MCI0616  7/18 
200522  DC  +  +  H5  Or48  MCI0626  1/18 
200522  DC  +  +  H2  Or46  MCI0627  1/18 
200522  PC  +  +  H+(NT)2  Or7  MCI0617  9/18 
200522  PC  +  +  H+(NT)2  Or52  MCI0623  8/18 
200522  PC  -  -  NA  NA  NA  1/18 
200522  IL  +  +  H+(NT)2  Or7  MCI0618  5/18 
200522  IL  +  +  H+(NT)2  Or52  MCI0624  4/18 
200522  IL  -  -  NA  NA  NA  9/18 
 
 
Table A2: Bovine E. coli strains isolated by necropsy sampling during this study: Numbers of each O/H 
pattern combination are given as a fraction of the total number of E. coli colonies picked from each site (# same 
O/H). 
Isolation site: TR: terminal rectum, PR: proximal rectum, DC: distal colon, PC: proximal colon, IL: ileum. 
GLUC: glucuronidase positive (+)/negative (-); SOR-F: sorbitol-fermenting(+)/non-fermenting (-), O-pattern: O-
RFLP pattern, H-pattern: H-RFLP-pattern. NA: was not culturable in LB and therefore discounted from the final 
analysis). 
Notes 
*: unfortunately, this strain was lost from the collection. 
a: This strain was omitted from PCR-screening for virulence factors, although as the only representative of this 
O/H pattern from this animal, it would have been discounted from the analysis presented in Section 4.2.3 
regardless.   294 
 
Animal  Isolation  Colony  GLUC  SOR-F  H-pattern  O-pattern  Ref. No. 
700217  RS  1  +  ND  H8  Or17  MCI 0628 
700217  RS  2  +  ND  H+(NT)5  Or55  MCI 0629 
700217  RS  3  +  ND  H8  Or17  MCI 0630 
400354  RS  1  +  ND  H+(NT)5  Or55  MCI 0631 
400354  RS  2  +  ND  H2  Or56  MCI 0632 
400354  RS  3  +  ND  H2  Or56  MCI 0633 
301437  RS  1  +  ND  H+(NT)6  O80  MCI 0634 
301437  RS  2  +  ND  H+(NT)6  O80  MCI 0635 
301437  RS  3  +  ND  H+(NT)6  O80  MCI 0636 
301437  RS  4  +/-  ND  H16NM  Or50  MCI 0637 
401473  RS  1  +  ND  H+(NT)5  Or55  MCI 0638 
401473  RS  2  +  ND  H+(NT)5  Or55  MCI 0639 
401473  RS  3  +  ND  H16NM  Or42  MCI 0640 
200522  RS  1  +  ND  H25  Or54  MCI 0641 
200522  RS  2  +  ND  H+(NT)5  Or55  MCI 0642 
200522  RS  3  +  ND  H+(NT)5  Or55  MCI 0643 
200522  RS  4  +/-  ND  H2  -  MCI 0644 
 
Table A3: Summary of E coli isolated by rectal swab three weeks prior to necropsy sampling: (Gluc: 
glucuronidase  positive/negative,  SorF:  sorbitol-fermenting/non-fermenting,  O-pattern:  O-RFLP  pattern,  H-
pattern: H-RFLP-pattern).   295 
Appendix III  Molecular Serotyping Data 
 
Supporting  images  for  the  assignation  of  serotype  by  molecular  method  (O-RFLP  and  H-
RFLP;  Section  4.2.1.2)  are  given  in  Figures  A2-A7.  H-RFLP  patterns  were  matched  to 
expected patterns given in Table A4.    296 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  A2:  H-RFLP  patterns  of  bovine  isolates  provided  by  Neil  Paton  and  Stuart 
Naylor: Each number corresponds to the MCI reference numbers given in Table A1. 
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Figure A3 (part 1): H-RFLP patterns of bovine E. coli strains isolated during this study 
Animal 001
TR: 1 . 2 . 3 . 4 .  5   .6          7 . 8 . 9. 10. 11. 12.      13. 14.15.16.17.18.        19. 20.21. 22. 23.24.        25.26. 27.28. 29.30.       31. 32. 33.34.35. 36.       37.38. 39. 40.41.42.
TR:43.44. 45.46.47.48.        49.50. 51. 52.53.54. PR  1.  2.   3.   4.  5.  6.          7 . 8 . 9. 10. 11. 12.       13. 14. 15.16. 17.18.        19.20. 21. 22.23.24.       25. 26.27.28.29. 30. 
PR: 31. 32. 33.*. 35. 36.       37.38. 39. 40.41.42.       43. 44.45.46.47.48.        49.50. 51. 52.53.54   PC: 1.  2.   3.   4. 5.  6.         7 .  8 . 9. 10. 11. 12.       13. 14. 15.16. 17.18.        
PC:19. 20.21. 22. 23.24.        25.26. 27.28. 29.30.       31.32. 33.34.35. 36.       37.38. 39. 40.41.42.        43.44. 45. 46. 47.48.       49.50. 51.52.53. 54.               PR13 PR34
Animal 02757
TR: PR: PC:
1. 2.   3.  4.  5.  6.   8.  9. 12. 14. 15. 16. H7       TR: 17.18. 19.20. 21.  *.   2.  3.   4.  5.   6.  8.   9.          10.11.12.13. 14. 15. 16. 17.18.19.20.  1.  2.
PC: IL:
3.   4.   5.   6.  7.    8.  9. 10. 11. 12. 13. 14. 15.  PC:  16. 17. 18.19. 20. 21.  1.   2.   3.   4.   5.   6.  7.            8.     9.   10.   11. 12.    15.   16.   18.  19.    PR1      TR3. TR5.  TR15.
Animal 04097
TR: PR:
1.   2.   3.   4.   *.   *.  9. 11. 12. 13. 14. 15. 16.      17. 18. 19.20.  1.   2.  3.   4.  5.   6. 7.   8.   9.        10.  11.   12.  13.  14.  15.  16.  17.   18.  19.  20. 
PC IL
H7  1.              2.   3.   4.   5.   6.   7.     8.  9.  10.  11. 12. 15. 16.           17. 18. 19.   1.    2.    3.    8.   9.  15.  16. 17.  18. 19.            20      TR5. TR6.  PC10.  298 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3 (part 2): H-RFLP patterns of bovine E. coli strains isolated during this study 
TR: TR:                      PR PC
H7   1.   2.  3.  4.   5.  6.   7 .  *.  9. 10. 11.12.13.     H7 14.15. 16. 17. 18.  1.   2.  3.   4.   5.   6.   7.   8.            H7. 9.  10. 11.  12. 13. 14. 15. 16. 17. 18. 1.   2.   3. 
Animal 600096
PC PC IL                                                      
H7 4.  5.  6.   7 .  8.  9. *.   11.12. 13. 14.15. 16. H7. 17. 18.  1.   2.  3.   4.   5.   6.   7.   8.  9.  10. 11.                 TR8. PC10     TR4.  PR6  
Animal 200927
TR: PR
1.   2.    3.    4.   5.   6.    7 .   8.   9.   10.  11. 12. 13.  14.  15.  16.  17.  18.   1.    2.    3.   4. 5.     6.                7.   8.    9.   10.  11.  12. 13.  14.  15.  16.  17.18.           PC4.PC5.IL5.IL6
DC: PC IL
1.   2.    3.    4.    7 .   8.   9.   10. 12.  13.  14.  15.  16.  17.   1.    2.    3.     4.   5.     6.   7.    8.    9.   10.              11.  12. 13.  14.  15.  16.  17.  5. 6.   7.   12.  17      TR13.  DC1.  DC9. H7
Animal 601223
TR                                       PR DC PC                                                   
1.   2.    3.  8*.  13. 14.  15.  1.    2.    3.   4.    5.   6.    7.   8.    9.   10.   11.  12. 13.  14.  15.  16.    1.               2.   3.     7.    8.   9.    13.  14.  15. 1.    2.    3.    7.
PC                                           IL
8.    9.   12.  13. 14. 15.  16.  1.   2.   3.    7.    8.   9.   10. 13. 14.  15.18.    
Animal 300710
TR                                                             PR DC                  PC
1.    2.    4.   5.    7.   11. 13.  14.  16.  17.  4.   6.   7.   9.   13. 15. 16.  2.   4.   5.   8.   1.   2.   5.            7.    11.  12.  13.  1.     2.   7.   13.      TR1.TR2. PR4. PC7
TR: TR:                      PR PC
H7   1.   2.  3.  4.   5.  6.   7 .  *.  9. 10. 11.12.13.     H7 14.15. 16. 17. 18.  1.   2.  3.   4.   5.   6.   7.   8.            H7. 9.  10. 11.  12. 13. 14. 15. 16. 17. 18. 1.   2.   3. 
Animal 600096
PC PC IL                                                      
H7 4.  5.  6.   7 .  8.  9. *.   11.12. 13. 14.15. 16. H7. 17. 18.  1.   2.  3.   4.   5.   6.   7.   8.  9.  10. 11.                 TR8. PC10     TR4.  PR6  
Animal 600096
PC PC IL                                                      
H7 4.  5.  6.   7 .  8.  9. *.   11.12. 13. 14.15. 16. H7. 17. 18.  1.   2.  3.   4.   5.   6.   7.   8.  9.  10. 11.                 TR8. PC10     TR4.  PR6  
Animal 200927
TR: PR
1.   2.    3.    4.   5.   6.    7 .   8.   9.   10.  11. 12. 13.  14.  15.  16.  17.  18.   1.    2.    3.   4. 5.     6.                7.   8.    9.   10.  11.  12. 13.  14.  15.  16.  17.18.           PC4.PC5.IL5.IL6
DC: PC IL
1.   2.    3.    4.    7 .   8.   9.   10. 12.  13.  14.  15.  16.  17.   1.    2.    3.     4.   5.     6.   7.    8.    9.   10.              11.  12. 13.  14.  15.  16.  17.  5. 6.   7.   12.  17      TR13.  DC1.  DC9. H7
Animal 601223
TR                                       PR DC PC                                                   
1.   2.    3.  8*.  13. 14.  15.  1.    2.    3.   4.    5.   6.    7.   8.    9.   10.   11.  12. 13.  14.  15.  16.    1.               2.   3.     7.    8.   9.    13.  14.  15. 1.    2.    3.    7.
PC                                           IL
8.    9.   12.  13. 14. 15.  16.  1.   2.   3.    7.    8.   9.   10. 13. 14.  15.18.    
Animal 300710
TR                                                             PR DC                  PC
1.    2.    4.   5.    7.   11. 13.  14.  16.  17.  4.   6.   7.   9.   13. 15. 16.  2.   4.   5.   8.   1.   2.   5.            7.    11.  12.  13.  1.     2.   7.   13.      TR1.TR2. PR4. PC7  299 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3 (part 3): H-RFLP patterns of bovine E. coli strains isolated during this study 
 
Animal 300129
TR                                                              PR PR
1.    2.    3.      4.    5.    6.   7.    8.    9.    10.  11. 12.        13.  14.  15. 16.  17.  18.   1.   2.    3.     4.  5.    6.   H7               7.  8.   9. 10.  11.  12. 13. 14. 15.  16.  17.18.H7
DC                                                            PC PC
1.   2.    3.     4.   5.   6.   7.    8.    9.   10. 11. 12.   H7    13.  14.  15. 16.  17.  18.   1.   2.    3.     4.    5.    6.   H7       7.  8.   9. 10.  11.  12. 13. 14.  15.  16. 17.  18. H7
IL                                                              IL
1.    2.    3.   4.   5.    6.  7.   8.     9.   10.  11. 12. H7              13. 14. 15. 16.  17. 18.      TR2  TR8 TR9  TR16 TR17 PR6   H7                PR15.DC3.DC5.DC11.DC12.PC4.PC15.PC17
TR                                                              PR
1.    2.    3.    4.    5.    6.   7.    8.    9.    10.  11. 12.           13.  14.  15. 16.  17.  18.   1.   2.    3.     4. 5.    6.             7.   8.    9.   10.   11.   12.   13.  14.  15.  16. 17. 18.
DC                                                              PC
1.    2.    3.    4.    5.    6.   7.    8.    9.    10.  11. 12.            13.  14.  15. 16.  17.  18.   1.   2.    3.     4.    5.    6.               7.   8.    9.   10.   11.   12.   13.  14.  15.  16. 17. 18.
Animal 300136
IL                                                              IL
1.    2.    3.     4.    5.     6.   7.   8.     9.   10.   11. 12.               13.  14.  15.  16.   17.  18.           IL18 H7  
Animal 300129
TR                                                              PR PR
1.    2.    3.      4.    5.    6.   7.    8.    9.    10.  11. 12.        13.  14.  15. 16.  17.  18.   1.   2.    3.     4.  5.    6.   H7               7.  8.   9. 10.  11.  12. 13. 14. 15.  16.  17.18.H7
DC                                                            PC PC
1.   2.    3.     4.   5.   6.   7.    8.    9.   10. 11. 12.   H7    13.  14.  15. 16.  17.  18.   1.   2.    3.     4.    5.    6.   H7       7.  8.   9. 10.  11.  12. 13. 14.  15.  16. 17.  18. H7
IL                                                              IL
1.    2.    3.   4.   5.    6.  7.   8.     9.   10.  11. 12. H7              13. 14. 15. 16.  17. 18.      TR2  TR8 TR9  TR16 TR17 PR6   H7                PR15.DC3.DC5.DC11.DC12.PC4.PC15.PC17
TR                                                              PR
1.    2.    3.    4.    5.    6.   7.    8.    9.    10.  11. 12.           13.  14.  15. 16.  17.  18.   1.   2.    3.     4. 5.    6.             7.   8.    9.   10.   11.   12.   13.  14.  15.  16. 17. 18.
DC                                                              PC
1.    2.    3.    4.    5.    6.   7.    8.    9.    10.  11. 12.            13.  14.  15. 16.  17.  18.   1.   2.    3.     4.    5.    6.               7.   8.    9.   10.   11.   12.   13.  14.  15.  16. 17. 18.
Animal 300136
IL                                                              IL
1.    2.    3.     4.    5.     6.   7.   8.     9.   10.   11. 12.               13.  14.  15.  16.   17.  18.           IL18 H7    300 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3 (part 4): H-RFLP patterns of bovine E. coli strains isolated during this study 
Animal 700140
TR                                                              PR
1.    2.    3.     4.   5.   6.   7.    8.    9.   10. 11.  12.            13.  14.  15. 16.  17.  18.   1.   2.    3.     4.  5.    6.                   7.   8.   9.    10.  11.  12. 13.  14. 15.  16. 17 .18
DC                                                            PC
1.   2.    3.     4.   5.   6.   7.    8.    9.   10. 11. 12.            13. 14.  15. 16.  17.  18.   1.   2.    3.     4.  5.   6.                   7.    8.   9. 10.  11.  12. 13. 14. 15.  16.  17.  18.
IL                                                             
1.    2.    3.   4.   5.    6.  7.   8.     9.   10.  11. 12.  13.  14. 15. 16.  17. 18.                       PC7.PC8.PC9.PC14.PC16.IL13.IL16.IL18 
TR                                                              PR
1.    2.    3.    4.    5.    6.     7.     8.    9.   10.  11.  12.           13.  14.  15. 16. 17. 18.  1.   2.   3.    4.   5.   6.              7.    8.     9.     10.   11.  12.     13. 14.   15.   16.   17.  18.
DC                                                              PC
1.    2.    3.    4.    5.    6.   7.    8.    9.    10.  11.  1.   2.    3.     4.    5.    6.    7.    8.    9.   10.   11.                    12.   13.  14.  15.  16.  17.  18.    1.   2.    3.    4.     5.
Animal 700217
IL                                                             
6.   7.   8.     9.   10.   11. 12.  13.    14.  15.   16.   17. TR14.TR15.PR4.PR5.PR6.PR12.H7              PR13. IL14. IL17         
Animal 700140
TR                                                              PR
1.    2.    3.     4.   5.   6.   7.    8.    9.   10. 11.  12.            13.  14.  15. 16.  17.  18.   1.   2.    3.     4.  5.    6.                   7.   8.   9.    10.  11.  12. 13.  14. 15.  16. 17 .18
DC                                                            PC
1.   2.    3.     4.   5.   6.   7.    8.    9.   10. 11. 12.            13. 14.  15. 16.  17.  18.   1.   2.    3.     4.  5.   6.                   7.    8.   9. 10.  11.  12. 13. 14. 15.  16.  17.  18.
IL                                                             
1.    2.    3.   4.   5.    6.  7.   8.     9.   10.  11. 12.  13.  14. 15. 16.  17. 18.                       PC7.PC8.PC9.PC14.PC16.IL13.IL16.IL18 
TR                                                              PR
1.    2.    3.    4.    5.    6.     7.     8.    9.   10.  11.  12.           13.  14.  15. 16. 17. 18.  1.   2.   3.    4.   5.   6.              7.    8.     9.     10.   11.  12.     13. 14.   15.   16.   17.  18.
DC                                                              PC
1.    2.    3.    4.    5.    6.   7.    8.    9.    10.  11.  1.   2.    3.     4.    5.    6.    7.    8.    9.   10.   11.                    12.   13.  14.  15.  16.  17.  18.    1.   2.    3.    4.     5.
Animal 700217
IL                                                             
6.   7.   8.     9.   10.   11. 12.  13.    14.  15.   16.   17. TR14.TR15.PR4.PR5.PR6.PR12.H7              PR13. IL14. IL17           301 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3 (part 5): H-RFLP patterns of bovine E. coli strains isolated during this study 
Animal 400354
TR                                                              PR DC
1.    2.    3.    4.   7.    8.    9.   10. 13.  14.  15. 16.  17.  18.   1.   2.    3.                    4.    5.    7.    8.     9.   12.   13.   14.  15.   16.   17    1.   2.   3.     7.      8.   9.  
DC                PC IL
13.   14.  15.  1.   2.    3.     4.    7.    8.    9.   10.  13.   14.  15.  16. 18.    1.           2.  3.  4.  7.  8. 9.  10.  13.  14.  15.  16.  -C  H7         TR9. PR7.PC18.IL9        
TR                                                            PR
1.     2.    3.    4.    5.    6.     7.     8.    9.   10.  11.  12.  13.  14.   15.  16.  17.               1.    2.   3.  4.   5.    6.    7.    8.    9.  10.  11. 12.  13.  14. 15. 16..17. 18.
DC                                                              PC
1.    2.    3.    4.    5.    6.   7.    8.  9.     10.  11.  12.  13. 14. 15. 16.  17.  18.               1.   2.    3.    4. 5.    6.    7.   8.   9.   10.   11. 12. 13. 14.  15. 16. 17. 18.   
IL                                                             
1.    2.    3.    4.    5.    7.    8.   9.   13.  14.  15. 16.     PR2.PC5.DC11.DC18
Animal 301437
Animal 400354
TR                                                              PR DC
1.    2.    3.    4.   7.    8.    9.   10. 13.  14.  15. 16.  17.  18.   1.   2.    3.                    4.    5.    7.    8.     9.   12.   13.   14.  15.   16.   17    1.   2.   3.     7.      8.   9.  
DC                PC IL
13.   14.  15.  1.   2.    3.     4.    7.    8.    9.   10.  13.   14.  15.  16. 18.    1.           2.  3.  4.  7.  8. 9.  10.  13.  14.  15.  16.  -C  H7         TR9. PR7.PC18.IL9        
TR                                                            PR
1.     2.    3.    4.    5.    6.     7.     8.    9.   10.  11.  12.  13.  14.   15.  16.  17.               1.    2.   3.  4.   5.    6.    7.    8.    9.  10.  11. 12.  13.  14. 15. 16..17. 18.
DC                                                              PC
1.    2.    3.    4.    5.    6.   7.    8.  9.     10.  11.  12.  13. 14. 15. 16.  17.  18.               1.   2.    3.    4. 5.    6.    7.   8.   9.   10.   11. 12. 13. 14.  15. 16. 17. 18.   
IL                                                             
1.    2.    3.    4.    5.    7.    8.   9.   13.  14.  15. 16.     PR2.PC5.DC11.DC18
Animal 301437  302 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3 (part 6): H-RFLP patterns of bovine E. coli strains isolated during this study 
 
 
 
TR                                                            PR
1.     2.      3.    4.     5.     6.     7.     8.     9.   10.   11.    12.   13.   14.  15.  16.                 1.    2. 3.    4.   5.    6.    7.    8.    9.  10.  11. 12.  13.  14. 15. 16..17. 18.
DC                                                              PC
1.    2.    3.    4.    5.    6.   7.    8.    9.   10.  11.  12.  13.  14.  15.   16. 17.  18.               1.   2.    3.    4.   5.   6.   7.   8.  9.  10.  11. 12.13.14.  15. 16. 17. 18.
IL                                                           
1.    2.    3.    4.    5.    6.    7.    8.    9.  10.  11.  12.   13.  14.  15.  16.  17.  18          TR5.TR6.PR13.H7      DC11.DC18. IL14. IL16.
Animal 401473
TR                                                            PR
1.     2.    3.    4.   5.    6.   7.    8.    9.   10. 11.  12.  13.  14. 15. 16.  17               1.    2.   3.    4.   5.    6.    7.    8.    9.  10.  11. 12.  13.  14. 15. 16..17. 18.
DC                                                              PC
1.    2.    3.    4.    5.    6.   7.    8.    9.   10.  11.  12.  13.  14.  15.   16. 17.  18.               1.   2.    3.    4.   5.   6.   7.   8.  9.  10.  11. 12.13.14.  15. 16. 17. 18.
IL                                                           
1.    2.    3.  7.   8.    9.  13.  14.  15. –C       DC11
Animal 200522
TR                                                            PR
1.     2.      3.    4.     5.     6.     7.     8.     9.   10.   11.    12.   13.   14.  15.  16.                 1.    2. 3.    4.   5.    6.    7.    8.    9.  10.  11. 12.  13.  14. 15. 16..17. 18.
DC                                                              PC
1.    2.    3.    4.    5.    6.   7.    8.    9.   10.  11.  12.  13.  14.  15.   16. 17.  18.               1.   2.    3.    4.   5.   6.   7.   8.  9.  10.  11. 12.13.14.  15. 16. 17. 18.
IL                                                           
1.    2.    3.    4.    5.    6.    7.    8.    9.  10.  11.  12.   13.  14.  15.  16.  17.  18          TR5.TR6.PR13.H7      DC11.DC18. IL14. IL16.
Animal 401473
TR                                                            PR
1.     2.    3.    4.   5.    6.   7.    8.    9.   10. 11.  12.  13.  14. 15. 16.  17               1.    2.   3.    4.   5.    6.    7.    8.    9.  10.  11. 12.  13.  14. 15. 16..17. 18.
DC                                                              PC
1.    2.    3.    4.    5.    6.   7.    8.    9.   10.  11.  12.  13.  14.  15.   16. 17.  18.               1.   2.    3.    4.   5.   6.   7.   8.  9.  10.  11. 12.13.14.  15. 16. 17. 18.
IL                                                           
1.    2.    3.  7.   8.    9.  13.  14.  15. –C       DC11
Animal 200522  303 
Figure A3: H-RFLP patterns of bovine E. coli strains isolated during this study (shown in 
6 parts above). Isolation site is given above the colony number, which was assigned arbitrarily 
to each colony recovered from each site. Isolation sites were: TR: terminal rectum, PR: 
proximal rectum, DC: distal colon, PC: proximal colon, IL: ileum.  304 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A4: All H-RFLP patterns identified in bovine E. coli isolated during this study: 
visualised on 18cm agarose gels for greater resolution in order to match observed patterns to a 
database of expected RFLP fragment sizes (Table A4). 
 
 
 
628.   629.  630.  631. 632. 633.  634.  635.  636.  637.  638.  639.  640. 641. 642. 643.  644.   H7 
         H7 430. 435.437.439. 441.442.454. 455.457.459.461.464.465. 483. 487. 490.H7                          H7.494.512.517.521. 522. 653. 654.655.656.523.528.529.534.535. * .  541.  H7 
  H7.542.543. 545.546.548.549.550.551.555.556.557.561.564.566.657. 658.  H7                         H7.567.569. 574. 575.578. * . 581. 586. 589.590.591.592.594. 595.597. 602.H7 
  H7.607.611.613.614.659.615.619.622.625.626.627.660.661.628.629.631.H7                         H7.       632.635.637.638.640.641.642.644.  595.  H7   305 
H-TYPE  Pattern  Expected fragment sizes (bp) 
H1  1  726  410  281  210  127  34     
H1  M  740  420  290  170  140       
H2  1  546  391  306  116  75  41  22   
H2  M  550  400  310  160  120       
H3  M  390  340  300  290  160  150     
H4  1  495  359  84  78  34       
H4  2  495  293  84  78  66  34     
H4  M  490  290             
H5  1  1311               
H5  2  1256  24  31           
H5  M  1300               
H6  1  570  410  316  209  142       
H6  M  510  410  320  220  150       
H7  1  537  341  308  222  196  120  34   
H7  2  410  341  308  222  196  127  120  34 
H7  3  537  341  308  222  196  120  77   
H7  M1  410  350  310  230  210  140  130   
H7  M2  540  500  350  230  130       
H8  M  710  320  290  170  150       
H9  1  1077  305  288  153  150  34  6   
H9  M  1120  310  300  160         
H10  1  427  318  306  31  30       
H10  M  520  330  310           
H10NM  1  544  318  306  34  31  30     
H11  M  540  280  170  150  130       
H11NM  1  539  276  275  142  141  41     
H12  1  726  410  281  156  127  54  34   
H12  M  740  420  290  170  140       
H14  1  1035  557  34  27         
H14  2  625  557  410  34  27       
H14  M  610  560  420           
H15  1  437  312  306  286  213  78  34  27 
H15  M  440  320  280  220         
H16  M  390  340  300  290  160  150     
H16NM  1  372  318  290  282  142  41  34  26 
H18  1  741  557  195  105  34  33     
H18  M  760  560  200  110         
H19NM  1  620  615  273  238  71  34     
H19  1  629  597  238  71  34       
H19  M1  590  410  280  240  200       
H19  M2  630  590  280  240         
H20  1  377  306  285  215  183  80  78  72 
H20  M  380  310  290  220  190       
H21  M1  380  320  290  280  170  150     
H21  M2  380  320  290  230  170  150     
H21  M3  380  320  290  260  170  150     
H23  1  479  288  282  275  207  133  38  34 
H23  M  480  290  270  200  130       
H24  1  370  320  290  280  160  140     
H25  M  900  300               306 
H26/H26NM  1  841  545  138  75  41  34     
H26  M  520  320  140           
H27  1  533  276  275  142  120       
H27  M  540  280  170  150  130       
H28  1  413  410  318  190  186  114  41   
H28  M  400  310  180  150         
H29  1  337  306  225  171  146  104  34   
H29  2  380  337  306  171  104  34     
H29  M  380  330  300  170  100       
H30  1  562  310  407  298  102  34     
H30  M  550  390  300  290  90       
H31  1  553  434  410  175  62  34     
H31  M  540  420  390  220  170       
H32  1  743  513  306  117  34       
H32  M  750  520  320  120         
H33  1  656  412  88  79  52       
H33  M  640  400             
H34  1  622  506  410  66  34       
H34  M  620  510  390           
H35  1  546  391  306  116  75  41  22   
H35  M  540  390  320  300         
H36  M  680  540  280  210  140  100     
H37  1  806  306  211  120  104  53  43  34 
H37  M  820  310  220  130  110       
H38/H38NM  1  306  300  171  154  141  134  104  34 
Moreno  M  310  180  160  150  140  110     
H39  1  306  282  271  205  104  80  27  18 
H39  M  320  280  270  210         
H40  M  290  250  160           
H41  1  621  490  261  204  70  34     
H41  M  620  490  260  200         
H42/H42NM  1  620  321  306  34         
H42  M  620  330  310           
H43  1  392  347  304  290  125  48     
H43  M  400  360  310  300  130       
H44  1  356  306  301  245  205  75  60  48 
H44  M  720  600  500  330  300  210  130   
H45  1  424  410  368  214  107  86     
H45  M  420  310  270  240  190  110     
H46  1  476  306  285  237  187  104  72  34 
H46  M  460  310  270  240  190  110     
H47  M  550  280  170  150         
H48  1  614  456  290  87  34  16     
H48  M  600  460  280  80         
H49  1  410  306  282  257  201  127  78  34 
H49  2  675  340  308  283  257  201  127  78 
H49  M  420  310  290  260  210  130     
H51  1  335  290  249  231  192  138  132  102 
H51  M  350  290  250  230  200  140  130  100 
H52  1  689  370  171  80  34       
H52  M  690  370  170           
H55  M  1300                 307 
H56  1  901  306  104           
H56  M  910  300  100           
 
Table A4: Expected H-RFLP fragment sizes: predicted sizes (in basepairs) of theoretical 
fliC amplicon digested with RsaI restriction enzyme are shown. Those predicted in silico using 
sequences available on the NCBI nucleotide database are assigned a number, whereas those 
given in Ramos Moreno et al. (2006) are denoted “M”.  
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Figure  A5:  O-RFLP  patterns  of  bovine  isolates  provided  by  Neil  Paton  and  Stuart 
Naylor: Each number corresponds to the MCI reference numbers given in Table A1. 
11.   22.    76.  278.                    O157.105.          104. 106. 108.  122.  171. 179.               O157.181. .319.327. 344. O157            308.333.    373.382.O157
O157.105. *  . 107.   *  . 109.            *.    112. 113.       *  .  *   .  119. 120.          123.124. *  . 125. 160.    162. * .*.  166.* .168.*  .170.171.* . * .174.
308.309. 310.O157        334.335. 379.          320.321.328.    356.          357.358. 362. 363.364.377.        378. 380.  381. 386. 387. 388.          392.  393.  394. 308.309. 310.O157        334.335. 379.          320.321.328.    356.          357.358. 362. 363.364.377.        378. 380.  381. 386. 387. 388.          392.  393.  394.
*  .    177. 179.  180. 181. 182.  311.  312.  313.  344. 346.             *  .  398.399.400. 404. 405.406.410.411.   113. 116. 123.  * .  126  O157
111. 114.  116.  117. 118.  121.   164. 165. 167. 169.           171. 172.  173.  176. 181.  329.  368.  370.  377.  412
345   309 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A6 (part 1): O-RFLP patterns of bovine E. coli strains isolated during this study 
 
 
H37: H7 H39         H2 H8              H37             H7
TR .TR. TR  PR. PR. PR          PC. PC. PC. TR. TR. TR.    PR. PR. PC. PC. PC. O157. TR   PR   TR  PC.  PC.O157         TR PR.   PR. PR. PR.PR
Animal 001
H- | H19NM: H- H8        H19NM |H8  |H19NM          H10
TR  | TR .PR      *.     PR.   PC.  PC.  PC.    IL.   IL.  IL    TR. TR.    *       PC.      TR.TR.TR.TR.O157    TR | TR | PR                  TR
Animal 04097
Animal 02757
H19NM:                                                           H36 H8| H-|  H8|H- |H8| H21/29|H7|  H25     H19NM
TR.TR.PR.PR.PR.PC. PC.PC.IL.IL.IL.       TR.TRTR.PR PR.PR.PC.PC.PC.IL.IL.IL    TR|TR| TR| PR|PR|      PR|PC|  IL        TR   
H+NT1 H20                  
TR .TR.TR TR. PR PR.PR. PC.PC. PC. IL. IL. IL.          TR. TR. TR
Animal 600096
H37: H7 H39         H2 H8              H37             H7
TR .TR. TR  PR. PR. PR          PC. PC. PC. TR. TR. TR.    PR. PR. PC. PC. PC. O157. TR   PR   TR  PC.  PC.O157         TR PR.   PR. PR. PR.PR
Animal 001
H- | H19NM: H- H8        H19NM |H8  |H19NM          H10
TR  | TR .PR      *.     PR.   PC.  PC.  PC.    IL.   IL.  IL    TR. TR.    *       PC.      TR.TR.TR.TR.O157    TR | TR | PR                  TR
Animal 04097
Animal 02757
H19NM:                                                           H36 H8| H-|  H8|H- |H8| H21/29|H7|  H25     H19NM
TR.TR.PR.PR.PR.PC. PC.PC.IL.IL.IL.       TR.TRTR.PR PR.PR.PC.PC.PC.IL.IL.IL    TR|TR| TR| PR|PR|      PR|PC|  IL        TR   
H+NT1 H20                  
TR .TR.TR TR. PR PR.PR. PC.PC. PC. IL. IL. IL.          TR. TR. TR
Animal 600096
H29   310 
H+NT2 |H47|H+NT2                             |H47|  H+NT2
O157  TR . TR. TR   TR.  PR   PR.   PR.  PC. PC.  PC. PC.    PC.  DC.DC       O157|DC | DC.
Animal 200927
H+NT2                                                            H+NT2
TR . TR. TR   PR  PR.  PR. PC.  PC.  PC.  IL.  IL     IL.           O157 DC.DC. DC
Animal 601223
H+NT2                                                            H+NT2
TR . TR.  TR   PR   PR.  PC.   PC.   PC.  IL.   IL      IL.                 *   DC. DC. DC
Animal 300710
H49                       H+NT1     | H49             |H- |H5| H49            |H+NT2|H- H49                |H- |                H49              |H-|  H- |H+NT2|H-|                                                               
TR . TR. TR. TR.| TR.TR.TR| PR. PR.PR. |PR.PR           |PR| DC.DC.DC.|DC.|DC.*.*.PC.  PC.  PC. |PC.|          IL.IL.IL.IL.   * .IL.   TR.TR. PR. DC.PC..PC.
Animal 300129
H+NT2 |H47|H+NT2                             |H47|  H+NT2
O157  TR . TR. TR   TR.  PR   PR.   PR.  PC. PC.  PC. PC.    PC.  DC.DC       O157|DC | DC.
Animal 200927
H+NT2 |H47|H+NT2                             |H47|  H+NT2
O157  TR . TR. TR   TR.  PR   PR.   PR.  PC. PC.  PC. PC.    PC.  DC.DC       O157|DC | DC.
Animal 200927
H+NT2                                                            H+NT2
TR . TR. TR   PR  PR.  PR. PC.  PC.  PC.  IL.  IL     IL.           O157 DC.DC. DC
Animal 601223
H+NT2                                                            H+NT2
TR . TR.  TR   PR   PR.  PC.   PC.   PC.  IL.   IL      IL.                 *   DC. DC. DC
Animal 300710
H+NT2                                                            H+NT2
TR . TR.  TR   PR   PR.  PC.   PC.   PC.  IL.   IL      IL.                 *   DC. DC. DC
Animal 300710
H49                       H+NT1     | H49             |H- |H5| H49            |H+NT2|H- H49                |H- |                H49              |H-|  H- |H+NT2|H-|                                                               
TR . TR. TR. TR.| TR.TR.TR| PR. PR.PR. |PR.PR           |PR| DC.DC.DC.|DC.|DC.*.*.PC.  PC.  PC. |PC.|          IL.IL.IL.IL.   * .IL.   TR.TR. PR. DC.PC..PC.
Animal 300129
 
 
 
Figure A6 (part 2): O-RFLP patterns of bovine E. coli strains isolated during this study 
 
   311 
H+NT2 |H47|H+NT2                             |H47|  H+NT2
O157  TR . TR. TR   TR.  PR   PR.   PR.  PC. PC.  PC. PC.    PC.  DC.DC       O157|DC | DC.
Animal 200927
H+NT2                                                            H+NT2
TR . TR. TR   PR  PR.  PR. PC.  PC.  PC.  IL.  IL     IL.           O157 DC.DC. DC
Animal 601223
H+NT2                                                            H+NT2
TR . TR.  TR   PR   PR.  PC.   PC.   PC.  IL.   IL      IL.                 *   DC. DC. DC
Animal 300710
H49                       H+NT1     | H49             |H- |H5| H49            |H+NT2|H- H49                |H- |                H49              |H-|  H- |H+NT2|H-|                                                               
TR . TR. TR. TR.| TR.TR.TR| PR. PR.PR. |PR.PR           |PR| DC.DC.DC.|DC.|DC.*.*.PC.  PC.  PC. |PC.|          IL.IL.IL.IL.   * .IL.   TR.TR. PR. DC.PC..PC.
Animal 300129
H+NT2 |H47|H+NT2                             |H47|  H+NT2
O157  TR . TR. TR   TR.  PR   PR.   PR.  PC. PC.  PC. PC.    PC.  DC.DC       O157|DC | DC.
Animal 200927
H+NT2 |H47|H+NT2                             |H47|  H+NT2
O157  TR . TR. TR   TR.  PR   PR.   PR.  PC. PC.  PC. PC.    PC.  DC.DC       O157|DC | DC.
Animal 200927
H+NT2                                                            H+NT2
TR . TR. TR   PR  PR.  PR. PC.  PC.  PC.  IL.  IL     IL.           O157 DC.DC. DC
Animal 601223
H+NT2                                                            H+NT2
TR . TR.  TR   PR   PR.  PC.   PC.   PC.  IL.   IL      IL.                 *   DC. DC. DC
Animal 300710
H+NT2                                                            H+NT2
TR . TR.  TR   PR   PR.  PC.   PC.   PC.  IL.   IL      IL.                 *   DC. DC. DC
Animal 300710
H49                       H+NT1     | H49             |H- |H5| H49            |H+NT2|H- H49                |H- |                H49              |H-|  H- |H+NT2|H-|                                                               
TR . TR. TR. TR.| TR.TR.TR| PR. PR.PR. |PR.PR           |PR| DC.DC.DC.|DC.|DC.*.*.PC.  PC.  PC. |PC.|          IL.IL.IL.IL.   * .IL.   TR.TR. PR. DC.PC..PC.
Animal 300129
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H- |H+NT1                          | H+NT8|  H- |H+NT8                 |H- |H+NT8
TR . TR. TR.    |TR.  TR.   TR|                |   TR.| PR.PR.   PR.  PR   PR.  PR.   |PR  DC. DC. DC. |DC.              DC.DC.DC.DC.DC. *  . PC.PC. PC. PC.PC.|PC
Animal 300136
H+NT8      |H- |H+NT8             |H- |
PC.    PC.  |IL.   IL.     IL.   IL.    IL.    IL.   |IL.    IL. IL.       PC
H47                  |H+NT2                                      |H47 |H+NT2             H+NT3| H-
TR . TR. TR.    |TR.  TR.  TR. PR. PR.  PR. DC. DC. DC.          PC. PC. PC.  PC.  PC. PC.  PC. PC.|  IL.  IL.  IL.           IL| IL.
Animal 700140
Animal 700217
H25|H8 |H25  |H8        |H2                   |H8   |H+NT2       |H2                |                       | H25  |         |H8      |H25   
TR | TR |  TR  |TR. TR|  TR.  TR.  TR |TR.  |PR.| O157           PR.|PR.  PR. PR.|   *   .*   . *  .  PR.  PR. PR.  *     PR     TR. TR.  TR.
H+NT2       | H16       |H2        |H+NT7 |H+NT2       |         |H2              |H16NM      |H8| H2              | H+NT2 |H16NM          H+NT7           
DC.DC.DC.| DC. DC| DC.DC.|DC.DC|PC. PC. PC.|O157           PC.PC. PC.|PC. PC. PC.|PC| IL.  IL.  IL. | IL. IL.          | IL.  IL.  IL.     |IL.|
H- |H+NT1                          | H+NT8|  H- |H+NT8                 |H- |H+NT8
TR . TR. TR.    |TR.  TR.   TR|                |   TR.| PR.PR.   PR.  PR   PR.  PR.   |PR  DC. DC. DC. |DC.              DC.DC.DC.DC.DC. *  . PC.PC. PC. PC.PC.|PC
Animal 300136
H+NT8      |H- |H+NT8             |H- |
PC.    PC.  |IL.   IL.     IL.   IL.    IL.    IL.   |IL.    IL. IL.       PC
H47                  |H+NT2                                      |H47 |H+NT2             H+NT3| H-
TR . TR. TR.    |TR.  TR.  TR. PR. PR.  PR. DC. DC. DC.          PC. PC. PC.  PC.  PC. PC.  PC. PC.|  IL.  IL.  IL.           IL| IL.
Animal 700140
Animal 700217
H25|H8 |H25  |H8        |H2                   |H8   |H+NT2       |H2                |                       | H25  |         |H8      |H25   
TR | TR |  TR  |TR. TR|  TR.  TR.  TR |TR.  |PR.| O157           PR.|PR.  PR. PR.|   *   .*   . *  .  PR.  PR. PR.  *     PR     TR. TR.  TR.
H+NT2       | H16       |H2        |H+NT7 |H+NT2       |         |H2              |H16NM      |H8| H2              | H+NT2 |H16NM          H+NT7           
DC.DC.DC.| DC. DC| DC.DC.|DC.DC|PC. PC. PC.|O157           PC.PC. PC.|PC. PC. PC.|PC| IL.  IL.  IL. | IL. IL.          | IL.  IL.  IL.     |IL.|
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H2                |H+NT2                                      H+NT2|H12|             |H40               |H+NT2|H+NT4    |         |H+NT2       |H40| H5 |H40             |H+NT2     | H+NT4
TR .TR. TR.|TR. TR. TR  *   PR|O157          PR. PR. PR    *. *. DC. DC. DC.|DC|DC.DC.DC.|         |PC. PC. PC.|PC. | IL .|IL. IL.  IL.  |IL. IL.  IL. |IL
Animal 400354
H40             |H12|H40            |H5|H16NM|H40                        |H- |H- | H12|H40             |H- | H40            |H12|   |H2|
TR .TR. TR.|TR |PR. PR. PR.|PR |PR |DC.DC.DC.            |DC.|DC.| DC.|PC. PC. PC. |PC.| IL. IL.  IL.  |IL.  |   TR
Animal 301437
H25             |H2                               |H40           |H+NT2                 |H16NM|H- |H9 |H+NT2       |H2                |
TR .TR. TR.|TR  TR. TR.    *    *   |PR PR. PR.|PR.            PR.PR|  PR  PR.|PR|PR.|DC.DC.DC.|DC.DC. DC.|
Animal 401473
H16NM| H- |H+NT2        |H- |H2        |H9      |H- |H+NT2- |H2 ??       |H-|H+NT2|     |H2                            |H8|         
DC.|DC.|PC. PC. PC. |PC.|PC.|PC.|PC.PC| PC.| IL.               IL. IL.|IL.| IL.| IL| IL|  IL. IL.|     PR. PR. PR.PC. PC. IL.
Animal 700217
H25             |H-| H2                             |H2
TR .TR.TR.|PR.|TR TR. TR. PR. PR. DC..PC.PC.  PC. PC. IL.     IL. IL. 
H2                |H+NT2                                      H+NT2|H12|             |H40               |H+NT2|H+NT4    |         |H+NT2       |H40| H5 |H40             |H+NT2     | H+NT4
TR .TR. TR.|TR. TR. TR  *   PR|O157          PR. PR. PR    *. *. DC. DC. DC.|DC|DC.DC.DC.|         |PC. PC. PC.|PC. | IL .|IL. IL.  IL.  |IL. IL.  IL. |IL
Animal 400354
H40             |H12|H40            |H5|H16NM|H40                        |H- |H- | H12|H40             |H- | H40            |H12|   |H2|
TR .TR. TR.|TR |PR. PR. PR.|PR |PR |DC.DC.DC.            |DC.|DC.| DC.|PC. PC. PC. |PC.| IL. IL.  IL.  |IL.  |   TR
Animal 301437
H25             |H2                               |H40           |H+NT2                 |H16NM|H- |H9 |H+NT2       |H2                |
TR .TR. TR.|TR  TR. TR.    *    *   |PR PR. PR.|PR.            PR.PR|  PR  PR.|PR|PR.|DC.DC.DC.|DC.DC. DC.|
Animal 401473
H16NM| H- |H+NT2        |H- |H2        |H9      |H- |H+NT2- |H2 ??       |H-|H+NT2|     |H2                            |H8|         
DC.|DC.|PC. PC. PC. |PC.|PC.|PC.|PC.PC| PC.| IL.               IL. IL.|IL.| IL.| IL| IL|  IL. IL.|     PR. PR. PR.PC. PC. IL.
Animal 700217
H25             |H-| H2                             |H2
TR .TR.TR.|PR.|TR TR. TR. PR. PR. DC..PC.PC.  PC. PC. IL.     IL. IL. 
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H+NT2                                H+NT2 |H25| H5| H2  | H- |H+NT2
TR . TR.  TR.  O157            TR  TR.   PR   PR.   PR.  DC. DC. DC.  DC.  DC. DC.               DC.  PC.  PC.  PC.   IL.   IL.   IL.
Animal 200522
H+NT2                          
TR . TR.  TR.  TR.   TR.  TR.  TR.  TR.   TR. TR.   TR.  TR.  PC.             PR  PR. PR. PR.PR. PR. PR. PR. PR. PR. PR.PR
H+NT2                          
PR. PR.  DC.DC.DC. DC. DC. DC. DC.DC. DC. DC      PC. PC.  PC.  PC.  PC. PC.  PC.  PC. PC.  PC. PC.
H+NT2                          
PC.   PC.   IL.   IL.    IL.    IL.    IL.    IL
H+NT2                                H+NT2 |H25| H5| H2  | H- |H+NT2
TR . TR.  TR.  O157            TR  TR.   PR   PR.   PR.  DC. DC. DC.  DC.  DC. DC.               DC.  PC.  PC.  PC.   IL.   IL.   IL.
Animal 200522
H+NT2                          
TR . TR.  TR.  TR.   TR.  TR.  TR.  TR.   TR. TR.   TR.  TR.  PC.             PR  PR. PR. PR.PR. PR. PR. PR. PR. PR. PR.PR
H+NT2                          
PR. PR.  DC.DC.DC. DC. DC. DC. DC.DC. DC. DC      PC. PC.  PC.  PC.  PC. PC.  PC.  PC. PC.  PC. PC.
H+NT2                          
PC.   PC.   IL.   IL.    IL.    IL.    IL.    IL
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Figure A6: O-RFLP patterns of bovine E. coli strains isolated during this study: For each animal from 
which E. coli was isolated, O-RFLP was conducted according to Section 2.6.4.1 and Coimbra et al (2000). 
Restriction fragments were visualised by agarose gel electrophoresis and are shown in 6 parts in previous pages. 
H-RFLP pattern and then the site from which the strain was isolated are given above each lane.   315 
 
 
 
Figure A7 (part 1): All O-RFLP patterns identified during this study. 
 
 
       
     
       
       
   
   
   316 
 
 
 
Figure A7: (part 2): All O-RFLP patterns identified during this study. 
 
 
Figure  A7:  All  O-RFLP  patterns  identified  during  this  study:  All  O-RFLP  patterns 
identified in bovine E. coli isolated during this study, visualised on 18cm agarose gels for 
greater resolution and to enable pattern-matching between strains. Numbers above each lane 
correspond  to  MCI  reference  numbers.  O-RFLP  patterns  were  assigned  arbitrary  numbers 
(unless patterns matched those of E. coli of known serotype, given in Table 2.1). 
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Appendix IV  PCR-screening of bovine E. coli isolates 
 
Images showing the results of the PCR-screening of selected bovine E. coli are included in 
Figures A8 and A9. Strains are labelled with MCI number (corresponding to Tables A1-A3) in 
the top row of each figure, with the target gene (Section 4.2.1.3) given to the right. These 
results are summarised in Tables 4.2 and 4.5. 
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Figure A8 (part 1): PCR screening of selected bovine E. coli isolates for selected genes 
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Figure A8 (part 2): PCR screening of selected bovine E. coli isolates for selected genes 
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Figure A8 (part 3): PCR screening of selected bovine E. coli isolates for selected genes 
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Figure A8 (part 4): PCR screening of selected bovine E. coli isolates for selected genes 
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Figure A8 (part 5): PCR screening of selected bovine E. coli isolates for selected genes 
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Figure A8 (part 6): PCR screening of selected bovine E. coli isolates for selected genes 
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Figure A8 (part 7): PCR screening of selected bovine E. coli isolates for selected genes 
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Figure A8 (part 8): PCR screening of selected bovine E. coli isolates for selected genes 
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Figure A8 (part 9): PCR screening of selected bovine E. coli isolates for selected genes 
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Figure A8 (part 10): PCR screening of selected bovine E. coli isolates for selected genes 
 
Figure A8: PCR screening of selected bovine E. coli isolates for selected genes: Results of 
PCR-screening of bovine E. coli isolates: MCI number (corresponding to Table A1) is given 
in the top row of each figure, with the target gene (Section 4.2.1.3) given to the right. These 
results summarised in Tables 4.2 and 4.5.  
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Figure A9: Results of PCR to determine phylogenetic group of bovine E. coli isolates: 
PCR to detect three genetic elements: chuA, yjaA and TSPE4.C2 was performed according to 
Section  2.6.3  and  Clermont  et  al.  (2000).  Isolates  encoding  chuA  were  assigned  to 
phylogenetic groups B2 (if positive for yjaA) or D (yjaA-negative). chuA negative strains were 
assigned to groups B1 (TSPE4.C2-positive) or A (TSPE4.C2-negative) 
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632. 653.  633.  654. 635. 655.   636. 656. 637.  657.  638. 658.  639.  659. 640.          641.         642.           643.           644. PosC   329 
Appendix V  Analysis of E. coli isolates by virulence gene 
nanoarray 
 
Composition of the virulence gene nanoarray (Section 4.2.1.4; described in detail by Anjum et 
al. 2007) and the results of the analysis of selected strains are given in Table A5. 
      Strain 
Target  Position  MCI 0105  MCI 0106  MCI 0108  MCI 0110  MCI 0319 
rrl_0101_0177_10  1  +  +  +  +  - 
rrl_0101_0177_20  2  +  +  +  +  + 
rrl_0260_0330_10  3  +  +  +  +  + 
rrl_0260_0330_20  4  +  +  +  +  + 
rrl_0260_0330_30  5  +  +  +  +  + 
rrl_0520_0580_10  6  +  +  +  +  + 
rrl_0520_0580_20  7  +  -  A  -  - 
rrl_1480_1560_coli_10  8  +  +  +  +  + 
rrl_1480_1560_coli_20  9  +  +  +  +  + 
rrl_1480_1560_coli_30  10  +  +  +  -  A 
rrl_1480_1560_shig_40  11  A  +  +  -  - 
rrl_1690_1770_coli_10  12  +  +  +  -  - 
rrl_1690_1770_shig_20  13  +  +  +  -  - 
rrl_1690_1770_freu_30  14  +  +  +  -  - 
K88ab_10  15  -  -  -  -  - 
astA_consens_10  16  -  A  -  A  - 
bfpA_10  17  -  -  -  -  - 
cba_10  18  -  -  -  +  - 
ccl_10  19  -  -  -  -  - 
cdtB_40  20  -  -  +  -  - 
cdtB_50  21  -  -  +  -  - 
cdtB_60  22  -  -  -  -  - 
celb_10  23  -  -  -  -  + 
cfa_c_10  24  -  -  -  -  - 
cma_20  25  -  -  -  -  - 
cnf1_20  26  -  -  +  -  - 
cofA_10  27  -  -  -  -  - 
eae_consensus_10  28  -  +  -  +  - 
eae_consensus_20  29  -  +  -  +  - 
eae_consensus_30  30  -  +  -  +  - 
eae_consensus_40  31  -  +  -  A  - 
espB_O157_20  32  -  -  -  +  - 
espB_O26_40  33  -  -  -  +  - 
f17-A_40  34  -  -  A  -  A 
f17-A_50  35  -  -  -  -  - 
f17-A_60  36  -  -  -  -  - 
f17-G_20  37  -  -  +  -  - 
fanA_10  38  -  -  -  -  - 
fasA_10  39  -  -  -  -  - 
fedA_10  40  -  -  -  -  A 
fedF_10  41  -  -  -  -  - 
fim41a_10  42  -  -  -  A  - 
gad_10  43  +  A  +  A  + 
hlyA_20  44  -  +  -  +  +   330 
hlyE_10  45  -  -  -  -  - 
ipaD_10  46  -  -  -  -  - 
ipaH9.8_20  47  -  -  -  -  - 
ireA_20  48  -  -  A  -  - 
iroN_10  49  -  -  -  -  - 
iss_10  50  -  -  +  +  + 
lngA_20  51  -  -  -  -  - 
ltcA_20  52  -  -  -  -  - 
mchB_10  53  -  -  -  -  + 
mchC_20  54  -  -  -  -  + 
mchF_10  55  -  -  -  -  + 
mcmA_10  56  -  -  -  -  - 
nfaE_10  57  -  -  -  -  - 
perA_10  58  -  -  -  -  - 
perA_20  59  -  -  -  -  - 
pet_20  60  -  -  A  -  - 
prfB_30  61  -  -  -  -  - 
senB_20  62  -  -  -  -  + 
sfaS_10  63  -  -  -  -  - 
sta1_110  64  -  -  -  -  - 
sta2_210  65  -  -  A  -  - 
stb_10  66  -  -  -  -  - 
stx1A_10  67  -  -  -  +  + 
stx2A_10  68  -  -  -  -  - 
virF_20  69  -  -  -  -  - 
 
Table A5: Composition and results of the virulence gene nanoarray: Names of each oligonucleotide are 
given in the first column, with the results for each strain given in subsequent columns (+: present, A: ambiguous, 
-: absent) For a full list of  oligonucleotides and sequences, refer  to Anjum et al. (2007). Position of each 
oligonucleotide in the array is shown in Figure 4.8.   331 
Appendix VI:  DNA sequencing 
 
The following sequences (corresponding to Tables 6.3, 6.4 and 6.5) represent those which 
yielded BLAST hits of lower than 90% identity meaning that they may represent previously 
undescribed gene sequences. 
 
>w2E9 
ATGCTCCGGCCGCCATGGCCGCGGGATTTCGAGCGGCCGCCCGGGCAGGTACTGGTGCGCTGAACATGCCGGATACGAATTCTCTGATGAAGCG
ACGCAGTTTGATGAGTTTCGTAAAAATCTGACAATTCTTGCCGGGTTTTATGATGTGGTCACAACCATAAGAGGCGAGGTGAGATATCGGGCAA
AAAGCCTGAGTTACGCGAATATGGATCAGGATGAGTTTGAACGTTGCTACAACTCAATGATTAATGCCGCGTTAAAGCATGTGTTTGGGCGCTC
AAACAGCCCTGAACTGAATAACCGCCTGCTGTCGTTTTTCTGAGGTGATGATGCAGCAACGTAAACCTAAAAAATGCAAAGTGTGCGGAACCCC
GTTTGTGCCGTTTCGCTCGTATCAGAAAGTTTGTTGCGGTCAGTGCGCACTTGAACTGGTCAGAAAAGAAAAGGCCATAGCCTTTGCAAAAGAA
CAGGCAGACAAACTTAAAGCGCGAAGAAGGGACTTACAGCCCCGCAGTTACTGGATTAAGCAGGCACAGCAGGCCGTGAATGCTTATATCAGAG
AACGAGACCGTAATTTGCCGTGCGTTTCATGCGGGACATTCGATTCTGCTCAGTGGGATGCAGGTCATTACCGTACCTCGGCCGCGACCACGCT
AATCACTAGTGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAAATA
GCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAA
AGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCAT
TAATGAATCGGGCCAACGCGCGGGGAGAGGCGGT 
 
>w2G10 
CGCATGCTCCGGCCGCCATGGCCGCGGGATTAGCGTGGTCGCGGCCGAGGTACATGACGAGTTTTGATGAGATGGTGCCGGAGTTCATCGACAA
AATGGACGAAGCACTGGCGGAAATTGGTTTTGTATTTGGAGAACAATGGGGGGTTAATAACTAATGGATGAAGTGATTTTTACTTATAACGAAG
AATCAGCACTGACCGCCGGACAAGGTGGTTTTATTACCGAAACGGGTGCGCATATCATTAACATCACCGAAGCAGAACTCAAGCAATCAGAAAA
AGGTGCCCGATTCATTGAGTTTTCTGGAGAATCCGACGACGGACGGAAAATCCAATATCTCAGTGTTTGTGTTCAGAAGAATGACGGCACTGAA
AATAAATTTGGGGCGAGCATTATTCACGCCATGATGGGATGCACAGGAATTGGGCAGTTAACGCAGCATATGGTTTCCGTCAGTAAATATGTTG
CACCTGAGTTTCACGGAAAGAAAATCGGACTCGTCCTCCAGAAAGTATTAACCACAAACAGAAAGACTGGCGCAGACGGTTACCAGATGGAAAT
CCGCATTCCATTCATTGCAGAAACAGGGCAGACACTGAAAGAAAAAGCTGAAGGAAAGAAACCAGAAACTGTAGCAAATATGGTTTCCACTCTC
AAAGACAAAGACAATCGCAGCAAAAACGTAAACCCGAATCACACGGACGCCCCAGGTTACTGGCAGTACCTGCCCGGGCGGCCGCTCGAAATCA
CTAGTGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAAATAGCTTG
GCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCT
GGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCA 
 
>w3A11 
CATGCTCCGGCCGCCATGGCCGCGGGATTTCGAGCGGCCGCCCGGGCAGGTACTACGAATGCCTGCTCAAGCCTACAACGATTCGTGAACTTAT
TCAGCGTGGTGATCTGAGCGATTACGGGTTTTTTGCCCCCTCAATGCCTGATCTGGCTGGCGTAAAAACCAGTAACACCGTATTTGGACGGGAT
TACAACGAGGAGCAGCTCGCATCCATCATGGGGAGTTCGGATCTGGTTGGCGATATCGTTCGCAACTGGCTTGAGAATGGCGAGGATTTGCCGA
CGATCTGCTTCTGCGTGAATGTTGCGCATGCGAATTTTGTTACCCGTGAGTTTTTACAGGCCGGTATTGGTGCAGAGGTGATGACGGCAGATAC
CCTCCATGATGAACGACAGGACATCATTCGCCGTTTTGAAGAGGGCGCGACCAAAATAATTGTCAACGTTGGTGTACCTCGGCCGCGACCACGC
TAATCACTAGTGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAAAT
AGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTA
AAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCA
TTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGG
CTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGAAAGAACATGTGAGCAAAAGGCCA
GCAAAAGGCCAGGAACCGTAAAAGGCCGCGTTGCTGGCGTTTTCCATAGGCTC 
 
>w3C4 
TCGCATGCTCCGGCCGCCATGGCCGCGGGATTAGCGTGGTCGCGGCCGAGGTACGTGCTGAGGCTCGCAACGAGGGTATTAACTATACCGCAAG
CCGTCTTGCTGCTGCTTTCAATCACGGATTTATCAATAAGCCTTTGGCTGAAGTTTTCGACGTTACACGCATGATTCTGTCAGCAAAAGAAGAG
TTAGCTAATGAATCGCATCCGATTGATGGCCTGTCCGGTGAATATGCAGAGAAATCCCTTGAAGAATGGGCGGAACGGCTTCGCAAAGGAGGCA
GCCAGTGACTGGACATGCAGCAATCCTCGACATGTGCTGTGGCAGTCGCATGTTCTGGTTCGATAAGAATGACGACCGGGCGATATTTAGCGAT
ATCAGAAAGGAAGAGCACACATTGTGTGATGGACGACGCCTGATTATCAGTCCTGATCTGATAGCTGATTTTCGTGCACTACCATTTGCAGACG
CATCTTTTTCGATGGTTATATTCGACCCTCCGCATCTTGAGCGTGTTGGTGATAACGCCTGGATGGGAAAGAAATATGGACGGCTGAATAAAGA
TACCTAGCGTGATGATTTGCGGCAGGGATTTAAAGAAGCCTTTCGTGTGTTGCGTCCATCCGGCGTTCTGATTTTTAAATGGAATGAAACGCAA
ATACCTGTTCGCCAGATATTGGTACCTGCCCGGGCGGCCGCTCGAAATCACTAGTGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAA
CGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAAATAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCC
GCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG   332 
 
>w1B4 
TCGCATGCTCCGGCCGCCATGGCCGCGGGATTAGCGTGGTCGCGGCCGAGGTACTGGTGCGCTGAACATGCCGGATACGAATTCTCTGATGAAG
CGACGCAGTTTGATGAGTTTCGTAAAAATCTGACAATTCTTGCCGGGTTTTATGATGTGGTCACAACCATAAGAGGCGAGGTGAGATATCGGGC
AAAAAGCCTGAGTTACGCGAATATGGATCAGGATGAGTTTGAACGTTGCTACAACTCAATGATTAATGCCGCGTTAAAGCATGTGTTTGGGCGC
TCAAACAGCCCTGAACTGAATAACCGCCTGCTGTCGTTTTTCTGAGGTGATGATGCAGCAACGTAAACCTAAAAAATGCAAAGTGTGCGGAACC
CCGTTTGTGCCGTTTCGCTCGTATCAGAAAGTTTGTTGCGGTCAGTGCGCACTTGAACTGGTCAGAAAAGAAAAGGCCATAGCCTTTGCAAAAG
AACAGGCAGACAAACTTAAAGCGCGAAGAAGGGACTTACAGCCCCGCAGTTACTGGATTAAGCAGGCACAGCAGGCCGTGAATGCTTATATCAG
AGAACGAGACCGTAATTTGCCGTGCGTTTCATGCGGGACATTCGATTCTGCTCAGTGGGATGCAGGTCATTACCGTACCTGCCCGGGCGGCCGC
TCGAAATCACTAGTGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTA
AATAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGT
GTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCT
GCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGT 
 
>w1B11 
GTCGCATGCTCCGGCCGCCATGGCCGCGGGATTTCGAGCGGCCCCCGGGCAGGTACCACGAAAAAAGGCTGTATGCCTGGATATCAGTTATATG
GGGCTTCTGCATCTGGCACAGGTCACAGGAGCCATTCAGTGGGGGCAATGCAAACTTGTTTACGAGAAGGACATTTACGAGTCCAACGGTATTG
ACTGCGCCCCCACGCACAAATACAACCCATTCGTCGACAGGGGCGCACGCATTGGCGGTTATTGTGTCGTAAAAACATCCGAAGGCGACTATCT
GACCGAAGAGATGAGCAACAGGGAAATCGAGGTCATCAGGGCGTGCAGCAAAGCCGGAAATAACGGAGGAAGTAGCCCGTGGGATAGTTTCCCC
GATGAAATGGCCAGAAAAGCCATTGTTAAGCGCGCCAGCAAATACTGGCCCCGTCGCGATCGCCTGGATACAGCTATCGACTACCTGAACACTC
AGGGCGGTGAAGGTATCATCCTGAATGCTGATCACATCCCTGAGCGTGACGTCACTCCCGCATCAGATGAGATTATCAATGAGATCACTCAGGC
AATCACCGAAATTAACAAGACATGGGATGACCTGCTTCCCTTATGTTCCAAAACATTCCGTCGCACGATTGCATCACATGAATATCTCAGTCAG
GAAGAAGCTGTCAAAACGCTTGATTTTGTCAAAAAGAAAGCTGCCAGAAACAAGGCCACGGCGGAAGCGAAAATTCACGCCACCACGGAAAATA
ACAGCGAGGCCGTGTCATGACACCAGAAATTATTCTCCAGCGAACTGGCGTGGATATTACCAGCCTCGACCAGGGCGATGATGGATGGTACAAG
CTGAGACTCGGTGTTATCACTGCTTCAGAAGTTCACAATGTGATAGCAAAGCCACGTTCCGGCAGCAAATGGCCTGATACAAAAATGTCATACT
TCCACACCCTGCTGGCTGAAGTTTGTACCTCGGCCGCGACCACGCTAATCACTAGTGCGGCCGCCTGCAG 
 
>w3E2 
CGCATGCTCCGGCCGCCATGGCCGCGGGATTTCGAGCGGCCGCCCGGGCAGGTACTACGAATGCCTGCTCAAGCCTACAACGATTCGTGAACTT
ATTCAGCGTGGTGATCTGAGCGATTACGAGTTTTTTGCCCCCTCAATGCCTGATCTGGCTGGCGTAAAAACCAGTAACACCGTATTTGGACGGG
ATTACAACGAGGAGCAGCTCGCATCCATCATGGGGAGTTCGGATCTGGTTGGCGATATCGTTCGCAACTGGCTTGAGAATGGCGAGGATTTGCC
GACGATCTGCTTCTGCGTGAATGTTACGCATGCGAATTTTGTTACCCGTGAGTTTTTACAGGCCGGTATTGGTGCAGAGGTGATGACGGCAGAT
ACCCTCCATGATGAACGACAGGACATCATTCGCCGTTTTGAAGAGGGCGCGACCAAAATAATTGTCAACGTTGGTGTACCTCGGCCGCGACCAC
GCTAATCACTAGTGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAA
ATAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTG
TAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTG
CATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTC
GGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCACGAAAGAACATGTGAGCAAAAGG
CCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAAATCGACGCTC
AAGTCAGAGGTGG 
 
>d1G4 
TGCTCCGGCCGCCATGGCCGCGGGATTAGAGCGTGGTCGCGGCCGAGGTACAGGTATTAGCAATGACAGATTTTCAATCGAACCTTCTTCCCAA
AGAATTACTATAAAATTAAATGGCAAAGAGTATGAATATGTAACTGAAGGCAAGTCATATATAGATGTATTAAAACAGGTGTTTTATGAGCTCT
ACTATCTTCCAGTCTTGTCCTAATTATATCCTACTATAATATTTATAATCTATAGCCGCGCTAGCGGCTTTTATACTCAGCCTTGTTAACTCCC
GCCTCCCTTGGACATCTCAGTAATTCTGCTCAGCGCTACTGGCTTGCTGTGCCAAACTTTCCGTTGCAGATTTCCTCATTCACAATAGCCTGAA
ACATGGAAACAGAATTTCTAGCCTTATCCCTCAGTGCATTAATGAGTTCTGTGTCGTGTATTTTGTTGTAGAAAATGAAAGTAGAAACATCAAA
CTGGAGTTTAAATGCTGCTTTCCTTATGGCTAAACCTGACGTGATCGTTATCTCATTATGTATGCGAAGATAGGCAAGATAATCATCGTTATTT
GCTTCACACTGCTCATATAAATATTTTTGCATGAGAGATTGAGACAAGGCCAGAAACTCCACATATCGTTTGGTTTTTATTTCTTTATCTTTTA
ATCCCTGTACCTGCCCGGGCGGCCGCTCGAAATCACTAGTGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATA
GCTTGAGTATTCTATAGTGTCACCTAAATAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACA
CAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTC
CAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGC
TCACTGACTCGCTGCGCTCGGTCGTTCGGCTGC 
 
>d1H10 
TCGCATGCTCCGGCCGCCATGGCCGCGGGATTAGCGTGGTCGCGGCCGAGGTACATTGCAGAAATTCCGCTTCCTCGCCCACTCGCTCACTAGC
GTTCGGTCGCTAGGGCTGCGGCGAGCGGTGCTATCTCTCGCATGTTGTCGGTAATTTCGCTATTGTTCTTTCGGAAACGAGGTCGTGATAACCG
CTAAAACACACTCAGAAGCACTTAGACAAATAAAACAGAATTCTTTCAGAGAATGGAAGGTGCGAAAGACTTTCAGCAGCTTCTGTCCATCAAA
ATCAGCTCCGGCGAAGACTGAGAAAGCTCTCATGTTTAGTCACATTCTGAATGTTTAATGTGATTGATGTAATGAGTTAATTTATTGATTTAAT
TAATTTTATATTGGCGGGGGTTTTAATTAAGATCCTCATTTCACTAACCGAGGATCTTCTCATGTTTCAATGAAATATACTTCAATATCAATAG
GATACACCAACCAAAGAGTTACCAGATGATGATCATTCATCATGACGGAGCATAAACTACAAAATTAACAGATCCAGTAACGATCCTTCCCCTA
ACCACCCCAGAAAAGCCATAAAACACGTCCTGTCGCTTTATTTTAGCCCTGGTAAGCCAAACCCACAGGGAAGCATTAAAAATTGCTCAGAACG
CGATTCAGAACGTTTTAGCGGAGTAGCATTGCGCCCGTAGCTCGCGATGCTCGCACGCGCAGTACCTGCCCGGGCGGCCGCTCGAAATCACTCG
TGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAAATAGCTTGGCGT
AATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGG
TGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGT 
 
>d2G9 
ATGCTCCGGCCGCCATGGCCGCGGGATTAGCGTGGTCGCGGCCGAGGTACAAATCCATTTTTGCAAATGCCGATGAACCAGACTGTTTTATTAA
CATCGTTCTGGATTCTTTTGATAAAGATTTTAATTTCTTAAATTCTTTTTCAACAAGACCAATTTTTTTATAACCATCAAATTCAGCATCTGGA
TTAGGCAACAAAATCTTTGTGGCTGTTTGCTGAACAAGAGCCGCAAAAATTGCACAGTTAACCGCATCCTCTGGCGACTGACTCGTTAGCCACA
TCATTTCATTTTTCAGACGTCCAGCTTTTAACGCAGATTTGATCATATCCTGAGTCAGAGGGAAGTTCGCAGGCATCCAGAACTCCTCGACAAT
AGTAAGCATTAGCTTTCCGTCACGTTGTATAAGCGTTTTATAGAAAAATAAAATCGCCAGCAGAGGTTCGCACGCCGGATGCGTTTCACCATTT
ACCTTTTCAAGGATAACGGTTGTGTCAAAACCTACCTTTTTATAATCCATCGGATTAAAAGTGTTCTCTGGCGAATCTGTTGCCCAGGAATACG
CACCATTTTTACACCATTTAGCAAGTCTGATACGCAGTTCACTATCGTTAACTATCTGGAGCAATGCTGACGTTCGGCGCAACTGGACAGGCAT  333 
AGTCATAAGACTCTCTACTGCCGCATCCATTTCTATTGCCTGTTGGTCAGAACAGGGGTTCCCCATGTTGTCCCGAACAAATGCCTTTGCAAGC
GATTTCGGAAACGCTAACAAACGCTTCCAGATTGGTGATGATTCATCTTCCGCAAGCTGCCACGGATTAAGACCAGTAAAAACACCTTCCTGTA
GAGCAAAATAACTACCACCATACGCACGAACAAATAATTCTGTAGAGCGGTTATAGTCAATAACGAACATGTAAGGATCAAAACGCTGTAAAAA
ACCAGCCGCGGATCCTTCAAAAGTCGTTTTACCAGTACCTGCCCGGGCGGGCGCTC 
 
>d1D1 
CATGCTCCCGGCCGCCATGGCCGCGGGATTAGCGTGGTCGCGGCCGAGGTACTTTTACCTGTATGCGCTGGAACAGTAAACAGGATTTACCCGT
GCCTTATCGTGTTGATGCTGATGGCAATGAAAACCTTGTTAATAAGCATATGGAAAATAACACAATGGTATTACATGAAGTGTCTGATAATTTC
CGCCTGAGAATAGGCGATCAAGTTGTTGATGTAAGAACATCTTCGACGGTTCCTAAAATGTGGAATAAAAAAGGTACCTGCCCGGGCGGCCGCT
CGAAATCACTAGTGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAA
ATAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTG
TAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTG
CATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTC
GGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGG
CCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCA
AGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCT 
 
>d1F7 
ATGCTCCGGCCGCCATGGCCGCGGGATTTCGAGCGGCCGCCCGGGCAGGTACGCCAACGGTGCGGAGAAGTGTTTCGCTACGCGATCATCACTG
GCCGCGCTGAATACAATCCAGCACCTGATTTAGCTATCGCATTAGCAGTGCCGAAGCAAAAACATCATCCTTTTCTATCAGCAGAGGAACTCCC
ACATTTTGTCAGAGATCTTGAGGCATACACTGGCAGCATAATCACTAAAAATGCAACCAAGATTGTGATGCTTACAGGTGTTCGAACACAAGAG
ATGCGCTTTGCTACATGGCAAGAGCTTGATTTAGAAAAAGGGCTATGGGAGATACCAGCAGAGCGTATGAAGATGCGTAGGCCACACATAGTCC
CGCTTTCAAGGCAGGTTATAAGGCTATTTCAACAACTAAAACCGATCACTGGTCACTATCCTTACATTTTCATTGGACGAAATAACCGAAAAAA
GCCTATAAGTAAGGAGAGCATAAACCAAGTGATTGAGTTATTGGGATTTAAGGGGAGAATCACTGGCCATGGTTTCAGACACACTATGTCAACC
ATACTACACGAAGCCGGTTTTAATAGTGCATGGATTGAAATGCAACTTGCCCACGTTGATAAGAACAGCATTCGCGGTGTATACAATCATGCAC
AATATCTTAATGGCCGATCTCGTATGCTTCAGTTTTATGCAGATAAACTATACCCAAACTGATAAATAAGGATAAAATAAAATGTCTTATTTCT
TTGACACGCCAGTAAATATTGAAGGAAATAAAAAACTCAGATCTCCTCAAATTGAGGCATATATAAAAATAAAAGAATTCTTCAGTGACGAAGA
GAATAAAGAGGCTCTCGTAGTTTTACCAACAGGAACAGGTAAAAGTGGTTTAATATCTATTGCACCATTTGGTGTTGCACGTAAAAAAGTATTA
ATAATAACTCCAGGTCTTATAACAAAAGAAAGCATAAGAAAAACGCAAGAGGTTTTAGAAAATAACTTCTGGGTTAATTTTGATATTGTTTTAT
AGCAAAGATATACC 
 
 
>d2G1 
CATGCTCCCGGCCGCCATGGCCGCGGGATTCGAGCGGCCGCCCGGGCAGGTACAGGGATTAAAAGATAAAGAAATAAAAACCAAACGATATGTG
GAGTTTCTGGCCTTGTCTCAATCTCTCATGCAAAAATATTTATATGAGCAGTGTGAAGCAAATAACGATGATTATCTTGCCTATCTTCGCATAC
ATAATGAGATAACGATCACGTCAGGTTTAGCCATAAGGAAAGCAGCATTTAAACTCCAGTTTGATGTTTCTACTTTCATTTTCTACAACAAAAT
ACACGACACAGAACTCATTAATGCACTGAGGGATAAGGCTAGAAATTCTGTTTCCATGTTTCAGGCTATTGTGAATGAGGAAATCTGCAACGGA
AAGTTTGGCACAGCAAGCCAGTAGCGCTGAGCAGAATTACTGAGATGTCCAAGGGAGGCGGGAGTTAACAAGGCTGAGTATAAAAGCCGCTAGC
GCGGCTATAGATTATAAATATTATAGTAGGATATAATTAGGACAAGACTGGAAGATAGTAGAGCTCATAAAACACCTGTTTTAATACATCTATA
TATGACTTGCCTTCAGTTACATATTCATACTCTTTGCCATTTAATTTTATAGTAATTCTTTGGGAAGAAGGTTCGATTGAAAATCTGTCATTGC
TAATACCTGTACCTCGGCCGCGACCACGCTAATCACTAGTGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATA
GCTTGAGTATTCTATAGTGTCACCTAAATAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACA
CAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTC
CAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGC 
 
>d2H12 
ATGCTCCGGCCGCCATGGCCGCGGGATTTCGAGCGGCCGCCCGGGCAGGTACTGCGCGTGCGAGCATCGCGAGCTACGGGCGCAATGCTACTCC
GCTAAAACGTTCTGAATCGCGTTCTGAGCGATTTTTAATGCTTCCCTGTGGGTTTGGCTTACCAGGGCTAAAATAAAGCGACAGGACGTGTTTT
ATGGCTTTTCTGGGGTGGTTAGGGGAAGGATCGTTACTGGATCTGTTAATTTTGTAGTTTATGCTCCGTCATGATGAATGATCACCATCTGGTA
ACTCTTTGGTTGGTGTATCCTATTGATATTGAAGTATATTTCATTGAAACATGAGAAGATCCTCGGTTAGTGAAATGAGGATCTTAATTAAAAC
CCCCGCCAATATAAAATTAATTAAATCAATAAATTAACTCATTACATCAATCACATTAAACATTCAGAATGTGACTAAACATGAGAGCTTTCTC
AGTCTTCGCCGGAGCTGATTTTGATGGACAGAAGCTGCTGAAAGTCTTTCGCACCTTCCATTCTCTGAAAGAATTCTGTTTTATTTGTCTAAGT
GCTTCTGAGTGTGTTTTAGCGGTTATCACGACCTCGTTTCCGAAAGAACAATAGCGAAATTACCGACAATATGCGAGAGATAGCACCGCTCGCC
GCAGCCCTAGCGACCGAACGCTAGTGAGCGAGTGGGCGAGGAAGCGGAATTTCTGCAATGTACCTCGGCCGCGACCACGCTAATCACTAGTGCG
GCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAAATAGCTTGGCGTAATC
ATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCC
TAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATC 
 
>sfA-10 
ATGCTCCGGCCGCCATGGCCGCGGGATTAGCGTGGTCGCGGCCGAGGTACGAAAACCACATCGTCGTTTGATTACGGGACGAAAACAACCTCAC
TATTTGACTATGGGACCAAAACTACCAGTAACGCCGGGAGTCACACGCATTCAATACCAACATCAGATGGTGCAAACCAGGGGGGGAAAATTCC
ACTGACATCTGGGCGTCTGGCAACTCAATATACATCAGCAACAACAGGTTCCTCTGGCTCACATTCTCATACTGTAGGTATTGGTTCTCATCAG
CACACTGTCGGTATTGGTGCACACACGCACTCGGTTGCGATTGGCTCACATGGACACACCATCACCGTTAACGCTGCTGGTAACGCGGAAAACA
CCGTCAAAAACATCGCATTTAACTATATTGTGAGGCTTGCATGATTACACTCATTCTTTCTGCACCAGTAACAGAAATGGCTGAAGCATTTAAG
CGGGTATTTGCAAACGCAGGTAATGTGAATATTGTCGGAAAGCCATTTGAAACAATCAGAGAATTTGACTGTATGGTAAGTGCGGCAAATAGTT
TCGGCCTGATGGATGGCGGTGTTGATGCCGCCATTACCGCATTCTTCGGTACCTGCCCGGGCGGCCGCTCGAAATCACTAGTGCGGCCGCCTGC
AGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAAATAGCTTGGCGTAATCATGGTCATA
GCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTG
AGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGG
GGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAG 
 
>sfA-55 
CATGCTCCGGCCGCCATGGCCGCGGGATTAGCGTGGTCGCGGCCGAGGTACCGCTATCGCTGGCATGGCAAGCCTAATCGACTTGGGCTTGGTC
GATACCCATCCCTGTCTTTGAAGGATGCCAGACAGATCACTGCTGACTTGCGAAAGCTCTATTTCTCAGGAACGGATCCACGCACTTATTTTGA
AGAGAAGGTGGAGAACTCCATGACGGTCGCCCAGTGTCTCGACTACTGGTTCGACAACTACGTCTCTACAACTCTCAGAGAAAAGACCCAAGCA
CTTTACCGATCAGCGGTTATGAAGCGCATGCATGACGCCTTCCCTAATCGTCCGGCATCTTCTATCACGGTTAAGCAATGGGTTGACCTGCTTA  334 
CCGAAGAAGAAAAAGATAATCCACGCCGAGCAAGGCAGGTGCTAAGTCAACTAAGATCAGCAATTAGTTGGTGCATGCGGCGTCAGTTGATAGA
TAGTTGCGCAATTATGAGCATCCAACCAAGGGACTTCGGCTCCCGCGCTGAGGTAGGGGATCGGGTACCTGCCCGGGCGGCCGCTCGAAATCAC
TAGTGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAAATAGCTTGG
CGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTG
GGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGA
ATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGC
GAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTT 
 
>sfP-10 
TGATAGATCATATAGGCGAATCGGGCCTCTAATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCTGCAGAATTCGCCCTTAGCGTGGTCGC
GGCCGAGGTCGGCCGAGGTACTCATTGCGGTGGCGAACTGCCCGGAAACGTACCGATCGATTATGAATCAATGATAGATTCAATCTATCAACGT
CAATATATCGATCGGTATAAACGATCAATTTATTGGGATATATTTATCCAAAAAGGCTTGCTAGCCTTACATCGAAAGCGAAGCTCTTCTGGAT
TGAGGTGCTGATTCGATGCGATTTNTTGGGGGAGAGGCATAATCTCTACCACTCTCACGTCAGTGATGGTTTTGTGTTTTAGAGGACGTTTAAG
GGTTGGGATTTTGAGGTTTTTCAACATACGATAAATTACATCGAGGTAGGGGATGTATTCCAACCACCTGAACGCTGAAACTGCATAGCTTTGG
TTGGGGGCTTCTTTTAACGCTTCTTTAGCACCAGCTTCTAAGTGAAACTGCTTTACAGAAGCGTTAGTGTATTCGTCCTGACCAGCACGGTTAT
CATGGATAAGCGCTTCTATGGGGCTGTGAACCACTCTTGTTGTGATTTCAGGAGCATCTGTAGTCATGAACGTACCTGCCCGGGCGGCCGCTCG
AAAGGGCGAATTCCAGCACACTGGCGGCCGTTACTAGTGGATCCGAGCTCGGTACCAAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGT
GAAATTGTTATCCGTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTA
ATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGGCCAACGCGCGGGGGAGAGGCGGTTT
GCGTATTGGGCGCTCTTCCGCTTTCCTCGCTCACTGACTCGCTGCGCTCGGGTCGTTCGGGCTGCGGCGAGCGGGTATCAGTCACTTCAAAGGC
GGTAATACCGGTTATCCACAG 
 
>sf1-29 
CATGCTCCGGCCGCCATGGCCGCGGGATTTCGAGCGGCCGCCCGGGCAGGTACAAATTCAGCGATCAGAGACTTGATCACATCGGAATCGGTGA
AAGAAATAGATAAAAAATTTCTTTCCAGTGATCAGGAGGTGGCTGGCGTATCCCCTGAGGGCGTGCTTAATGGTGCTGATGAGGCCGAAAACTT
CATAGAGATTTTCAAAAAGCACATAGCGAACGGTAACACGCTTTCCACGTCGTCGCTAATATTGCCCGTAGAAAACGCCTTACAGCTTACTGAT
GCTGAGTTCTGGCAGATAGAGCTTTTGAGAATACCGGTAATTGTGAGCGAACAGGCGGATCGCATGATGCTGATAGACGCTCAAAAGCTGATTA
TTAACGTTGAAGCCACGGTTATAACCCCAACTGATGAGGCGGTAATAAAAACCGAATCAGGGGCGGTTAGCCTTTTCCAGAATGACGCTACAGC
GTTCAGGGCAATCACCTATTGCGGATGGCAAAAACTCGATAAGGCCGTCACCGTTCTGGCGAAAAGCTGATTTTTCCAGCATCTATCCCGATAT
GGGGATCACCATATCGGGGAAGCACCTGAATCATCATTACCGTGATCAAGGGTATGTAAAGCCCACCAGCCTGATTAACGTTTAACCGGAAAAA
AAGCCAGGTATCCAATCTCGATATGGGGATCACCATATCGGGATACGGCGGTAACTGGTTGATATTTTCGAAATTCGCCAGCGGCGAACATCGG
GGAAACCAGCCTAACCCGTTGATTCTTCCCAATTTCCACAGACTGCGGAAATTGGCGCGGTAACTTACTGAGATTAAAGCAAAGCGCAAAATTG
CGTTGGCTGGTGGGCCTGATGCCGATAACTGGTTGGAATTGTTCCATAGTGCAAAATTGTACTATGGCCTAACCCATTGATTATTTCGAAACCC
CCATTGGGGGATGTTGGGGAAAGTAAGACTAACCCATTGATTCTTCTACAATCCTCAAT 
 
>sfA-77 
ATGCTCCGGCCGCCATGGCCGCGGGATTTCGAGCGGCCGCCCGGGCAGGTACATATCGGGAAGCAAGCGGGCAGTGCCATCTTATCTGTTACAA
TCCCGAAATGATTGTTCAGCCCGCTTTTTCTAACAGCATGTAAACATTCAGCTGCAAATTTCGTTGTTGCTGCATGTTATCTCCTCAAGTGCAG
CGGCGTTATAATCAACGGAATGATCAACCTGTGATGTAGGTCTGCCAAAAAATTCAACCCCTGACATAATCATGTTGCCGATATTCTCTCGCTG
TTTATCACTGAGCCTGTCCCACCACTCAGGGGATGAATATGTATTTTCGGCCTTTGTGAAGAAAAAATACAGAAGGGTATTGAACATCCTGTTA
GCCGGGATCTTAATTAGTGTCCGTATAAAACGTCTGATAATTGTTGAAGTTCTCAGCCAACTGAACACTACATATCCCTTACCTCCGCAGGAAA
AAGCATTGAAACATACTTGTTCCGCCGACACTGTAAGATCGCTCAAATCCTGAATTTTGGTCCCATCGAAATCCCTCTCCGGTGAAAGAATTGA
CGAAACTACAATTGGTAAAGGCTCTGCAAAAGTGAAGATAACACTTTCAATTTCTGAAAATTGCCTGCTAAGTAGGATGCGGTCGAGGCTAGTT
TTAAGATTATTTAATTCAATTATTGCTGCATTTAAGCCACTTTGGTGCTGGTCGATTAATTTCTGAATATAATACTGTTCAACTTGTAGCTTTC
CTTTATCGGCATTTTTAGCAAAATCGGAAGATAGCACTCCCCCTTCTGTGGCGTAAATTTCTTTAGACAATGAACGAAACATTAAGGCAAAGCA
CTGCTCGTCCGTGCCTGTAAATTTTTCGTTCTCTAGGCATGAAAACAAGATTCTGTCATGAACTGCACAAAATCCTGTAAAAGTGGATGCCTGA
TTGATACCGATCTTCTCGGGAAGCCATTTTCCGTTGTTTCTCATCAGG 